|
Name |
Accession |
Description |
Interval |
E-value |
| A_NRPS_SidN3_like |
cd05918 |
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); ... |
234-739 |
0e+00 |
|
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family of siderophore-synthesizing NRPS includes the third adenylation domain of SidN from the endophytic fungus Neotyphodium lolii, ferrichrome siderophore synthetase, HC-toxin synthetase, and enniatin synthase. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341242 [Multi-domain] Cd Length: 481 Bit Score: 654.23 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 234 IHTLFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLD 313
Cdd:cd05918 1 VHDLIEERARSQPDAPAVCAWDGSLTYAELDRLSSRLAHHLRSLGVGPGVFVPLCFEKSKWAVVAMLAVLKAGGAFVPLD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 314 QSYPTKRLVNICKDVDAKVIVCSQelsigvsgstlsigdhntetatysaiqavntaSHDAAYVVYTSGSTGAPKGIVIEH 393
Cdd:cd05918 81 PSHPLQRLQEILQDTGAKVVLTSS--------------------------------PSDAAYVIFTSGSTGKPKGVVIEH 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 394 GSFCTNAIASSQAQNLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQRVNSLKEAVSTLRVNWVELTPTVARL 473
Cdd:cd05918 129 RALSTSALAHGRALGLTSESRVLQFASYTFDVSILEIFTTLAAGGCLCIPSEEDRLNDLAGFINRLRVTWAFLTPSVARL 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 474 WCPADIPTVKTLVMGGEPMLPNDISLWKDKLRLVCAYGPAECTVVSTVQSCV--QELGNIGRSPCGTCWIVSKDNHHRLM 551
Cdd:cd05918 209 LDPEDVPSLRTLVLGGEALTQSDVDTWADRVRLINAYGPAECTIAATVSPVVpsTDPRNIGRPLGATCWVVDPDNHDRLV 288
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 552 PVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPEWASLFHLNGSYRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRV 631
Cdd:cd05918 289 PIGAVGELLIEGPILARGYLNDPEKTAAAFIEDPAWLKQEGSGRGRRLYRTGDLVRYNPDGSLEYVGRKDTQVKIRGQRV 368
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 632 ELGEIEHQAQPYFRDA-VIAAEVAAPAGR--KPILILFIARKYEYSVNMDCTMLLRPPSILFQEKAQGTNTLLQEVLPRH 708
Cdd:cd05918 369 ELGEIEHHLRQSLPGAkEVVVEVVKPKDGssSPQLVAFVVLDGSSSGSGDGDSLFLEPSDEFRALVAELRSKLRQRLPSY 448
|
490 500 510
....*....|....*....|....*....|.
gi 992230864 709 MIPAAYIELLAMPISRTGKVNRKLLREAVEQ 739
Cdd:cd05918 449 MVPSVFLPLSHLPLTASGKIDRRALRELAES 479
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
52-953 |
9.50e-122 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 418.88 E-value: 9.50e-122
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 52 TSLYQTLLVAWSILLAEYTDSNNVSFGVfPCEGSDissvqqwEAAIEPQ-------LPI----SDGVT----LRHTRRWL 116
Cdd:COG1020 262 VTLFMVLLAAFALLLARYSGQDDVVVGT-PVAGRP-------RPELEGLvgffvntLPLrvdlSGDPSfaelLARVRETL 333
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 117 LE--------------------DSARHELFNTCIVLStNASPEASQFKSLQsIEKLG--------DIILLVDLLSPLLKL 168
Cdd:COG1020 334 LAayahqdlpferlveelqperDLSRNPLFQVMFVLQ-NAPADELELPGLT-LEPLEldsgtakfDLTLTVVETGDGLRL 411
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 169 SLQYVPSALHNAHANNIISTLEQIIHCVIHSPGRPFADSCLLSKHHQDQI-AEWNRNAPIHPFDSCIHTLFRLQCILQPD 247
Cdd:COG1020 412 TLEYNTDLFDAATIERMAGHLVTLLEALAADPDQPLGDLPLLTAAERQQLlAEWNATAAPYPADATLHELFEAQAARTPD 491
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 248 AQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKD 327
Cdd:COG1020 492 AVAVVFGDQSLTYAELNARANRLAHHLRALGVGPGDLVGVCLERSLEMVVALLAVLKAGAAYVPLDPAYPAERLAYMLED 571
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 328 VDAKVIVCSQELSIGVSGS---TLSIgDHNTETATYSAIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASS 404
Cdd:COG1020 572 AGARLVLTQSALAARLPELgvpVLAL-DALALAAEPATNPPVPVTPDDLAYVIYTSGSTGRPKGVMVEHRALVNLLAWMQ 650
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 405 QAQNLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQRVN--SLKEAVSTLRVNWVELTPTVARLW---CPADI 479
Cdd:COG1020 651 RRYGLGPGDRVLQFASLSFDASVWEIFGALLSGATLVLAPPEARRDpaALAELLARHRVTVLNLTPSLLRALldaAPEAL 730
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 480 PTVKTLVMGGEPMLPNDISLWKDKL---RLVCAYGPAECTVVSTVQSCVQELGNIGRSPCG------TCWIVskDNHHRL 550
Cdd:COG1020 731 PSLRLVLVGGEALPPELVRRWRARLpgaRLVNLYGPTETTVDSTYYEVTPPDADGGSVPIGrpiantRVYVL--DAHLQP 808
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 551 MPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPewaslFHLNGSyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQR 630
Cdd:COG1020 809 VPVGVPGELYIGGAGLARGYLNRPELTAERFVADP-----FGFPGA-RLYRTGDLARWLPDGNLEFLGRADDQVKIRGFR 882
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 631 VELGEIEHQ--AQPYFRDAVIAAEVAAPAGRkpILILFIArkyeysvnmdctmllrpPSILFQEKAQGTNTLLQEVLPRH 708
Cdd:COG1020 883 IELGEIEAAllQHPGVREAVVVAREDAPGDK--RLVAYVV-----------------PEAGAAAAAALLRLALALLLPPY 943
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 709 MIPAAYIELLAMPISRTGKVNRKLLREAVEQASEkdfrayypithndmIQLPSTPVLDQLRLLFSAALRIPEEKIKPNDS 788
Cdd:COG1020 944 MVPAAVVLLLPLPLTGNGKLDRLALPAPAAAAAA--------------AAAAPPAEEEEEEAALALLLLLVVVVGDDDFF 1009
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 789 FFHLGGDSVSAIRLVGDARDQGLHITVESLFKRQTISKLAECTHQMSNGIGSPIPPFSLLDPLGKGTYIAQAteqcsvFP 868
Cdd:COG1020 1010 FFGGGLGLLLLLALARAARLLLLLLLLLLLFLAAAAAAAAAAAAAAAAAAAAPLAAAAAPLPLPPLLLSLLA------LL 1083
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 869 EQIEDIYPCTPLQEALMAYTSKRPGAFQAQFRFQLPHQLDMLRLKEAWRIVIAANPILRTRIVFCHTGALQVVLRPGEQL 948
Cdd:COG1020 1084 LALLLLLALLALLALLLLLLLLLLLLALLLLLALLLALLAALRARRAVRQEGPRLRLLVALAAALALAALLALLLAAAAA 1163
|
....*
gi 992230864 949 QWDLI 953
Cdd:COG1020 1164 AAELL 1168
|
|
| AA-adenyl-dom |
TIGR01733 |
amino acid adenylation domain; This model represents a domain responsible for the specific ... |
259-648 |
1.34e-120 |
|
amino acid adenylation domain; This model represents a domain responsible for the specific recognition of amino acids and activation as adenylyl amino acids. The reaction catalyzed is aa + ATP -> aa-AMP + PPi. These domains are usually found as components of multi-domain non-ribosomal peptide synthetases and are usually called "A-domains" in that context. A-domains are almost invariably followed by "T-domains" (thiolation domains, pfam00550) to which the amino acid adenylate is transferred as a thiol-ester to a bound pantetheine cofactor with the release of AMP (these are also called peptide carrier proteins, or PCPs. When the A-domain does not represent the first module (corresponding to the first amino acid in the product molecule) it is usually preceded by a "C-domain" (condensation domain, pfam00668) which catalyzes the ligation of two amino acid thiol-esters from neighboring modules. This domain is a subset of the AMP-binding domain found in Pfam (pfam00501) which also hits substrate--CoA ligases and luciferases. Sequences scoring in between trusted and noise for this model may be ambiguous as to whether they activate amino acids or other molecules lacking an alpha amino group.
Pssm-ID: 273779 [Multi-domain] Cd Length: 409 Bit Score: 387.39 E-value: 1.34e-120
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 259 TYRQLDRLSSTVQGLLQQYD-LGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVCSQ 337
Cdd:TIGR01733 1 TYRELDERANRLARHLRAAGgVGPGDRVAVLLERSAELVVAILAVLKAGAAYVPLDPAYPAERLAFILEDAGARLLLTDS 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 338 ELSIGVSGSTLSIG----DHNTETATYSAIQAVNTASH--DAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDR 411
Cdd:TIGR01733 81 ALASRLAGLVLPVIlldpLELAALDDAPAPPPPDAPSGpdDLAYVIYTSGSTGRPKGVVVTHRSLVNLLAWLARRYGLDP 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 412 SSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQR---VNSLKEAVSTLRVNWVELTPTVARLWCPADIP---TVKTL 485
Cdd:TIGR01733 161 DDRVLQFASLSFDASVEEIFGALLAGATLVVPPEDEErddAALLAALIAEHPVTVLNLTPSLLALLAAALPPalaSLRLV 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 486 VMGGEPMLPNDISLWKDK---LRLVCAYGPAECTVVSTVQSC------VQELGNIGRS-PCGTCWIVskDNHHRLMPVGC 555
Cdd:TIGR01733 241 ILGGEALTPALVDRWRARgpgARLINLYGPTETTVWSTATLVdpddapRESPVPIGRPlANTRLYVL--DDDLRPVPVGV 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 556 IGELIIGGPIVGRGYLKQPCLTANAFITNPEWASLFHlngsyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGE 635
Cdd:TIGR01733 319 VGELYIGGPGVARGYLNRPELTAERFVPDPFAGGDGA-----RLYRTGDLVRYLPDGNLEFLGRIDDQVKIRGYRIELGE 393
|
410
....*....|....*
gi 992230864 636 IEH--QAQPYFRDAV 648
Cdd:TIGR01733 394 IEAalLRHPGVREAV 408
|
|
| A_NRPS |
cd05930 |
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain ... |
246-733 |
3.54e-118 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341253 [Multi-domain] Cd Length: 444 Bit Score: 381.88 E-value: 3.54e-118
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNIC 325
Cdd:cd05930 1 PDAVAVVDGDQSLTYAELDARANRLARYLRERGVGPGDLVAVLLERSLEMVVAILAVLKAGAAYVPLDPSYPAERLAYIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 326 KDVDAKVIVcsqelsigvsgstlsigdhntetatysaiqavnTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQ 405
Cdd:cd05930 81 EDSGAKLVL---------------------------------TDPDDLAYVIYTSGSTGKPKGVMVEHRGLVNLLLWMQE 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 406 AQNLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQRVN--SLKEAVSTLRVNWVELTPTVARLW----CPADI 479
Cdd:cd05930 128 AYPLTPGDRVLQFTSFSFDVSVWEIFGALLAGATLVVLPEEVRKDpeALADLLAEEGITVLHLTPSLLRLLlqelELAAL 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 480 PTVKTLVMGGEPMLPNDISLWKDKL---RLVCAYGPAECTVVSTVQSCVQELGNIGRSPCGT------CWIVskDNHHRL 550
Cdd:cd05930 208 PSLRLVLVGGEALPPDLVRRWRELLpgaRLVNLYGPTEATVDATYYRVPPDDEEDGRVPIGRpipntrVYVL--DENLRP 285
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 551 MPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPewaslFHLNGsyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQR 630
Cdd:cd05930 286 VPPGVPGELYIGGAGLARGYLNRPELTAERFVPNP-----FGPGE--RMYRTGDLVRWLPDGNLEFLGRIDDQVKIRGYR 358
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 631 VELGEIEHQ--AQPYFRDAVIAAEVAAPAGrkPILILFIARKYEYSVNMDCtmlLRppsilfqekaqgtnTLLQEVLPRH 708
Cdd:cd05930 359 IELGEIEAAllAHPGVREAAVVAREDGDGE--KRLVAYVVPDEGGELDEEE---LR--------------AHLAERLPDY 419
|
490 500
....*....|....*....|....*
gi 992230864 709 MIPAAYIELLAMPISRTGKVNRKLL 733
Cdd:cd05930 420 MVPSAFVVLDALPLTPNGKVDRKAL 444
|
|
| FUM14_C_NRPS-like |
cd19545 |
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond ... |
874-1258 |
4.35e-110 |
|
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond forming Fusarium verticillioides FUM14 protein; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) typically catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. However, some C-domains have ester-bond forming activity. This subfamily includes Fusarium verticillioides FUM14 (also known as NRPS8), a bi-domain protein with an ester-bond forming NRPS C-domain, which catalyzes linkages between an aminoacyl/peptidyl-PCP donor and a hydroxyl-containing acceptor. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. FUM14 has an altered active site motif DHTHCD instead of the typical HHxxxD motif seen in other subfamily members. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380467 [Multi-domain] Cd Length: 395 Bit Score: 356.61 E-value: 4.35e-110
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 874 IYPCTPLQEALMAYTSKRPGAFQAQFRFQLPHQLDMLRLKEAWRIVIAANPILRTRIVFCHT-GALQVVLRPgEQLQWdl 952
Cdd:cd19545 1 IYPCTPLQEGLMALTARQPGAYVGQRVFELPPDIDLARLQAAWEQVVQANPILRTRIVQSDSgGLLQVVVKE-SPISW-- 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 953 inGVHTSPGSL--------MSYGVPLVDMAITNDTAGKlsRTFCLTMHHAIFDGWSYGLILGAVEDAYKHTNAVQR-PFA 1023
Cdd:cd19545 78 --TESTSLDEYleedraapMGLGGPLVRLALVEDPDTE--RYFVWTIHHALYDGWSLPLILRQVLAAYQGEPVPQPpPFS 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1024 PFIKYILHCNYESAKHFWCSEFKDMQALPFPVPPLSRgHMANSSTTTHRQIHVSEWLSSYCTPSTIIQLAFTLLIAWRTE 1103
Cdd:cd19545 154 RFVKYLRQLDDEAAAEFWRSYLAGLDPAVFPPLPSSR-YQPRPDATLEHSISLPSSASSGVTLATVLRAAWALVLSRYTG 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1104 SMDVLFGLTVTGRNAPVAGIHRTTGPTIATFPLRTILYGTMNITDALLCMQNHIATLIPFEHTGLRRIKSFGTETARACQ 1183
Cdd:cd19545 233 SDDVVFGVTLSGRNAPVPGIEQIVGPTIATVPLRVRIDPEQSVEDFLQTVQKDLLDMIPFEHTGLQNIRRLGPDARAACN 312
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 992230864 1184 FQSLLIIQPVTYRESSEIFFELESNEHEQSK-FSTCPLTLVCELRTHSVSVKAISDNAVVISGDMERLLDQLEYLI 1258
Cdd:cd19545 313 FQTLLVVQPALPSSTSESLELGIEEESEDLEdFSSYGLTLECQLSGSGLRVRARYDSSVISEEQVERLLDQFEHVL 388
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
196-1907 |
3.21e-103 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 371.21 E-value: 3.21e-103
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 196 VIHSPGRPFADSCLLSKHHQDQIAE-WNRNAPIHPFDSCIHTLFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLL 274
Cdd:PRK12316 3020 MVENPQRSVDELAMLDAEERGQLLEaWNATAAEYPLERGVHRLFEEQVERTPDAVALAFGEQRLSYAELNRRANRLAHRL 3099
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 275 QQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVCSQELSIGVSGSTLSIGDHN 354
Cdd:PRK12316 3100 IERGVGPDVLVGVAVERSLEMVVGLLAILKAGGAYVPLDPEYPEERLAYMLEDSGAQLLLSQSHLRLPLAQGVQVLDLDR 3179
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 355 TETATYSAIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASYAFDVSVHESLTPL 434
Cdd:PRK12316 3180 GDENYAEANPAIRTMPENLAYVIYTSGSTGKPKGVGIRHSALSNHLCWMQQAYGLGVGDRVLQFTTFSFDVFVEELFWPL 3259
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 435 LLGGCVCI--PSEAQRVNSLKEAVSTLRVNWVELTPTVARLWC----PADIPTVKTLVMGGEPMLPNDISLWKDKLRLVC 508
Cdd:PRK12316 3260 MSGARVVLagPEDWRDPALLVELINSEGVDVLHAYPSMLQAFLeeedAHRCTSLKRIVCGGEALPADLQQQVFAGLPLYN 3339
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 509 AYGPAECTVVSTVQSCVQELGN---IGRsPCGTCWIVSKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNP 585
Cdd:PRK12316 3340 LYGPTEATITVTHWQCVEEGKDavpIGR-PIANRACYILDGSLEPVPVGALGELYLGGEGLARGYHNRPGLTAERFVPDP 3418
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 586 EWAslfhlngSYRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRDAViaaeVAAPAGRKPIl 663
Cdd:PRK12316 3419 FVP-------GERLYRTGDLARYRADGVIEYIGRVDHQVKIRGFRIELGEIEArlLEHPWVREAV----VLAVDGRQLV- 3486
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 664 ilfiarkyEYSVNMDCTMLLRPpsilfQEKAQgtntlLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLREAVEQASEK 743
Cdd:PRK12316 3487 --------AYVVPEDEAGDLRE-----ALKAH-----LKASLPEYMVPAHLLFLERMPLTPNGKLDRKALPRPDAALLQQ 3548
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 744 DFRAyypithndmiqlPSTPVLDQLRLLFSAALRIPEekIKPNDSFFHLGGDSVSAIRLVGDARDQGLHITVESLFKRQT 823
Cdd:PRK12316 3549 DYVA------------PVNELERRLAAIWADVLKLEQ--VGLTDNFFELGGDSIISLQVVSRARQAGIRFTPKDLFQHQT 3614
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 824 ISKLAECTH-----QMSNGigsPIPPFSLLDPLgkgtyiaqateQCSVFPEQIediypctplqealmaytSKRPGAFQAQ 898
Cdd:PRK12316 3615 IQGLARVARvgggvAVDQG---PVSGETLLLPI-----------QQQFFEEPV-----------------PERHHWNQSL 3663
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 899 FrFQLPHQLDMLRLKEAWRIVIAANPILRTRIV--FCHTGALQVVLRPGEQLQWD-----------LINGVHTS----PG 961
Cdd:PRK12316 3664 L-LKPREALDAAALEAALQALVEHHDALRLRFVedAGGWTAEHLPVELGGALLWRaelddaeelerLGEEAQRSldlaDG 3742
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 962 SLMSygVPLVDMAitndtAGklSRTFCLTMHHAIFDGWSYGLILGAVEDAYKHTNAVQRPFAPfikyilhcnyesAKhfw 1041
Cdd:PRK12316 3743 PLLR--ALLATLA-----DG--SQRLLLVIHHLVVDGVSWRILLEDLQQAYQQLLQGEAPRLP------------AK--- 3798
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1042 CSEFKDMQAlpfpvpplsrghmanssttthrqiHVSEWLSSyctPSTIIQLAFtlliaWRTESMDVlfgltvtgrnapva 1121
Cdd:PRK12316 3799 TSSFKAWAE------------------------RLQEHARG---EALKAELAY-----WQEQLQGV-------------- 3832
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1122 gihrttgptiatfplrtilygtmniTDALLCMQNHIATLIPFEHTGLRRIKSFGTEtaracqfqSLLIIQPVTYRessei 1201
Cdd:PRK12316 3833 -------------------------SSELPCDHPQGALQNRHAASVQTRLDRELTR--------RLLQQAPAAYR----- 3874
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1202 ffelesneheqskfstcplTLVCELRthsvsVKAISDNAVVISGDMERLLdQLEylidmitksptleiqniipspqdtys 1281
Cdd:PRK12316 3875 -------------------TQVNDLL-----LTALARVVCRWTGEASALV-QLE-------------------------- 3903
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1282 yalqqsqywsSHIEKkvydyfggDVFVLVDAivpngssNRSTAMFVCETKRRREPTETSGLFTRPtdnIRWQLQQ----- 1356
Cdd:PRK12316 3904 ----------GHGRE--------DLFADIDL-------SRTVGWFTSLFPVRLSPVEDLGASIKA---IKEQLRAipnkg 3955
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1357 ----LISSLGQSLPRSAVPslCLPVSFIPVDPLGQPDRiylceaassmTLDFLHSLTDPVNKYIDYHILPeEARLRGIVA 1432
Cdd:PRK12316 3956 igfgLLRYLGDEESRRTLA--GLPVPRITFNYLGQFDG----------SFDEEMALFVPAGESAGAEQSP-DAPLDNWLS 4022
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1433 HVLSIDPQNISPKddfFTLGGDSISAMQVVSLCRKHQLSLTALDIFNGRtieliaTRLMPLTPytppstpaSDRSLdrrf 1512
Cdd:PRK12316 4023 LNGRVYGGELSLD---WTFSREMFEEATIQRLADDYAAELTALVEHCCD------AERHGVTP--------SDFPL---- 4081
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1513 sllflnSDRDMERLESLLMATydigsmDSIEDAYPCSESHQGLLqtqmLRPFYYQSYTIWEVTTRSKSSPVSPVRLCNAW 1592
Cdd:PRK12316 4082 ------AGLDQARLDALPLPL------GEIEDIYPLSPMQQGML----FHSLYEQEAGDYINQMRVDVQGLDVERFRAAW 4145
|
1450 1460 1470 1480 1490 1500 1510 1520
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1593 FTLARRHPALRTHLIDIplcDGMSSKIHVVHK---------DYMADAAILSCEDEHVITELRKPFLPSDTGLyyphaFRI 1663
Cdd:PRK12316 4146 QAALDRHDVLRSGFVWQ---GELGRPLQVVHKqvslpfaelDWRGRADLQAALDALAAAERERGFDLQRAPL-----LRL 4217
|
1530 1540 1550 1560 1570 1580 1590 1600
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1664 CQTVSGRVFCKL--EGGHAFLDATSVLIILRELAQAYDGQLSSVPGPSYSSAVAWLQSlPNGDNRMDYWRRQLKD----- 1736
Cdd:PRK12316 4218 VLVRTAEGRHHLiyTNHHILMDGWSNSQLLGEVLERYSGRPPAQPGGRYRDYIAWLQR-QDAAASEAFWREQLAAldept 4296
|
1610 1620 1630 1640 1650 1660 1670 1680
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1737 --ASPCIFPRLRDQDSPSDTLVVTeQLASTATLTPVCTRHGLTVSNVLQVAWGLMLRRYTESDDVCFGALISGRDSRIPD 1814
Cdd:PRK12316 4297 rlAQAIARADLRSANGYGEHVREL-DATATARLREFARTQRVTLNTLVQAAWLLLLQRYTGQDTVAFGATVAGRPAELPG 4375
|
1690 1700 1710 1720 1730 1740 1750 1760
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1815 VDKMVGPFFNVLVCQLRFGREDSLWDVLRRNQTEIGNRLLNQHCSLIEVLRFSTYFGQPLFNTCI-----SVEQPLSMDT 1889
Cdd:PRK12316 4376 IEGQIGLFINTLPVIATPRAQQSVVEWLQQVQRQNLALREHEHTPLYEIQRWAGQGGEALFDSLLvfenyPVSEALQQGA 4455
|
1770
....*....|....*...
gi 992230864 1890 PdASLCFKELETLEPTEY 1907
Cdd:PRK12316 4456 P-GGLRFGEVTNHEQTNY 4472
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
182-1168 |
1.78e-98 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 355.80 E-value: 1.78e-98
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 182 ANNIISTLEQIIHcvihSPGRPFADSCLL-SKHHQDQIAEWNRNAPIHPFDSCIHTLFRLQCILQPDAQAICAWDGTITY 260
Cdd:PRK12316 1956 DRHLLHLLEQMAE----DAQAALGELALLdAGERQRILADWDRTPEAYPRGPGVHQRIAEQAARAPEAIAVVFGDQHLSY 2031
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 261 RQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVC----S 336
Cdd:PRK12316 2032 AELDSRANRLAHRLRARGVGPEVRVAIAAERSFELVVALLAVLKAGGAYVPLDPNYPAERLAYMLEDSGAALLLTqrhlL 2111
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 337 QELSIGVSGSTLSIgDHNTETATY-SAIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRV 415
Cdd:PRK12316 2112 ERLPLPAGVARLPL-DRDAEWADYpDTAPAVQLAGENLAYVIYTSGSTGLPKGVAVSHGALVAHCQAAGERYELSPADCE 2190
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 416 LQFASYAFDVSVHESLTPLLLGGCVCIPSEAQR-----VNSLKE-AVSTLR---VNWVELTPTVARLWCPadiPTVKTLV 486
Cdd:PRK12316 2191 LQFMSFSFDGAHEQWFHPLLNGARVLIRDDELWdpeqlYDEMERhGVTILDfppVYLQQLAEHAERDGRP---PAVRVYC 2267
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 487 MGGEPMLPNDISLWKDKLR---LVCAYGPAECTVVSTVQSC-VQELGNIGRSPCGT------CWIVSKDNHhrLMPVGCI 556
Cdd:PRK12316 2268 FGGEAVPAASLRLAWEALRpvyLFNGYGPTEAVVTPLLWKCrPQDPCGAAYVPIGRalgnrrAYILDADLN--LLAPGMA 2345
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 557 GELIIGGPIVGRGYLKQPCLTANAFITNPewaslFHLNGSyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEI 636
Cdd:PRK12316 2346 GELYLGGEGLARGYLNRPGLTAERFVPDP-----FSASGE-RLYRTGDLARYRADGVVEYLGRIDHQVKIRGFRIELGEI 2419
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 637 EH--QAQPYFRDAVIAAEvAAPAGRKPIlilfiarkyEYSVNMDCTMLLRppsilfqekaQGTNTLLQEVLPRHMIPAAY 714
Cdd:PRK12316 2420 EArlQAHPAVREAVVVAQ-DGASGKQLV---------AYVVPDDAAEDLL----------AELRAWLAARLPAYMVPAHW 2479
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 715 IELLAMPISRTGKVNRKLL-REAVEQASekdfRAYYPithndmiqlPSTPVLDQLRLLFSAALRIpeEKIKPNDSFFHLG 793
Cdd:PRK12316 2480 VVLERLPLNPNGKLDRKALpKPDVSQLR----QAYVA---------PQEGLEQRLAAIWQAVLKV--EQVGLDDHFFELG 2544
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 794 GDSVSAIRLVGDAR-DQGLHITVESLFKRQTISKLAECTHQMSNGIGSPIPPFSLLDPLgkgtyIAQATEQCSVFPEQIE 872
Cdd:PRK12316 2545 GHSLLATQVVSRVRqDLGLEVPLRILFERPTLAAFAASLESGQTSRAPVLQKVTRVQPL-----PLSHAQQRQWFLWQLE 2619
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 873 DIYPCTPLQEAL----MAYTSKRPGAFQAQFRFQLPHQLDMLRLKEAWRIVIAANPILRTRIVFCHTGALQVVLRPGE-- 946
Cdd:PRK12316 2620 PESAAYHLPSALhlrgVLDQAALEQAFDALVLRHETLRTRFVEVGEQTRQVILPNMSLRIVLEDCAGVADAAIRQRVAee 2699
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 947 -QLQWDLINGvhtspgslmsygvPLVDMAITNDTAGklSRTFCLTMHHAIFDGWSYGLILGAVEDAYKHTNAVQRPFAPF 1025
Cdd:PRK12316 2700 iQRPFDLARG-------------PLLRVRLLALDGQ--EHVLVITQHHIVSDGWSMQVMVDELVQAYAGARRGEQPTLPP 2764
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1026 IKyILHCNYESAKHFWCSEFKDMQALPF---------PVPPLSRGHmANSSTTTHRQIHVSEWL-------------SSY 1083
Cdd:PRK12316 2765 LP-LQYADYAAWQRAWMDSGEGARQLDYwrerlggeqPVLELPLDR-PRPALQSHRGARLDVALdvalsrellalarREG 2842
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1084 CTPSTIIQLAFTLLIAWRTESMDVLFGLTVTGRNAPvaGIHRTTGPTIATFPLRTILYGTMNITDALLCMQNHIATLIPF 1163
Cdd:PRK12316 2843 VTLFMLLLASFQVLLHRYSGQSDIRVGVPIANRNRA--ETERLIGFFVNTQVLRAQVDAQLAFRDLLGQVKEQALGAQAH 2920
|
....*
gi 992230864 1164 EHTGL 1168
Cdd:PRK12316 2921 QDLPF 2925
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
40-830 |
1.92e-98 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 355.62 E-value: 1.92e-98
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 40 EFSPEVKVEQDTtsLYQTllvAWSILLAEYTDSNNVSFGVF----PCEGSDIS--------------------SVQQWEA 95
Cdd:PRK12467 2874 EFARRHRVTLNT--LVQG---AWLLLLQRFTGQDTVCFGATvagrPAQLRGAEqqlglfintlpviaspraeqTVSDWLQ 2948
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 96 AIEPQlpisdGVTLR---HT-----RRWllEDSARHELFNTCIVLST--------NASPEASQFKSLQSIEKLGDIILLV 159
Cdd:PRK12467 2949 QVQAQ-----NLALRefeHTpladiQRW--AGQGGEALFDSILVFENypisealkQGAPSGLRFGAVSSREQTNYPLTLA 3021
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 160 DLLSPLLKLSLQYVPSALHNAHANNIISTLEQIIHCVIHSPGRPFADSCLLSKHHQDQIAE-WNRNAPIHPFDSCIHTLF 238
Cdd:PRK12467 3022 VGLGDTLELEFSYDRQHFDAAAIERLAESFDRLLQAMLNNPAARLGELPTLAAHERRQVLHaWNATAAAYPSERLVHQLI 3101
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 239 RLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPT 318
Cdd:PRK12467 3102 EAQVARTPEAPALVFGDQQLSYAELNRRANRLAHRLIAIGVGPDVLVGVAVERSVEMIVALLAVLKAGGAYVPLDPEYPR 3181
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 319 KRLVNICKDVDAKVIVCSQ----ELSIGVSGSTLSIgDHNTETATYSAIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHG 394
Cdd:PRK12467 3182 ERLAYMIEDSGVKLLLTQAhlleQLPAPAGDTALTL-DRLDLNGYSENNPSTRVMGENLAYVIYTSGSTGKPKGVGVRHG 3260
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 395 SFCTNAIASSQAQNLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCI-PSEAQRVNSLKEAVSTLRVNWVELTPTVARL 473
Cdd:PRK12467 3261 ALANHLCWIAEAYELDANDRVLLFMSFSFDGAQERFLWTLICGGCLVVrDNDLWDPEELWQAIHAHRISIACFPPAYLQQ 3340
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 474 WC----PADIPTVKTLVMGGEPMLPNDISLWKDKLRLVC---AYGPAECTVVSTVQSCVQELGN------IGRSPCG-TC 539
Cdd:PRK12467 3341 FAedagGADCASLDIYVFGGEAVPPAAFEQVKRKLKPRGltnGYGPTEAVVTVTLWKCGGDAVCeapyapIGRPVAGrSI 3420
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 540 WIVskDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPewaslFHLNGSyRFYKTGDLVRYNADGTIAYIGR 619
Cdd:PRK12467 3421 YVL--DGQLNPVPVGVAGELYIGGVGLARGYHQRPSLTAERFVADP-----FSGSGG-RLYRTGDLARYRADGVIEYLGR 3492
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 620 KDTQVKLNGQRVELGEIEH--QAQPYFRDAVIAAeVAAPAGRKPIlilfiarkyEYSVnmdctmllrpPSILFQEKAQGT 697
Cdd:PRK12467 3493 IDHQVKIRGFRIELGEIEArlLQHPSVREAVVLA-RDGAGGKQLV---------AYVV----------PADPQGDWRETL 3552
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 698 NTLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKllreAVEQASEKDFRAYypithndmiQLPSTPVLDQLRLLFSAALR 777
Cdd:PRK12467 3553 RDHLAASLPDYMVPAQLLVLAAMPLGPNGKVDRK----ALPDPDAKGSREY---------VAPRSEVEQQLAAIWADVLG 3619
|
810 820 830 840 850
....*....|....*....|....*....|....*....|....*....|....
gi 992230864 778 IpeEKIKPNDSFFHLGGDSVSAIRLVGDARDQ-GLHITVESLFKRQTISKLAEC 830
Cdd:PRK12467 3620 V--EQVGVTDNFFELGGDSLLALQVLSRIRQSlGLKLSLRDLMSAPTIAELAGY 3671
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
189-1028 |
2.93e-97 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 351.77 E-value: 2.93e-97
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 189 LEQIIHCVIHSPGRPFAD-SCLLSKHHQDQIAEWNRNAPIHPFDsCIHTLFRLQCILQPDAQAICAWDGTITYRQLDRLS 267
Cdd:PRK12467 469 WRNLLEAIVAEPRRRLGElPLLDAEERARELVRWNAPATEYAPD-CVHQLIEAQARQHPERPALVFGEQVLSYAELNRQA 547
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 268 STVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVCSQE----LSIGV 343
Cdd:PRK12467 548 NRLAHVLIAAGVGPDVLVGIAVERSIEMVVGLLAVLKAGGAYVPLDPEYPQDRLAYMLDDSGVRLLLTQSHllaqLPVPA 627
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 344 SGSTLSIGDHNTETATYSAIQ-AVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASYA 422
Cdd:PRK12467 628 GLRSLCLDEPADLLCGYSGHNpEVALDPDNLAYVIYTSGSTGQPKGVAISHGALANYVCVIAERLQLAADDSMLMVSTFA 707
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 423 FDVSVHESLTPLLLGGCVCI--PSEAQRVNSLKEAVSTLRVNWVELTPTVARLW----CPADIPTVKTLVMGGEPMLPND 496
Cdd:PRK12467 708 FDLGVTELFGALASGATLHLlpPDCARDAEAFAALMADQGVTVLKIVPSHLQALlqasRVALPRPQRALVCGGEALQVDL 787
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 497 ISLWK---DKLRLVCAYGPAECTVVSTVQSCVQELGNIGRSPCG-----TCWIVSkDNHHRLMPVGCIGELIIGGPIVGR 568
Cdd:PRK12467 788 LARVRalgPGARLINHYGPTETTVGVSTYELSDEERDFGNVPIGqplanLGLYIL-DHYLNPVPVGVVGELYIGGAGLAR 866
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 569 GYLKQPCLTANAFITNPewaslFHLNGSyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRD 646
Cdd:PRK12467 867 GYHRRPALTAERFVPDP-----FGADGG-RLYRTGDLARYRADGVIEYLGRMDHQVKIRGFRIELGEIEArlLAQPGVRE 940
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 647 AVIaaeVAAPAGRKPILILFiarkyeysvnmdCTMLLRPPSILFQEKAQGTNTLLQEVLPRHMIPAAYIELLAMPISRTG 726
Cdd:PRK12467 941 AVV---LAQPGDAGLQLVAY------------LVPAAVADGAEHQATRDELKAQLRQVLPDYMVPAHLLLLDSLPLTPNG 1005
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 727 KVNRKLLREAVEQASEKDFRAyypithndmiqlPSTPVLDQLRLLFSAALRIpeEKIKPNDSFFHLGGDSVSAIRLVGDA 806
Cdd:PRK12467 1006 KLDRKALPKPDASAVQATFVA------------PQTELEKRLAAIWADVLKV--ERVGLTDNFFELGGHSLLATQVISRV 1071
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 807 RDQ-GLHITVESLFKRQTISKLAECTHQMSNGIGSPIPPFSLLDPLgKGTYiAQATEQcsvFPEQIEdiypctplqealm 885
Cdd:PRK12467 1072 RQRlGIQVPLRTLFEHQTLAGFAQAVAAQQQGAQPALPDVDRDQPL-PLSY-AQERQW---FLWQLE------------- 1133
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 886 aytskrPG--AFQAQFRFQLPHQLDMLRLKEAWRIVIAANPILRTRIVFcHTGALQVVLRPGEQLQWDL-INGVHTSPGS 962
Cdd:PRK12467 1134 ------PGsaAYHIPQALRLKGPLDIEALERSFDALVARHESLRTTFVQ-EDGRTRQVIHPVGSLTLEEpLLLAADKDEA 1206
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 963 LMSYGVPLVDMAITNDTAGKLSR-----------TFCLTMHHAIFDGWSYGLI---LGAVEDAYKHTNAVQRPFAPfIKY 1028
Cdd:PRK12467 1207 QLKVYVEAEARQPFDLEQGPLLRvgllrlaadehVLVLTLHHIVSDGWSMQVLvdeLVALYAAYSQGQSLQLPALP-IQY 1285
|
|
| A_NRPS_PvdJ-like |
cd17649 |
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal ... |
246-734 |
2.60e-96 |
|
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes pyoverdine biosynthesis protein PvdJ involved in the synthesis of pyoverdine, which consists of a chromophore group attached to a variable peptide chain and comprises around 6-12 amino acids that are specific for each Pseudomonas species, and for which the peptide might be first synthesized before the chromophore assembly. Also included is ornibactin biosynthesis protein OrbI; ornibactin is a tetrapeptide siderophore with an l-ornithine-d-hydroxyaspartate-l-serine-l-ornithine backbone. The adenylation domain at the N-terminal of OrbI possibly initiates the ornibactin with the binding of N5-hydroxyornithine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341304 [Multi-domain] Cd Length: 450 Bit Score: 319.31 E-value: 2.60e-96
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNIC 325
Cdd:cd17649 1 PDAVALVFGDQSLSYAELDARANRLAHRLRALGVGPEVRVGIALERSLEMVVALLAILKAGGAYVPLDPEYPAERLRYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 326 KDvdakvivcsqelsigvSGSTLSIGDHntetatysaiqavntaSHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQ 405
Cdd:cd17649 81 ED----------------SGAGLLLTHH----------------PRQLAYVIYTSGSTGTPKGVAVSHGPLAAHCQATAE 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 406 AQNLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQ--RVNSLKEAVSTLRVNWVELTPTVARLW-------CP 476
Cdd:cd17649 129 RYGLTPGDRELQFASFNFDGAHEQLLPPLICGACVVLRPDELwaSADELAEMVRELGVTVLDLPPAYLQQLaeeadrtGD 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 477 ADIPTVKTLVMGGEPMLPNDISLW-KDKLRLVCAYGPAECTVVSTVQSCVQELGNIG-RSPCGT------CWIVskDNHH 548
Cdd:cd17649 209 GRPPSLRLYIFGGEALSPELLRRWlKAPVRLFNAYGPTEATVTPLVWKCEAGAARAGaSMPIGRplggrsAYIL--DADL 286
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 549 RLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPewaslFHLNGSyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNG 628
Cdd:cd17649 287 NPVPVGVTGELYIGGEGLARGYLGRPELTAERFVPDP-----FGAPGS-RLYRTGDLARWRDDGVIEYLGRVDHQVKIRG 360
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 629 QRVELGEIEH--QAQPYFRDAVIAAEVAAPAGRkpiLILFIArkyeysvnmdctmlLRPPSILfQEKAQGTNTLLQEVLP 706
Cdd:cd17649 361 FRIELGEIEAalLEHPGVREAAVVALDGAGGKQ---LVAYVV--------------LRAAAAQ-PELRAQLRTALRASLP 422
|
490 500
....*....|....*....|....*...
gi 992230864 707 RHMIPAAYIELLAMPISRTGKVNRKLLR 734
Cdd:cd17649 423 DYMVPAHLVFLARLPLTPNGKLDRKALP 450
|
|
| A_NRPS_CmdD_like |
cd17652 |
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) ... |
246-733 |
4.86e-95 |
|
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes phosphinothricin tripeptide (PTT, phosphinothricylalanylalanine) synthetase, where PTT is a natural-product antibiotic and potent herbicide that is produced by Streptomyces hygroscopicus. This adenylation domain has been confirmed to directly activate beta-tyrosine, and fluorinated chondramides are produced through precursor-directed biosynthesis. Also included in this family is chondramide synthase D (also known as ATP-dependent phenylalanine adenylase or phenylalanine activase or tyrosine activase). Chondramides A-D are depsipeptide antitumor and antifungal antibiotics produced by C. crocatus, are a class of mixed peptide/polyketide depsipeptides comprised of three amino acids (alanine, N-methyltryptophan, plus the unusual amino acid beta-tyrosine or alpha-methoxy-beta-tyrosine) and a polyketide chain ([E]-7-hydroxy-2,4,6-trimethyloct-4-enoic acid).
Pssm-ID: 341307 [Multi-domain] Cd Length: 436 Bit Score: 314.96 E-value: 4.86e-95
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNIC 325
Cdd:cd17652 1 PDAPAVVFGDETLTYAELNARANRLARLLAARGVGPERLVALALPRSAELVVAILAVLKAGAAYLPLDPAYPAERIAYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 326 KDVDAKVIVcsqelsigvsgstlsigdhntetatysaiqavnTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQ 405
Cdd:cd17652 81 ADARPALLL---------------------------------TTPDNLAYVIYTSGSTGRPKGVVVTHRGLANLAAAQIA 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 406 AQNLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQRV--NSLKEAVSTLRVNWVELTPTVARLWCPADIPTVK 483
Cdd:cd17652 128 AFDVGPGSRVLQFASPSFDASVWELLMALLAGATLVLAPAEELLpgEPLADLLREHRITHVTLPPAALAALPPDDLPDLR 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 484 TLVMGGEPMLPNDISLWKDKLRLVCAYGPAECTVVSTVQSCVQELGN--IGRSPCGT-CWIVskDNHHRLMPVGCIGELI 560
Cdd:cd17652 208 TLVVAGEACPAELVDRWAPGRRMINAYGPTETTVCATMAGPLPGGGVppIGRPVPGTrVYVL--DARLRPVPPGVPGELY 285
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 561 IGGPIVGRGYLKQPCLTANAFITNPewaslFHLNGSyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH-- 638
Cdd:cd17652 286 IAGAGLARGYLNRPGLTAERFVADP-----FGAPGS-RMYRTGDLARWRADGQLEFLGRADDQVKIRGFRIELGEVEAal 359
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 639 QAQPYFRDAVIAAEVAAPAGRkpililfiaRKYEYSVNMDCTmllRPPsilfqekAQGTNTLLQEVLPRHMIPAAYIELL 718
Cdd:cd17652 360 TEHPGVAEAVVVVRDDRPGDK---------RLVAYVVPAPGA---APT-------AAELRAHLAERLPGYMVPAAFVVLD 420
|
490
....*....|....*
gi 992230864 719 AMPISRTGKVNRKLL 733
Cdd:cd17652 421 ALPLTPNGKLDRRAL 435
|
|
| A_NRPS_VisG_like |
cd17651 |
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) ... |
238-734 |
1.42e-94 |
|
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes virginiamycin S synthetase (VisG) in Streptomyces virginiae; VisG is involved in virginiamycin S (VS) biosynthesis as the provider of an L-pheGly molecule, a highly specific substrate for the last condensation step by VisF. This family also includes linear gramicidin synthetase B (LgrB) in Brevibacillus brevis. Substrate specificity analysis using residues of the substrate-binding pockets of all 16 adenylation domains has shown good agreement of the substrate amino acids predicted with the sequence of linear gramicidin. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341306 [Multi-domain] Cd Length: 491 Bit Score: 315.82 E-value: 1.42e-94
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 238 FRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYP 317
Cdd:cd17651 1 FERQAARTPDAPALVAEGRRLTYAELDRRANRLAHRLRARGVGPGDLVALCARRSAELVVALLAILKAGAAYVPLDPAYP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 318 TKRLVNICKDVDAKVIVCSQELSIGVSGS--TLSIGDHNTETATYSAIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGS 395
Cdd:cd17651 81 AERLAFMLADAGPVLVLTHPALAGELAVElvAVTLLDQPGAAAGADAEPDPALDADDLAYVIYTSGSTGRPKGVVMPHRS 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 396 FcTNAIA-SSQAQNLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQRVNS--LKEAVSTLRVNWVELTPTVAR 472
Cdd:cd17651 161 L-ANLVAwQARASSLGPGARTLQFAGLGFDVSVQEIFSTLCAGATLVLPPEEVRTDPpaLAAWLDEQRISRVFLPTVALR 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 473 LWC------PADIPTVKTLVMGGEPmLPNDISL-----WKDKLRLVCAYGPAECTVVsTVQSCVQELGN------IGRsP 535
Cdd:cd17651 240 ALAehgrplGVRLAALRYLLTGGEQ-LVLTEDLrefcaGLPGLRLHNHYGPTETHVV-TALSLPGDPAAwpapppIGR-P 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 536 CGTCWIVSKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPEwaslfhlNGSYRFYKTGDLVRYNADGTIA 615
Cdd:cd17651 317 IDNTRVYVLDAALRPVPPGVPGELYIGGAGLARGYLNRPELTAERFVPDPF-------VPGARMYRTGDLARWLPDGELE 389
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 616 YIGRKDTQVKLNGQRVELGEIEHQ--AQPYFRDAVIAAEVAAPAGRKpiLILFIARKYEYSVnmdctmllrPPSILfqeK 693
Cdd:cd17651 390 FLGRADDQVKIRGFRIELGEIEAAlaRHPGVREAVVLAREDRPGEKR--LVAYVVGDPEAPV---------DAAEL---R 455
|
490 500 510 520
....*....|....*....|....*....|....*....|.
gi 992230864 694 AQgtntlLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLR 734
Cdd:cd17651 456 AA-----LATHLPEYMVPSAFVLLDALPLTPNGKLDRRALP 491
|
|
| A_NRPS_Bac |
cd17655 |
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of ... |
237-736 |
2.60e-91 |
|
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetases 1, 2, and 3 (BA1, also known as ATP-dependent cysteine adenylase or cysteine activase, BA2, also known as ATP-dependent lysine adenylase or lysine activase, and BA3, also known as ATP-dependent isoleucine adenylase or isoleucine activase) in Bacilli. Bacitracin is a mixture of related cyclic peptides used as a polypeptide antibiotic. This family also includes gramicidin synthetase 1 involved in synthesis of the cyclic peptide antibiotic gramicidin S via activation of phenylalanine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341310 [Multi-domain] Cd Length: 490 Bit Score: 306.56 E-value: 2.60e-91
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 237 LFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSY 316
Cdd:cd17655 2 LFEEQAEKTPDHTAVVFEDQTLTYRELNERANQLARTLREKGVGPDTIVGIMAERSLEMIVGILGILKAGGAYLPIDPDY 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 317 PTKRLVNICKDVDAKVIVCSQELSIGV--SGSTLSIGDHNTETATYSAIQAVNTAShDAAYVVYTSGSTGAPKGIVIEHG 394
Cdd:cd17655 82 PEERIQYILEDSGADILLTQSHLQPPIafIGLIDLLDEDTIYHEESENLEPVSKSD-DLAYVIYTSGSTGKPKGVMIEHR 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 395 SFCTNAIASSQAQNLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQRVN--SLKEAVSTLRVNWVELTPTVAR 472
Cdd:cd17655 161 GVVNLVEWANKVIYQGEHLRVALFASISFDASVTEIFASLLSGNTLYIVRKETVLDgqALTQYIRQNRITIIDLTPAHLK 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 473 LWCPADI---PTVKTLVMGGEPMLPNDISLWKDKLRLVC----AYGPAECTVVSTVQSCVQELGNIGRSPCGT------C 539
Cdd:cd17655 241 LLDAADDsegLSLKHLIVGGEALSTELAKKIIELFGTNPtitnAYGPTETTVDASIYQYEPETDQQVSVPIGKplgntrI 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 540 WIVskDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPewaslFHLNGsyRFYKTGDLVRYNADGTIAYIGR 619
Cdd:cd17655 321 YIL--DQYGRPQPVGVAGELYIGGEGVARGYLNRPELTAEKFVDDP-----FVPGE--RMYRTGDLARWLPDGNIEFLGR 391
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 620 KDTQVKLNGQRVELGEIEHQAQ--PYFRDAVIaaevaapagrkpililfIARKYEYSVNMDCTMLLRPPSIlfqeKAQGT 697
Cdd:cd17655 392 IDHQVKIRGYRIELGEIEARLLqhPDIKEAVV-----------------IARKDEQGQNYLCAYIVSEKEL----PVAQL 450
|
490 500 510
....*....|....*....|....*....|....*....
gi 992230864 698 NTLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLREA 736
Cdd:cd17655 451 REFLARELPDYMIPSYFIKLDEIPLTPNGKVDRKALPEP 489
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
200-829 |
3.22e-91 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 332.31 E-value: 3.22e-91
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 200 PGRPFADSCLLSKHHQDQI-AEWNRNAPIHPFDSCIHTLFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYD 278
Cdd:PRK12316 4518 PQRRLGELQLLEKAEQQRIvALWNRTDAGYPATRCVHQLVAERARMTPDAVAVVFDEEKLTYAELNRRANRLAHALIARG 4597
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 279 LGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVC----SQELSIGVSGSTLSIgDHN 354
Cdd:PRK12316 4598 VGPEVLVGIAMERSAEMMVGLLAVLKAGGAYVPLDPEYPRERLAYMMEDSGAALLLTqshlLQRLPIPDGLASLAL-DRD 4676
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 355 TETATYSAIQ-AVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASYAFDVSVHESLTP 433
Cdd:PRK12316 4677 EDWEGFPAHDpAVRLHPDNLAYVIYTSGSTGRPKGVAVSHGSLVNHLHATGERYELTPDDRVLQFMSFSFDGSHEGLYHP 4756
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 434 LLLGGCVCIPSEAQRV-NSLKEAVSTLRVNWVELTPTVARLWC-----PADIPTVKTLVMGGEPMLPNDISLWKDKL--- 504
Cdd:PRK12316 4757 LINGASVVIRDDSLWDpERLYAEIHEHRVTVLVFPPVYLQQLAehaerDGEPPSLRVYCFGGEAVAQASYDLAWRALkpv 4836
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 505 RLVCAYGPAECTVVSTVQS------CVQELGNIGRsPCGTCWIVSKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTA 578
Cdd:PRK12316 4837 YLFNGYGPTETTVTVLLWKardgdaCGAAYMPIGT-PLGNRSGYVLDGQLNPLPVGVAGELYLGGEGVARGYLERPALTA 4915
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 579 NAFITNPewaslFHLNGSyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRDAVIAAeVAAP 656
Cdd:PRK12316 4916 ERFVPDP-----FGAPGG-RLYRTGDLARYRADGVIDYLGRVDHQVKIRGFRIELGEIEArlREHPAVREAVVIA-QEGA 4988
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 657 AGRKPIlilfiarkyEYSVNMDCTMLlrPPSILFQEKAQGTNTLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLREA 736
Cdd:PRK12316 4989 VGKQLV---------GYVVPQDPALA--DADEAQAELRDELKAALRERLPEYMVPAHLVFLARMPLTPNGKLDRKALPQP 5057
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 737 veQASEKDfRAYYPithndmiqlPSTPVLDQLRLLFSAALRIpeEKIKPNDSFFHLGGDSVSAIRLVGDARDQ-GLHITV 815
Cdd:PRK12316 5058 --DASLLQ-QAYVA---------PRSELEQQVAAIWAEVLQL--ERVGLDDNFFELGGHSLLAIQVTSRIQLElGLELPL 5123
|
650
....*....|....
gi 992230864 816 ESLFKRQTISKLAE 829
Cdd:PRK12316 5124 RELFQTPTLAAFVE 5137
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
191-1019 |
4.46e-91 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 331.74 E-value: 4.46e-91
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 191 QIIHCVIHSPGRPFADSCLLSKHHQDQIAE-WNRNAPIHPFDSCIHTLFRLQCILQPDAQAICAWDGTITYRQLDRLSST 269
Cdd:PRK12467 1532 NLLQGLVADPERRLGELDLLDEAERRQILEgWNATHTGYPLARLVHQLIEDQAAATPEAVALVFGEQELTYGELNRRANR 1611
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 270 VQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVCS----QELSIGVSG 345
Cdd:PRK12467 1612 LAHRLIALGVGPEVLVGIAVERSLEMVVGLLAILKAGGAYVPLDPEYPRERLAYMIEDSGIELLLTQshlqARLPLPDGL 1691
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 346 STLSIGDHNTETATYSAIQ-AVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASYAFD 424
Cdd:PRK12467 1692 RSLVLDQEDDWLEGYSDSNpAVNLAPQNLAYVIYTSGSTGRPKGAGNRHGALVNRLCATQEAYQLSAADVVLQFTSFAFD 1771
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 425 VSVHESLTPLLLGGCVCI--PSEAQRVNSLKEAVSTLRVNWVELTPTV--ARLWCPADI---PTVKTLVMGGEPMLPNDI 497
Cdd:PRK12467 1772 VSVWELFWPLINGARLVIapPGAHRDPEQLIQLIERQQVTTLHFVPSMlqQLLQMDEQVehpLSLRRVVCGGEALEVEAL 1851
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 498 SLWKDKLR---LVCAYGPAECTVVSTVQSC-VQELGNIGRSPCGT-----CWIVsKDNHHRLMPVGCIGELIIGGPIVGR 568
Cdd:PRK12467 1852 RPWLERLPdtgLFNLYGPTETAVDVTHWTCrRKDLEGRDSVPIGQpianlSTYI-LDASLNPVPIGVAGELYLGGVGLAR 1930
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 569 GYLKQPCLTANAFITNPewaslFHLNGSyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRD 646
Cdd:PRK12467 1931 GYLNRPALTAERFVADP-----FGTVGS-RLYRTGDLARYRADGVIEYLGRIDHQVKIRGFRIELGEIEArlREQGGVRE 2004
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 647 AVIAAeVAAPAGRkpiliLFIArkyeYSVNMDctmllrpPSILFQEKAQGT--NTL---LQEVLPRHMIPAAYIELLAMP 721
Cdd:PRK12467 2005 AVVIA-QDGANGK-----QLVA----YVVPTD-------PGLVDDDEAQVAlrAILknhLKASLPEYMVPAHLVFLARMP 2067
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 722 ISRTGKVNRKLLREAVEQASEKDFRAyypithndmiqlPSTPVLDQLRLLFSAALRIpeEKIKPNDSFFHLGGDSVSAIR 801
Cdd:PRK12467 2068 LTPNGKLDRKALPAPDASELQQAYVA------------PQSELEQRLAAIWQDVLGL--EQVGLHDNFFELGGDSIISIQ 2133
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 802 LVGDARDQGLHITVESLFKRQTISKLAECTHQMSNGIG---SPIPPFSLLDPLgKGTYIAQATEQ-----CSVFPEQIED 873
Cdd:PRK12467 2134 VVSRARQAGIRFTPKDLFQHQTVQSLAAVAQEGDGTVSidqGPVTGDLPLLPI-QQMFFADDIPErhhwnQSVLLEPREA 2212
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 874 IYPcTPLQEALMAYT----------SKRPGAFQAQFRFQLPHQLDMLrlkeaWRIVIAAnpilrtrivfchTGALQVVlr 943
Cdd:PRK12467 2213 LDA-ELLEAALQALLvhhdalrlgfVQEDGGWSAMHRAPEQERRPLL-----WQVVVAD------------KEELEAL-- 2272
|
810 820 830 840 850 860 870
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 992230864 944 pGEQLQ--WDLINGvhtspgslmsygvPLVDMAITNDTAGklSRTFCLTMHHAIFDGWSYGLILGAVEDAYKHTNAVQ 1019
Cdd:PRK12467 2273 -CEQAQrsLDLEEG-------------PLLRAVLATLPDG--SQRLLLVIHHLVVDGVSWRILLEDLQTAYRQLQGGQ 2334
|
|
| A_NRPS_Srf_like |
cd12117 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis ... |
237-733 |
7.59e-91 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis termination module Surfactin (SrfA-C); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the adenylation domain of the Bacillus subtilis termination module (Surfactin domain, SrfA-C) which recognizes a specific amino acid building block, which is then activated and transferred to the terminal thiol of the 4'-phosphopantetheine (Ppan) arm of the downstream peptidyl carrier protein (PCP) domain.
Pssm-ID: 341282 [Multi-domain] Cd Length: 483 Bit Score: 304.89 E-value: 7.59e-91
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 237 LFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSY 316
Cdd:cd12117 2 LFEEQAARTPDAVAVVYGDRSLTYAELNERANRLARRLRAAGVGPGDVVGVLAERSPELVVALLAVLKAGAAYVPLDPEL 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 317 PTKRLVNICKDVDAKVIVCSQELSIGVSG-STLSIGDHNTETATYSAIQAVNTAsHDAAYVVYTSGSTGAPKGIVIEHGS 395
Cdd:cd12117 82 PAERLAFMLADAGAKVLLTDRSLAGRAGGlEVAVVIDEALDAGPAGNPAVPVSP-DDLAYVMYTSGSTGRPKGVAVTHRG 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 396 -----FCTNAIAssqaqnLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCI--PSEAQRVNSLKEAVSTLRVNWVELTP 468
Cdd:cd12117 161 vvrlvKNTNYVT------LGPDDRVLQTSPLAFDASTFEIWGALLNGARLVLapKGTLLDPDALGALIAEEGVTVLWLTA 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 469 TVARLWC---PADIPTVKTLVMGGEPMLPNDISLWKDK---LRLVCAYGPAECTVVSTVQSCVQELGNIGRSPCG----- 537
Cdd:cd12117 235 ALFNQLAdedPECFAGLRELLTGGEVVSPPHVRRVLAAcpgLRLVNGYGPTENTTFTTSHVVTELDEVAGSIPIGrpian 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 538 -TCWIVskDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPewaslfHLNGSyRFYKTGDLVRYNADGTIAY 616
Cdd:cd12117 315 tRVYVL--DEDGRPVPPGVPGELYVGGDGLALGYLNRPALTAERFVADP------FGPGE-RLYRTGDLARWLPDGRLEF 385
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 617 IGRKDTQVKLNGQRVELGEIEHQ--AQPYFRDAVIAAEVAAPaGRKPILILFIARkyeysvnmdctmllRPPSilfqekA 694
Cdd:cd12117 386 LGRIDDQVKIRGFRIELGEIEAAlrAHPGVREAVVVVREDAG-GDKRLVAYVVAE--------------GALD------A 444
|
490 500 510
....*....|....*....|....*....|....*....
gi 992230864 695 QGTNTLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLL 733
Cdd:cd12117 445 AELRAFLRERLPAYMVPAAFVVLDELPLTANGKVDRRAL 483
|
|
| A_NRPS_Ta1_like |
cd12116 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A ... |
246-733 |
1.64e-89 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A polyketide synthase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the myxovirescin (TA) antibiotic biosynthetic gene in Myxococcus xanthus; TA production plays a role in predation. It also includes the salinosporamide A polyketide synthase which is involved in the biosynthesis of salinosporamide A, a marine microbial metabolite whose chlorine atom is crucial for potent proteasome inhibition and anticancer activity.
Pssm-ID: 341281 [Multi-domain] Cd Length: 470 Bit Score: 300.36 E-value: 1.64e-89
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNIC 325
Cdd:cd12116 1 PDATAVRDDDRSLSYAELDERANRLAARLRARGVGPGDRVAVYLPRSARLVAAMLAVLKAGAAYVPLDPDYPADRLRYIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 326 KDVDAKVIVCSQELSIGVSGSTLSIGDHNtETATYSAIQAVNTAS-HDAAYVVYTSGSTGAPKGIVIEHGSFcTNAIASS 404
Cdd:cd12116 81 EDAEPALVLTDDALPDRLPAGLPVLLLAL-AAAAAAPAAPRTPVSpDDLAYVIYTSGSTGRPKGVVVSHRNL-VNFLHSM 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 405 QAQ-NLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCI-PSEAQR-VNSLKEAVSTLRVNWVELTPTVARL-----WCP 476
Cdd:cd12116 159 RERlGLGPGDRLLAVTTYAFDISLLELLLPLLAGARVVIaPRETQRdPEALARLIEAHSITVMQATPATWRMlldagWQG 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 477 AdiPTVKTLVmGGEPmLPNDIslwKDKL-----RLVCAYGPAECTVVSTVQSCVQELG--NIGRSPCGT-CWIVskDNHH 548
Cdd:cd12116 239 R--AGLTALC-GGEA-LPPDL---AARLlsrvgSLWNLYGPTETTIWSTAARVTAAAGpiPIGRPLANTqVYVL--DAAL 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 549 RLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPewaslFHLNGSyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNG 628
Cdd:cd12116 310 RPVPPGVPGELYIGGDGVAQGYLGRPALTAERFVPDP-----FAGPGS-RLYRTGDLVRRRADGRLEYLGRADGQVKIRG 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 629 QRVELGEIEH--QAQPYFRDAVIaaeVAAPAGRKPILILFIARKYEYSVNMDctmLLRppsilfqekaqgtnTLLQEVLP 706
Cdd:cd12116 384 HRIELGEIEAalAAHPGVAQAAV---VVREDGGDRRLVAYVVLKAGAAPDAA---ALR--------------AHLRATLP 443
|
490 500
....*....|....*....|....*..
gi 992230864 707 RHMIPAAYIELLAMPISRTGKVNRKLL 733
Cdd:cd12116 444 AYMVPSAFVRLDALPLTANGKLDRKAL 470
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
214-1017 |
8.84e-87 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 318.05 E-value: 8.84e-87
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 214 HQDQIAEWNRNAPIHPFDSCIHTLFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSK 293
Cdd:PRK12316 493 RGQLVEGWNATAAEYPLQRGVHRLFEEQVERTPEAPALAFGEETLDYAELNRRANRLAHALIERGVGPDVLVGVAMERSI 572
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 294 WAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVCSQ----ELSIGVSGSTLSIGDHNTETATYSAiQAVNTA 369
Cdd:PRK12316 573 EMVVALLAILKAGGAYVPLDPEYPAERLAYMLEDSGVQLLLSQShlgrKLPLAAGVQVLDLDRPAAWLEGYSE-ENPGTE 651
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 370 SH--DAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASYAFDVSVHESLTPLLLGG--CVCIPSE 445
Cdd:PRK12316 652 LNpeNLAYVIYTSGSTGKPKGAGNRHRALSNRLCWMQQAYGLGVGDTVLQKTPFSFDVSVWEFFWPLMSGArlVVAAPGD 731
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 446 AQRVNSLKEAVSTLRVNWVELTPTVARLWC----PADIPTVKTLVMGGEPmLPNDISLW----KDKLRLVCAYGPAECTV 517
Cdd:PRK12316 732 HRDPAKLVELINREGVDTLHFVPSMLQAFLqdedVASCTSLRRIVCSGEA-LPADAQEQvfakLPQAGLYNLYGPTEAAI 810
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 518 VSTVQSCVQELGN---IGRSPCGT-CWIVskDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPewaslfHL 593
Cdd:PRK12316 811 DVTHWTCVEEGGDsvpIGRPIANLaCYIL--DANLEPVPVGVLGELYLAGRGLARGYHGRPGLTAERFVPSP------FV 882
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 594 NGSyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRDAVIAAevaapAGRKPILilfiarky 671
Cdd:PRK12316 883 AGE-RMYRTGDLARYRADGVIEYAGRIDHQVKLRGLRIELGEIEArlLEHPWVREAAVLA-----VDGKQLV-------- 948
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 672 EYSVNMDCTMLLRppsilfQEKAQGtntlLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLREAVEQASEKDFRAyypi 751
Cdd:PRK12316 949 GYVVLESEGGDWR------EALKAH----LAASLPEYMVPAQWLALERLPLTPNGKLDRKALPAPEASVAQQGYVA---- 1014
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 752 thndmiqlPSTPVLDQLRLLFSAALRIpeEKIKPNDSFFHLGGDSVSAIRLVGDARDQGLHITVESLFKRQTISKLAECT 831
Cdd:PRK12316 1015 --------PRNALERTLAAIWQDVLGV--ERVGLDDNFFELGGDSIVSIQVVSRARQAGIQLSPRDLFQHQTIRSLALVA 1084
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 832 HQmsngigspippfslldplGKGTYIAQATEQCSVfpeqiediyPCTPLQEALMAYTSKRPGAFQAQFRFQLPHQLDMLR 911
Cdd:PRK12316 1085 KA------------------GQATAADQGPASGEV---------ALAPVQRWFFEQAIPQRQHWNQSLLLQARQPLDPDR 1137
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 912 LKEAWRIVIAANPILRTRIVfCHTGALQVVLRP--GEQLQW--------DLINGVHTSPGSL-MSYG----VPLVDMAit 976
Cdd:PRK12316 1138 LGRALERLVAHHDALRLRFR-EEDGGWQQAYAApqAGEVLWqrqaaseeELLALCEEAQRSLdLEQGpllrALLVDMA-- 1214
|
810 820 830 840
....*....|....*....|....*....|....*....|.
gi 992230864 977 nDTAGKLsrtfCLTMHHAIFDGWSYGLILGAVEDAYKHTNA 1017
Cdd:PRK12316 1215 -DGSQRL----LLVIHHLVVDGVSWRILLEDLQRAYADLDA 1250
|
|
| A_NRPS_ApnA-like |
cd17644 |
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the ... |
233-733 |
2.96e-86 |
|
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Planktothrix agardhii anabaenopeptin synthetase (ApnA A1), which is capable of activating two chemically distinct amino acids (Arg and Tyr). Structural studies show that the architecture of the active site forces Arg to adopt a Tyr-like conformation, thus explaining the bispecificity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341299 [Multi-domain] Cd Length: 465 Bit Score: 290.88 E-value: 2.96e-86
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 233 CIHTLFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCML 312
Cdd:cd17644 1 CIHQLFEEQVERTPDAVAVVFEDQQLTYEELNTKANQLAHYLQSLGVKSESLVGICVERSLEMIIGLLAILKAGGAYVPL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 313 DQSYPTKRLVNICKDVDAKVIVcsqelsigvsgstlsigdhntetatysaiqavnTASHDAAYVVYTSGSTGAPKGIVIE 392
Cdd:cd17644 81 DPNYPQERLTYILEDAQISVLL---------------------------------TQPENLAYVIYTSGSTGKPKGVMIE 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 393 HGSFCTNAIASSQAQNLDRSSRVLQFASYAFDVSVHEsLTPLLLGGCVCIPSEAQRVNSLKEAVSTLRVNWVE---LTPT 469
Cdd:cd17644 128 HQSLVNLSHGLIKEYGITSSDRVLQFASIAFDVAAEE-IYVTLLSGATLVLRPEEMRSSLEDFVQYIQQWQLTvlsLPPA 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 470 VARLWCPA------DIP-TVKTLVMGGEPMLPNDISLW----KDKLRLVCAYGPAECTVVSTVQSCVQELGN------IG 532
Cdd:cd17644 207 YWHLLVLElllstiDLPsSLRLVIVGGEAVQPELVRQWqknvGNFIQLINVYGPTEATIAATVCRLTQLTERnitsvpIG 286
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 533 RsPCGTCWIVSKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPewaslFHLNGSYRFYKTGDLVRYNADG 612
Cdd:cd17644 287 R-PIANTQVYILDENLQPVPVGVPGELHIGGVGLARGYLNRPELTAEKFISHP-----FNSSESERLYKTGDLARYLPDG 360
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 613 TIAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRDAVIAAEVAAPAGRKpiLILFIARKYEYSVNmdctmllrpPSILF 690
Cdd:cd17644 361 NIEYLGRIDNQVKIRGFRIELGEIEAvlSQHNDVKTAVVIVREDQPGNKR--LVAYIVPHYEESPS---------TVELR 429
|
490 500 510 520
....*....|....*....|....*....|....*....|...
gi 992230864 691 QekaqgtntLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLL 733
Cdd:cd17644 430 Q--------FLKAKLPDYMIPSAFVVLEELPLTPNGKIDRRAL 464
|
|
| A_NRPS_AB3403-like |
cd17646 |
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or ... |
235-733 |
3.38e-86 |
|
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341301 [Multi-domain] Cd Length: 488 Bit Score: 291.49 E-value: 3.38e-86
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 235 HTLFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQ 314
Cdd:cd17646 1 HALVAEQAARTPDAPAVVDEGRTLTYRELDERANRLAHLLRARGVGPEDRVAVLLPRSADLVVALLAVLKAGAAYLPLDP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 315 SYPTKRLVNICKDVDAKVIVCSQELSIGVSGSTLSIGDHNTETATYSA-IQAVNTASHDAAYVVYTSGSTGAPKGIVIEH 393
Cdd:cd17646 81 GYPADRLAYMLADAGPAVVLTTADLAARLPAGGDVALLGDEALAAPPAtPPLVPPRPDNLAYVIYTSGSTGRPKGVMVTH 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 394 GSFcTNAIASSQAQ-NLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCI--PSEAQRVNSLKEAVSTLRVNWVELTPTV 470
Cdd:cd17646 161 AGI-VNRLLWMQDEyPLGPGDRVLQKTPLSFDVSVWELFWPLVAGARLVVarPGGHRDPAYLAALIREHGVTTCHFVPSM 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 471 ARLWC----PADIPTVKTLVMGGEPMLPNDISLWKDKL--RLVCAYGPAECTVVSTVQSCVQELGN----IGRS-PCGTC 539
Cdd:cd17646 240 LRVFLaepaAGSCASLRRVFCSGEALPPELAARFLALPgaELHNLYGPTEAAIDVTHWPVRGPAETpsvpIGRPvPNTRL 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 540 WIVskDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPewaslfHLNGSyRFYKTGDLVRYNADGTIAYIGR 619
Cdd:cd17646 320 YVL--DDALRPVPVGVPGELYLGGVQLARGYLGRPALTAERFVPDP------FGPGS-RMYRTGDLARWRPDGALEFLGR 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 620 KDTQVKLNGQRVELGEIEH--QAQPYFRDAVIAAEvAAPAGRKPILILFIARKYEYSVNMDctmllrppsilfQEKAQgt 697
Cdd:cd17646 391 SDDQVKIRGFRVEPGEIEAalAAHPAVTHAVVVAR-AAPAGAARLVGYVVPAAGAAGPDTA------------ALRAH-- 455
|
490 500 510
....*....|....*....|....*....|....*.
gi 992230864 698 ntlLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLL 733
Cdd:cd17646 456 ---LAERLPEYMVPAAFVVLDALPLTANGKLDRAAL 488
|
|
| A_NRPS_GliP_like |
cd17653 |
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of ... |
237-735 |
4.94e-86 |
|
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of nonribosomal peptide synthases (NRPS) gliotoxin biosynthesis protein P (GliP), thioclapurine biosynthesis protein P (tcpP) and Sirodesmin biosynthesis protein P (SirP). In the filamentous fungus Aspergillus fumigatus, NRPS GliP is involved in the biosynthesis of gliotoxin, which is initiated by the condensation of serine and phenylalanine. Studies show that GliP is not required for invasive aspergillosis, suggesting that the principal targets of gliotoxin are neutrophils or other phagocytes. SirP is a phytotoxin produced by the fungus Leptosphaeria maculans, which causes blackleg disease of canola (Brassica napus). In the fungus Claviceps purpurea, NRPS tcpP catalyzes condensation of tyrosine and glycine, part of biosynthesis of an unusual class of epipolythiodioxopiperazines (ETPs) that lacks the reactive thiol group for toxicity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341308 [Multi-domain] Cd Length: 433 Bit Score: 289.21 E-value: 4.94e-86
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 237 LFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSY 316
Cdd:cd17653 2 AFERIAAAHPDAVAVESLGGSLTYGELDAASNALANRLLQLGVVPGDVVPLLSDRSLEMLVAILAILKAGAAYVPLDAKL 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 317 PTKRLVNICKDVDAKVIVCsqelsigvsgstlsigdhntetatysaiqavNTASHDAAYVVYTSGSTGAPKGIVIEHGSF 396
Cdd:cd17653 82 PSARIQAILRTSGATLLLT-------------------------------TDSPDDLAYIIFTSGSTGIPKGVMVPHRGV 130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 397 cTNAIASSQAqNLDR--SSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQRVNSLKEAVSTLrvnwvELTPTVARLW 474
Cdd:cd17653 131 -LNYVSQPPA-RLDVgpGSRVAQVLSIAFDACIGEIFSTLCNGGTLVLADPSDPFAHVARTVDAL-----MSTPSILSTL 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 475 CPADIPTVKTLVMGGEPMLPNDISLWKDKLRLVCAYGPAECTVVSTVQSCvqELGN---IGRS-PCGTCWIVSKDNhhRL 550
Cdd:cd17653 204 SPQDFPNLKTIFLGGEAVPPSLLDRWSPGRRLYNAYGPTECTISSTMTEL--LPGQpvtIGKPiPNSTCYILDADL--QP 279
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 551 MPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPEWaslfhlNGSyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQR 630
Cdd:cd17653 280 VPEGVVGEICISGVQVARGYLGNPALTASKFVPDPFW------PGS-RMYRTGDYGRWTEDGGLEFLGREDNQVKVRGFR 352
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 631 VELGEIEH---QAQPYFRDAviAAEVAAPAgrkpiLILFIARKyeySVNMDctmllrppsiLFQEKaqgtntlLQEVLPR 707
Cdd:cd17653 353 INLEEIEEvvlQSQPEVTQA--AAIVVNGR-----LVAFVTPE---TVDVD----------GLRSE-------LAKHLPS 405
|
490 500
....*....|....*....|....*...
gi 992230864 708 HMIPAAYIELLAMPISRTGKVNRKLLRE 735
Cdd:cd17653 406 YAVPDRIIALDSFPLTANGKVDRKALRE 433
|
|
| A_NRPS_Sfm_like |
cd12115 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene ... |
234-733 |
2.42e-85 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene cluster from Streptomyces lavendulae; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the saframycin A gene cluster from Streptomyces lavendulae which implicates the NRPS system for assembling the unusual tetrapeptidyl skeleton in an iterative manner. It also includes saframycin Mx1 produced by Myxococcus xanthus NRPS.
Pssm-ID: 341280 [Multi-domain] Cd Length: 447 Bit Score: 287.68 E-value: 2.42e-85
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 234 IHTLFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLD 313
Cdd:cd12115 1 LHDLVEAQAARTPDAIALVCGDESLTYAELNRRANRLAARLRAAGVGPESRVGVCLERTPDLVVALLAVLKAGAAYVPLD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 314 QSYPTKRLVNICKDVDAKVIVcsqelsigvsgstlsigdhntetatysaiqavnTASHDAAYVVYTSGSTGAPKGIVIEH 393
Cdd:cd12115 81 PAYPPERLRFILEDAQARLVL---------------------------------TDPDDLAYVIYTSGSTGRPKGVAIEH 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 394 GsfctNAIA----SSQAQNLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCIpseAQRVNSLKEAVSTLRVNWVELTPT 469
Cdd:cd12115 128 R----NAAAflqwAAAAFSAEELAGVLASTSICFDLSVFELFGPLATGGKVVL---ADNVLALPDLPAAAEVTLINTVPS 200
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 470 VARLWCPAD-IPT-VKTLVMGGEPmLPNDISlwkDKL-------RLVCAYGPAECTVVSTVqsCVQELGN-----IGRSP 535
Cdd:cd12115 201 AAAELLRHDaLPAsVRVVNLAGEP-LPRDLV---QRLyarlqveRVVNLYGPSEDTTYSTV--APVPPGAsgevsIGRPL 274
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 536 CGT-CWIVskDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPEWASLfhlngsyRFYKTGDLVRYNADGTI 614
Cdd:cd12115 275 ANTqAYVL--DRALQPVPLGVPGELYIGGAGVARGYLGRPGLTAERFLPDPFGPGA-------RLYRTGDLVRWRPDGLL 345
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 615 AYIGRKDTQVKLNGQRVELGEIEHQ--AQPYFRDAVIAAEVAAPAGRKpiLILFIArkyeysvnmdctmlLRPPSILFQE 692
Cdd:cd12115 346 EFLGRADNQVKVRGFRIELGEIEAAlrSIPGVREAVVVAIGDAAGERR--LVAYIV--------------AEPGAAGLVE 409
|
490 500 510 520
....*....|....*....|....*....|....*....|.
gi 992230864 693 KAQGTntlLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLL 733
Cdd:cd12115 410 DLRRH---LGTRLPAYMVPSRFVRLDALPLTPNGKIDRSAL 447
|
|
| CT_NRPS-like |
cd19542 |
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike ... |
1546-1951 |
5.39e-80 |
|
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike bacterial NRPS, which typically have specialized terminal thioesterase (TE) domains to cyclize peptide products, many fungal NRPSs employ a terminal condensation-like (CT) domain to produce macrocyclic peptidyl products (e.g. cyclosporine and echinocandin). Domains in this subfamily (which includes both terminal and non-terminal domains) typically have a non-canonical conserved [SN]HxxxDx(14)Y motif at their active site compared to the standard Condensation (C) domain active site motif (HHxxxD). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380464 [Multi-domain] Cd Length: 401 Bit Score: 270.33 E-value: 5.39e-80
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1546 YPCSESHQGLLQTQMLRPFYYQSYTIWEVttrskSSPVSPVRLCNAWFTLARRHPALRTHLIDIPLCDGMsskIHVVHKD 1625
Cdd:cd19542 2 YPCTPMQEGMLLSQLRSPGLYFNHFVFDL-----DSSVDVERLRNAWRQLVQRHDILRTVFVESSAEGTF---LQVVLKS 73
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1626 YMADAAILSCEDEhVITELRKPFLPSDTGLYYP-HAFRICQTVSGRVFCKLEGGHAFLDATSVLIILRELAQAYDGQLSS 1704
Cdd:cd19542 74 LDPPIEEVETDED-SLDALTRDLLDDPTLFGQPpHRLTLLETSSGEVYLVLRISHALYDGVSLPIILRDLAAAYNGQLLP 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1705 vPGPSYSSAVAWLQSLpNGDNRMDYWRRQLKDASPCIFPRLRDQDSPSDTLVVTEqlASTATLTPVCTRHGLTVSNVLQV 1784
Cdd:cd19542 153 -PAPPFSDYISYLQSQ-SQEESLQYWRKYLQGASPCAFPSLSPKRPAERSLSSTR--RSLAKLEAFCASLGVTLASLFQA 228
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1785 AWGLMLRRYTESDDVCFGALISGRDSRIPDVDKMVGPFFNVLVCQLRFGREDSLWDVLRRNQTEIGNRLLNQHCSLIEVL 1864
Cdd:cd19542 229 AWALVLARYTGSRDVVFGYVVSGRDLPVPGIDDIVGPCINTLPVRVKLDPDWTVLDLLRQLQQQYLRSLPHQHLSLREIQ 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1865 RFST-YFGQPLFNTCISVEQ--PLSMDTPDASLCFKELETLEPTEYGIIATITIGTTDVGLGLTYKSDLLTEDQALAVAD 1941
Cdd:cd19542 309 RALGlWPSGTLFNTLVSYQNfeASPESELSGSSVFELSAAEDPTEYPVAVEVEPSGDSLKVSLAYSTSVLSEEQAEELLE 388
|
410
....*....|
gi 992230864 1942 RFKMSITEIM 1951
Cdd:cd19542 389 QFDDILEALL 398
|
|
| A_NRPS_Cytc1-like |
cd17643 |
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation ... |
246-733 |
4.18e-79 |
|
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Streptomyces sp. cytotrienin synthetase (CytC1), a relatively promiscuous adenylation enzyme that installs the aminoacyl moieties on the phosphopantetheinyl arm of the holo carrier protein CytC2. Also included are Streptomyces sp Thr1, involved in the biosynthesis of 4-chlorothreonine, Pseudomonas aeruginosa pyoverdine synthetase D (PvdD), involved in the biosynthesis of the siderophore pyoverdine and Pseudomonas syringae syringopeptin synthetase, where syringpeptin is a necrosis-inducing phytotoxin that functions as a virulence determinant in the plant-pathogen interaction. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341298 [Multi-domain] Cd Length: 450 Bit Score: 269.56 E-value: 4.18e-79
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNIC 325
Cdd:cd17643 1 PEAVAVVDEDRRLTYGELDARANRLARTLRAEGVGPGDRVALALPRSAELIVALLAILKAGGAYVPIDPAYPVERIAFIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 326 KDvdakvivcsqelsigvsgstlsigdhntetatySAIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQ 405
Cdd:cd17643 81 AD---------------------------------SGPSLLLTDPDDLAYVIYTSGSTGRPKGVVVSHANVLALFAATQR 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 406 AQNLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQRVN--SLKEAVSTLRVNWVELTPTVARLWCPAD----- 478
Cdd:cd17643 128 WFGFNEDDVWTLFHSYAFDFSVWEIWGALLHGGRLVVVPYEVARSpeDFARLLRDEGVTVLNQTPSAFYQLVEAAdrdgr 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 479 -IPTVKTLVMGGEPMLPNDISLW-----KDKLRLVCAYGPAECTVVSTVQ------SCVQELGNIGRsPCGTCWIVSKDN 546
Cdd:cd17643 208 dPLALRYVIFGGEALEAAMLRPWagrfgLDRPQLVNMYGITETTVHVTFRpldaadLPAAAASPIGR-PLPGLRVYVLDA 286
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 547 HHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPewaslFHLNGSyRFYKTGDLVRYNADGTIAYIGRKDTQVKL 626
Cdd:cd17643 287 DGRPVPPGVVGELYVSGAGVARGYLGRPELTAERFVANP-----FGGPGS-RMYRTGDLARRLPDGELEYLGRADEQVKI 360
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 627 NGQRVELGEIEH--QAQPYFRDAVIAAEVAAPAGrkpililfiARKYEYSVNMDCTMLLRPpsilfqekaqGTNTLLQEV 704
Cdd:cd17643 361 RGFRIELGEIEAalATHPSVRDAAVIVREDEPGD---------TRLVAYVVADDGAAADIA----------ELRALLKEL 421
|
490 500
....*....|....*....|....*....
gi 992230864 705 LPRHMIPAAYIELLAMPISRTGKVNRKLL 733
Cdd:cd17643 422 LPDYMVPARYVPLDALPLTVNGKLDRAAL 450
|
|
| DltA |
cd05945 |
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes ... |
245-733 |
3.71e-77 |
|
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes D-alanyl carrier protein ligase DltA and aliphatic beta-amino acid adenylation enzymes IdnL1 and CmiS6. DltA incorporates D-ala in techoic acids in gram-positive bacteria via a two-step process, starting with adenylation of D-alanine that transfers D-alanine to the D-alanyl carrier protein. IdnL1, a short-chain aliphatic beta-amino acid adenylation enzyme, recognizes 3-aminobutanoic acid, and is involved in the synthesis of the macrolactam antibiotic incednine. CmiS6 is a medium-chain beta-amino acid adenylation enzyme that recognizes 3-aminononanoic acid, and is involved in the synthesis of cremimycin, also a macrolactam antibiotic. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341267 [Multi-domain] Cd Length: 449 Bit Score: 264.11 E-value: 3.71e-77
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 245 QPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNI 324
Cdd:cd05945 4 NPDRPAVVEGGRTLTYRELKERADALAAALASLGLDAGDPVVVYGHKSPDAIAAFLAALKAGHAYVPLDASSPAERIREI 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 325 CKDVDAKVIVcsqelsigvsgstlsigdhntetatysaiqavnTASHDAAYVVYTSGSTGAPKGIVIEHG---SFcTNAI 401
Cdd:cd05945 84 LDAAKPALLI---------------------------------ADGDDNAYIIFTSGSTGRPKGVQISHDnlvSF-TNWM 129
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 402 ASsqAQNLDRSSRVLQFASYAFDVSVHESLTPLLLGGC-VCIPSEAQR-VNSLKEAVSTLRVN-WVElTPTVARL----- 473
Cdd:cd05945 130 LS--DFPLGPGDVFLNQAPFSFDLSVMDLYPALASGATlVPVPRDATAdPKQLFRFLAEHGITvWVS-TPSFAAMcllsp 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 474 -WCPADIPTVKTLVMGGEPMLPNDISLWKDKL---RLVCAYGPAECTVVSTVQSCVQELGN------IGRS-PCGTCWIV 542
Cdd:cd05945 207 tFTPESLPSLRHFLFCGEVLPHKTARALQQRFpdaRIYNTYGPTEATVAVTYIEVTPEVLDgydrlpIGYAkPGAKLVIL 286
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 543 skDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFitnpewaslFHLNGsYRFYKTGDLVRYNADGTIAYIGRKDT 622
Cdd:cd05945 287 --DEDGRPVPPGEKGELVISGPSVSKGYLNNPEKTAAAF---------FPDEG-QRAYRTGDLVRLEADGLLFYRGRLDF 354
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 623 QVKLNGQRVELGEIEH--QAQPYFRDAVIaaeVAAPAGRK-PILILFIarKYEYSVNMDCTMLLRppsilfQEkaqgtnt 699
Cdd:cd05945 355 QVKLNGYRIELEEIEAalRQVPGVKEAVV---VPKYKGEKvTELIAFV--VPKPGAEAGLTKAIK------AE------- 416
|
490 500 510
....*....|....*....|....*....|....
gi 992230864 700 lLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLL 733
Cdd:cd05945 417 -LAERLPPYMIPRRFVYLDELPLNANGKIDRKAL 449
|
|
| A_NRPS_ProA |
cd17656 |
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the ... |
246-733 |
1.32e-76 |
|
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains gramicidin S synthase 2 (also known as ATP-dependent proline adenylase or proline activase or ProA). ProA is a multifunctional enzyme involved in synthesis of the cyclic peptide antibiotic gramicidin S and able to activate and polymerize the amino acids proline, valine, ornithine and leucine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341311 [Multi-domain] Cd Length: 479 Bit Score: 263.57 E-value: 1.32e-76
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNIC 325
Cdd:cd17656 2 PDAVAVVFENQKLTYRELNERSNQLARFLREKGVKKDSIVAIMMERSAEMIVGILGILKAGGAFVPIDPEYPEERRIYIM 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 326 KDVDAKVIVCSQELSIGVS--GSTLSIGDHNTETATYSAIQAVNtASHDAAYVVYTSGSTGAPKGIVIEHGSFcTNAIAS 403
Cdd:cd17656 82 LDSGVRVVLTQRHLKSKLSfnKSTILLEDPSISQEDTSNIDYIN-NSDDLLYIIYTSGTTGKPKGVQLEHKNM-VNLLHF 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 404 SQAQ-NLDRSSRVLQFASYAFDVSVHESLTPLLLGGCV-CIPSEAQR-VNSLKEAVSTLRVNWVELTPTVARLWCPA--- 477
Cdd:cd17656 160 EREKtNINFSDKVLQFATCSFDVCYQEIFSTLLSGGTLyIIREETKRdVEQLFDLVKRHNIEVVFLPVAFLKFIFSEref 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 478 --DIPT-VKTLVMGGEPMLPNDisLWKDKLR-----LVCAYGPAECTVVSTV----QSCVQELGNIGRsPCGTCWIVSKD 545
Cdd:cd17656 240 inRFPTcVKHIITAGEQLVITN--EFKEMLHehnvhLHNHYGPSETHVVTTYtinpEAEIPELPPIGK-PISNTWIYILD 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 546 NHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPewaslfhLNGSYRFYKTGDLVRYNADGTIAYIGRKDTQVK 625
Cdd:cd17656 317 QEQQLQPQGIVGELYISGASVARGYLNRQELTAEKFFPDP-------FDPNERMYRTGDLARYLPDGNIEFLGRADHQVK 389
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 626 LNGQRVELGEIEHQ--AQPYFRDAVIAAEvAAPAGRKPIlilfiarkYEYSVnmdctMLLRPPSILFQEKaqgtntlLQE 703
Cdd:cd17656 390 IRGYRIELGEIEAQllNHPGVSEAVVLDK-ADDKGEKYL--------CAYFV-----MEQELNISQLREY-------LAK 448
|
490 500 510
....*....|....*....|....*....|
gi 992230864 704 VLPRHMIPAAYIELLAMPISRTGKVNRKLL 733
Cdd:cd17656 449 QLPEYMIPSFFVPLDQLPLTPNGKVDRKAL 478
|
|
| A_NRPS_PpsD_like |
cd17650 |
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation ... |
246-733 |
3.10e-76 |
|
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetase 1 (BacA) in Bacillus licheniformis, tyrocidine synthetase in Brevibacillus brevis, plipastatin synthase (PpsD, an important antifungal protein) in Bacillus subtilis and mannopeptimycin peptide synthetase (MppB) in Streptomyces hygroscopicus. Plipastatin has strong fungitoxic activity and is involved in inhibition of phospholipase A2 and biofilm formation. Bacitracin, a mixture of related cyclic peptides, is used as a polypeptide antibiotic while function of tyrocidine is thought to be regulation of sporulation. MppB is involved in biosynthetic pathway of mannopeptimycin, a novel class of mannosylated lipoglycopeptides. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341305 [Multi-domain] Cd Length: 447 Bit Score: 261.25 E-value: 3.10e-76
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNIC 325
Cdd:cd17650 1 PDAIAVSDATRQLTYRELNERANQLARTLRGLGVAPGSVVGVCADRSLDAIVGLLAVLKAGGAYVPIDPDYPAERLQYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 326 KDVDAKVIVcsqelsigvsgstlsigdhntetatysaiqavnTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQ 405
Cdd:cd17650 81 EDSGAKLLL---------------------------------TQPEDLAYVIYTSGTTGKPKGVMVEHRNVAHAAHAWRR 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 406 AQNLDRSS-RVLQFASYAFDVSVHESLTPLLLGGCVCI-PSEAQ-RVNSLKEAVSTLRVNWVELTPTVAR------LWCP 476
Cdd:cd17650 128 EYELDSFPvRLLQMASFSFDVFAGDFARSLLNGGTLVIcPDEVKlDPAALYDLILKSRITLMESTPALIRpvmayvYRNG 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 477 ADIPTVKTLVMGGEPMLPNDISLWKDKL----RLVCAYGPAECTVVSTV-QSCVQELGNIGRSPCG------TCWIVskD 545
Cdd:cd17650 208 LDLSAMRLLIVGSDGCKAQDFKTLAARFgqgmRIINSYGVTEATIDSTYyEEGRDPLGDSANVPIGrplpntAMYVL--D 285
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 546 NHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPewaslfhLNGSYRFYKTGDLVRYNADGTIAYIGRKDTQVK 625
Cdd:cd17650 286 ERLQPQPVGVAGELYIGGAGVARGYLNRPELTAERFVENP-------FAPGERMYRTGDLARWRADGNVELLGRVDHQVK 358
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 626 LNGQRVELGEIEHQ--AQPYFRDAVIAAEVAApAGRKPILILFIARKyeySVNmdcTMLLRppsilfqekaqgtnTLLQE 703
Cdd:cd17650 359 IRGFRIELGEIESQlaRHPAIDEAVVAVREDK-GGEARLCAYVVAAA---TLN---TAELR--------------AFLAK 417
|
490 500 510
....*....|....*....|....*....|
gi 992230864 704 VLPRHMIPAAYIELLAMPISRTGKVNRKLL 733
Cdd:cd17650 418 ELPSYMIPSYYVQLDALPLTPNGKVDRRAL 447
|
|
| A_NRPS_TlmIV_like |
cd12114 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including ... |
246-733 |
1.12e-75 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Streptoalloteichus tallysomycin biosynthesis genes; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the TLM biosynthetic gene cluster from Streptoalloteichus that consists of nine NRPS genes; the N-terminal module of TlmVI (NRPS-5) and the starter module of BlmVI (NRPS-5) are comprised of the acyl CoA ligase (AL) and acyl carrier protein (ACP)-like domains, which are thought to be involved in the biosynthesis of the beta-aminoalaninamide moiety.
Pssm-ID: 341279 [Multi-domain] Cd Length: 477 Bit Score: 260.67 E-value: 1.12e-75
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNIC 325
Cdd:cd12114 1 PDATAVICGDGTLTYGELAERARRVAGALKAAGVRPGDLVAVTLPKGPEQVVAVLGILAAGAAYVPVDIDQPAARREAIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 326 KDVDAK-VIVCSQELSIGVSGSTLSIGDHNTETAtySAIQA-VNTASHDAAYVVYTSGSTGAPKGIVIEHGSfCTNAIAS 403
Cdd:cd12114 81 ADAGARlVLTDGPDAQLDVAVFDVLILDLDALAA--PAPPPpVDVAPDDLAYVIFTSGSTGTPKGVMISHRA-ALNTILD 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 404 SQAQ-NLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQR--VNSLKEAVSTLRVN-------WVELTPTVARL 473
Cdd:cd12114 158 INRRfAVGPDDRVLALSSLSFDLSVYDIFGALSAGATLVLPDEARRrdPAHWAELIERHGVTlwnsvpaLLEMLLDVLEA 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 474 wCPADIPTVKTLVMGGE---PMLPNDI-SLWKDkLRLVCAYGPAECTVVSTVQScVQELGNIGRS-PCG------TCWIV 542
Cdd:cd12114 238 -AQALLPSLRLVLLSGDwipLDLPARLrALAPD-ARLISLGGATEASIWSIYHP-IDEVPPDWRSiPYGrplanqRYRVL 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 543 skDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPEWAslfhlngsyRFYKTGDLVRYNADGTIAYIGRKDT 622
Cdd:cd12114 315 --DPRGRDCPDWVPGELWIGGRGVALGYLGDPELTAARFVTHPDGE---------RLYRTGDLGRYRPDGTLEFLGRRDG 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 623 QVKLNGQRVELGEIEHQAQpyfRDAVIAAEVAAPAGRKPI--LILFIARKYEYSVNMDCTMLLRppsilfqekaqgtntl 700
Cdd:cd12114 384 QVKVRGYRIELGEIEAALQ---AHPGVARAVVVVLGDPGGkrLAAFVVPDNDGTPIAPDALRAF---------------- 444
|
490 500 510
....*....|....*....|....*....|...
gi 992230864 701 LQEVLPRHMIPAAYIELLAMPISRTGKVNRKLL 733
Cdd:cd12114 445 LAQTLPAYMIPSRVIALEALPLTANGKVDRAAL 477
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
172-828 |
3.85e-74 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 273.07 E-value: 3.85e-74
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 172 YVPSALHnAHANNIISTLEQIIHcvihSPGRPFADSCLLSKHHQDQIAEWNRNApiHPF-DSCIHTLFRLQCILQPDAQA 250
Cdd:PRK10252 404 YDEATLI-AHAERLKALIAQFAA----DPALLCGDVDILLPGEYAQLAQVNATA--VEIpETTLSALVAQQAAKTPDAPA 476
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 251 ICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDA 330
Cdd:PRK10252 477 LADARYQFSYREMREQVVALANLLRERGVKPGDSVAVALPRSVFLTLALHAIVEAGAAWLPLDTGYPDDRLKMMLEDARP 556
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 331 KVIVCSQELSIGVSG-STLSIGDHNTETATYSAIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFcTNAIASSQAQ-N 408
Cdd:PRK10252 557 SLLITTADQLPRFADvPDLTSLCYNAPLAPQGAAPLQLSQPHHTAYIIFTSGSTGRPKGVMVGQTAI-VNRLLWMQNHyP 635
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 409 LDRSSRVLQFASYAFDVSVHESLTPLLLGGC-VCIPSEAQR-------------VNSLKEAVSTLRVNWVELTPTVARLW 474
Cdd:PRK10252 636 LTADDVVLQKTPCSFDVSVWEFFWPFIAGAKlVMAEPEAHRdplamqqffaeygVTTTHFVPSMLAAFVASLTPEGARQS 715
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 475 CpadiPTVKTLVMGGEPMlpnDISLWKDKLRLVCA-----YGPAECTV-VSTVQSCVQELGNI-GRS-PCG-TCW---IV 542
Cdd:PRK10252 716 C----ASLRQVFCSGEAL---PADLCREWQQLTGAplhnlYGPTEAAVdVSWYPAFGEELAAVrGSSvPIGyPVWntgLR 788
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 543 SKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPewaslfHLNGSyRFYKTGDLVRYNADGTIAYIGRKDT 622
Cdd:PRK10252 789 ILDARMRPVPPGVAGDLYLTGIQLAQGYLGRPDLTASRFIADP------FAPGE-RMYRTGDVARWLDDGAVEYLGRSDD 861
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 623 QVKLNGQRVELGEIEH--QAQPYFRDAVIAAEV----AAPAGRKPILILFIARkyEYSVNMDCTMLLrppsilfqekaqg 696
Cdd:PRK10252 862 QLKIRGQRIELGEIDRamQALPDVEQAVTHACVinqaAATGGDARQLVGYLVS--QSGLPLDTSALQ------------- 926
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 697 tnTLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLrEAVEQASEKDFRAyypithndmiqlPSTPVLDQLRLLFSAAL 776
Cdd:PRK10252 927 --AQLRERLPPHMVPVVLLQLDQLPLSANGKLDRKAL-PLPELKAQVPGRA------------PKTGTETIIAAAFSSLL 991
|
650 660 670 680 690
....*....|....*....|....*....|....*....|....*....|...
gi 992230864 777 RIPEEKIkpNDSFFHLGGDSVSAIRLVGD-ARDQGLHITVESLFKRQTISKLA 828
Cdd:PRK10252 992 GCDVVDA--DADFFALGGHSLLAMKLAAQlSRQFARQVTPGQVMVASTVAKLA 1042
|
|
| MenE/FadK |
COG0318 |
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid ... |
234-741 |
2.05e-73 |
|
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) is part of the Pathway/BioSystem: Menaquinone biosynthesis
Pssm-ID: 440087 [Multi-domain] Cd Length: 452 Bit Score: 253.19 E-value: 2.05e-73
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 234 IHTLFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLD 313
Cdd:COG0318 1 LADLLRRAAARHPDRPALVFGGRRLTYAELDARARRLAAALRALGVGPGDRVALLLPNSPEFVVAFLAALRAGAVVVPLN 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 314 QSYPTKRLVNICKDVDAKVIVCsqelsigvsgstlsigdhntetatysaiqavntashdaAYVVYTSGSTGAPKGIVIEH 393
Cdd:COG0318 81 PRLTAEELAYILEDSGARALVT--------------------------------------ALILYTSGTTGRPKGVMLTH 122
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 394 GSFCTNAIASSQAQNLDRSSRVLQ----FASYAFDVSVhesLTPLLLGGC-VCIPS-EAQRVNslkEAVSTLRVNWVELT 467
Cdd:COG0318 123 RNLLANAAAIAAALGLTPGDVVLValplFHVFGLTVGL---LAPLLAGATlVLLPRfDPERVL---ELIERERVTVLFGV 196
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 468 PTVARLWC------PADIPTVKTLVMGGEPMLPNDISLWKDKL--RLVCAYGPAECTVVSTV---QSCVQELGNIGRSPC 536
Cdd:COG0318 197 PTMLARLLrhpefaRYDLSSLRLVVSGGAPLPPELLERFEERFgvRIVEGYGLTETSPVVTVnpeDPGERRPGSVGRPLP 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 537 GT-CWIVskDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFItnpewaslfhlNGsyrFYKTGDLVRYNADGTIA 615
Cdd:COG0318 277 GVeVRIV--DEDGRELPPGEVGEIVVRGPNVMKGYWNDPEATAEAFR-----------DG---WLRTGDLGRLDEDGYLY 340
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 616 YIGRKDTQVKLNGQRVELGEIEH--QAQPYFRDAVIAAEVAAPAGRKPILILFiarkyeysvnmdctmlLRPPSILfqeK 693
Cdd:COG0318 341 IVGRKKDMIISGGENVYPAEVEEvlAAHPGVAEAAVVGVPDEKWGERVVAFVV----------------LRPGAEL---D 401
|
490 500 510 520
....*....|....*....|....*....|....*....|....*...
gi 992230864 694 AQGTNTLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLREAVEQAS 741
Cdd:COG0318 402 AEELRAFLRERLARYKVPRRVEFVDELPRTASGKIDRRALRERYAAGA 449
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
191-1024 |
2.97e-72 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 270.12 E-value: 2.97e-72
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 191 QIIHCVIHSPGRPFADSCLLSKHHQDQI-AEWNRNAPIHPFDSCIHTLFRLQCILQPDAQAICAWDGTITYRQLDRLSST 269
Cdd:PRK05691 2146 NLLEALLGDPQQRLAELPLLAAAEQQQLlDSLAGEAGEARLDQTLHGLFAAQAARTPQAPALTFAGQTLSYAELDARANR 2225
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 270 VQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDV-------DAKVIVCSQELSIG 342
Cdd:PRK05691 2226 LARALRERGVGPQVRVGLALERSLEMVVGLLAILKAGGAYVPLDPEYPLERLHYMIEDSgiglllsDRALFEALGELPAG 2305
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 343 VSGSTLSigDHNTETATYSA--IQAVNTASHDAaYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFAS 420
Cdd:PRK05691 2306 VARWCLE--DDAAALAAYSDapLPFLSLPQHQA-YLIYTSGSTGKPKGVVVSHGEIAMHCQAVIERFGMRADDCELHFYS 2382
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 421 YAFDVSVHESLTPLLLGGCVCIPSEAQ-RVNSLKEAVSTLRVNWVELTPTVAR-----LWCPADIPTVKTLVMGGEPMLP 494
Cdd:PRK05691 2383 INFDAASERLLVPLLCGARVVLRAQGQwGAEEICQLIREQQVSILGFTPSYGSqlaqwLAGQGEQLPVRMCITGGEALTG 2462
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 495 NDISLWKDKLR---LVCAYGPAEcTVVSTVQSCVQEL--GNIGRSPCG------TCWIVSKDnhHRLMPVGCIGELIIGG 563
Cdd:PRK05691 2463 EHLQRIRQAFApqlFFNAYGPTE-TVVMPLACLAPEQleEGAASVPIGrvvgarVAYILDAD--LALVPQGATGELYVGG 2539
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 564 PIVGRGYLKQPCLTANAFITNPewaslFHLNGSyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH--QAQ 641
Cdd:PRK05691 2540 AGLAQGYHDRPGLTAERFVADP-----FAADGG-RLYRTGDLVRLRADGLVEYVGRIDHQVKIRGFRIELGEIESrlLEH 2613
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 642 PYFRDAVIAAeVAAPAGRKpiLILFIARKyEYSVNMDCTMLLRppsilfqekaQGTNTLLQEVLPRHMIPAAYIELLAMP 721
Cdd:PRK05691 2614 PAVREAVVLA-LDTPSGKQ--LAGYLVSA-VAGQDDEAQAALR----------EALKAHLKQQLPDYMVPAHLILLDSLP 2679
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 722 ISRTGKVNRKLLREAVEQASEKDFRAyypithndmiqlPSTPVLDQLRLLFSAALRIpeEKIKPNDSFFHLGGDSVSAIR 801
Cdd:PRK05691 2680 LTANGKLDRRALPAPDPELNRQAYQA------------PRSELEQQLAQIWREVLNV--ERVGLGDNFFELGGDSILSIQ 2745
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 802 LVGDARDQGLHITVESLFKRQTISKLAEcthqmsngigspippfslldplgkgtyIAQATEQCSVFPEQIEDIYPCTPLQ 881
Cdd:PRK05691 2746 VVSRARQLGIHFSPRDLFQHQTVQTLAA---------------------------VATHSEAAQAEQGPLQGASGLTPIQ 2798
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 882 EALMAYTSKRPGAFQAQFRFQLPHQLDMLRLKEAWRIVIAANPILRTRIVfCHTGALQVVLRP--GEQLQW--------- 950
Cdd:PRK05691 2799 HWFFDSPVPQPQHWNQALLLEPRQALDPALLEQALQALVEHHDALRLRFS-QADGRWQAEYRAvtAQELLWqvtvadfae 2877
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 951 ------------DLINGvhtspgslmsygvPLVDMAITNDTAGklSRTFCLTMHHAIFDGWSYGLILGAVEDAYKHTNAV 1018
Cdd:PRK05691 2878 caalfadaqrslDLQQG-------------PLLRALLVDGPQG--QQRLLLAIHHLVVDGVSWRVLLEDLQALYRQLSAG 2942
|
....*.
gi 992230864 1019 QRPFAP 1024
Cdd:PRK05691 2943 AEPALP 2948
|
|
| AMP-binding |
pfam00501 |
AMP-binding enzyme; |
238-626 |
5.82e-71 |
|
AMP-binding enzyme;
Pssm-ID: 459834 [Multi-domain] Cd Length: 417 Bit Score: 244.91 E-value: 5.82e-71
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 238 FRLQCILQPDAQAICAWDG-TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSY 316
Cdd:pfam00501 1 LERQAARTPDKTALEVGEGrRLTYRELDERANRLAAGLRALGVGKGDRVAILLPNSPEWVVAFLACLKAGAVYVPLNPRL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 317 PTKRLVNICKDVDAKVIVCSQELSIGVSGSTLSIGDHNTETATYSA--------------------IQAVNTASHDAAYV 376
Cdd:pfam00501 81 PAEELAYILEDSGAKVLITDDALKLEELLEALGKLEVVKLVLVLDRdpvlkeeplpeeakpadvppPPPPPPDPDDLAYI 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 377 VYTSGSTGAPKGIVIEHGSFCTNAIASSQAQ----NLDRSSRVLQFASYAFDVSV-HESLTPLLLGGCVCIPSEAQR--V 449
Cdd:pfam00501 161 IYTSGTTGKPKGVMLTHRNLVANVLSIKRVRprgfGLGPDDRVLSTLPLFHDFGLsLGLLGPLLAGATVVLPPGFPAldP 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 450 NSLKEAVSTLRVNWVELTPTVARLW------CPADIPTVKTLVMGGEPMLPNDISLWKDKLR--LVCAYGPAECTVVSTV 521
Cdd:pfam00501 241 AALLELIERYKVTVLYGVPTLLNMLleagapKRALLSSLRLVLSGGAPLPPELARRFRELFGgaLVNGYGLTETTGVVTT 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 522 ----QSCVQELGNIGRSPCGTCWIVSKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNpewaslfhlngsy 597
Cdd:pfam00501 321 plplDEDLRSLGSVGRPLPGTEVKIVDDETGEPVPPGEPGELCVRGPGVMKGYLNDPELTAEAFDED------------- 387
|
410 420
....*....|....*....|....*....
gi 992230864 598 RFYKTGDLVRYNADGTIAYIGRKDTQVKL 626
Cdd:pfam00501 388 GWYRTGDLGRRDEDGYLEIVGRKKDQIKL 416
|
|
| A_NRPS_ACVS-like |
cd17648 |
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV ... |
246-733 |
8.97e-70 |
|
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV synthetase (ACVS, EC 6.3.2.26; also known as N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase or delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase) is involved in medically important antibiotic biosynthesis. ACV synthetase is active in an early step in the penicillin G biosynthesis pathway which involves the formation of the tripeptide 6-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine (ACV); each of the constituent amino acids of the tripeptide ACV are activated as aminoacyl-adenylates with peptide bonds formed through the participation of amino acid thioester intermediates. ACV is then cyclized by the action of isopenicillin N synthase.
Pssm-ID: 341303 [Multi-domain] Cd Length: 453 Bit Score: 242.69 E-value: 8.97e-70
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDGTITYRQLD-RLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNI 324
Cdd:cd17648 1 PDRVAVVYGDKRLTYRELNeRANRLAHYLLSVAEIRPDDLVGLVLDKSELMIIAILAVWKAGAAYVPIDPSYPDERIQFI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 325 CKDVDAKVIVcsqelsigvsgstlsigdhntetatysaiqavnTASHDAAYVVYTSGSTGAPKGIVIEHGS---FCTNAI 401
Cdd:cd17648 81 LEDTGARVVI---------------------------------TNSTDLAYAIYTSGTTGKPKGVLVEHGSvvnLRTSLS 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 402 ASSQAQNlDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQRVN--SLKEAVSTLRVNWVELTPTVARLWCPADI 479
Cdd:cd17648 128 ERYFGRD-NGDEAVLFFSNYVFDFFVEQMTLALLNGQKLVVPPDEMRFDpdRFYAYINREKVTYLSGTPSVLQQYDLARL 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 480 PTVKTLVMGGEPMLPNDIslwkDKLR------LVCAYGPAECTVVSTVQ--SCVQELGN-IGRSPCGTCWIVSKDNHHRL 550
Cdd:cd17648 207 PHLKRVDAAGEEFTAPVF----EKLRsrfaglIINAYGPTETTVTNHKRffPGDQRFDKsLGRPVRNTKCYVLNDAMKRV 282
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 551 mPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPEWASLFHLNGSY-RFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQ 629
Cdd:cd17648 283 -PVGAVGELYLGGDGVARGYLNRPELTAERFLPNPFQTEQERARGRNaRLYKTGDLVRWLPSGELEYLGRNDFQVKIRGQ 361
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 630 RVELGEIEHQAQPY---FRDAVIAAEVAAPAGrkpililfiARKYEYSVnmdCTMLLRPPSIlfqeKAQGTNTLLQEVLP 706
Cdd:cd17648 362 RIEPGEVEAALASYpgvRECAVVAKEDASQAQ---------SRIQKYLV---GYYLPEPGHV----PESDLLSFLRAKLP 425
|
490 500
....*....|....*....|....*..
gi 992230864 707 RHMIPAAYIELLAMPISRTGKVNRKLL 733
Cdd:cd17648 426 RYMVPARLVRLEGIPVTINGKLDVRAL 452
|
|
| A_NRPS_LgrA-like |
cd17645 |
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This ... |
235-733 |
1.18e-65 |
|
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes linear gramicidin synthetase (LgrA) in Brevibacillus brevis. LgrA has a formylation domain fused to the N-terminal end that formylates its substrate for linear gramicidin synthesis to proceed. This formyl group is essential for the clinically important antibacterial activity of gramicidin by enabling head-to-head gramicidin dimers to make a beta-helical pore in gram-positive bacterial membranes, allowing free passage of monovalent cations, destroying the ion gradient and killing bacteria. This family also includes bacitracin synthetase 1 (known as ATP-dependent cysteine adenylase or BA1); it activates cysteine, incorporates two D-amino acids, releases and cyclizes the mature bacitracin, an antibiotic that is a mixture of related cyclic peptides that disrupt gram positive bacteria by interfering with cell wall and peptidoglycan synthesis. Also included is surfactin synthetase which activates and polymerizes the amino acids Leu, Glu, Asp, and Val to form the antibiotic surfactin.
Pssm-ID: 341300 [Multi-domain] Cd Length: 440 Bit Score: 230.13 E-value: 1.18e-65
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 235 HTLFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQ 314
Cdd:cd17645 1 HQLFEEQVERTPDHVAVVDRGQSLTYKQLNEKANQLARHLRGKGVKPDDQVGIMLDKSLDMIAAILGVLKAGGAYVPIDP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 315 SYPTKRLVNICKDVDAKVIVcsqelsigvsgstlsigdhntetatysaiqavnTASHDAAYVVYTSGSTGAPKGIVIEHG 394
Cdd:cd17645 81 DYPGERIAYMLADSSAKILL---------------------------------TNPDDLAYVIYTSGSTGLPKGVMIEHH 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 395 SFCTNAIASSQAQNLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQR--VNSLKEAVSTLRVNWVELTPTVAR 472
Cdd:cd17645 128 NLVNLCEWHRPYFGVTPADKSLVYASFSFDASAWEIFPHLTAGAALHVVPSERRldLDALNDYFNQEGITISFLPTGAAE 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 473 LWCPADIPTVKTLVMGGEPMlpNDISlwKDKLRLVCAYGPAECTVVSTVQSCVQELGN--IGRSPCGT-CWIVSKDNhhR 549
Cdd:cd17645 208 QFMQLDNQSLRVLLTGGDKL--KKIE--RKGYKLVNNYGPTENTVVATSFEIDKPYANipIGKPIDNTrVYILDEAL--Q 281
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 550 LMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPEWASlfhlngsYRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQ 629
Cdd:cd17645 282 LQPIGVAGELCIAGEGLARGYLNRPELTAEKFIVHPFVPG-------ERMYRTGDLAKFLPDGNIEFLGRLDQQVKIRGY 354
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 630 RVELGEIEHQAQPYFR---DAVIAAEvaaPAGRKPILILFIArkyeysvnmdctmllrPPSILFQEKAQGTntlLQEVLP 706
Cdd:cd17645 355 RIEPGEIEPFLMNHPLielAAVLAKE---DADGRKYLVAYVT----------------APEEIPHEELREW---LKNDLP 412
|
490 500
....*....|....*....|....*..
gi 992230864 707 RHMIPAAYIELLAMPISRTGKVNRKLL 733
Cdd:cd17645 413 DYMIPTYFVHLKALPLTANGKVDRKAL 439
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
182-807 |
6.12e-61 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 233.14 E-value: 6.12e-61
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 182 ANNIISTLEQiihcVIHSPGRPFADSCLLSKHHQDQIAEWNRnAPIHPFDSCIHTLFRLQCILQPDAQAIcAWDG-TITY 260
Cdd:PRK05691 1086 AEHFLALLEQ----VCEDPQRALGDVQLLDAAERAQLAQWGQ-APCAPAQAWLPELLNEQARQTPERIAL-VWDGgSLDY 1159
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 261 RQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVCSQELS 340
Cdd:PRK05691 1160 AELHAQANRLAHYLRDKGVGPDVCVAIAAERSPQLLVGLLAILKAGGAYVPLDPDYPAERLAYMLADSGVELLLTQSHLL 1239
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 341 IGVSGS--TLSIGDHNTETATY-SAIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQ 417
Cdd:PRK05691 1240 ERLPQAegVSAIALDSLHLDSWpSQAPGLHLHGDNLAYVIYTSGSTGQPKGVGNTHAALAERLQWMQATYALDDSDVLMQ 1319
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 418 FASYAFDVSVHESLTPLLLGGCVCIPS-----EAQRVNSL--KEAVSTLrvnwvELTPTVARLWC----PADIPTVKTLV 486
Cdd:PRK05691 1320 KAPISFDVSVWECFWPLITGCRLVLAGpgehrDPQRIAELvqQYGVTTL-----HFVPPLLQLFIdeplAAACTSLRRLF 1394
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 487 MGGE---PMLPNDISLWKDKLRLVCAYGPAECTVVSTVQSCVQELGN---IGRsPCGTCWIVSKDNHHRLMPVGCIGELI 560
Cdd:PRK05691 1395 SGGEalpAELRNRVLQRLPQVQLHNRYGPTETAINVTHWQCQAEDGErspIGR-PLGNVLCRVLDAELNLLPPGVAGELC 1473
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 561 IGGPIVGRGYLKQPCLTANAFITNPEWaslfhlNGSYRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEHQ- 639
Cdd:PRK05691 1474 IGGAGLARGYLGRPALTAERFVPDPLG------EDGARLYRTGDRARWNADGALEYLGRLDQQVKLRGFRVEPEEIQARl 1547
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 640 -AQPYFRDAVIAAEVAApAGrkPILILFiarkYEYSVNMDctmllrppsilfqEKAQGTNTLLQEVLPRHMIPAAYIELL 718
Cdd:PRK05691 1548 lAQPGVAQAAVLVREGA-AG--AQLVGY----YTGEAGQE-------------AEAERLKAALAAELPEYMVPAQLIRLD 1607
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 719 AMPISRTGKVNRKLLREAVEQASEkdfrayypitHNDmiqlPSTPVLDQLRLLFSAALRIPeeKIKPNDSFFHLGGDSVS 798
Cdd:PRK05691 1608 QMPLGPSGKLDRRALPEPVWQQRE----------HVE----PRTELQQQIAAIWREVLGLP--RVGLRDDFFALGGHSLL 1671
|
....*....
gi 992230864 799 AIRLVGDAR 807
Cdd:PRK05691 1672 ATQIVSRTR 1680
|
|
| CT_NRPS-like |
cd19542 |
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike ... |
874-1265 |
1.13e-55 |
|
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike bacterial NRPS, which typically have specialized terminal thioesterase (TE) domains to cyclize peptide products, many fungal NRPSs employ a terminal condensation-like (CT) domain to produce macrocyclic peptidyl products (e.g. cyclosporine and echinocandin). Domains in this subfamily (which includes both terminal and non-terminal domains) typically have a non-canonical conserved [SN]HxxxDx(14)Y motif at their active site compared to the standard Condensation (C) domain active site motif (HHxxxD). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380464 [Multi-domain] Cd Length: 401 Bit Score: 199.84 E-value: 1.13e-55
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 874 IYPCTPLQEALMAYTSKRPGAFQAQFRFQLPHQLDMLRLKEAWRIVIAANPILRTriVFCHTGA----LQVVLRpgeQLQ 949
Cdd:cd19542 1 IYPCTPMQEGMLLSQLRSPGLYFNHFVFDLDSSVDVERLRNAWRQLVQRHDILRT--VFVESSAegtfLQVVLK---SLD 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 950 WDLInGVHTSPGSLMSY-----------GVPLVDMAITNDTAGKlsRTFCLTMHHAIFDGWSYGLILGAVEDAYKHTNAV 1018
Cdd:cd19542 76 PPIE-EVETDEDSLDALtrdllddptlfGQPPHRLTLLETSSGE--VYLVLRISHALYDGVSLPIILRDLAAAYNGQLLP 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1019 QRP-FAPFIKYILHCNYESAKHFWCSEFKDMQALPFPVpplsrghmANSSTTTHRQIHVSEW----LSSYC-----TPST 1088
Cdd:cd19542 153 PAPpFSDYISYLQSQSQEESLQYWRKYLQGASPCAFPS--------LSPKRPAERSLSSTRRslakLEAFCaslgvTLAS 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1089 IIQLAFTLLIAWRTESMDVLFGLTVTGRNAPVAGIHRTTGPTIATFPLRTILYGTMNITDALLCMQNHIATLIPFEHTGL 1168
Cdd:cd19542 225 LFQAAWALVLARYTGSRDVVFGYVVSGRDLPVPGIDDIVGPCINTLPVRVKLDPDWTVLDLLRQLQQQYLRSLPHQHLSL 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1169 RRIKSFGTETARACQFQSLLIIQPVTYRESSEIFFELESNEHEQSKFSTCPLTLVCELRTHSVSVKAISDNAVVISGDME 1248
Cdd:cd19542 305 REIQRALGLWPSGTLFNTLVSYQNFEASPESELSGSSVFELSAAEDPTEYPVAVEVEPSGDSLKVSLAYSTSVLSEEQAE 384
|
410
....*....|....*..
gi 992230864 1249 RLLDQLEYLIDMITKSP 1265
Cdd:cd19542 385 ELLEQFDDILEALLANP 401
|
|
| PRK04813 |
PRK04813 |
D-alanine--poly(phosphoribitol) ligase subunit DltA; |
245-737 |
1.22e-55 |
|
D-alanine--poly(phosphoribitol) ligase subunit DltA;
Pssm-ID: 235313 [Multi-domain] Cd Length: 503 Bit Score: 202.82 E-value: 1.22e-55
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 245 QPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVpIIF-KKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVN 323
Cdd:PRK04813 15 QPDFPAYDYLGEKLTYGQLKEDSDALAAFIDSLKLPDKSPI-IVFgHMSPEMLATFLGAVKAGHAYIPVDVSSPAERIEM 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 324 ICKDVDAKVIVCSQELSIGVSG-STLSIGDHNTETA---TYSAIQAVNtaSHDAAYVVYTSGSTGAPKGIVIEHG---SF 396
Cdd:PRK04813 94 IIEVAKPSLIIATEELPLEILGiPVITLDELKDIFAtgnPYDFDHAVK--GDDNYYIIFTSGTTGKPKGVQISHDnlvSF 171
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 397 cTNAIASsqAQNLDRSSRVLQFASYAFDVSVHeSLTP-LLLGGC-VCIPSEA-QRVNSLKEAVSTLRVN-WVElTPTVAR 472
Cdd:PRK04813 172 -TNWMLE--DFALPEGPQFLNQAPYSFDLSVM-DLYPtLASGGTlVALPKDMtANFKQLFETLPQLPINvWVS-TPSFAD 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 473 L------WCPADIPTVKTLVMGGEpMLPNDISlwkDKL-------RLVCAYGPAECTV-VSTVQSCVQELGNIGRSPCG- 537
Cdd:PRK04813 247 MclldpsFNEEHLPNLTHFLFCGE-ELPHKTA---KKLlerfpsaTIYNTYGPTEATVaVTSIEITDEMLDQYKRLPIGy 322
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 538 ---TCWIVSKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFitnpewaslFHLNGsYRFYKTGDLVrYNADGTI 614
Cdd:PRK04813 323 akpDSPLLIIDEEGTKLPDGEQGEIVISGPSVSKGYLNNPEKTAEAF---------FTFDG-QPAYHTGDAG-YLEDGLL 391
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 615 AYIGRKDTQVKLNGQRVELGEIEHQ--AQPYFRDAviaaeVAAPagrkpililfiarkyeYSVNMDCTMLLR---PPSIL 689
Cdd:PRK04813 392 FYQGRIDFQIKLNGYRIELEEIEQNlrQSSYVESA-----VVVP----------------YNKDHKVQYLIAyvvPKEED 450
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|.
gi 992230864 690 FQEKAQGTNTL---LQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLREAV 737
Cdd:PRK04813 451 FEREFELTKAIkkeLKERLMEYMIPRKFIYRDSLPLTPNGKIDRKALIEEV 501
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
205-829 |
3.03e-55 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 214.26 E-value: 3.03e-55
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 205 ADSCLLSKHHQD-QIAEWNRNAPIHPFDSCIHTLFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGS 283
Cdd:PRK05691 3692 SELPLLGEQERDfLLDGCNRSERDYPLEQSYVRLFEAQVAAHPQRIAASCLDQQWSYAELNRAANRLGHALRAAGVGVDQ 3771
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 284 VVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVCSQE-LSIGVSGSTLSIGDHNTETATYSA 362
Cdd:PRK05691 3772 PVALLAERGLDLLGMIVGSFKAGAGYLPLDPGLPAQRLQRIIELSRTPVLVCSAAcREQARALLDELGCANRPRLLVWEE 3851
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 363 IQAVNTASHDA---------AYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASYAFDVSVHESLTP 433
Cdd:PRK05691 3852 VQAGEVASHNPgiysgpdnlAYVIYTSGSTGLPKGVMVEQRGMLNNQLSKVPYLALSEADVIAQTASQSFDISVWQFLAA 3931
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 434 LLLGGCVCI-PSE-AQRVNSLKEAVSTLRVNWVELTPTVARLWCPAD---IPTVKTLVMGGEPMLPNDISLWKDK---LR 505
Cdd:PRK05691 3932 PLFGARVEIvPNAiAHDPQGLLAHVQAQGITVLESVPSLIQGMLAEDrqaLDGLRWMLPTGEAMPPELARQWLQRypqIG 4011
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 506 LVCAYGPAECT---------VVSTVQSCVQelgnIGrSPCGTCWIVSKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCL 576
Cdd:PRK05691 4012 LVNAYGPAECSddvaffrvdLASTRGSYLP----IG-SPTDNNRLYLLDEALELVPLGAVGELCVAGTGVGRGYVGDPLR 4086
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 577 TANAFITNPewaslFHLNGSyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIE---HQaQPYFRDAVIAAeV 653
Cdd:PRK05691 4087 TALAFVPHP-----FGAPGE-RLYRTGDLARRRSDGVLEYVGRIDHQVKIRGYRIELGEIEarlHE-QAEVREAAVAV-Q 4158
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 654 AAPAGRKPIlilfiarkyEYSVNMDCTMLlrpPSILFQEKAQgtntLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLL 733
Cdd:PRK05691 4159 EGVNGKHLV---------GYLVPHQTVLA---QGALLERIKQ----RLRAELPDYMVPLHWLWLDRLPLNANGKLDRKAL 4222
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 734 REA-VEQASEKDFRAyypithndmiqlPSTPVLDQLRLLFSAALRIpeEKIKPNDSFFHLGGDSVSAIRLVGDARDQ-GL 811
Cdd:PRK05691 4223 PALdIGQLQSQAYLA------------PRNELEQTLATIWADVLKV--ERVGVHDNFFELGGHSLLATQIASRVQKAlQR 4288
|
650
....*....|....*...
gi 992230864 812 HITVESLFKRQTISKLAE 829
Cdd:PRK05691 4289 NVPLRAMFECSTVEELAE 4306
|
|
| AFD_class_I |
cd04433 |
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as ... |
372-728 |
2.22e-40 |
|
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as the ANL (acyl-CoA synthetases, the NRPS adenylation domains, and the Luciferase enzymes) superfamily. It includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases.The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341228 [Multi-domain] Cd Length: 336 Bit Score: 153.60 E-value: 2.22e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 372 DAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASYaFDVSVHESL-TPLLLGGCVCI--PSEAQR 448
Cdd:cd04433 1 DPALILYTSGTTGKPKGVVLSHRNLLAAAAALAASGGLTEGDVFLSTLPL-FHIGGLFGLlGALLAGGTVVLlpKFDPEA 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 449 VNslkEAVSTLRVNWVELTPTVARLWC------PADIPTVKTLVMGGEPMLPNDISLWKD--KLRLVCAYGPAECTVVST 520
Cdd:cd04433 80 AL---ELIEREKVTILLGVPTLLARLLkapesaGYDLSSLRALVSGGAPLPPELLERFEEapGIKLVNGYGLTETGGTVA 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 521 vqSCVQELGNIGRSPCGTCWIVSK----DNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTanAFITNPEWaslfhlngs 596
Cdd:cd04433 157 --TGPPDDDARKPGSVGRPVPGVEvrivDPDGGELPPGEIGELVVRGPSVMKGYWNNPEAT--AAVDEDGW--------- 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 597 yrfYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRDAVIaaeVAAP-AGRKPILILFIArkyey 673
Cdd:cd04433 224 ---YRTGDLGRLDEDGYLYIVGRLKDMIKSGGENVYPAEVEAvlLGHPGVAEAAV---VGVPdPEWGERVVAVVV----- 292
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*
gi 992230864 674 svnmdctmlLRPPSILFQEKAQgtnTLLQEVLPRHMIPAAYIELLAMPISRTGKV 728
Cdd:cd04433 293 ---------LRPGADLDAEELR---AHVRERLAPYKVPRRVVFVDALPRTASGKI 335
|
|
| FUM14_C_NRPS-like |
cd19545 |
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond ... |
1545-1952 |
4.26e-39 |
|
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond forming Fusarium verticillioides FUM14 protein; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) typically catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. However, some C-domains have ester-bond forming activity. This subfamily includes Fusarium verticillioides FUM14 (also known as NRPS8), a bi-domain protein with an ester-bond forming NRPS C-domain, which catalyzes linkages between an aminoacyl/peptidyl-PCP donor and a hydroxyl-containing acceptor. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. FUM14 has an altered active site motif DHTHCD instead of the typical HHxxxD motif seen in other subfamily members. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380467 [Multi-domain] Cd Length: 395 Bit Score: 151.30 E-value: 4.26e-39
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1545 AYPCSESHQGLLQTQMLRPFYYQSYTIWEVttrskSSPVSPVRLCNAWFTLARRHPALRTHLIDIPLCDGMsskiHVVHK 1624
Cdd:cd19545 1 IYPCTPLQEGLMALTARQPGAYVGQRVFEL-----PPDIDLARLQAAWEQVVQANPILRTRIVQSDSGGLL----QVVVK 71
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1625 DYmadaaILSCEDEHVITEL--RKPFLPSDTGLYyPHAFRICQTVSGRVFCKLEGGHAFLDATSVLIILRELAQAYDGQL 1702
Cdd:cd19545 72 ES-----PISWTESTSLDEYleEDRAAPMGLGGP-LVRLALVEDPDTERYFVWTIHHALYDGWSLPLILRQVLAAYQGEP 145
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1703 SSVPgPSYSSAVAWLQSLPNGDNRmDYWRRQLKDASPCIFPRL---RDQDSPSDTLVVTEQLastatltPVCTRHGLTVS 1779
Cdd:cd19545 146 VPQP-PPFSRFVKYLRQLDDEAAA-EFWRSYLAGLDPAVFPPLpssRYQPRPDATLEHSISL-------PSSASSGVTLA 216
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1780 NVLQVAWGLMLRRYTESDDVCFGALISGRDSRIPDVDKMVGPFFNVLVCQLRFGREDSLWDVLRRNQTEIGNRLLNQHCS 1859
Cdd:cd19545 217 TVLRAAWALVLSRYTGSDDVVFGVTLSGRNAPVPGIEQIVGPTIATVPLRVRIDPEQSVEDFLQTVQKDLLDMIPFEHTG 296
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1860 LIEVLRFSTYFGQ-PLFNTCISVeQPLSMDTPDASLCFKELETLEP----TEYGIIATITIGTTDVGLGLTYKSDLLTED 1934
Cdd:cd19545 297 LQNIRRLGPDARAaCNFQTLLVV-QPALPSSTSESLELGIEEESEDledfSSYGLTLECQLSGSGLRVRARYDSSVISEE 375
|
410
....*....|....*...
gi 992230864 1935 QALAVADRFKMSITEIMG 1952
Cdd:cd19545 376 QVERLLDQFEHVLQQLAS 393
|
|
| DCL_NRPS |
cd19543 |
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the ... |
874-1265 |
3.25e-37 |
|
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor; The DCL-type Condensation (C) domain catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. This domain is D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains in addition to the LCL- and DCL-types such as starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380465 [Multi-domain] Cd Length: 423 Bit Score: 146.58 E-value: 3.25e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 874 IYPCTPLQE-----ALMAYTSkrpGAFQAQFRFQLPHQLDMLRLKEAWRIVIAANPILRTRIVFCHTG-ALQVVLRPGEq 947
Cdd:cd19543 1 IYPLSPMQEgmlfhSLLDPGS---GAYVEQMVITLEGPLDPDRFRAAWQAVVDRHPILRTSFVWEGLGePLQVVLKDRK- 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 948 LQWDLINGVHTSP-----------------------GSLMSygVPLVDMAitnDTAGKLSRTFcltmHHAIFDGWSYGLI 1004
Cdd:cd19543 77 LPWRELDLSHLSEaeqeaelealaeedrergfdlarAPLMR--LTLIRLG---DDRYRLVWSF----HHILLDGWSLPIL 147
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1005 LGAVEDAYKHTNAVQ-------RPFAPFIKYILHCNYESAKHFWCSEFKDMQALPfPVPPLSRGHMANSSTTTHRQIHVS 1077
Cdd:cd19543 148 LKELFAIYAALGEGQppslppvRPYRDYIAWLQRQDKEAAEAYWREYLAGFEEPT-PLPKELPADADGSYEPGEVSFELS 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1078 EWLSSYC---------TPSTIIQLAFTLLIAWRTESMDVLFGLTVTGRNAPVAGIHRTTGPTIATFPLRTILYGTMNITD 1148
Cdd:cd19543 227 AELTARLqelarqhgvTLNTVVQGAWALLLSRYSGRDDVVFGTTVSGRPAELPGIETMVGLFINTLPVRVRLDPDQTVLE 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1149 ALLCMQNHIATLIPFEHTGLRRIKSfGTETARACqFQSLLIIQ--PV-----TYRESSEIFFELESNEhEQSKFstcPLT 1221
Cdd:cd19543 307 LLKDLQAQQLELREHEYVPLYEIQA-WSEGKQAL-FDHLLVFEnyPVdesleEEQDEDGLRITDVSAE-EQTNY---PLT 380
|
410 420 430 440
....*....|....*....|....*....|....*....|....
gi 992230864 1222 LVCeLRTHSVSVKAISDNAVVISGDMERLLDQLEYLIDMITKSP 1265
Cdd:cd19543 381 VVA-IPGEELTIKLSYDAEVFDEATIERLLGHLRRVLEQVAANP 423
|
|
| DCL_NRPS |
cd19543 |
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the ... |
1582-1944 |
8.23e-37 |
|
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor; The DCL-type Condensation (C) domain catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. This domain is D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains in addition to the LCL- and DCL-types such as starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380465 [Multi-domain] Cd Length: 423 Bit Score: 145.42 E-value: 8.23e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1582 PVSPVRLCNAWFTLARRHPALRTHLIDiplcDGMSSKIHVVHKDYMADAAIL------SCEDEHVITEL-----RKPFLP 1650
Cdd:cd19543 35 PLDPDRFRAAWQAVVDRHPILRTSFVW----EGLGEPLQVVLKDRKLPWRELdlshlsEAEQEAELEALaeedrERGFDL 110
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1651 SDTGLyyphaFRIC--QTVSGRVFCKLEGGHAFLDATSVLIILRELAQAY----DGQLSSVPGP-SYSSAVAWLQSLPNG 1723
Cdd:cd19543 111 ARAPL-----MRLTliRLGDDRYRLVWSFHHILLDGWSLPILLKELFAIYaalgEGQPPSLPPVrPYRDYIAWLQRQDKE 185
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1724 DNRmDYWRRQLK---DASPCIFPRLRDQDSPSDTLVVTEQLASTAT--LTPVCTRHGLTVSNVLQVAWGLMLRRYTESDD 1798
Cdd:cd19543 186 AAE-AYWREYLAgfeEPTPLPKELPADADGSYEPGEVSFELSAELTarLQELARQHGVTLNTVVQGAWALLLSRYSGRDD 264
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1799 VCFGALISGRDSRIPDVDKMVGPFFNVLVCQLRFGREDSLWDVLRRNQTEIGNRLLNQHCSLIEVLRFSTyFGQPLFNTC 1878
Cdd:cd19543 265 VVFGTTVSGRPAELPGIETMVGLFINTLPVRVRLDPDQTVLELLKDLQAQQLELREHEYVPLYEIQAWSE-GKQALFDHL 343
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 992230864 1879 ISVE-----QPLSMDTPDASLCFKELETLEPTEYGIIATitigttdVGLG------LTYKSDLLTEDQALAVADRFK 1944
Cdd:cd19543 344 LVFEnypvdESLEEEQDEDGLRITDVSAEEQTNYPLTVV-------AIPGeeltikLSYDAEVFDEATIERLLGHLR 413
|
|
| A_NRPS_acs4 |
cd17654 |
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal ... |
255-733 |
7.28e-36 |
|
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains acyl-CoA synthethase family member 4, also known as 2-aminoadipic 6-semialdehyde dehydrogenase or aminoadipate-semialdehyde dehydrogenase, most of which are uncharacterized. Acyl-CoA synthetase catalyzes the initial reaction in fatty acid metabolism, by forming a thioester with CoA. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341309 [Multi-domain] Cd Length: 449 Bit Score: 143.38 E-value: 7.28e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 255 DGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIV 334
Cdd:cd17654 14 DTTVSYADLAEKISNLSNFLRKKFQTEERAIGLRCDRGTESPVAILAILFLGAAYAPIDPASPEQRSLTVMKKCHVSYLL 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 335 csqelsigvsgstlsIGDHNTETATYSAIQAVNTA-SHDA--AYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLdR 411
Cdd:cd17654 94 ---------------QNKELDNAPLSFTPEHRHFNiRTDEclAYVIHTSGTTGTPKIVAVPHKCILPNIQHFRSLFNI-T 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 412 SSRVLQFASYA-FDVSVHESLTPLLLGGCVCIPSEAQRVNSLKEAVSTL---RVNWVELTPTVARLWCPADIP------- 480
Cdd:cd17654 158 SEDILFLTSPLtFDPSVVEIFLSLSSGATLLIVPTSVKVLPSKLADILFkrhRITVLQATPTLFRRFGSQSIKstvlsat 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 481 -TVKTLVMGGEPmLPND--ISLWK---DKLRLVCAYGPAECTVVSTVQSCVQELG--NIGrSPCGTCWIVSKDNHHRLMP 552
Cdd:cd17654 238 sSLRVLALGGEP-FPSLviLSSWRgkgNRTRIFNIYGITEVSCWALAYKVPEEDSpvQLG-SPLLGTVIEVRDQNGSEGT 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 553 vgciGELIIGGpIVGRGYLKQPCLTANAfitnpewaslfhlngsyRFYKTGDLVRYNaDGTIAYIGRKDTQVKLNGQRVE 632
Cdd:cd17654 316 ----GQVFLGG-LNRVCILDDEVTVPKG-----------------TMRATGDFVTVK-DGELFFLGRKDSQIKRRGKRIN 372
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 633 LGEIEHQAQPyfRDAVIAAEVAAPAGRKpiLILFIARKyeysvnmdctmllrppsilfQEKAQGTNTLLQEVLPRHMIPA 712
Cdd:cd17654 373 LDLIQQVIES--CLGVESCAVTLSDQQR--LIAFIVGE--------------------SSSSRIHKELQLTLLSSHAIPD 428
|
490 500
....*....|....*....|.
gi 992230864 713 AYIELLAMPISRTGKVNRKLL 733
Cdd:cd17654 429 TFVQIDKLPLTSHGKVDKSEL 449
|
|
| alpha_am_amid |
TIGR03443 |
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are ... |
230-837 |
1.11e-35 |
|
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), product of the LYS2 gene. It is also called alpha-aminoadipate reductase. In fungi, lysine is synthesized via aminoadipate. Currently, all members of this family are fungal.
Pssm-ID: 274582 [Multi-domain] Cd Length: 1389 Bit Score: 149.06 E-value: 1.11e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 230 FDSCIHTLF---------RLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAML 300
Cdd:TIGR03443 234 FRGAIHDIFadnaekhpdRTCVVETPSFLDPSSKTRSFTYKQINEASNILAHYLLKTGIKRGDVVMIYAYRGVDLVVAVM 313
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 301 GVLKAGAAFCMLDQSYPTKR------------LVNICK--DVDAKVI-VCSQELSIGVSGSTLSIGDHNTETATYSAIQA 365
Cdd:TIGR03443 314 GVLKAGATFSVIDPAYPPARqtiylsvakpraLIVIEKagTLDQLVRdYIDKELELRTEIPALALQDDGSLVGGSLEGGE 393
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 366 VNTASHDAAY------VV----------YTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASYAFDVSVHE 429
Cdd:TIGR03443 394 TDVLAPYQALkdtptgVVvgpdsnptlsFTSGSEGIPKGVLGRHFSLAYYFPWMAKRFGLSENDKFTMLSGIAHDPIQRD 473
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 430 SLTPLLLGGCVCIPS--EAQRVNSLKEAVSTLRVNWVELTPTVARLW---CPADIPTVKTLVMGGepmlpnDISLWKDKL 504
Cdd:TIGR03443 474 MFTPLFLGAQLLVPTadDIGTPGRLAEWMAKYGATVTHLTPAMGQLLsaqATTPIPSLHHAFFVG------DILTKRDCL 547
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 505 RL------VC---AYGPAEC---------TVVSTVQSCVQELGNIgrSPCGTCWI------VSKDNHHRLMPVGCIGELI 560
Cdd:TIGR03443 548 RLqtlaenVCivnMYGTTETqravsyfeiPSRSSDSTFLKNLKDV--MPAGKGMKnvqllvVNRNDRTQTCGVGEVGEIY 625
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 561 I--GGpiVGRGYLKQPCLTANAFITN---------------PEWASLFHLNGSYRFYKTGDLVRYNADGTIAYIGRKDTQ 623
Cdd:TIGR03443 626 VraGG--LAEGYLGLPELNAEKFVNNwfvdpshwidldkenNKPEREFWLGPRDRLYRTGDLGRYLPDGNVECCGRADDQ 703
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 624 VKLNGQRVELGEIE-HQAQ-PYFRDAVIAaeVAAPAGRKPILILFIARKYEySVNMDCTMLLRPPS----------ILFQ 691
Cdd:TIGR03443 704 VKIRGFRIELGEIDtHLSQhPLVRENVTL--VRRDKDEEPTLVSYIVPQDK-SDELEEFKSEVDDEessdpvvkglIKYR 780
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 692 EKAQGTNTLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLR----EAVEQASEKDFRAYYPITHndmiqlpsTPVLDQ 767
Cdd:TIGR03443 781 KLIKDIREYLKKKLPSYAIPTVIVPLKKLPLNPNGKVDKPALPfpdtAQLAAVAKNRSASAADEEF--------TETERE 852
|
650 660 670 680 690 700 710
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 992230864 768 LRLLFSAALRIPEEKIKPNDSFFHLGGDSVSAIRLVGDARDQ-GLHITVESLFKRQTISKLAECTHQMSNG 837
Cdd:TIGR03443 853 IRDLWLELLPNRPATISPDDSFFDLGGHSILATRMIFELRKKlNVELPLGLIFKSPTIKGFAKEVDRLKKG 923
|
|
| ligase_PEP_1 |
TIGR03098 |
acyl-CoA ligase (AMP-forming), exosortase A-associated; This group of proteins contains an ... |
234-733 |
2.91e-35 |
|
acyl-CoA ligase (AMP-forming), exosortase A-associated; This group of proteins contains an AMP-binding domain (pfam00501) associated with acyl CoA-ligases. These proteins are generally found in genomes containing the exosortase/PEP-CTERM protein expoert system, specifically the type 1 variant of this system described by the Genome Property GenProp0652. When found in this context they are invariably present next to a decarboxylase enzyme. A number of sequences from Burkholderia species also hit this model, but the genomic context is obviously different. The hypothesis of a constant substrate for this family is only strong where the exosortase context is present.
Pssm-ID: 211788 [Multi-domain] Cd Length: 517 Bit Score: 143.00 E-value: 2.91e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 234 IHTLFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLD 313
Cdd:TIGR03098 2 LHHLLEDAAARLPDATALVHHDRTLTYAALSERVLALASGLRGLGLARGERVAIYLDKRLETVTAMFGAALAGGVFVPIN 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 314 QSYPTKRLVNICKDVDAKVIVCSQE----LSIGVSG----STLSIGDHNTET----------------ATYSAIQAVNTA 369
Cdd:TIGR03098 82 PLLKAEQVAHILADCNVRLLVTSSErldlLHPALPGchdlRTLIIVGDPAHAseghpgeepaswpkllALGDADPPHPVI 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 370 SHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVcIPSEAQRV 449
Cdd:TIGR03098 162 DSDMAAILYTSGSTGRPKGVVLSHRNLVAGAQSVATYLENRPDDRLLAVLPLSFDYGFNQLTTAFYVGATV-VLHDYLLP 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 450 NSLKEAVSTLRVN--------WVELtptvARL-WCPADIPTVKTLVMGGEPMLPNDISLWKDKL---RLVCAYGPAECTV 517
Cdd:TIGR03098 241 RDVLKALEKHGITglaavpplWAQL----AQLdWPESAAPSLRYLTNSGGAMPRATLSRLRSFLpnaRLFLMYGLTEAFR 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 518 VSTVQScvQEL----GNIGRS-PCGTCWIVSKDNHHRLmpVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPEWASLFH 592
Cdd:TIGR03098 317 STYLPP--EEVdrrpDSIGKAiPNAEVLVLREDGSECA--PGEEGELVHRGALVAMGYWNDPEKTAERFRPLPPFPGELH 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 593 LNGSYRFykTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEhqaqpyfrDAVIA----AEVAAPAGRKPIL---IL 665
Cdd:TIGR03098 393 LPELAVW--SGDTVRRDEEGFLYFVGRRDEMIKTSGYRVSPTEVE--------EVAYAtglvAEAVAFGVPDPTLgqaIV 462
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 992230864 666 FIARkyeysvnmdctmllrpPSILFQEKAQGTNTLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLL 733
Cdd:TIGR03098 463 LVVT----------------PPGGEELDRAALLAECRARLPNYMVPALIHVRQALPRNANGKIDRKAL 514
|
|
| FC-FACS_FadD_like |
cd05936 |
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This ... |
237-734 |
2.48e-33 |
|
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This subfamily of the AMP-forming adenylation family contains Escherichia coli FadD and similar prokaryotic fatty acid CoA synthetases. FadD was characterized as a long-chain fatty acid CoA synthetase. The gene fadD is regulated by the fatty acid regulatory protein FadR. Fatty acid CoA synthetase catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341259 [Multi-domain] Cd Length: 468 Bit Score: 136.15 E-value: 2.48e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 237 LFRLQCILQPDAQAiCAWDG-TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQS 315
Cdd:cd05936 4 LLEEAARRFPDKTA-LIFMGrKLTYRELDALAEAFAAGLQNLGVQPGDRVALMLPNCPQFPIAYFGALKAGAVVVPLNPL 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 316 YPTKRLVNICKDVDAKVIVCSQELSigvsgstlsigdHNTETATYSAIQAVNTAsHDAAYVVYTSGSTGAPKGIVIEHGS 395
Cdd:cd05936 83 YTPRELEHILNDSGAKALIVAVSFT------------DLLAAGAPLGERVALTP-EDVAVLQYTSGTTGVPKGAMLTHRN 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 396 FCTNA--IASSQAQNLDRSSRVLQ----FASYAFDVSVhesLTPLLLGGC-VCIPS----------EAQRVNSLKeAVST 458
Cdd:cd05936 150 LVANAlqIKAWLEDLLEGDDVVLAalplFHVFGLTVAL---LLPLALGATiVLIPRfrpigvlkeiRKHRVTIFP-GVPT 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 459 LrvnWVELTPTVARLwcPADIPTVKTLVMGGEPMLPNDISLWKDKL--RLVCAYGPAECTVVSTVQSC--VQELGNIGRS 534
Cdd:cd05936 226 M---YIALLNAPEFK--KRDFSSLRLCISGGAPLPVEVAERFEELTgvPIVEGYGLTETSPVVAVNPLdgPRKPGSIGIP 300
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 535 PCGTCW-IVSKDNHhrLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFItnpewaslfhlNGsyrFYKTGDLVRYNADGT 613
Cdd:cd05936 301 LPGTEVkIVDDDGE--ELPPGEVGELWVRGPQVMKGYWNRPEETAEAFV-----------DG---WLRTGDIGYMDEDGY 364
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 614 IAYIGRKDTQVKLNGQRVELGEIE-----HqaqPYFRDAVIAAEVAAPAGRkpILILFIARKYEYSVNmdctmllrppsi 688
Cdd:cd05936 365 FFIVDRKKDMIIVGGFNVYPREVEevlyeH---PAVAEAAVVGVPDPYSGE--AVKAFVVLKEGASLT------------ 427
|
490 500 510 520
....*....|....*....|....*....|....*....|....*.
gi 992230864 689 lfqekAQGTNTLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLR 734
Cdd:cd05936 428 -----EEEIIAFCREQLAGYKVPRQVEFRDELPKSAVGKILRRELR 468
|
|
| DCL_NRPS-like |
cd19536 |
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal ... |
1545-1952 |
5.55e-30 |
|
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal fungal CT domains and Dual Epimerization/Condensation (E/C) domains; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type [D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L))], which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380459 [Multi-domain] Cd Length: 419 Bit Score: 125.25 E-value: 5.55e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1545 AYPCSESHQGLL---QTQMLRPFYYQSYTiWEVTTRSKSSpvspvRLCNAWFTLARRHPALRTHLIDiplcDGMSSKIHV 1621
Cdd:cd19536 1 MYPLSSLQEGMLfhsLLNPGGSVYLHNYT-YTVGRRLNLD-----LLLEALQVLIDRHDILRTSFIE----DGLGQPVQV 70
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1622 VHK-------------DYMADAAILSCEDEhvitELRKPFlpsDTGLYYPHAFRIC-QTVSGRVFCKLEGGHAFLDATSV 1687
Cdd:cd19536 71 VHRqaqvpvteldltpLEEQLDPLRAYKEE----TKIRRF---DLGRAPLVRAALVrKDERERFLLVISDHHSILDGWSL 143
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1688 LIILRELAQAYDGQLSSV-----PGPSYSSAVAWLQSLPNGDNRMDYWRRQLKDA--SPCIFPRLRDQDSPSDTLVVTEQ 1760
Cdd:cd19536 144 YLLVKEILAVYNQLLEYKplslpPAQPYRDFVAHERASIQQAASERYWREYLAGAtlATLPALSEAVGGGPEQDSELLVS 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1761 LASTATLTPVCTRHGLTVSNVLQVAWGLMLRRYTESDDVCFGALISGRDSRIPDVDKMVGPFFNVLVCQLRFgREDSLWD 1840
Cdd:cd19536 224 VPLPVRSRSLAKRSGIPLSTLLLAAWALVLSRHSGSDDVVFGTVVHGRSEETTGAERLLGLFLNTLPLRVTL-SEETVED 302
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1841 VLRRNQTEIGNRLLNQHCSLIEVLRFSTyfGQPLFNTCIS-VEQPLSMDTPDASLCFKELETL----EPTEYGIIATITI 1915
Cdd:cd19536 303 LLKRAQEQELESLSHEQVPLADIQRCSE--GEPLFDSIVNfRHFDLDFGLPEWGSDEGMRRGLlfseFKSNYDVNLSVLP 380
|
410 420 430
....*....|....*....|....*....|....*..
gi 992230864 1916 GTTDVGLGLTYKSDLLTEDQALAVADRFKMSITEIMG 1952
Cdd:cd19536 381 KQDRLELKLAYNSQVLDEEQAQRLAAYYKSAIAELAT 417
|
|
| MACS_like |
cd05972 |
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of ... |
259-734 |
9.21e-29 |
|
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes.
Pssm-ID: 341276 [Multi-domain] Cd Length: 428 Bit Score: 121.68 E-value: 9.21e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 259 TYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVCSQE 338
Cdd:cd05972 2 SFRELKRESAKAANVLAKLGLRKGDRVAVLLPRVPELWAVILAVIKLGAVYVPLTTLLGPKDIEYRLEAAGAKAIVTDAE 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 339 lsigvsgstlsigdhntetatysaiqavntashDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQF 418
Cdd:cd05972 82 ---------------------------------DPALIYFTSGTTGLPKGVLHTHSYPLGHIPTAAYWLGLRPDDIHWNI 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 419 ASYAFDVSVHESLT-PLLLGGCVcIPSEAQRVNSLK--EAVSTLRVNWVELTPTVARLWCPADI-----PTVKTLVMGGE 490
Cdd:cd05972 129 ADPGWAKGAWSSFFgPWLLGATV-FVYEGPRFDAERilELLERYGVTSFCGPPTAYRMLIKQDLssykfSHLRLVVSAGE 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 491 PMLPNDISLWKDKLRLVC--AYGPAECTVVSTVQSCvQEL--GNIGRS-PCGTCWIVSKDNhhRLMPVGCIGELIIGGPI 565
Cdd:cd05972 208 PLNPEVIEWWRAATGLPIrdGYGQTETGLTVGNFPD-MPVkpGSMGRPtPGYDVAIIDDDG--RELPPGEEGDIAIKLPP 284
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 566 VG--RGYLKQPcltanafitnPEWASLFHlnGSYrfYKTGDLVRYNADGTIAYIGRKDTQVKLNGQR-----VELGEIEH 638
Cdd:cd05972 285 PGlfLGYVGDP----------EKTEASIR--GDY--YLTGDRAYRDEDGYFWFVGRADDIIKSSGYRigpfeVESALLEH 350
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 639 QAqpyfrdAVIAAEVAAP-AGRKPILILFIARKYEYSvnmdctmllrPPSILFQEkaqgtntlLQEVLPRHMIPAAY--- 714
Cdd:cd05972 351 PA------VAEAAVVGSPdPVRGEVVKAFVVLTSGYE----------PSEELAEE--------LQGHVKKVLAPYKYpre 406
|
490 500
....*....|....*....|.
gi 992230864 715 IELLA-MPISRTGKVNRKLLR 734
Cdd:cd05972 407 IEFVEeLPKTISGKIRRVELR 427
|
|
| A_NRPS_alphaAR |
cd17647 |
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as ... |
257-733 |
9.44e-29 |
|
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as alpha-aminoadipate reductase (EC 1.2.1.95) or alpha-AR or L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), which catalyzes the activation of alpha-aminoadipate by ATP-dependent adenylation and the reduction of activated alpha-aminoadipate by NADPH. The activated alpha-aminoadipate is bound to the phosphopantheinyl group of the enzyme itself before it is reduced to (S)-2-amino-6-oxohexanoate.
Pssm-ID: 341302 [Multi-domain] Cd Length: 520 Bit Score: 123.01 E-value: 9.44e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 257 TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLvNICKDVdAKvivcs 336
Cdd:cd17647 20 SFTYRDINEASNIVAHYLIKTGIKRGDVVMIYSYRGVDLMVAVMGVLKAGATFSVIDPAYPPARQ-NIYLGV-AK----- 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 337 QELSIGVSGSTLSIGDHNTETATYsaiqavntashdaayvvyTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVL 416
Cdd:cd17647 93 PRGLIVIRAAGVVVGPDSNPTLSF------------------TSGSEGIPKGVLGRHFSLAYYFPWMAKRFNLSENDKFT 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 417 QFASYAFDVSVHESLTPLLLGGCVCIPSEAQRVN--SLKEAVSTLRVNWVELTPTVARLWCP-ADIPTVKTLvmggEPML 493
Cdd:cd17647 155 MLSGIAHDPIQRDMFTPLFLGAQLLVPTQDDIGTpgRLAEWMAKYGATVTHLTPAMGQLLTAqATTPFPKLH----HAFF 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 494 PNDISLWKDKLRL---------VCAYGPAECT-VVS--TVQSCVQELGNIGRS----PCGT------CWIVSKDNHHRLM 551
Cdd:cd17647 231 VGDILTKRDCLRLqtlaenvriVNMYGTTETQrAVSyfEVPSRSSDPTFLKNLkdvmPAGRgmlnvqLLVVNRNDRTQIC 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 552 PVGCIGELIIGGPIVGRGYLKQPCLTANAFITN----PE-WASL----------FHLNGSYRFYKTGDLVRYNADGTIAY 616
Cdd:cd17647 311 GIGEVGEIYVRAGGLAEGYRGLPELNKEKFVNNwfvePDhWNYLdkdnnepwrqFWLGPRDRLYRTGDLGRYLPNGDCEC 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 617 IGRKDTQVKLNGQRVELGEIE-HQAQ-PYFRDAVIAaeVAAPAGRKPILILFIARKYEYSVNMDCTMLLRPPS------- 687
Cdd:cd17647 391 CGRADDQVKIRGFRIELGEIDtHISQhPLVRENITL--VRRDKDEEPTLVSYIVPRFDKPDDESFAQEDVPKEvstdpiv 468
|
490 500 510 520
....*....|....*....|....*....|....*....|....*....
gi 992230864 688 ---ILFQEKAQGTNTLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLL 733
Cdd:cd17647 469 kglIGYRKLIKDIREFLKKRLASYAIPSLIVVLDKLPLNPNGKVDKPKL 517
|
|
| FACL_like_6 |
cd05922 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
265-734 |
2.74e-28 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341246 [Multi-domain] Cd Length: 457 Bit Score: 120.62 E-value: 2.74e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 265 RLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCM----LDQSYPTKRLVNICKDVDAKVIVCSQ--- 337
Cdd:cd05922 1 LGVSAAASALLEAGGVRGERVVLILPNRFTYIELSFAVAYAGGRLGLvfvpLNPTLKESVLRYLVADAGGRIVLADAgaa 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 338 -ELSIG--VSGSTLSIGDHNTETATYSAIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSR 414
Cdd:cd05922 81 dRLRDAlpASPDPGTVLDADGIRAARASAPAHEVSHEDLALLLYTSGSTGSPKLVRLSHQNLLANARSIAEYLGITADDR 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 415 VLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQRVNSLKEAVSTLRVNWVELTPTVARL-----WCPADIPTVKTLVMGG 489
Cdd:cd05922 161 ALTVLPLSYDYGLSVLNTHLLRGATLVLTNDGVLDDAFWEDLREHGATGLAGVPSTYAMltrlgFDPAKLPSLRYLTQAG 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 490 EPMLPNDISLWKDKL---RLVCAYGPAECTVVSTVQSCVQE---LGNIGRSPCGTCWIVSKDNHHRLmPVGCIGELIIGG 563
Cdd:cd05922 241 GRLPQETIARLRELLpgaQVYVMYGQTEATRRMTYLPPERIlekPGSIGLAIPGGEFEILDDDGTPT-PPGEPGEIVHRG 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 564 PIVGRGYLKQPcltanAFITNP-EWASLFHlngsyrfykTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEHQA-- 640
Cdd:cd05922 320 PNVMKGYWNDP-----PYRRKEgRGGGVLH---------TGDLARRDEDGFLFIVGRRDRMIKLFGNRISPTEIEAAArs 385
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 641 QPYFRDAVIAAeVAAPAGRKpiLILFIARKYEysvnMDCTMLLRppsilfqekaqgtntLLQEVLPRHMIPAAYIELLAM 720
Cdd:cd05922 386 IGLIIEAAAVG-LPDPLGEK--LALFVTAPDK----IDPKDVLR---------------SLAERLPPYKVPATVRVVDEL 443
|
490
....*....|....
gi 992230864 721 PISRTGKVNRKLLR 734
Cdd:cd05922 444 PLTASGKVDYAALR 457
|
|
| FACL_FadD13-like |
cd17631 |
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, ... |
244-637 |
4.46e-28 |
|
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, including Mycobacterium tuberculosis acid-induced operon MymA encoding the fatty acyl-CoA synthetase FadD13 which is essential for virulence and intracellular growth of the pathogen. The fatty acyl-CoA synthetase activates lipids before entering into the metabolic pathways and is also involved in transmembrane lipid transport. However, unlike soluble fatty acyl-CoA synthetases, but like the mammalian integral-membrane very-long-chain acyl-CoA synthetases, FadD13 accepts lipid substrates up to the maximum length of C26, and this is facilitated by an extensive hydrophobic tunnel from the active site to a positively charged patch. Also included is feruloyl-CoA synthetase (Fcs) in Rhodococcus strains where it is involved in biotechnological vanillin production from eugenol and ferulic acid via a non-beta-oxidative pathway.
Pssm-ID: 341286 [Multi-domain] Cd Length: 435 Bit Score: 119.64 E-value: 4.46e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 244 LQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVN 323
Cdd:cd17631 7 RHPDRTALVFGGRSLTYAELDERVNRLAHALRALGVAKGDRVAVLSKNSPEFLELLFAAARLGAVFVPLNFRLTPPEVAY 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 324 ICKDVDAKVIVcsqelsigvsgstlsigdhntetatysaiqavntasHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIAS 403
Cdd:cd17631 87 ILADSGAKVLF------------------------------------DDLALLMYTSGTTGRPKGAMLTHRNLLWNAVNA 130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 404 SQAQNLDRSSRVLQ----FASYAFDVSVhesLTPLLLGGCVCIPS--EAQRVNSLKEAVstlRVNWVELTPTV--ARLWC 475
Cdd:cd17631 131 LAALDLGPDDVLLVvaplFHIGGLGVFT---LPTLLRGGTVVILRkfDPETVLDLIERH---RVTSFFLVPTMiqALLQH 204
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 476 PA----DIPTVKTLVMGGEPMLPNDISLWKDK-LRLVCAYGPAECTVVSTVQS---CVQELGNIGRsPCGTCWIVSKDNH 547
Cdd:cd17631 205 PRfattDLSSLRAVIYGGAPMPERLLRALQARgVKFVQGYGMTETSPGVTFLSpedHRRKLGSAGR-PVFFVEVRIVDPD 283
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 548 HRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFItnpewaslfhlNGSYRfykTGDLVRYNADGTIAYIGRKDTQVKLN 627
Cdd:cd17631 284 GREVPPGEVGEIVVRGPHVMAGYWNRPEATAAAFR-----------DGWFH---TGDLGRLDEDGYLYIVDRKKDMIISG 349
|
410
....*....|
gi 992230864 628 GQRVELGEIE 637
Cdd:cd17631 350 GENVYPAEVE 359
|
|
| AAS_C |
cd05909 |
C-terminal domain of the acyl-acyl carrier protein synthetase (also called ... |
256-734 |
5.08e-28 |
|
C-terminal domain of the acyl-acyl carrier protein synthetase (also called 2-acylglycerophosphoethanolamine acyltransferase, Aas); Acyl-acyl carrier protein synthase (Aas) is a membrane protein responsible for a minor pathway of incorporating exogenous fatty acids into membrane phospholipids. Its in vitro activity is characterized by the ligation of free fatty acids between 8 and 18 carbons in length to the acyl carrier protein sulfydryl group (ACP-SH) in the presence of ATP and Mg2+. However, its in vivo function is as a 2-acylglycerophosphoethanolamine (2-acyl-GPE) acyltransferase. The reaction occurs in two steps: the acyl chain is first esterified to acyl carrier protein (ACP) via a thioester bond, followed by a second step where the acyl chain is transferred to a 2-acyllysophospholipid, thus completing the transacylation reaction. This model represents the C-terminal domain of the enzyme, which belongs to the class I adenylate-forming enzyme family, including acyl-CoA synthetases.
Pssm-ID: 341235 [Multi-domain] Cd Length: 490 Bit Score: 120.51 E-value: 5.08e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 256 GTITYRQLDRLSSTVQGLLQQYDLgPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVC 335
Cdd:cd05909 6 TSLTYRKLLTGAIALARKLAKMTK-EGENVGVMLPPSAGGALANFALALSGKVPVMLNYTAGLRELRACIKLAGIKTVLT 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 336 SQ------------------------ELSIGVSGS-TLSIGDHNTETATYSAIQA--VNTASHDAAYVVYTSGSTGAPKG 388
Cdd:cd05909 85 SKqfieklklhhlfdveydarivyleDLRAKISKAdKCKAFLAGKFPPKWLLRIFgvAPVQPDDPAVILFTSGSEGLPKG 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 389 IVIEHGSFCTNAIASSQAQNLDRSSRVLQ----FASYAFDVSVhesLTPLLLGGCVCIPSEAQRVNSLKEAVSTLRVNWV 464
Cdd:cd05909 165 VVLSHKNLLANVEQITAIFDPNPEDVVFGalpfFHSFGLTGCL---WLPLLSGIKVVFHPNPLDYKKIPELIYDKKATIL 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 465 ELTPT----VARLWCPADIPTVKTLVMGGEPMLPNDISLWKDK--LRLVCAYGPAECTVV---STVQSCVQElGNIGR-S 534
Cdd:cd05909 242 LGTPTflrgYARAAHPEDFSSLRLVVAGAEKLKDTLRQEFQEKfgIRILEGYGTTECSPVisvNTPQSPNKE-GTVGRpL 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 535 PCGTCWIVSKDNHHRLmPVGCIGELIIGGPIVGRGYLKQPCLTANAFitNPEWaslfhlngsyrfYKTGDLVRYNADGTI 614
Cdd:cd05909 321 PGMEVKIVSVETHEEV-PIGEGGLLLVRGPNVMLGYLNEPELTSFAF--GDGW------------YDTGDIGKIDGEGFL 385
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 615 AYIGRKDTQVKLNGQRVELGEIEHQAQPYFRDAVIAAEVAAPAGRK-PILILFIARKyeysvnmdctmLLRPPSILFQEK 693
Cdd:cd05909 386 TITGRLSRFAKIAGEMVSLEAIEDILSEILPEDNEVAVVSVPDGRKgEKIVLLTTTT-----------DTDPSSLNDILK 454
|
490 500 510 520
....*....|....*....|....*....|....*....|.
gi 992230864 694 AQGTNTLLQevlprhmiPAAYIELLAMPISRTGKVNRKLLR 734
Cdd:cd05909 455 NAGISNLAK--------PSYIHQVEEIPLLGTGKPDYVTLK 487
|
|
| Acs |
COG0365 |
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism]; |
257-744 |
1.99e-27 |
|
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism];
Pssm-ID: 440134 [Multi-domain] Cd Length: 565 Bit Score: 119.83 E-value: 1.99e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 257 TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVCS 336
Cdd:COG0365 39 TLTYAELRREVNRFANALRALGVKKGDRVAIYLPNIPEAVIAMLACARIGAVHSPVFPGFGAEALADRIEDAEAKVLITA 118
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 337 QELS-------------------------IGVSGSTLSI---GDHNTETATYSA---IQAVNTASHDAAYVVYTSGSTGA 385
Cdd:COG0365 119 DGGLrggkvidlkekvdealeelpslehvIVVGRTGADVpmeGDLDWDELLAAAsaeFEPEPTDADDPLFILYTSGTTGK 198
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 386 PKGIVIEHGSFCTNAIASSQA-QNLDRSSRVLQFA--------SYAFdvsvhesLTPLLLGGCVCI------PSEAQRvn 450
Cdd:COG0365 199 PKGVVHTHGGYLVHAATTAKYvLDLKPGDVFWCTAdigwatghSYIV-------YGPLLNGATVVLyegrpdFPDPGR-- 269
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 451 sLKEAVSTLRVNWVELTPTVARL---WCPA-----DIPTVKTLVMGGEPMLPNDISLWKD--KLRLVCAYGPAECTvvst 520
Cdd:COG0365 270 -LWELIEKYGVTVFFTAPTAIRAlmkAGDEplkkyDLSSLRLLGSAGEPLNPEVWEWWYEavGVPIVDGWGQTETG---- 344
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 521 vqSCVqeLGNIGRSPC--GTCW---------IVSKDNHHrlMPVGCIGELIIGGPIVG--RGYLKQPCLTANAFI-TNPE 586
Cdd:COG0365 345 --GIF--ISNLPGLPVkpGSMGkpvpgydvaVVDEDGNP--VPPGEEGELVIKGPWPGmfRGYWNDPERYRETYFgRFPG 418
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 587 WaslfhlngsyrfYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIE-----HqaqpyfrDAVI-AAEVAAP-AGR 659
Cdd:COG0365 419 W------------YRTGDGARRDEDGYFWILGRSDDVINVSGHRIGTAEIEsalvsH-------PAVAeAAVVGVPdEIR 479
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 660 KPILILFIArkyeysvnmdctmlLRPPsilFQEKAQGTNTLLQEV---LPRHMIPAAYIELLAMPISRTGKVNRKLLREA 736
Cdd:COG0365 480 GQVVKAFVV--------------LKPG---VEPSDELAKELQAHVreeLGPYAYPREIEFVDELPKTRSGKIMRRLLRKI 542
|
....*...
gi 992230864 737 VEQASEKD 744
Cdd:COG0365 543 AEGRPLGD 550
|
|
| Condensation |
pfam00668 |
Condensation domain; This domain is found in many multi-domain enzymes which synthesize ... |
1542-1849 |
7.97e-27 |
|
Condensation domain; This domain is found in many multi-domain enzymes which synthesize peptide antibiotics. This domain catalyzes a condensation reaction to form peptide bonds in non- ribosomal peptide biosynthesis. It is usually found to the carboxy side of a phosphopantetheine binding domain (pfam00550). It has been shown that mutations in the HHXXXDG motif abolish activity suggesting this is part of the active site.
Pssm-ID: 395541 [Multi-domain] Cd Length: 454 Bit Score: 116.28 E-value: 7.97e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1542 IEDAYPCSESHQGLLQTQMLrpfyYQSYTIWEVTTRSKSSP-VSPVRLCNAWFTLARRHPALRTHLI-----DIPLC--D 1613
Cdd:pfam00668 1 VQDEYPLSPAQKRMWFLEKL----EPHSSAYNMPAVLKLTGeLDPERLEKALQELINRHDALRTVFIrqengEPVQVilE 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1614 GMSSKIHVVHKDYMADAAILSCEDEHVITELRKPFLPSDTGLYYPHAFRIcqtVSGRVFCKLEGGHAFLDATSVLIILRE 1693
Cdd:pfam00668 77 ERPFELEIIDISDLSESEEEEAIEAFIQRDLQSPFDLEKGPLFRAGLFRI---AENRHHLLLSMHHIIVDGVSLGILLRD 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1694 LAQAYDG-----QLSSVPGPSYSSAVAWLQSLPNGDNRMD---YWRRQLKDASPCI-----FPRLRDQDSPSDTLVVTEQ 1760
Cdd:pfam00668 154 LADLYQQllkgePLPLPPKTPYKDYAEWLQQYLQSEDYQKdaaYWLEQLEGELPVLqlpkdYARPADRSFKGDRLSFTLD 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1761 LASTATLTPVCTRHGLTVSNVLQVAWGLMLRRYTESDDVCFGALISGRDSriPDVDKMVGPFFNVLVCQLRFGREDSLWD 1840
Cdd:pfam00668 234 EDTEELLRKLAKAHGTTLNDVLLAAYGLLLSRYTGQDDIVVGTPGSGRPS--PDIERMVGMFVNTLPLRIDPKGGKTFSE 311
|
....*....
gi 992230864 1841 VLRRNQTEI 1849
Cdd:pfam00668 312 LIKRVQEDL 320
|
|
| FAAL |
cd05931 |
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and ... |
245-670 |
9.14e-25 |
|
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and is homologous to fatty acyl-coenzyme A (CoA) ligases (FACLs). However, FAALs produce only the acyl adenylate and are unable to perform the thioester-forming reaction, while FACLs perform a two-step catalytic reaction; AMP ligation followed by CoA ligation using ATP and CoA as cofactors. FAALs have insertion motifs between the N-terminal and C-terminal subdomains that distinguish them from the FACLs. This insertion motif precludes the binding of CoA, thus preventing CoA ligation. It has been suggested that the acyl adenylates serve as substrates for multifunctional polyketide synthases to permit synthesis of complex lipids such as phthiocerol dimycocerosate, sulfolipids, mycolic acids, and mycobactin.
Pssm-ID: 341254 [Multi-domain] Cd Length: 547 Bit Score: 111.18 E-value: 9.14e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 245 QPDAQAICAWDG------TITYRQLDRLSSTVQGLLQQYDlGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLdqSYPT 318
Cdd:cd05931 6 RPDRPAYTFLDDeggreeTLTYAELDRRARAIAARLQAVG-KPGDRVLLLAPPGLDFVAAFLGCLYAGAIAVPL--PPPT 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 319 -----KRLVNICKDVDAKVIVCSQELSIGVSGSTLSIGDHNT---------ETATYSAIQAVNTASHDAAYVVYTSGSTG 384
Cdd:cd05931 83 pgrhaERLAAILADAGPRVVLTTAAALAAVRAFAASRPAAGTprllvvdllPDTSAADWPPPSPDPDDIAYLQYTSGSTG 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 385 APKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASYAFDVSVHES-LTPLLLGG-CVCIPSEA--QRvnslkeavsTLR 460
Cdd:cd05931 163 TPKGVVVTHRNLLANVRQIRRAYGLDPGDVVVSWLPLYHDMGLIGGlLTPLYSGGpSVLMSPAAflRR---------PLR 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 461 vnWVEL----------TPTVARLWC-----PADIP-----TVKTLVMGGEPMLPNDISLWKDK-----LR---LVCAYGP 512
Cdd:cd05931 234 --WLRLisryratisaAPNFAYDLCvrrvrDEDLEgldlsSWRVALNGAEPVRPATLRRFAEAfapfgFRpeaFRPSYGL 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 513 AECTVVSTVQSC----------VQELGNIGRSP------------CGTCW------IVSkDNHHRLMPVGCIGELIIGGP 564
Cdd:cd05931 312 AEATLFVSGGPPgtgpvvlrvdRDALAGRAVAVaaddpaarelvsCGRPLpdqevrIVD-PETGRELPDGEVGEIWVRGP 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 565 IVGRGYLKQPCLTANAFITNPEwaslfhlNGSYRFYKTGDLVRYnADGTIaYI-GR-KDTQVkLNGQRVELGEIEH---Q 639
Cdd:cd05931 391 SVASGYWGRPEATAETFGALAA-------TDEGGWLRTGDLGFL-HDGEL-YItGRlKDLII-VRGRNHYPQDIEAtaeE 460
|
490 500 510
....*....|....*....|....*....|.
gi 992230864 640 AQPYFRDAVIAAeVAAPAGRKPILILFIARK 670
Cdd:cd05931 461 AHPALRPGCVAA-FSVPDDGEERLVVVAEVE 490
|
|
| MCS |
cd05941 |
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step ... |
247-735 |
5.09e-24 |
|
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step reaction consisting of the adenylation of malonate with ATP, followed by malonyl transfer from malonyl-AMP to CoA. Malonic acid and its derivatives are the building blocks of polyketides and malonyl-CoA serves as the substrate of polyketide synthases. Malonyl-CoA synthetase has broad substrate tolerance and can activate a variety of malonyl acid derivatives. MCS may play an important role in biosynthesis of polyketides, the important secondary metabolites with therapeutic and agrochemical utility.
Pssm-ID: 341264 [Multi-domain] Cd Length: 442 Bit Score: 107.38 E-value: 5.09e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 247 DAQAICAWDGTITYRQLDRLS-STVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNIC 325
Cdd:cd05941 1 DRIAIVDDGDSITYADLVARAaRLANRLLALGKDLRGDRVAFLAPPSAEYVVAQLAIWRAGGVAVPLNPSYPLAELEYVI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 326 KDVDAKVIVcsqelsigvsgstlsigdhntetatysaiqavntashDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQ 405
Cdd:cd05941 81 TDSEPSLVL-------------------------------------DPALILYTSGTTGRPKGVVLTHANLAANVRALVD 123
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 406 AQNLDRSSRVLQfASYAFDVS--VHESLTPLLLGG-CVCIPS-EAQRVNSLKE--------AVSTLR---VNWVELTPTV 470
Cdd:cd05941 124 AWRWTEDDVLLH-VLPLHHVHglVNALLCPLFAGAsVEFLPKfDPKEVAISRLmpsitvfmGVPTIYtrlLQYYEAHFTD 202
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 471 ARLWCPADIPTVKTLVMGGEPMLPNDISLWKDK--LRLVCAYGPAEcTVVSTvqSC----VQELGNIGRS-PCGTCWIVS 543
Cdd:cd05941 203 PQFARAAAAERLRLMVSGSAALPVPTLEEWEAItgHTLLERYGMTE-IGMAL--SNpldgERRPGTVGMPlPGVQARIVD 279
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 544 KDNHHRLmPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNpewaslfhlngsyRFYKTGDLVRYNADGTIAYIGR-KDT 622
Cdd:cd05941 280 EETGEPL-PRGEVGEIQVRGPSVFKEYWNKPEATKEEFTDD-------------GWFKTGDLGVVDEDGYYWILGRsSVD 345
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 623 QVKLNGQRVELGEIEHQ--AQPYFRD-AVIAaeVAAPA-GRKPILILFIArkyeysvNMDCTMLLRPpsilFQEKAqgtn 698
Cdd:cd05941 346 IIKSGGYKVSALEIERVllAHPGVSEcAVIG--VPDPDwGERVVAVVVLR-------AGAAALSLEE----LKEWA---- 408
|
490 500 510
....*....|....*....|....*....|....*..
gi 992230864 699 tllQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLRE 735
Cdd:cd05941 409 ---KQRLAPYKRPRRLILVDELPRNAMGKVNKKELRK 442
|
|
| VL_LC_FACS_like |
cd05907 |
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA ... |
257-672 |
5.52e-24 |
|
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA synthetases; This family includes long-chain fatty acid (C12-C20) CoA synthetases and Bubblegum-like very long-chain (>C20) fatty acid CoA synthetases. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Drosophila melanogaster mutant bubblegum (BGM) have elevated levels of very-long-chain fatty acids (VLCFA) caused by a defective gene later named bubblegum. The human homolog (hsBG) of bubblegum has been characterized as a very long chain fatty acid CoA synthetase that functions specifically in the brain; hsBG may play a central role in brain VLCFA metabolism and myelinogenesis. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341233 [Multi-domain] Cd Length: 452 Bit Score: 107.68 E-value: 5.52e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 257 TITYRQL-DRLSSTVQGLLQQyDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVC 335
Cdd:cd05907 5 PITWAEFaEEVRALAKGLIAL-GVEPGDRVAILSRNRPEWTIADLAILAIGAVPVPIYPTSSAEQIAYILNDSEAKALFV 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 336 sqelsigvsgstlsigDHNTETATysaiqavntashdaayVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRV 415
Cdd:cd05907 84 ----------------EDPDDLAT----------------IIYTSGTTGRPKGVMLSHRNILSNALALAERLPATEGDRH 131
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 416 LQF--ASYAF-DVSVHesLTPLLLGGCVCIPSEAQRVNS-LKEA-----VSTLRVnW--------VELTPTVAR---LWC 475
Cdd:cd05907 132 LSFlpLAHVFeRRAGL--YVPLLAGARIYFASSAETLLDdLSEVrptvfLAVPRV-WekvyaaikVKAVPGLKRklfDLA 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 476 PADIptVKTLVMGGEPmLPNDISLWKDKLRL--VCAYGPAECTVVSTVQScvqelgnIGRSPCGTCWIVSKDNHHRLMPV 553
Cdd:cd05907 209 VGGR--LRFAASGGAP-LPAELLHFFRALGIpvYEGYGLTETSAVVTLNP-------PGDNRIGTVGKPLPGVEVRIADD 278
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 554 gciGELIIGGPIVGRGYLKQPCLTANAFITNPeWaslfhlngsyrfYKTGDLVRYNADGTIAYIGR-KDTQVKLNGQRVE 632
Cdd:cd05907 279 ---GEILVRGPNVMLGYYKNPEATAEALDADG-W------------LHTGDLGEIDEDGFLHITGRkKDLIITSGGKNIS 342
|
410 420 430 440
....*....|....*....|....*....|....*....|..
gi 992230864 633 LGEIEHQAQ--PYFRDAVIAAEvaapagRKPILILFIARKYE 672
Cdd:cd05907 343 PEPIENALKasPLISQAVVIGD------GRPFLVALIVPDPE 378
|
|
| 23DHB-AMP_lg |
cd05920 |
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2, ... |
246-733 |
1.16e-23 |
|
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2,3-dihydroxybenzoate (DHB) by ligation of AMP from ATP with the release of pyrophosphate. However, it can also catalyze the ATP-PPi exchange for 2,3-DHB analogs, such as salicyclic acid (o-hydrobenzoate), as well as 2,4-DHB and 2,5-DHB, but with less efficiency. Proteins in this family are the stand-alone adenylation components of non-ribosomal peptide synthases (NRPSs) involved in the biosynthesis of siderophores, which are low molecular weight iron-chelating compounds synthesized by many bacteria to aid in the acquisition of this vital trace elements. In Escherichia coli, the 2,3-dihydroxybenzoate-AMP ligase is called EntE, the adenylation component of the enterobactin NRPS system.
Pssm-ID: 341244 [Multi-domain] Cd Length: 482 Bit Score: 107.03 E-value: 1.16e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAA--FCMldqsyPTKRLVN 323
Cdd:cd05920 29 PDRIAVVDGDRRLTYRELDRRADRLAAGLRGLGIRPGDRVVVQLPNVAEFVVLFFALLRLGAVpvLAL-----PSHRRSE 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 324 I---CKDVDAKVIVCSQELSIGvsgstlsigDHNtETATYSAiqavntASH-DAAYVVYTSGSTGAPKGIVIEHGSFCTN 399
Cdd:cd05920 104 LsafCAHAEAVAYIVPDRHAGF---------DHR-ALARELA------ESIpEVALFLLSGGTTGTPKLIPRTHNDYAYN 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 400 AIASSQAQNLDRSSRVLQF--ASYAFDVSVHESLTPLLLGGCVCIPSEAQRVNSLKeAVSTLRVNWVELTPTVARLWC-- 475
Cdd:cd05920 168 VRASAEVCGLDQDTVYLAVlpAAHNFPLACPGVLGTLLAGGRVVLAPDPSPDAAFP-LIEREGVTVTALVPALVSLWLda 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 476 ----PADIPTVKTLVMGGEPMLPNDISLWKDKL--RLVCAYGPAECTVVSTV--QSCVQELGNIGR--SPCGTCWIVskD 545
Cdd:cd05920 247 aasrRADLSSLRLLQVGGARLSPALARRVPPVLgcTLQQVFGMAEGLLNYTRldDPDEVIIHTQGRpmSPDDEIRVV--D 324
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 546 NHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFitNPewaslfhlNGsyrFYKTGDLVRYNADGTIAYIGRKDTQVK 625
Cdd:cd05920 325 EEGNPVPPGEEGELLTRGPYTIRGYYRAPEHNARAF--TP--------DG---FYRTGDLVRRTPDGYLVVEGRIKDQIN 391
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 626 LNGQRVELGEIEHQ--AQPYFRDaviAAEVAAPAGrkpiliLFIARKYEYSVnmdctmlLRPPSI-LFQEKAQgtntLLQ 702
Cdd:cd05920 392 RGGEKIAAEEVENLllRHPAVHD---AAVVAMPDE------LLGERSCAFVV-------LRDPPPsAAQLRRF----LRE 451
|
490 500 510
....*....|....*....|....*....|.
gi 992230864 703 EVLPRHMIPAAYIELLAMPISRTGKVNRKLL 733
Cdd:cd05920 452 RGLAAYKLPDRIEFVDSLPLTAVGKIDKKAL 482
|
|
| PRK06187 |
PRK06187 |
long-chain-fatty-acid--CoA ligase; Validated |
234-735 |
1.31e-23 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235730 [Multi-domain] Cd Length: 521 Bit Score: 107.19 E-value: 1.31e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 234 IHTLFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLD 313
Cdd:PRK06187 8 IGRILRHGARKHPDKEAVYFDGRRTTYAELDERVNRLANALRALGVKKGDRVAVFDWNSHEYLEAYFAVPKIGAVLHPIN 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 314 QSYPTKRLVNICKDVDAKVIVCSQELS----------------IGVSGSTLSigDHNTETATYSAIQA--------VNTA 369
Cdd:PRK06187 88 IRLKPEEIAYILNDAEDRVVLVDSEFVpllaailpqlptvrtvIVEGDGPAA--PLAPEVGEYEELLAaasdtfdfPDID 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 370 SHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVL----QFASYAFDVSVHesltPLLLGGCVCIPSE 445
Cdd:PRK06187 166 ENDAAAMLYTSGTTGHPKGVVLSHRNLFLHSLAVCAWLKLSRDDVYLvivpMFHVHAWGLPYL----ALMAGAKQVIPRR 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 446 AQrVNSLKEAVSTLRVNWVELTPTV------ARLWCPADIPTVKTLVMGGEPMLPNDISLWKDKL--RLVCAYGPAECTV 517
Cdd:PRK06187 242 FD-PENLLDLIETERVTFFFAVPTIwqmllkAPRAYFVDFSSLRLVIYGGAALPPALLREFKEKFgiDLVQGYGMTETSP 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 518 VSTV-------QSCVQELGNIGRSPCGTCWIVSKDNHHRLMPV-GCIGELIIGGPIVGRGYLKQPCLTANAFItnpewas 589
Cdd:PRK06187 321 VVSVlppedqlPGQWTKRRSAGRPLPGVEARIVDDDGDELPPDgGEVGEIIVRGPWLMQGYWNRPEATAETID------- 393
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 590 lfhlNGsyrFYKTGDLVRYNADGTIaYI-GRKDTQVKLNGQRVELGEIEhqaqpyfrDAVIA----AEVA---AP---AG 658
Cdd:PRK06187 394 ----GG---WLHTGDVGYIDEDGYL-YItDRIKDVIISGGENIYPRELE--------DALYGhpavAEVAvigVPdekWG 457
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 992230864 659 RKPiLILFIARKyeysvNMDCTmllrPPSILfqekaqgtnTLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLRE 735
Cdd:PRK06187 458 ERP-VAVVVLKP-----GATLD----AKELR---------AFLRGRLAKFKLPKRIAFVDELPRTSVGKILKRVLRE 515
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
1553-1943 |
1.44e-23 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 109.56 E-value: 1.44e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1553 QGLLQTQMLRPFYYQSYTIWEVTTRSKSSPVSPVRLCNAWFTLARRHPALRTHLIDIPLCDGMSSKIHVVHKDYMADAAI 1632
Cdd:COG1020 28 WLLLLLLLGSAAYNLALALLLLGLLLVAALLLLAALLARRRRALRTRLRTRAGRPVQVIQPVVAAPLPVVVLLVDLEALA 107
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1633 LSCEDEHVITELRKPFLPSDTGLYYPHAFRICQTVSGRVfckLEGGHAFLDATSVLIILRELAQAYD----GQLSSVPGP 1708
Cdd:COG1020 108 EAAAEAAAAAEALAPFDLLRGPLLRLLLLLLLLLLLLLL---LALHHIISDGLSDGLLLAELLRLYLaayaGAPLPLPPL 184
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1709 SYSSA------VAWLQSLPNGDNRmDYWRRQLKDA-----SPCIFPRLRDQDSPSDTLVVTEQLASTATLTPVCTRHGLT 1777
Cdd:COG1020 185 PIQYAdyalwqREWLQGEELARQL-AYWRQQLAGLpplleLPTDRPRPAVQSYRGARVSFRLPAELTAALRALARRHGVT 263
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1778 VSNVLQVAWGLMLRRYTESDDVCFGALISGRDSriPDVDKMVGPFFNVLVCQLRFGREDSLWDVLRRNQTEIGNRLLNQH 1857
Cdd:COG1020 264 LFMVLLAAFALLLARYSGQDDVVVGTPVAGRPR--PELEGLVGFFVNTLPLRVDLSGDPSFAELLARVRETLLAAYAHQD 341
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1858 CS---LIEVLRFSTYFG-QPLFNTCISVEQ--PLSMDTPDASLCFKELETlEPTEYGIIATITIGTTDVGLGLTYKSDLL 1931
Cdd:COG1020 342 LPferLVEELQPERDLSrNPLFQVMFVLQNapADELELPGLTLEPLELDS-GTAKFDLTLTVVETGDGLRLTLEYNTDLF 420
|
410
....*....|..
gi 992230864 1932 TEDQALAVADRF 1943
Cdd:COG1020 421 DAATIERMAGHL 432
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1540-1907 |
2.17e-23 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 109.28 E-value: 2.17e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1540 DSIEDAYPCSESHQGLLqtqmLRPFYYQSYTIWEVTTRSKSSPVSPVRLCNAWFTLARRHPALRTHLIDIplcDGMSSKI 1619
Cdd:PRK12316 1551 GEIADIYPLSPMQQGML----FHSLYEQEAGDYINQLRVDVQGLDPDRFRAAWQATVDRHEILRSGFLWQ---DGLEQPL 1623
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1620 HVVHK---------DYMADAAILSCEDEHVITELRKPFLPSDTGLyyphaFRIC--QTVSGRVFCKLEGGHAFLDATSVL 1688
Cdd:PRK12316 1624 QVIHKqvelpfaelDWRGREDLGQALDALAQAERQKGFDLTRAPL-----LRLVlvRTGEGRHHLIYTNHHILMDGWSNA 1698
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1689 IILRELAQAYDGQLSSVPGPSYSSAVAWLQSlPNGDNRMDYWRRQLKD-ASPCIFPR-LRDQDSPSD--TLVVTEQLAST 1764
Cdd:PRK12316 1699 QLLGEVLQRYAGQPVAAPGGRYRDYIAWLQR-QDAAASEAFWKEQLAAlEEPTRLAQaARTEDGQVGygDHQQLLDPAQT 1777
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1765 ATLTPVCTRHGLTVSNVLQVAWGLMLRRYTESDDVCFGALISGRDSRIPDVDKMVGPFFNVLVCQLRFGREDSLWDVLRR 1844
Cdd:PRK12316 1778 RALAEFARAQKVTLNTLVQAAWLLLLQRYTGQETVAFGATVAGRPAELPGIEQQIGLFINTLPVIAAPRPDQSVADWLQE 1857
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1845 NQTEigNRLL--NQHCSLIEVLRFSTYFGQPLFNTCISVE-----QPLSMDTPdASLCFKELETLEPTEY 1907
Cdd:PRK12316 1858 VQAL--NLALreHEHTPLYDIQRWAGQGGEALFDSLLVFEnypvaEALKQGAP-AGLVFGRVSNHEQTNY 1924
|
|
| DCL_NRPS-like |
cd19536 |
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal ... |
874-1137 |
2.36e-23 |
|
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal fungal CT domains and Dual Epimerization/Condensation (E/C) domains; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type [D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L))], which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380459 [Multi-domain] Cd Length: 419 Bit Score: 105.22 E-value: 2.36e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 874 IYPCTPLQEALM---AYTSKRPGAFQaQFRFQLPHQLDMLRLKEAWRIVIAANPILRTRIVFCHTG-ALQVVLRpGEQLQ 949
Cdd:cd19536 1 MYPLSSLQEGMLfhsLLNPGGSVYLH-NYTYTVGRRLNLDLLLEALQVLIDRHDILRTSFIEDGLGqPVQVVHR-QAQVP 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 950 WDLINGVHTSPGSLM--------------SYGVPLVDMAITNDTaGKLSRTFCLTMHHAIFDGWSYGLILGAVEDAYKHT 1015
Cdd:cd19536 79 VTELDLTPLEEQLDPlraykeetkirrfdLGRAPLVRAALVRKD-ERERFLLVISDHHSILDGWSLYLLVKEILAVYNQL 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1016 NAVQR----PFAPFIKYILH--CNYESAKH--FWCSEFKD--MQALPFPV-----PPLSRGHMANSSTTTHRQihVSEWL 1080
Cdd:cd19536 158 LEYKPlslpPAQPYRDFVAHerASIQQAASerYWREYLAGatLATLPALSeavggGPEQDSELLVSVPLPVRS--RSLAK 235
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*..
gi 992230864 1081 SSYCTPSTIIQLAFTLLIAWRTESMDVLFGLTVTGRNAPVAGIHRTTGPTIATFPLR 1137
Cdd:cd19536 236 RSGIPLSTLLLAAWALVLSRHSGSDDVVFGTVVHGRSEETTGAERLLGLFLNTLPLR 292
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1346-1933 |
1.76e-22 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 106.58 E-value: 1.76e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1346 PTDNIRWQLQQLISSLGQSLPRSAVPSLCLPVSFIPVDPLGQPDRIYLCEAASSMTLdflHSLTDPVNkyidyhilPEEA 1425
Cdd:PRK12316 2451 PDDAAEDLLAELRAWLAARLPAYMVPAHWVVLERLPLNPNGKLDRKALPKPDVSQLR---QAYVAPQE--------GLEQ 2519
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1426 RLRGIVAHVLSIdpQNISPKDDFFTLGGDSISAMQVVSLCRKH-QLSLTALDIFNGRTIELIATRLMPLTPYTPPSTPAS 1504
Cdd:PRK12316 2520 RLAAIWQAVLKV--EQVGLDDHFFELGGHSLLATQVVSRVRQDlGLEVPLRILFERPTLAAFAASLESGQTSRAPVLQKV 2597
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1505 DRSLDrrfsllflnsdrdmerleslLMATYDIGSMDSIEDAYPCSESHQgllQTQMLRPfyyqsytiwevttrskSSPVS 1584
Cdd:PRK12316 2598 TRVQP--------------------LPLSHAQQRQWFLWQLEPESAAYH---LPSALHL----------------RGVLD 2638
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1585 PVRLCNAWFTLARRHPALRTHLIDIPlcDGMSSKIHVV--HKDYMADAAILSCE--DEHVITELRKPFLPSDTGLYYPHA 1660
Cdd:PRK12316 2639 QAALEQAFDALVLRHETLRTRFVEVG--EQTRQVILPNmsLRIVLEDCAGVADAaiRQRVAEEIQRPFDLARGPLLRVRL 2716
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1661 FRICQTVSGRVfckLEGGHAFLDATSVLIILRELAQAYDG--QLSSVPGPS----YSSAVAWLQSL---PNGDNRMDYWR 1731
Cdd:PRK12316 2717 LALDGQEHVLV---ITQHHIVSDGWSMQVMVDELVQAYAGarRGEQPTLPPlplqYADYAAWQRAWmdsGEGARQLDYWR 2793
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1732 RQLKDASPCI-----FPRLRDQDSPSDTLVVTEQLASTATLTPVCTRHGLTVSNVLQVAWGLMLRRYTESDDVCFGALIS 1806
Cdd:PRK12316 2794 ERLGGEQPVLelpldRPRPALQSHRGARLDVALDVALSRELLALARREGVTLFMLLLASFQVLLHRYSGQSDIRVGVPIA 2873
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1807 GRDSriPDVDKMVGPFFNVLVCQLRFGREDSLWDVLRRNQTEIGNRLLNQHC---SLIEVL-RFSTYFGQPLFNTCISVE 1882
Cdd:PRK12316 2874 NRNR--AETERLIGFFVNTQVLRAQVDAQLAFRDLLGQVKEQALGAQAHQDLpfeQLVEALqPERSLSHSPLFQVMYNHQ 2951
|
570 580 590 600 610
....*....|....*....|....*....|....*....|....*....|....*
gi 992230864 1883 QPLSmdtPDASLCFKELETLEP----TEYGIIATITIGTTDVGLGLTYKSDLLTE 1933
Cdd:PRK12316 2952 SGER---AAAQLPGLHIESFAWdgaaTQFDLALDTWESAEGLGASLTYATDLFDA 3003
|
|
| PRK09088 |
PRK09088 |
acyl-CoA synthetase; Validated |
240-736 |
3.33e-22 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181644 [Multi-domain] Cd Length: 488 Bit Score: 102.58 E-value: 3.33e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 240 LQCILQPDAQAIC------AWdgtiTYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLD 313
Cdd:PRK09088 3 FHARLQPQRLAAVdlalgrRW----TYAELDALVGRLAAVLRRRGCVDGERLAVLARNSVWLVALHFACARVGAIYVPLN 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 314 QSYPTKRLVNICKDVDAKVIVCSQELSIGvsgsTLSIGDHNTETATYSAIQAVNTASHDA---AYVVYTSGSTGAPKGIV 390
Cdd:PRK09088 79 WRLSASELDALLQDAEPRLLLGDDAVAAG----RTDVEDLAAFIASADALEPADTPSIPPervSLILFTSGTSGQPKGVM 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 391 IEHGSFCTNAIASSQAQNLDRSSRVLQFASYAFDVSVHESLTPLLL-GGCVCIPS--EAQRVNSlKEAVSTLRVNWVELT 467
Cdd:PRK09088 155 LSERNLQQTAHNFGVLGRVDAHSSFLCDAPMFHIIGLITSVRPVLAvGGSILVSNgfEPKRTLG-RLGDPALGITHYFCV 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 468 PTVARL------WCPADIPTVKTLVMGGEPMLPNDISLWKDK-LRLVCAYG----------PAECTVVSTvqscvqELGN 530
Cdd:PRK09088 234 PQMAQAfraqpgFDAAALRHLTALFTGGAPHAAEDILGWLDDgIPMVDGFGmseagtvfgmSVDCDVIRA------KAGA 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 531 IG-RSPCGTCWIVskDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFiTNPEWaslfhlngsyrfYKTGDLVRYN 609
Cdd:PRK09088 308 AGiPTPTVQTRVV--DDQGNDCPAGVPGELLLRGPNLSPGYWRRPQATARAF-TGDGW------------FRTGDIARRD 372
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 610 ADGTIAYIGRKDTQVKLNGQRVELGEIEhqaqpyfrdAVIAAEvaaPAGRKPILI-LFIARKYEYSVnmdCTMLLRPPSI 688
Cdd:PRK09088 373 ADGFFWVVDRKKDMFISGGENVYPAEIE---------AVLADH---PGIRECAVVgMADAQWGEVGY---LAIVPADGAP 437
|
490 500 510 520
....*....|....*....|....*....|....*....|....*...
gi 992230864 689 LfqeKAQGTNTLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLREA 736
Cdd:PRK09088 438 L---DLERIRSHLSTRLAKYKVPKHLRLVDALPRTASGKLQKARLRDA 482
|
|
| BCL_like |
cd05919 |
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate ... |
250-734 |
4.03e-22 |
|
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate CoA ligase (BCL) and related ligases that catalyze the acylation of benzoate derivatives, 2-aminobenzoate and 4-hydroxybenzoate. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Xenobiotic aromatic compounds are also a major class of man-made pollutants. Some bacteria use benzoate as the sole source of carbon and energy through benzoate degradation. Benzoate degradation starts with its activation to benzoyl-CoA by benzoate CoA ligase. The reaction catalyzed by benzoate CoA ligase proceeds via a two-step process; the first ATP-dependent step forms an acyl-AMP intermediate, and the second step forms the acyl-CoA ester with release of the AMP.
Pssm-ID: 341243 [Multi-domain] Cd Length: 436 Bit Score: 101.77 E-value: 4.03e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 250 AICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVD 329
Cdd:cd05919 3 AFYAADRSVTYGQLHDGANRLGSALRNLGVSSGDRVLLLMLDSPELVQLFLGCLARGAIAVVINPLLHPDDYAYIARDCE 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 330 AKVIVCSQElsigvsgstlsigdhntetatysaiqavntashDAAYVVYTSGSTGAPKGIVIEHGS-------FCTNAIA 402
Cdd:cd05919 83 ARLVVTSAD---------------------------------DIAYLLYSSGTTGPPKGVMHAHRDpllfadaMAREALG 129
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 403 ssqaqnLDRSSRVLQFASYAFDVSVHESLT-PLLLGGCVCIPSEAQRVNSLKEAVSTLRVNWVELTPTV-ARL-----WC 475
Cdd:cd05919 130 ------LTPGDRVFSSAKMFFGYGLGNSLWfPLAVGASAVLNPGWPTAERVLATLARFRPTVLYGVPTFyANLldscaGS 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 476 PADIPTVKTLVMGGEPMLPNDISLWKDKLRLVCAYGPAeCTVVSTVQSCVQ----ELGNIGRS-PCGTCWIVSKDNHHrl 550
Cdd:cd05919 204 PDALRSLRLCVSAGEALPRGLGERWMEHFGGPILDGIG-ATEVGHIFLSNRpgawRLGSTGRPvPGYEIRLVDEEGHT-- 280
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 551 MPVGCIGELIIGGPIVGRGYLKQPCLTANAFitNPEWaslfhlngsyrfYKTGDLVRYNADGTIAYIGRKDTQVKLNGQR 630
Cdd:cd05919 281 IPPGEEGDLLVRGPSAAVGYWNNPEKSRATF--NGGW------------YRTGDKFCRDADGWYTHAGRADDMLKVGGQW 346
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 631 VELGEIEHQAQPYfrDAVI-AAEVAAPAGRKPI-LILFIarkyeysvnmdctmLLRPPSILFQEKAQGTNTLLQEVLPRH 708
Cdd:cd05919 347 VSPVEVESLIIQH--PAVAeAAVVAVPESTGLSrLTAFV--------------VLKSPAAPQESLARDIHRHLLERLSAH 410
|
490 500
....*....|....*....|....*.
gi 992230864 709 MIPAAYIELLAMPISRTGKVNRKLLR 734
Cdd:cd05919 411 KVPRRIAFVDELPRTATGKLQRFKLR 436
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
865-1295 |
5.69e-22 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 104.65 E-value: 5.69e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 865 SVFPEQIEDIYPCTPLQEALMAYTSKRP--GAFQAQFRFQLpHQLDMLRLKEAWRIVIAANPILRTRIVFcHTG---ALQ 939
Cdd:PRK12316 1547 PLPAGEIADIYPLSPMQQGMLFHSLYEQeaGDYINQLRVDV-QGLDPDRFRAAWQATVDRHEILRSGFLW-QDGleqPLQ 1624
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 940 VVLR----PGEQLQWDLINGVHTSPGSLMS---------YGVPLVDMAITNDTAGKLSRTFclTMHHAIFDGWSYGLILG 1006
Cdd:PRK12316 1625 VIHKqvelPFAELDWRGREDLGQALDALAQaerqkgfdlTRAPLLRLVLVRTGEGRHHLIY--TNHHILMDGWSNAQLLG 1702
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1007 AVEDAYkhtnAVQRPFAP------FIKYILHCNYESAKHFWCSEFKD-------MQALPFPVPPlsRGHMANSSTTTHRQ 1073
Cdd:PRK12316 1703 EVLQRY----AGQPVAAPggryrdYIAWLQRQDAAASEAFWKEQLAAleeptrlAQAARTEDGQ--VGYGDHQQLLDPAQ 1776
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1074 IHVsewLSSYC-----TPSTIIQLAFTLLIAWRTESMDVLFGLTVTGRNAPVAGIHRTTGPTIATFPLRTILYGTMNITD 1148
Cdd:PRK12316 1777 TRA---LAEFAraqkvTLNTLVQAAWLLLLQRYTGQETVAFGATVAGRPAELPGIEQQIGLFINTLPVIAAPRPDQSVAD 1853
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1149 ALLCMQNHIATLIPFEHTGLRRIKSFGTETARACqFQSLLIIQ--PVTyrESSE------IFFELESNeHEQSKFstcPL 1220
Cdd:PRK12316 1854 WLQEVQALNLALREHEHTPLYDIQRWAGQGGEAL-FDSLLVFEnyPVA--EALKqgapagLVFGRVSN-HEQTNY---PL 1926
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 992230864 1221 TLVCELrTHSVSVKAISDNAVVISGDMERLLDQLEYLIDMITKSPTLEIQNIipSPQDTYSYALQQSQyWSSHIE 1295
Cdd:PRK12316 1927 TLAVTL-GETLSLQYSYDRGHFDAAAIERLDRHLLHLLEQMAEDAQAALGEL--ALLDAGERQRILAD-WDRTPE 1997
|
|
| Condensation |
pfam00668 |
Condensation domain; This domain is found in many multi-domain enzymes which synthesize ... |
871-1269 |
1.41e-21 |
|
Condensation domain; This domain is found in many multi-domain enzymes which synthesize peptide antibiotics. This domain catalyzes a condensation reaction to form peptide bonds in non- ribosomal peptide biosynthesis. It is usually found to the carboxy side of a phosphopantetheine binding domain (pfam00550). It has been shown that mutations in the HHXXXDG motif abolish activity suggesting this is part of the active site.
Pssm-ID: 395541 [Multi-domain] Cd Length: 454 Bit Score: 100.10 E-value: 1.41e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 871 IEDIYPCTPLQEAlMAYTSK---RPGAFQAQFRFQLPHQLDMLRLKEAWRIVIAANPILRTRIVFCHTGALQVVLRPGEQ 947
Cdd:pfam00668 1 VQDEYPLSPAQKR-MWFLEKlepHSSAYNMPAVLKLTGELDPERLEKALQELINRHDALRTVFIRQENGEPVQVILEERP 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 948 LQWDLINGVHTSpgslMSYGVPLVDMAITNDTAGKL-----------------SRTFCL-TMHHAIFDGWSYGLILGAVE 1009
Cdd:pfam00668 80 FELEIIDISDLS----ESEEEEAIEAFIQRDLQSPFdlekgplfraglfriaeNRHHLLlSMHHIIVDGVSLGILLRDLA 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1010 DAYKHT----NAVQRPFAPFIKYILHCN-------YESAKHFW---CSEFKDMQALPFPVPPLS-------------RGH 1062
Cdd:pfam00668 156 DLYQQLlkgePLPLPPKTPYKDYAEWLQqylqsedYQKDAAYWleqLEGELPVLQLPKDYARPAdrsfkgdrlsftlDED 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1063 MANSSTTTHRQIHVsewlssycTPSTIIQLAFTLLIAWRTESMDVLFGLTVTGRNAPvaGIHRTTGPTIATFPLRTILYG 1142
Cdd:pfam00668 236 TEELLRKLAKAHGT--------TLNDVLLAAYGLLLSRYTGQDDIVVGTPGSGRPSP--DIERMVGMFVNTLPLRIDPKG 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1143 TMNITDALLCMQNHIATLIPFEHTGLRRIKSFGT---ETARACQFQSLLIIQPVTYRES-------SEIFFELESNEHEQ 1212
Cdd:pfam00668 306 GKTFSELIKRVQEDLLSAEPHQGYPFGDLVNDLRlprDLSRHPLFDPMFSFQNYLGQDSqeeefqlSELDLSVSSVIEEE 385
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*..
gi 992230864 1213 SKFstcPLTLVCELRTHSVSVKAISDNAVVISGDMERLLDQLEYLIDMITKSPTLEI 1269
Cdd:pfam00668 386 AKY---DLSLTASERGGGLTIKIDYNTSLFDEETIERFAEHFKELLEQAIAHPSQPL 439
|
|
| CHC_CoA_lg |
cd05903 |
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); ... |
257-637 |
1.68e-21 |
|
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); Cyclohexanecarboxylate-CoA ligase activates the aliphatic ring compound, cyclohexanecarboxylate, for degradation. It catalyzes the synthesis of cyclohexanecarboxylate-CoA thioesters in a two-step reaction involving the formation of cyclohexanecarboxylate-AMP anhydride, followed by the nucleophilic substitution of AMP by CoA.
Pssm-ID: 341229 [Multi-domain] Cd Length: 437 Bit Score: 99.76 E-value: 1.68e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 257 TITYRQLDRLSSTVQGLLQQYDLGPGSVVpiIFKKSKW--AIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIV 334
Cdd:cd05903 1 RLTYSELDTRADRLAAGLAALGVGPGDVV--AFQLPNWweFAVLYLACLRIGAVTNPILPFFREHELAFILRRAKAKVFV 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 335 CSQELsigvsGSTlsigDHNTETAtysaiqavntashDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSR 414
Cdd:cd05903 79 VPERF-----RQF----DPAAMPD-------------AVALLLFTSGTTGEPKGVMHSHNTLSASIRQYAERLGLGPGDV 136
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 415 VLQFASYA-FDVSVHESLTPLLLGgcvcIPSEAQRVNSLKEAVSTLRVNWVEL----TPTVARL-----WCPADIPTVKT 484
Cdd:cd05903 137 FLVASPMAhQTGFVYGFTLPLLLG----APVVLQDIWDPDKALALMREHGVTFmmgaTPFLTDLlnaveEAGEPLSRLRT 212
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 485 LVMGGEPMLPNDIS-LWKDKLRLVC-AYGPAECTvvSTVQSC-----VQELGNIGRSPCGTCWIVSKDNHHRLMPvGCIG 557
Cdd:cd05903 213 FVCGGATVPRSLARrAAELLGAKVCsAYGSTECP--GAVTSItpapeDRRLYTDGRPLPGVEIKVVDDTGATLAP-GVEG 289
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 558 ELIIGGPIVGRGYLKQPCLTANAFitnPEwaslfhlngsyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIE 637
Cdd:cd05903 290 ELLSRGPSVFLGYLDRPDLTADAA---PE-----------GWFRTGDLARLDEDGYLRITGRSKDIIIRGGENIPVLEVE 355
|
|
| PRK06087 |
PRK06087 |
medium-chain fatty-acid--CoA ligase; |
259-735 |
1.36e-20 |
|
medium-chain fatty-acid--CoA ligase;
Pssm-ID: 180393 [Multi-domain] Cd Length: 547 Bit Score: 98.28 E-value: 1.36e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 259 TYRQLDRLSSTVQGLLQQYDLGPGSVVPiiFKKSKWA--IVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVC- 335
Cdd:PRK06087 51 TYSALDHAASRLANWLLAKGIEPGDRVA--FQLPGWCefTIIYLACLKVGAVSVPLLPSWREAELVWVLNKCQAKMFFAp 128
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 336 ---------SQELSIGVSGSTLsigDH---------NTETATYSAI--------QAVNTASHDAAYVVYTSGSTGAPKGI 389
Cdd:PRK06087 129 tlfkqtrpvDLILPLQNQLPQL---QQivgvdklapATSSLSLSQIiadyepltTAITTHGDELAAVLFTSGTEGLPKGV 205
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 390 VIEHgsfcTNAIASSQA----QNLDRSSRVLQFASYAFDVSVHESLT-PLLLGGCVCIpseAQRVNSLK--EAVSTLRVN 462
Cdd:PRK06087 206 MLTH----NNILASERAycarLNLTWQDVFMMPAPLGHATGFLHGVTaPFLIGARSVL---LDIFTPDAclALLEQQRCT 278
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 463 WVE-LTPTVARLWC-----PADIPTVKTLVMGGEPmLPNDIS--LWKDKLRLVCAYGPAECT--VVSTVQSCVQELGNIG 532
Cdd:PRK06087 279 CMLgATPFIYDLLNllekqPADLSALRFFLCGGTT-IPKKVAreCQQRGIKLLSVYGSTESSphAVVNLDDPLSRFMHTD 357
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 533 RSPCGTCWIVSKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAfITNPEWaslfhlngsyrFYkTGDLVRYNADG 612
Cdd:PRK06087 358 GYAAAGVEIKVVDEARKTLPPGCEGEEASRGPNVFMGYLDEPELTARA-LDEEGW-----------YY-SGDLCRMDEAG 424
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 613 TIAYIGRKDTQVKLNGQRVELGEIE-HQAQ-PYFRDaviAAEVAAPAGRKPILIlfiarkyeysvnmdCTMLLRPPSILF 690
Cdd:PRK06087 425 YIKITGRKKDIIVRGGENISSREVEdILLQhPKIHD---ACVVAMPDERLGERS--------------CAYVVLKAPHHS 487
|
490 500 510 520
....*....|....*....|....*....|....*....|....*
gi 992230864 691 QEKAQGTNTLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLRE 735
Cdd:PRK06087 488 LTLEEVVAFFSRKRVAKYKYPEHIVVIDKLPRTASGKIQKFLLRK 532
|
|
| PRK06188 |
PRK06188 |
acyl-CoA synthetase; Validated |
246-620 |
1.76e-20 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235731 [Multi-domain] Cd Length: 524 Bit Score: 97.75 E-value: 1.76e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCML-------DQSYpt 318
Cdd:PRK06188 26 PDRPALVLGDTRLTYGQLADRISRYIQAFEALGLGTGDAVALLSLNRPEVLMAIGAAQLAGLRRTALhplgsldDHAY-- 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 319 krlvnICKDVDAKVIVC--------SQELSIGVSGST--LSIG------DHNTETATYSAIQAVNTASH-DAAYVVYTSG 381
Cdd:PRK06188 104 -----VLEDAGISTLIVdpapfverALALLARVPSLKhvLTLGpvpdgvDLLAAAAKFGPAPLVAAALPpDIAGLAYTGG 178
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 382 STGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVL-----QFASYAFDVSVhesltpLLLGGCVCI-----PSEAQRvns 451
Cdd:PRK06188 179 TTGKPKGVMGTHRSIATMAQIQLAEWEWPADPRFLmctplSHAGGAFFLPT------LLRGGTVIVlakfdPAEVLR--- 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 452 lkeAVSTLRVNWVELTPTV--ARLWCP----ADIPTVKTLVMGGEPMLPndislwkDKLR---------LVCAYGPAECT 516
Cdd:PRK06188 250 ---AIEEQRITATFLVPTMiyALLDHPdlrtRDLSSLETVYYGASPMSP-------VRLAeaierfgpiFAQYYGQTEAP 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 517 VVSTV-------QSCVQELGNIGRsPCGTCWIVSKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFitnpewas 589
Cdd:PRK06188 320 MVITYlrkrdhdPDDPKRLTSCGR-PTPGLRVALLDEDGREVAQGEVGEICVRGPLVMDGYWNRPEETAEAF-------- 390
|
410 420 430
....*....|....*....|....*....|.
gi 992230864 590 lfhLNGsyrFYKTGDLVRYNADGTIAYIGRK 620
Cdd:PRK06188 391 ---RDG---WLHTGDVAREDEDGFYYIVDRK 415
|
|
| LC_FACS_like |
cd05935 |
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain ... |
258-733 |
2.02e-20 |
|
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain fatty acyl-CoA synthetases, which catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters.
Pssm-ID: 341258 [Multi-domain] Cd Length: 430 Bit Score: 96.39 E-value: 2.02e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 258 ITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVCSQ 337
Cdd:cd05935 2 LTYLELLEVVKKLASFLSNKGVRKGDRVGICLQNSPQYVIAYFAIWRANAVVVPINPMLKERELEYILNDSGAKVAVVGS 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 338 ELSigvsgstlsigdhntetatysaiqavntashDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQ 417
Cdd:cd05935 82 ELD-------------------------------DLALIPYTSGTTGLPKGCMHTHFSAAANALQSAVWTGLTPSDVILA 130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 418 FASYaFDVS--VHESLTPLLLGGCVCIPSEAQRvNSLKEAVSTLRVN-WVELTPTVARLWCP-----ADIPTVKTLVMGG 489
Cdd:cd05935 131 CLPL-FHVTgfVGSLNTAVYVGGTYVLMARWDR-ETALELIEKYKVTfWTNIPTMLVDLLATpefktRDLSSLKVLTGGG 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 490 EPMLPNDISLWKDK--LRLVCAYGPAE-CTVVSTVQSCVQELGNIGRSPCGTCWIVSKDNHHRLMPVGCIGELIIGGPIV 566
Cdd:cd05935 209 APMPPAVAEKLLKLtgLRFVEGYGLTEtMSQTHTNPPLRPKLQCLGIP*FGVDARVIDIETGRELPPNEVGEIVVRGPQI 288
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 567 GRGYLKQPCLTANAFITnpewaslfhLNGSyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEhqAQPYFRD 646
Cdd:cd05935 289 FKGYWNRPEETEESFIE---------IKGR-RFFRTGDLGYMDEEGYFFFVDRVKRMINVSGFKVWPAEVE--AKLYKHP 356
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 647 AVI-AAEVAAP---AGRKPilILFIARKYEYSVNMDctmllrppsilfqekAQGTNTLLQEVLPRHMIPAAYIELLAMPI 722
Cdd:cd05935 357 AI*eVCVISVPderVGEEV--KAFIVLRPEYRGKVT---------------EEDIIEWAREQMAAYKYPREVEFVDELPR 419
|
490
....*....|.
gi 992230864 723 SRTGKVNRKLL 733
Cdd:cd05935 420 SASGKILWRLL 430
|
|
| MACS_like_3 |
cd05971 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
259-734 |
2.03e-20 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341275 [Multi-domain] Cd Length: 439 Bit Score: 96.35 E-value: 2.03e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 259 TYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAafcmldqsyptkrlvnickdvdakvivcsqe 338
Cdd:cd05971 8 TFKELKTASNRFANVLKEIGLEKGDRVGVFLSQGPECAIAHIAILRSGA------------------------------- 56
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 339 lsIGVSGSTLsIGDHNTE--TATYSAIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVL 416
Cdd:cd05971 57 --IAVPLFAL-FGPEALEyrLSNSGASALVTDGSDDPALIIYTSGTTGPPKGALHAHRVLLGHLPGVQFPFNLFPRDGDL 133
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 417 QF--ASYAFDVSVHESLTPLLLGGCVCIPSEAQRVNSLK--EAVSTLRVNWVELTPTVARLWCPADIP------TVKTLV 486
Cdd:cd05971 134 YWtpADWAWIGGLLDVLLPSLYFGVPVLAHRMTKFDPKAalDLMSRYGVTTAFLPPTALKMMRQQGEQlkhaqvKLRAIA 213
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 487 MGGEPmLPNDISLW-KDKLRLVCA--YGPAECTVVSTVQSCVQEL--GNIGRSPCGTCWIVSKDNHHRLmPVGCIGELII 561
Cdd:cd05971 214 TGGES-LGEELLGWaREQFGVEVNefYGQTECNLVIGNCSALFPIkpGSMGKPIPGHRVAIVDDNGTPL-PPGEVGEIAV 291
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 562 ggpivgrgylKQPCltANAFIT---NPEwASLFHLNGSYrfYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH 638
Cdd:cd05971 292 ----------ELPD--PVAFLGywnNPS-ATEKKMAGDW--LLTGDLGRKDSDGYFWYVGRDDDVITSSGYRIGPAEIEE 356
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 639 --QAQPYFRDaviAAEVAAP-AGRKPILILFIarkyeysvnmdctmLLRPPSILFQEKAQGTNTLLQEVLPRHMIPAAYI 715
Cdd:cd05971 357 clLKHPAVLM---AAVVGIPdPIRGEIVKAFV--------------VLNPGETPSDALAREIQELVKTRLAAHEYPREIE 419
|
490
....*....|....*....
gi 992230864 716 ELLAMPISRTGKVNRKLLR 734
Cdd:cd05971 420 FVNELPRTATGKIRRRELR 438
|
|
| PRK08633 |
PRK08633 |
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated |
372-742 |
2.51e-20 |
|
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated
Pssm-ID: 236315 [Multi-domain] Cd Length: 1146 Bit Score: 98.84 E-value: 2.51e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 372 DAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQ----FASYAFDVSVhesLTPLLLG-GCVCIPS-- 444
Cdd:PRK08633 783 DTATIIFSSGSEGEPKGVMLSHHNILSNIEQISDVFNLRNDDVILSslpfFHSFGLTVTL---WLPLLEGiKVVYHPDpt 859
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 445 EAQRVNslkEAVSTLRVNWVELTPTVARLWC------PADIPTVKtLVMGGEPMLPNDISL-WKDK--LRLVCAYGPAEC 515
Cdd:PRK08633 860 DALGIA---KLVAKHRATILLGTPTFLRLYLrnkklhPLMFASLR-LVVAGAEKLKPEVADaFEEKfgIRILEGYGATET 935
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 516 TVVSTV--------QSCVQ---ELGNIGRSPCGTCW-IVSKDNHHRLmPVGCIGELIIGGPIVGRGYLKQPCLTANAfit 583
Cdd:PRK08633 936 SPVASVnlpdvlaaDFKRQtgsKEGSVGMPLPGVAVrIVDPETFEEL-PPGEDGLILIGGPQVMKGYLGDPEKTAEV--- 1011
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 584 npewasLFHLNGSyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEHQAQPYFRD-AVIAAEVAAPAgrkpi 662
Cdd:PRK08633 1012 ------IKDIDGI-GWYVTGDKGHLDEDGFLTITDRYSRFAKIGGEMVPLGAVEEELAKALGGeEVVFAVTAVPD----- 1079
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 663 lilfiARKYEYSVnmdctMLLRPPSILFQEKAQGtntLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLREAVEQASE 742
Cdd:PRK08633 1080 -----EKKGEKLV-----VLHTCGAEDVEELKRA---IKESGLPNLWKPSRYFKVEALPLLGSGKLDLKGLKELALALLG 1146
|
|
| beta-lac_NRPS |
cd19547 |
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis ... |
874-1188 |
3.12e-20 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis NocB which exhibits an unusual cyclization to form beta-lactam rings in pro-nocardicin G synthesis; Nocardia uniformis NRPS NocB acts centrally in the biosynthesis of the nocardicin monocyclic beta-lactam antibiotics. Along with another NRPS NocA, it mediates an unusual cyclization to form beta-lactam rings in the synthesis of the beta-lactam-containing pentapeptide pro-nocardicin G. This small subfamily is related to DCL-type Condensation (C) domains, which catalyze condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; domains belonging to this subfamily have an HHHxxxD motif at the active site.
Pssm-ID: 380469 [Multi-domain] Cd Length: 422 Bit Score: 95.84 E-value: 3.12e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 874 IYPCTPLQEALMAYTSKRPG--AFQAQFRFQLPHQLDMLRLKEAWRIVIAANPILRTRIVFCHTGALQVVLRPGEQLQWD 951
Cdd:cd19547 1 VYPLAPMQEGMLFRGLFWPDsdAYFNQNVLELVGGTDEDVLREAWRRVADRYEILRTGFTWRDRAEPLQYVRDDLAPPWA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 952 LINGVHTSPgslmSYGVPLVDMAITNDTAGKLSRTFC----LTM--------------HHAIFDGWSYGLILGAVEDAYK 1013
Cdd:cd19547 81 LLDWSGEDP----DRRAELLERLLADDRAAGLSLADCplyrLTLvrlgggrhyllwshHHILLDGWCLSLIWGDVFRVYE 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1014 ---HTNAVQ----RPFAPFIKYILH--CNYESAKHFWCSEFKDMQALPFPVPPLSRG---HMANSSTTTHRQIHVSEWLS 1081
Cdd:cd19547 157 elaHGREPQlspcRPYRDYVRWIRArtAQSEESERFWREYLRDLTPSPFSTAPADREgefDTVVHEFPEQLTRLVNEAAR 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1082 SY-CTPSTIIQLAFTLLIAWRTESMDVLFGLTVTGRNAPVAGIHRTTGPTIATFPLRTILYGTMNITDALLCMQNHIATL 1160
Cdd:cd19547 237 GYgVTTNAISQAAWSMLLALQTGARDVVHGLTIAGRPPELEGSEHMVGIFINTIPLRIRLDPDQTVTGLLETIHRDLATT 316
|
330 340 350
....*....|....*....|....*....|
gi 992230864 1161 IPFEHTGLRRIKSF--GTETARACQFQSLL 1188
Cdd:cd19547 317 AAHGHVPLAQIKSWasGERLSGGRVFDNLV 346
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
866-1265 |
6.30e-20 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 97.92 E-value: 6.30e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 866 VFPEQIEDIYPCTPLQEALMAYT--SKRPGAFQAQFRFQLpHQLDMLRLKEAWRIVIAANPILRTRivFCHTGA----LQ 939
Cdd:PRK12467 2638 VAVGDIEDIYPLSPMQQGMLFHTlyEGGAGDYINQMRVDV-EGLDVERFRTAWQAVIDRHEILRSG--FLWDGEleepLQ 2714
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 940 VVLR----PGEQLQWdliNGVHTSPGSLMSYGV------------PLVDMAITNdTAGKLSRtFCLTMHHAIFDGWSYGL 1003
Cdd:PRK12467 2715 VVYKqarlPFSRLDW---RDRADLEQALDALAAadrqqgfdllsaPLLRLTLVR-TGEDRHH-LIYTNHHILMDGWSGSQ 2789
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1004 ILGAVEDAYkhtnAVQRPFAP------FIKYILHCNYESAKHFWCSEFKDMQ-------ALPF-PVPPLSrGHMAN---- 1065
Cdd:PRK12467 2790 LLGEVLQRY----FGQPPPARegryrdYIAWLQAQDAEASEAFWKEQLAALEeptrlarALYPaPAEAVA-GHGAHylhl 2864
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1066 SSTTTHRqihVSEWLSSY-CTPSTIIQLAFTLLIAWRTESMDVLFGLTVTGRNAPVAGIHRTTGPTIATFPLRTILYGTM 1144
Cdd:PRK12467 2865 DATQTRQ---LIEFARRHrVTLNTLVQGAWLLLLQRFTGQDTVCFGATVAGRPAQLRGAEQQLGLFINTLPVIASPRAEQ 2941
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1145 NITDALLCMQNHIATLIPFEHTGLRRIKSFGTETARACqFQSLLIIQ--PVTYR----ESSEIFFELESNeHEQSKFstc 1218
Cdd:PRK12467 2942 TVSDWLQQVQAQNLALREFEHTPLADIQRWAGQGGEAL-FDSILVFEnyPISEAlkqgAPSGLRFGAVSS-REQTNY--- 3016
|
410 420 430 440
....*....|....*....|....*....|....*....|....*..
gi 992230864 1219 PLTLVCELrTHSVSVKAISDNAVVISGDMERLLDQLEYLIDMITKSP 1265
Cdd:PRK12467 3017 PLTLAVGL-GDTLELEFSYDRQHFDAAAIERLAESFDRLLQAMLNNP 3062
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
1522-1907 |
2.16e-19 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 96.00 E-value: 2.16e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1522 DMERLESLLMATYDIgsmdsiEDAYPCSESHQGLLqtqmLRPFYYQSYTIWEVTTRSKSSPVSPVRLCNAWFTLARRHPA 1601
Cdd:PRK12467 2629 SQEQLDRLPVAVGDI------EDIYPLSPMQQGML----FHTLYEGGAGDYINQMRVDVEGLDVERFRTAWQAVIDRHEI 2698
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1602 LRTHLIDIplcDGMSSKIHVVHKDYMADAAILSCEDEHVITELRKPFLPSDTG----LYYPHAFRICQTVSGRVFCKL-- 1675
Cdd:PRK12467 2699 LRSGFLWD---GELEEPLQVVYKQARLPFSRLDWRDRADLEQALDALAAADRQqgfdLLSAPLLRLTLVRTGEDRHHLiy 2775
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1676 EGGHAFLDATSVLIILRELAQAYDGQLSSVPGPSYSSAVAWLQSLPNGDNRMdYWRRQLKD-ASPCIFPRLRdQDSPSDT 1754
Cdd:PRK12467 2776 TNHHILMDGWSGSQLLGEVLQRYFGQPPPAREGRYRDYIAWLQAQDAEASEA-FWKEQLAAlEEPTRLARAL-YPAPAEA 2853
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1755 LVVTEQL------ASTATLTPVCTRHGLTVSNVLQVAWGLMLRRYTESDDVCFGALISGRDSRIPDVDKMVGPFFNVL-- 1826
Cdd:PRK12467 2854 VAGHGAHylhldaTQTRQLIEFARRHRVTLNTLVQGAWLLLLQRFTGQDTVCFGATVAGRPAQLRGAEQQLGLFINTLpv 2933
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1827 VCQLRfgREDSLWDVLRRNQTEigNRLLN--QHCSLIEVLRFSTYFGQPLFNTCISVEQ-PLS---MDTPDASLCFKELE 1900
Cdd:PRK12467 2934 IASPR--AEQTVSDWLQQVQAQ--NLALRefEHTPLADIQRWAGQGGEALFDSILVFENyPISealKQGAPSGLRFGAVS 3009
|
....*..
gi 992230864 1901 TLEPTEY 1907
Cdd:PRK12467 3010 SREQTNY 3016
|
|
| MACS_like_4 |
cd05969 |
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most ... |
259-734 |
2.41e-19 |
|
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most similar to acetyl-CoA synthetase. Acetyl-CoA synthetase (ACS) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is only present in bacteria.
Pssm-ID: 341273 [Multi-domain] Cd Length: 442 Bit Score: 93.34 E-value: 2.41e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 259 TYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVCSQE 338
Cdd:cd05969 2 TFAQLKVLSARFANVLKSLGVGKGDRVFVLSPRSPELYFSMLGIGKIGAVICPLFSAFGPEAIRDRLENSEAKVLITTEE 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 339 LsigvsgstlsigdhntetatysaiqAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQF 418
Cdd:cd05969 82 L-------------------------YERTDPEDPTLLHYTSGTTGTPKGVLHVHDAMIFYYFTGKYVLDLHPDDIYWCT 136
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 419 ASYAFDVSVHESLTPLLLGGCVCIPSEAQ-RVNSLKEAVSTLRVNWVELTPTVARLWCPA--------DIPTVKTLVMGG 489
Cdd:cd05969 137 ADPGWVTGTVYGIWAPWLNGVTNVVYEGRfDAESWYGIIERVKVTVWYTAPTAIRMLMKEgdelarkyDLSSLRFIHSVG 216
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 490 EPMLPnDISLWKDK---LRLVCAYGPAEcTVVSTVQSCVQ---ELGNIGRSPCGTCWIVSKDNHHRLmPVGCIGELII-- 561
Cdd:cd05969 217 EPLNP-EAIRWGMEvfgVPIHDTWWQTE-TGSIMIANYPCmpiKPGSMGKPLPGVKAAVVDENGNEL-PPGTKGILALkp 293
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 562 GGPIVGRGYLKQPCLTANAFITNpewaslfhlngsyrFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQR-----VELGEI 636
Cdd:cd05969 294 GWPSMFRGIWNDEERYKNSFIDG--------------WYLTGDLAYRDEDGYFWFVGRADDIIKTSGHRvgpfeVESALM 359
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 637 EHQAqpyfrdaviAAEVAAPAGRKPIL----ILFIARKYEYSVnmdcTMLLRPPSILFQEKAQGTNtllqeVLPRHmipa 712
Cdd:cd05969 360 EHPA---------VAEAGVIGKPDPLRgeiiKAFISLKEGFEP----SDELKEEIINFVRQKLGAH-----VAPRE---- 417
|
490 500
....*....|....*....|...
gi 992230864 713 ayIELL-AMPISRTGKVNRKLLR 734
Cdd:cd05969 418 --IEFVdNLPKTRSGKIMRRVLK 438
|
|
| PRK07786 |
PRK07786 |
long-chain-fatty-acid--CoA ligase; Validated |
244-744 |
3.85e-19 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 169098 [Multi-domain] Cd Length: 542 Bit Score: 93.69 E-value: 3.85e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 244 LQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVN 323
Cdd:PRK07786 29 MQPDAPALRFLGNTTTWRELDDRVAALAGALSRRGVGFGDRVLILMLNRTEFVESVLAANMLGAIAVPVNFRLTPPEIAF 108
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 324 ICKDVDAKVIVCSQELS------------------IGVSGSTLSIGDHNTETATYSAIQAVNTASHDAAYVVYTSGSTGA 385
Cdd:PRK07786 109 LVSDCGAHVVVTEAALApvatavrdivpllstvvvAGGSSDDSVLGYEDLLAEAGPAHAPVDIPNDSPALIMYTSGTTGR 188
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 386 PKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASYAFDVSVHESLTP-LLLGGCVCI-PSEAQRVNSLKEAVSTLRVNW 463
Cdd:PRK07786 189 PKGAVLTHANLTGQAMTCLRTNGADINSDVGFVGVPLFHIAGIGSMLPgLLLGAPTVIyPLGAFDPGQLLDVLEAEKVTG 268
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 464 VELTPTVARLWC------PADIpTVKTLVMGGEP---MLPNDISLWKDKLRLVCAYGPAECTVVSTV---QSCVQELGNI 531
Cdd:PRK07786 269 IFLVPAQWQAVCaeqqarPRDL-ALRVLSWGAAPasdTLLRQMAATFPEAQILAAFGQTEMSPVTCMllgEDAIRKLGSV 347
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 532 GRsPCGTCWIVSKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNpeWaslFHlngsyrfykTGDLVRYNAD 611
Cdd:PRK07786 348 GK-VIPTVAARVVDENMNDVPVGEVGEIVYRAPTLMSGYWNNPEATAEAFAGG--W---FH---------SGDLVRQDEE 412
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 612 GTIAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRDAVIAAEVAAPAGRKPILIlfiarkyeysvnmdctMLLRPPS-- 687
Cdd:PRK07786 413 GYVWVVDRKKDMIISGGENIYCAEVENvlASHPDIVEVAVIGRADEKWGEVPVAV----------------AAVRNDDaa 476
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*..
gi 992230864 688 ILFQEKAQgtntLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLREAVEQASEKD 744
Cdd:PRK07786 477 LTLEDLAE----FLTDRLARYKHPKALEIVDALPRNPAGKVLKTELRERYGACVNVE 529
|
|
| menE |
TIGR01923 |
O-succinylbenzoate-CoA ligase; This model represents an enzyme, O-succinylbenzoate-CoA ligase, ... |
259-733 |
4.45e-19 |
|
O-succinylbenzoate-CoA ligase; This model represents an enzyme, O-succinylbenzoate-CoA ligase, which is involved in the fourth step of the menaquinone biosynthesis pathway. O-succinylbenzoate-CoA ligase, together with menB - naphtoate synthase, take 2-succinylbenzoate and convert it into 1,4-di-hydroxy-2- naphtoate. [Biosynthesis of cofactors, prosthetic groups, and carriers, Menaquinone and ubiquinone]
Pssm-ID: 162605 [Multi-domain] Cd Length: 436 Bit Score: 92.51 E-value: 4.45e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 259 TYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVCSQE 338
Cdd:TIGR01923 1 TWQDLDCEAAHLAKALKAQGIRSGSRVALVGQNSIEMVLLLHACLLLGAEIAMLNTRLTENERTNQLEDLDVQLLLTDSL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 339 LSIGVsgsTLSIGDHNTETATYSAIQAVNTASHDA-AYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLq 417
Cdd:TIGR01923 81 LEEKD---FQADSLDRIEAAGRYETSLSASFNMDQiATLMFTSGTTGKPKAVPHTFRNHYASAVGSKENLGFTEDDNWL- 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 418 FASYAFDVSVHESL-TPLLLGGCVCIPseaQRVNSLKEAVSTLRVNWVELTPTVARLWCPADIP--TVKTLVMGGEPM-- 492
Cdd:TIGR01923 157 LSLPLYHISGLSILfRWLIEGATLRIV---DKFNQLLEMIANERVTHISLVPTQLNRLLDEGGHneNLRKILLGGSAIpa 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 493 ------LPNDISLWKdklrlvcAYGPAE-CTVVSTVQSCV-QELGNIGRsPCGTCWI-VSKDNHHRlmpvgcIGELIIGG 563
Cdd:TIGR01923 234 plieeaQQYGLPIYL-------SYGMTEtCSQVTTATPEMlHARPDVGR-PLAGREIkIKVDNKEG------HGEIMVKG 299
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 564 PIVGRGYLKQPCLTanafitnpewaSLFHLNGsyrFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEHQAQ-- 641
Cdd:TIGR01923 300 ANLMKGYLYQGELT-----------PAFEQQG---WFNTGDIGELDGEGFLYVLGRRDDLIISGGENIYPEEIETVLYqh 365
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 642 PYFRDAVIAAEVAAPAGRKPILIlFIARKyeysvnmdctmllrPPSilfqeKAQGTNtLLQEVLPRHMIPAAYIELLAMP 721
Cdd:TIGR01923 366 PGIQEAVVVPKPDAEWGQVPVAY-IVSES--------------DIS-----QAKLIA-YLTEKLAKYKVPIAFEKLDELP 424
|
490
....*....|..
gi 992230864 722 ISRTGKVNRKLL 733
Cdd:TIGR01923 425 YNASGKILRNQL 436
|
|
| C_NRPS-like |
cd19066 |
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of ... |
1679-1950 |
8.65e-19 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long, with various activities such as antibiotic, antifungal, antitumor and immunosuppression. There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380453 [Multi-domain] Cd Length: 427 Bit Score: 91.32 E-value: 8.65e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1679 HAFLDATSVLIILRELAQAYDGQL-----SSVPGPSYSSAVAWLQSLPNG---DNRMDYWRRQLKDASP-CIFPRL-RDQ 1748
Cdd:cd19066 134 HIIVDGGSFQILFEDISSVYDAAErqkptLPPPVGSYADYAAWLEKQLESeaaQADLAYWTSYLHGLPPpLPLPKAkRPS 213
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1749 DSPSDTLVVTEQ---LASTATLTPVCTRHGLTVSNVLQVAWGLMLRRYTESDDVCFGALISGRDSriPDVDKMVGPFFNV 1825
Cdd:cd19066 214 QVASYEVLTLEFflrSEETKRLREVARESGTTPTQLLLAAFALALKRLTASIDVVIGLTFLNRPD--EAVEDTIGLFLNL 291
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1826 LVCQLRFGREDSLWDVLRRNQTEIGNRLLNQHCSLIEVLRFSTYFGQ----PLFNTCISVEQPLSMD--TPDASLCFKEL 1899
Cdd:cd19066 292 LPLRIDTSPDATFPELLKRTKEQSREAIEHQRVPFIELVRHLGVVPEapkhPLFEPVFTFKNNQQQLgkTGGFIFTTPVY 371
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|..
gi 992230864 1900 ETLEPTEYGIIATITIGTT-DVGLGLTYKSDLLTEDQALAVADRFKMSITEI 1950
Cdd:cd19066 372 TSSEGTVFDLDLEASEDPDgDLLLRLEYSRGVYDERTIDRFAERYMTALRQL 423
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
1542-1877 |
9.15e-19 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 94.08 E-value: 9.15e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1542 IEDAYPCSESHQGLLQTQMLRP----FYYQS-YTIwevttrskSSPVSPVRLCNAWFTLARRHPALRTHLIdiplCDGMS 1616
Cdd:PRK05691 3254 IEDVYPLTPMQEGLLLHTLLEPgtglYYMQDrYRI--------NSALDPERFAQAWQAVVARHEALRASFS----WNAGE 3321
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1617 SKIHVVHK------DY-----MADA-------AILSCEDEHVITELRKPflpsdtglyyPHAFRICQTVSGRVFCKLEGG 1678
Cdd:PRK05691 3322 TMLQVIHKpgrtpiDYldwrgLPEDgqeqrlqALHKQEREAGFDLLNQP----------PFHLRLIRVDEARYWFMMSNH 3391
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1679 HAFLDA--TSVLI-----ILRELAQAYDGQLSsvPGPSYSSAVAWLQSLPNGDNRmDYWRRQLK-----DASPCIFPRLR 1746
Cdd:PRK05691 3392 HILIDAwcRSLLMndffeIYTALGEGREAQLP--VPPRYRDYIGWLQRQDLAQAR-QWWQDNLRgferpTPIPSDRPFLR 3468
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1747 DQDSPSDTLVVTE-----QLASTATLTPVCTRHGLTVSNVLQVAWGLMLRRYTESDDVCFGALISGRDSRIPDVDKMVGP 1821
Cdd:PRK05691 3469 EHAGDSGGMVVGDcytrlDAADGARLRELAQAHQLTVNTFAQAAWALVLRRYSGDRDVLFGVTVAGRPVSMPQMQRTVGL 3548
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 992230864 1822 FFNVLVCQLRFGREDSlwdvlRRNQTEIGNRLLN--------QHCSLIEVLRFSTY-FGQPLFNT 1877
Cdd:PRK05691 3549 FINSIALRVQLPAAGQ-----RCSVRQWLQGLLDsnmelreyEYLPLVAIQECSELpKGQPLFDS 3608
|
|
| EntE |
COG1021 |
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase ... |
234-739 |
1.43e-18 |
|
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440644 [Multi-domain] Cd Length: 533 Bit Score: 91.75 E-value: 1.43e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 234 IHTLFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVV----PII--FkkskwaIVAMLGVLKAGA 307
Cdd:COG1021 27 LGDLLRRRAERHPDRIAVVDGERRLSYAELDRRADRLAAGLLALGLRPGDRVvvqlPNVaeF------VIVFFALFRAGA 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 308 A--FCMldqsyPTKR---LVNICKDVDAKVIVCS------------QELSIGVSG--STLSIGDHNTETATYSAIQA--- 365
Cdd:COG1021 101 IpvFAL-----PAHRraeISHFAEQSEAVAYIIPdrhrgfdyralaRELQAEVPSlrHVLVVGDAGEFTSLDALLAApad 175
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 366 ---VNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQF--ASYAFDVSVHESLTPLLLGGC- 439
Cdd:COG1021 176 lsePRPDPDDVAFFQLSGGTTGLPKLIPRTHDDYLYSVRASAEICGLDADTVYLAAlpAAHNFPLSSPGVLGVLYAGGTv 255
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 440 VCIPS-EAQRVNSLKEAVstlRVNWVELTPTVARLWC------PADIPTVKTLVMGGEPMLPNDISLWKDKL--RLVCAY 510
Cdd:COG1021 256 VLAPDpSPDTAFPLIERE---RVTVTALVPPLALLWLdaaersRYDLSSLRVLQVGGAKLSPELARRVRPALgcTLQQVF 332
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 511 GPAE----CT--------VVSTVqscvqelgniGR--SPCGTCWIVskDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCL 576
Cdd:COG1021 333 GMAEglvnYTrlddpeevILTTQ----------GRpiSPDDEVRIV--DEDGNPVPPGEVGELLTRGPYTIRGYYRAPEH 400
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 577 TANAFiTNpewaslfhlNGsyrFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEHQ--AQPyfrdAVI-AAEV 653
Cdd:COG1021 401 NARAF-TP---------DG---FYRTGDLVRRTPDGYLVVEGRAKDQINRGGEKIAAEEVENLllAHP----AVHdAAVV 463
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 654 AAPagrkpililfiarkyeysvnmDCTM--------LLRPPSIlfqeKAQGTNTLLQEV-LPRHMIPAAyIELL-AMPIS 723
Cdd:COG1021 464 AMP---------------------DEYLgerscafvVPRGEPL----TLAELRRFLRERgLAAFKLPDR-LEFVdALPLT 517
|
570
....*....|....*.
gi 992230864 724 RTGKVNRKLLREAVEQ 739
Cdd:COG1021 518 AVGKIDKKALRAALAA 533
|
|
| C_NRPS-like |
cd19066 |
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of ... |
875-1265 |
2.44e-18 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long, with various activities such as antibiotic, antifungal, antitumor and immunosuppression. There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380453 [Multi-domain] Cd Length: 427 Bit Score: 89.78 E-value: 2.44e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 875 YPCTPLQEAL--MAYTSKRPGAFQAQFRFQLPHQLDMLRLKEAWRIVIAANPILRTRIVFCHTGALQVVLRPGEQLQWDL 952
Cdd:cd19066 2 IPLSPMQRGMwfLKKLATDPSAFNVAIEMFLTGSLDLARLKQALDAVMERHDVLRTRFCEEAGRYEQVVLDKTVRFRIEI 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 953 IN--GVHTSPGSLMSYGVPLVdMAITNDTAGKLSR-----------TFCLTMHHAIFDGWSYGLILGAVEDAY----KHT 1015
Cdd:cd19066 82 IDlrNLADPEARLLELIDQIQ-QTIYDLERGPLVRvalfrladerdVLVVAIHHIIVDGGSFQILFEDISSVYdaaeRQK 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1016 NAVQRPFAPFIKYILHcnYESAKH---------FWcsefKDMQALPFPVPPLSRGHM--ANSSTTTHrqiHVSEWL---- 1080
Cdd:cd19066 161 PTLPPPVGSYADYAAW--LEKQLEseaaqadlaYW----TSYLHGLPPPLPLPKAKRpsQVASYEVL---TLEFFLrsee 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1081 ---------SSYCTPSTIIQLAFTLLIAWRTESMDVLFGLTVTGRNAPvaGIHRTTGPTIATFPLRtiLYGTMNIT-DAL 1150
Cdd:cd19066 232 tkrlrevarESGTTPTQLLLAAFALALKRLTASIDVVIGLTFLNRPDE--AVEDTIGLFLNLLPLR--IDTSPDATfPEL 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1151 L---------CMQNHIatlIPFEHtgLRRIKSFGTETARACQFQSLLIIQPVTYRESSEIFFELESNEHeqSKFSTCPLT 1221
Cdd:cd19066 308 LkrtkeqsreAIEHQR---VPFIE--LVRHLGVVPEAPKHPLFEPVFTFKNNQQQLGKTGGFIFTTPVY--TSSEGTVFD 380
|
410 420 430 440
....*....|....*....|....*....|....*....|....*....
gi 992230864 1222 LVCELRTHS-----VSVKAISDnaVVISGDMERLLDQLEYLIDMITKSP 1265
Cdd:cd19066 381 LDLEASEDPdgdllLRLEYSRG--VYDERTIDRFAERYMTALRQLIENP 427
|
|
| FACL_DitJ_like |
cd05934 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
258-734 |
2.97e-18 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Members of this family include DitJ from Pseudomonas and similar proteins.
Pssm-ID: 341257 [Multi-domain] Cd Length: 422 Bit Score: 89.66 E-value: 2.97e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 258 ITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVCsq 337
Cdd:cd05934 4 WTYAELLRESARIAAALAALGIRPGDRVALMLDNCPEFLFAWFALAKLGAVLVPINTALRGDELAYIIDHSGAQLVVV-- 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 338 elsigvsgstlsigdhntetatysaiqavntashDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQ 417
Cdd:cd05934 82 ----------------------------------DPASILYTSGTTGPPKGVVITHANLTFAGYYSARRFGLGEDDVYLT 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 418 ----FASYAFDVSVheslTPLLLGGCVCIPSEAQRVNSLKEAVSTLRVNWVELTPTVARLWC---PADIPTVKTL-VMGG 489
Cdd:cd05934 128 vlplFHINAQAVSV----LAALSVGATLVLLPRFSASRFWSDVRRYGATVTNYLGAMLSYLLaqpPSPDDRAHRLrAAYG 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 490 EPMLPNDISLWKDK--LRLVCAYGPAE--CTVVSTVQSCVQElGNIGR-SPCGTCWIVskDNHHRLMPVGCIGELII--- 561
Cdd:cd05934 204 APNPPELHEEFEERfgVRLLEGYGMTEtiVGVIGPRDEPRRP-GSIGRpAPGYEVRIV--DDDGQELPAGEPGELVIrgl 280
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 562 GGPIVGRGYLKQPCLTANAfitnpeWAslfhlNGsyrFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEHQAQ 641
Cdd:cd05934 281 RGWGFFKGYYNMPEATAEA------MR-----NG---WFHTGDLGYRDADGFFYFVDRKKDMIRRRGENISSAEVERAIL 346
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 642 --PYFRDAVIAA--------EVAApagrkpililfiarkyeysvnmdcTMLLRPPSILFQEKAQgtnTLLQEVLPRHMIP 711
Cdd:cd05934 347 rhPAVREAAVVAvpdevgedEVKA------------------------VVVLRPGETLDPEELF---AFCEGQLAYFKVP 399
|
490 500
....*....|....*....|....
gi 992230864 712 aAYIELL-AMPISRTGKVNRKLLR 734
Cdd:cd05934 400 -RYIRFVdDLPKTPTEKVAKAQLR 422
|
|
| PRK08314 |
PRK08314 |
long-chain-fatty-acid--CoA ligase; Validated |
246-612 |
3.35e-18 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236235 [Multi-domain] Cd Length: 546 Bit Score: 90.40 E-value: 3.35e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDGTITYRQL----DRLSSTVQgllQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRL 321
Cdd:PRK08314 24 PDKTAIVFYGRAISYRELleeaERLAGYLQ---QECGVRKGDRVLLYMQNSPQFVIAYYAILRANAVVVPVNPMNREEEL 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 322 VNICKDVDAKVIVCSQELSIGVSGSTLSIGDHNTETATYS----------------------------------AIQA-- 365
Cdd:PRK08314 101 AHYVTDSGARVAIVGSELAPKVAPAVGNLRLRHVIVAQYSdylpaepeiavpawlraepplqalapggvvawkeALAAgl 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 366 ----VNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASYaFDVS--VHESLTPLLLGGC 439
Cdd:PRK08314 181 apppHTAGPDDLAVLPYTSGTTGVPKGCMHTHRTVMANAVGSVLWSNSTPESVVLAVLPL-FHVTgmVHSMNAPIYAGAT 259
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 440 VCIPSEAQRvNSLKEAVSTLRV-NW-------VEL--TPTVARlwcpADIPTVKTLVMGGEPMlPNDIS--LWKD-KLRL 506
Cdd:PRK08314 260 VVLMPRWDR-EAAARLIERYRVtHWtniptmvVDFlaSPGLAE----RDLSSLRYIGGGGAAM-PEAVAerLKELtGLDY 333
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 507 VCAYGPAEcTVVSTV--------QSCvqeLGnigrspcgtcwIVSKDNHHRL--------MPVGCIGELIIGGPIVGRGY 570
Cdd:PRK08314 334 VEGYGLTE-TMAQTHsnppdrpkLQC---LG-----------IPTFGVDARVidpetleeLPPGEVGEIVVHGPQVFKGY 398
|
410 420 430 440
....*....|....*....|....*....|....*....|..
gi 992230864 571 LKQPCLTANAFITnpewaslfhLNGSyRFYKTGDLVRYNADG 612
Cdd:PRK08314 399 WNRPEATAEAFIE---------IDGK-RFFRTGDLGRMDEEG 430
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
862-1286 |
3.55e-18 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 92.33 E-value: 3.55e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 862 EQCSVFPEQIEDIYPCTPLQEALMAYT--SKRPGAFQAQFRFQLpHQLDMLRLKEAWRIVIAANPILRTRIVF--CHTGA 937
Cdd:PRK12316 4090 DALPLPLGEIEDIYPLSPMQQGMLFHSlyEQEAGDYINQMRVDV-QGLDVERFRAAWQAALDRHDVLRSGFVWqgELGRP 4168
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 938 LQVVLR----PGEQLQWDlingvhtspgslmsyGVPLVDMAITNDTAGKLSRTFCL----------------------TM 991
Cdd:PRK12316 4169 LQVVHKqvslPFAELDWR---------------GRADLQAALDALAAAERERGFDLqrapllrlvlvrtaegrhhliyTN 4233
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 992 HHAIFDGWSYGLILGAVEDAYKHTNAVQRP--FAPFIKYILHCNYESAKHFWCSEFKDMQALPFPVPPLSRGHMANSSTT 1069
Cdd:PRK12316 4234 HHILMDGWSNSQLLGEVLERYSGRPPAQPGgrYRDYIAWLQRQDAAASEAFWREQLAALDEPTRLAQAIARADLRSANGY 4313
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1070 THrqiHVSEW-------LSSYC-----TPSTIIQLAFTLLIAWRTESMDVLFGLTVTGRNAPVAGIHRTTGPTIATFPLR 1137
Cdd:PRK12316 4314 GE---HVRELdatatarLREFArtqrvTLNTLVQAAWLLLLQRYTGQDTVAFGATVAGRPAELPGIEGQIGLFINTLPVI 4390
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1138 TILYGTMNITDALLCMQNHIATLIPFEHTGLRRIKSFGTETARACqFQSLLIIQ--PVT---YRESSE--IFFELESneH 1210
Cdd:PRK12316 4391 ATPRAQQSVVEWLQQVQRQNLALREHEHTPLYEIQRWAGQGGEAL-FDSLLVFEnyPVSealQQGAPGglRFGEVTN--H 4467
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 992230864 1211 EQSKFstcPLTLVCELrTHSVSVKAISDNAVVISGDMERLLDQLEYLIDMITKSPTLEIQNIIPSPQDTYSYALQQ 1286
Cdd:PRK12316 4468 EQTNY---PLTLAVGL-GETLSLQFSYDRGHFDAATIERLARHLTNLLEAMAEDPQRRLGELQLLEKAEQQRIVAL 4539
|
|
| PRK06178 |
PRK06178 |
acyl-CoA synthetase; Validated |
244-740 |
4.00e-18 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235724 [Multi-domain] Cd Length: 567 Bit Score: 90.49 E-value: 4.00e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 244 LQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVN 323
Cdd:PRK06178 45 ERPQRPAIIFYGHVITYAELDELSDRFAALLRQRGVGAGDRVAVFLPNCPQFHIVFFGILKLGAVHVPVSPLFREHELSY 124
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 324 ICKDVDAKVIVC-----------SQELSI----------------------GVSGSTLSIGDH----NTETATYSAIQAV 366
Cdd:PRK06178 125 ELNDAGAEVLLAldqlapvveqvRAETSLrhvivtsladvlpaeptlplpdSLRAPRLAAAGAidllPALRACTAPVPLP 204
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 367 NTASHDAAYVVYTSGSTGAPKGIVIEHGSFC-TNAIASSQAQNLDRSSRVLQF------ASYAFDVsvhesLTPLLLGGC 439
Cdd:PRK06178 205 PPALDALAALNYTGGTTGMPKGCEHTQRDMVyTAAAAYAVAVVGGEDSVFLSFlpefwiAGENFGL-----LFPLFSGAT 279
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 440 VCIPSEAQRVNSLkEAVSTLRV--------NWVEL--TPTVARLwcpaDIPTVK-TLVMGGEPMLPNDI-SLWKDKLRLV 507
Cdd:PRK06178 280 LVLLARWDAVAFM-AAVERYRVtrtvmlvdNAVELmdHPRFAEY----DLSSLRqVRVVSFVKKLNPDYrQRWRALTGSV 354
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 508 ---CAYGPAECTVVSTVQSCVQ----ELGN----IGRSPCGTCWIVSKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCL 576
Cdd:PRK06178 355 laeAAWGMTETHTCDTFTAGFQdddfDLLSqpvfVGLPVPGTEFKICDFETGELLPLGAEGEIVVRTPSLLKGYWNKPEA 434
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 577 TANAFITNpeWaslfhlngsyrfYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIE-----HqaqPyfrdAVIAA 651
Cdd:PRK06178 435 TAEALRDG--W------------LHTGDIGKIDEQGFLHYLGRRKEMLKVNGMSVFPSEVEallgqH---P----AVLGS 493
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 652 EVAAPA--GRKPILILFIarkyeysvnmdctmLLRPPSILFQEKaqgtntlLQEVLPRHMipAAY----IELL-AMPISR 724
Cdd:PRK06178 494 AVVGRPdpDKGQVPVAFV--------------QLKPGADLTAAA-------LQAWCRENM--AVYkvpeIRIVdALPMTA 550
|
570
....*....|....*.
gi 992230864 725 TGKVNRKLLREAVEQA 740
Cdd:PRK06178 551 TGKVRKQDLQALAEEL 566
|
|
| PRK08043 |
PRK08043 |
bifunctional acyl-ACP--phospholipid O-acyltransferase/long-chain-fatty-acid--ACP ligase; |
372-666 |
4.50e-18 |
|
bifunctional acyl-ACP--phospholipid O-acyltransferase/long-chain-fatty-acid--ACP ligase;
Pssm-ID: 181207 [Multi-domain] Cd Length: 718 Bit Score: 90.92 E-value: 4.50e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 372 DAAYVVYTSGSTGAPKGIVIEHGSFCTN-----AIASSQAQNLDRSSRVLqFASYAFDVSVhesLTPLLLGGCVCI-PSE 445
Cdd:PRK08043 366 DAALILFTSGSEGHPKGVVHSHKSLLANveqikTIADFTPNDRFMSALPL-FHSFGLTVGL---FTPLLTGAEVFLyPSP 441
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 446 AQ-RVnsLKEAV-----------STLRVNWveltptvARLWCPADIPTVKTLVMGGEPMLPNDISLWKDK--LRLVCAYG 511
Cdd:PRK08043 442 LHyRI--VPELVydrnctvlfgtSTFLGNY-------ARFANPYDFARLRYVVAGAEKLQESTKQLWQDKfgLRILEGYG 512
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 512 PAECT-VVSTVQSCVQELGNIGRSPCGTcwivskdnHHRLMPVGCI---GELIIGGPIVGRGYLKqpclTANAFITNPEW 587
Cdd:PRK08043 513 VTECApVVSINVPMAAKPGTVGRILPGM--------DARLLSVPGIeqgGRLQLKGPNIMNGYLR----VEKPGVLEVPT 580
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 992230864 588 ASLFHLNGSYRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEHQAQPYFRDAVIAAEVAAPAGRKPILILF 666
Cdd:PRK08043 581 AENARGEMERGWYDTGDIVRFDEQGFVQIQGRAKRFAKIAGEMVSLEMVEQLALGVSPDKQHATAIKSDASKGEALVLF 659
|
|
| Firefly_Luc_like |
cd05911 |
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family ... |
251-637 |
5.95e-18 |
|
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family contains insect firefly luciferases that share significant sequence similarity to plant 4-coumarate:coenzyme A ligases, despite their functional diversity. Luciferase catalyzes the production of light in the presence of MgATP, molecular oxygen, and luciferin. In the first step, luciferin is activated by acylation of its carboxylate group with ATP, resulting in an enzyme-bound luciferyl adenylate. In the second step, luciferyl adenylate reacts with molecular oxygen, producing an enzyme-bound excited state product (Luc=O*) and releasing AMP. This excited-state product then decays to the ground state (Luc=O), emitting a quantum of visible light.
Pssm-ID: 341237 [Multi-domain] Cd Length: 486 Bit Score: 89.19 E-value: 5.95e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 251 ICAWDG-TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVD 329
Cdd:cd05911 3 IDADTGkELTYAQLRTLSRRLAAGLRKLGLKKGDVVGIISPNSTYYPPVFLGCLFAGGIFSAANPIYTADELAHQLKISK 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 330 AKVIVCSQEL---------SIGVSGSTLSIGDHN-------------TETATYSAIQAVNTASHDAAYVVYTSGSTGAPK 387
Cdd:cd05911 83 PKVIFTDPDGlekvkeaakELGPKDKIIVLDDKPdgvlsiedllsptLGEEDEDLPPPLKDGKDDTAAILYSSGTTGLPK 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 388 GIVIEHGSFCTNaiaSSQAQ-----NLDRSSRVLQFAS----YAFDVSVHesltpLLLGGCVCIPSEAQRVNSLKEAVST 458
Cdd:cd05911 163 GVCLSHRNLIAN---LSQVQtflygNDGSNDVILGFLPlyhiYGLFTTLA-----SLLNGATVIIMPKFDSELFLDLIEK 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 459 LRVNWVELTPTVArLW---CP----ADIPTVKTLVMGGEPM-------LPNDISLWkdklRLVCAYGPAECTVVSTV-QS 523
Cdd:cd05911 235 YKITFLYLVPPIA-AAlakSPlldkYDLSSLRVILSGGAPLskelqelLAKRFPNA----TIKQGYGMTETGGILTVnPD 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 524 CVQELGNIGR-SPCGTCWIVSKDNHHRLmPVGCIGELIIGGPIVGRGYLKQPclTANafitnpewASLFHLNGsyrFYKT 602
Cdd:cd05911 310 GDDKPGSVGRlLPNVEAKIVDDDGKDSL-GPNEPGEICVRGPQVMKGYYNNP--EAT--------KETFDEDG---WLHT 375
|
410 420 430
....*....|....*....|....*....|....*
gi 992230864 603 GDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIE 637
Cdd:cd05911 376 GDIGYFDEDGYLYIVDRKKELIKYKGFQVAPAELE 410
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
819-1137 |
2.01e-17 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 89.84 E-value: 2.01e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 819 FKRQTISKLAE---------CTHQMSNGIGSPIPP-FslldPLGKgtyIAQAT-EQCSVFPEQIEDIYPCTPLQEALMAY 887
Cdd:PRK05691 3198 YDEQTIAELAEaylaelqalIAHCLADGAGGLTPSdF----PLAQ---LTQAQlDALPVPAAEIEDVYPLTPMQEGLLLH 3270
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 888 TSKRPGA--FQAQFRFQLPHQLDMLRLKEAWRIVIAANPILRTRivFCHTGA---LQVVLRPG----EQLQWDLINGVHT 958
Cdd:PRK05691 3271 TLLEPGTglYYMQDRYRINSALDPERFAQAWQAVVARHEALRAS--FSWNAGetmLQVIHKPGrtpiDYLDWRGLPEDGQ 3348
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 959 SP------GSLMSYGVPLVDMA------ITNDTAgklSRTFCLTMHHAIFDGWSYGLILGAVEDAYK---HTNAVQRPFA 1023
Cdd:PRK05691 3349 EQrlqalhKQEREAGFDLLNQPpfhlrlIRVDEA---RYWFMMSNHHILIDAWCRSLLMNDFFEIYTalgEGREAQLPVP 3425
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1024 P----FIKYILHCNYESAKHFWCSEFKDMQAlPFPVP---PLSRGHMANSSTT------THRQIHVSEWLSSYC-----T 1085
Cdd:PRK05691 3426 PryrdYIGWLQRQDLAQARQWWQDNLRGFER-PTPIPsdrPFLREHAGDSGGMvvgdcyTRLDAADGARLRELAqahqlT 3504
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|..
gi 992230864 1086 PSTIIQLAFTLLIAWRTESMDVLFGLTVTGRNAPVAGIHRTTGPTIATFPLR 1137
Cdd:PRK05691 3505 VNTFAQAAWALVLRRYSGDRDVLFGVTVAGRPVSMPQMQRTVGLFINSIALR 3556
|
|
| PRK06145 |
PRK06145 |
acyl-CoA synthetase; Validated |
246-637 |
4.96e-17 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 102207 [Multi-domain] Cd Length: 497 Bit Score: 86.48 E-value: 4.96e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNIC 325
Cdd:PRK06145 16 PDRAALVYRDQEISYAEFHQRILQAAGMLHARGIGQGDVVALLMKNSAAFLELAFAASYLGAVFLPINYRLAADEVAYIL 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 326 KDVDAKVIVCSQELSI--GVSGSTLSIGDHNTETATY------SAIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFC 397
Cdd:PRK06145 96 GDAGAKLLLVDEEFDAivALETPKIVIDAAAQADSRRlaqgglEIPPQAAVAPTDLVRLMYTSGTTDRPKGVMHSYGNLH 175
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 398 TNAIASSQAQNLDRSSRVLQFASY----AFDVSvheSLTPLLLGGCVCIPSEAQRVNSLkEAVSTLRVN--WVELTPTVA 471
Cdd:PRK06145 176 WKSIDHVIALGLTASERLLVVGPLyhvgAFDLP---GIAVLWVGGTLRIHREFDPEAVL-AAIERHRLTcaWMAPVMLSR 251
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 472 RLWCPA----DIPTVKTLVMGGE--PMLP-NDISLWKDKLRLVCAYGPAECTVVSTVQSCVQELGNIGRS--PCGTCWIV 542
Cdd:PRK06145 252 VLTVPDrdrfDLDSLAWCIGGGEktPESRiRDFTRVFTRARYIDAYGLTETCSGDTLMEAGREIEKIGSTgrALAHVEIR 331
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 543 SKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNpeWaslfhlngsyrfYKTGDLVRYNADGTIAYIGRKDT 622
Cdd:PRK06145 332 IADGAGRWLPPNMKGEICMRGPKVTKGYWKDPEKTAEAFYGD--W------------FRSGDVGYLDEEGFLYLTDRKKD 397
|
410
....*....|....*
gi 992230864 623 QVKLNGQRVELGEIE 637
Cdd:PRK06145 398 MIISGGENIASSEVE 412
|
|
| PRK09274 |
PRK09274 |
peptide synthase; Provisional |
245-644 |
5.93e-17 |
|
peptide synthase; Provisional
Pssm-ID: 236443 [Multi-domain] Cd Length: 552 Bit Score: 86.49 E-value: 5.93e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 245 QPDAQAICAWDG----------TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQ 314
Cdd:PRK09274 19 RPDQLAVAVPGGrgadgklaydELSFAELDARSDAIAHGLNAAGIGRGMRAVLMVTPSLEFFALTFALFKAGAVPVLVDP 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 315 SYPTKRLVNICKDVDA------------------------KVIVCSQELSIGvsGSTLSIGDHNTETATYsaiQAVNTAS 370
Cdd:PRK09274 99 GMGIKNLKQCLAEAQPdafigipkahlarrlfgwgkpsvrRLVTVGGRLLWG--GTTLATLLRDGAAAPF---PMADLAP 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 371 HDAAYVVYTSGSTGAPKGIVIEHGSFCtnaiasSQAQNLDrssrvlqfASYAF---DVSVHE----SLTPLLLGGCVCIP 443
Cdd:PRK09274 174 DDMAAILFTSGSTGTPKGVVYTHGMFE------AQIEALR--------EDYGIepgEIDLPTfplfALFGPALGMTSVIP 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 444 ----SEAQRVNSLK-------EAVSTLRVNwveltPT----VARlWCPAD---IPTVKTLVMGGEP-----------MLP 494
Cdd:PRK09274 240 dmdpTRPATVDPAKlfaaierYGVTNLFGS-----PAllerLGR-YGEANgikLPSLRRVISAGAPvpiavierfraMLP 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 495 NDISLWKdklrlvcAYGPAECTVVSTVQS--CVQELGNIGRSPCGTCW------------------IVSKDNHHRLmPVG 554
Cdd:PRK09274 314 PDAEILT-------PYGATEALPISSIESreILFATRAATDNGAGICVgrpvdgvevriiaisdapIPEWDDALRL-ATG 385
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 555 CIGELIIGGPIVGRGYLKQPCLTANAFITNPEwASLFHlngsyrfyKTGDLVRYNADGTIAYIGRKdtqvklnGQRVELg 634
Cdd:PRK09274 386 EIGEIVVAGPMVTRSYYNRPEATRLAKIPDGQ-GDVWH--------RMGDLGYLDAQGRLWFCGRK-------AHRVET- 448
|
490
....*....|
gi 992230864 635 eiehQAQPYF 644
Cdd:PRK09274 449 ----AGGTLY 454
|
|
| PRK05605 |
PRK05605 |
long-chain-fatty-acid--CoA ligase; Validated |
368-743 |
6.83e-17 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235531 [Multi-domain] Cd Length: 573 Bit Score: 86.59 E-value: 6.83e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 368 TASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAiASSQA--QNL-DRSSRVLQ----FasYAFDVSVHESLTPLLLGGCV 440
Cdd:PRK05605 216 PTPDDVALILYTSGTTGKPKGAQLTHRNLFANA-AQGKAwvPGLgDGPERVLAalpmF--HAYGLTLCLTLAVSIGGELV 292
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 441 CIPseAQRVNSLKEAVSTLRVNWVELTPTV-ARLWCPA-----DIPTVKTLVMGGEPMLPNDISLWKDKL--RLVCAYGP 512
Cdd:PRK05605 293 LLP--APDIDLILDAMKKHPPTWLPGVPPLyEKIAEAAeergvDLSGVRNAFSGAMALPVSTVELWEKLTggLLVEGYGL 370
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 513 AECT--VVSTVQSCVQELGNIGRS-PCGTCWIVSKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFItnPEWas 589
Cdd:PRK05605 371 TETSpiIVGNPMSDDRRPGYVGVPfPDTEVRIVDPEDPDETMPDGEEGELLVRGPQVFKGYWNRPEETAKSFL--DGW-- 446
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 590 lfhlngsyrfYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRDA-------------VIAAEVA 654
Cdd:PRK05605 447 ----------FRTGDVVVMEEDGFIRIVDRIKELIITGGFNVYPAEVEEvlREHPGVEDAavvglpredgseeVVAAVVL 516
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 655 APAgrkpililfiarkyeysVNMDctmllrppsilfqekAQGTNTLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLR 734
Cdd:PRK05605 517 EPG-----------------AALD---------------PEGLRAYCREHLTRYKVPRRFYHVDELPRDQLGKVRRREVR 564
|
....*....
gi 992230864 735 EAVEQASEK 743
Cdd:PRK05605 565 EELLEKLGA 573
|
|
| PRK06839 |
PRK06839 |
o-succinylbenzoate--CoA ligase; |
241-735 |
1.26e-16 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 168698 [Multi-domain] Cd Length: 496 Bit Score: 85.30 E-value: 1.26e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 241 QCILQPDAQAICAWDGTITYRQL-DRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTK 319
Cdd:PRK06839 11 RAYLHPDRIAIITEEEEMTYKQLhEYVSKVAAYLIYELNVKKGERIAILSQNSLEYIVLLFAIAKVECIAVPLNIRLTEN 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 320 RLVNICKDVDAKVIVCSQELSIGVSGSTLSIGDHN-------TETATYSAIQAVNTASHDAAYVVYTSGSTGAPKGIVIE 392
Cdd:PRK06839 91 ELIFQLKDSGTTVLFVEKTFQNMALSMQKVSYVQRvisitslKEIEDRKIDNFVEKNESASFIICYTSGTTGKPKGAVLT 170
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 393 HGSFCTNAIASSQAQNL---DRSSRVLQF------ASYAFDVsvhesltpLLLGGCVCIPSEAQRVNSLKeAVSTLRVNW 463
Cdd:PRK06839 171 QENMFWNALNNTFAIDLtmhDRSIVLLPLfhiggiGLFAFPT--------LFAGGVIIVPRKFEPTKALS-MIEKHKVTV 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 464 VELTPTV--ARLWCP----ADIPTVKTLVMGGEPMLPNDISLWKDK-LRLVCAYGPAECTvvSTVQSCVQE-----LGNI 531
Cdd:PRK06839 242 VMGVPTIhqALINCSkfetTNLQSVRWFYNGGAPCPEELMREFIDRgFLFGQGFGMTETS--PTVFMLSEEdarrkVGSI 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 532 GRsPCGTCWIVSKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAfITNpEWaslFHlngsyrfykTGDLVRYNAD 611
Cdd:PRK06839 320 GK-PVLFCDYELIDENKNKVEVGEVGELLIRGPNVMKEYWNRPDATEET-IQD-GW---LC---------TGDLARVDED 384
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 612 GTIAYIGRKDTQVKLNGQRVELGEIEhQAQPYFRDAVIAAEVAAPAGR-KPILILFIARKyeysvnmdctmllrpPSILF 690
Cdd:PRK06839 385 GFVYIVGRKKEMIISGGENIYPLEVE-QVINKLSDVYEVAVVGRQHVKwGEIPIAFIVKK---------------SSSVL 448
|
490 500 510 520
....*....|....*....|....*....|....*....|....*
gi 992230864 691 QEKAQGTNTLLQevLPRHMIPAAYIELLAMPISRTGKVNRKLLRE 735
Cdd:PRK06839 449 IEKDVIEHCRLF--LAKYKIPKEIVFLKELPKNATGKIQKAQLVN 491
|
|
| PRK07656 |
PRK07656 |
long-chain-fatty-acid--CoA ligase; Validated |
246-620 |
2.00e-16 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236072 [Multi-domain] Cd Length: 513 Bit Score: 84.57 E-value: 2.00e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNIC 325
Cdd:PRK07656 19 GDKEAYVFGDQRLTYAELNARVRRAAAALAALGIGKGDRVAIWAPNSPHWVIAALGALKAGAVVVPLNTRYTADEAAYIL 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 326 KDVDAKVIVCSQEL---SIGVSGSTLSIG-----------DHNTETATYSAI--------QAVNTASHDAAYVVYTSGST 383
Cdd:PRK07656 99 ARGDAKALFVLGLFlgvDYSATTRLPALEhvviceteeddPHTEKMKTFTDFlaagdpaeRAPEVDPDDVADILFTSGTT 178
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 384 GAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQ----FASYAFDVSVhesLTPLLLGGCVCI-----PSE------AQR 448
Cdd:PRK07656 179 GRPKGAMLTHRQLLSNAADWAEYLGLTEGDRYLAanpfFHVFGYKAGV---NAPLMRGATILPlpvfdPDEvfrlieTER 255
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 449 V----------NSL-------KEAVSTLRvnwveLTPTVArlwcpADIPTVktLVMGGEPMLPNDISLwkdklrlvCAYG 511
Cdd:PRK07656 256 ItvlpgpptmyNSLlqhpdrsAEDLSSLR-----LAVTGA-----ASMPVA--LLERFESELGVDIVL--------TGYG 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 512 PAECTVVSTV----QSCVQELGNIGRSpcgtCW-----IVskDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAfI 582
Cdd:PRK07656 316 LSEASGVTTFnrldDDRKTVAGTIGTA----IAgvenkIV--NELGEEVPVGEVGELLVRGPNVMKGYYDDPEATAAA-I 388
|
410 420 430
....*....|....*....|....*....|....*...
gi 992230864 583 TNPEWaslFHlngsyrfykTGDLVRYNADGTIAYIGRK 620
Cdd:PRK07656 389 DADGW---LH---------TGDLGRLDEEGYLYIVDRK 414
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
258-1005 |
2.02e-16 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 86.38 E-value: 2.02e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 258 ITYRQLDRLSSTVQGLLQQyDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAafcMLDQSYP--------TKRLVNICKDVD 329
Cdd:PRK05691 41 LSYRDLDLRARTIAAALQA-RASFGDRAVLLFPSGPDYVAAFFGCLYAGV---IAVPAYPpesarrhhQERLLSIIADAE 116
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 330 AKVIVCSQELSIGVSGSTLSIGDHNTETATYSAI--------QAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAI 401
Cdd:PRK05691 117 PRLLLTVADLRDSLLQMEELAAANAPELLCVDTLdpalaeawQEPALQPDDIAFLQYTSGSTALPKGVQVSHGNLVANEQ 196
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 402 ASSQAQNLDRSSRvlqfasyafDVSVheSLTPL-----LLGG----------CVCIPSE---AQRVNSLkEAVSTLRvNW 463
Cdd:PRK05691 197 LIRHGFGIDLNPD---------DVIV--SWLPLyhdmgLIGGllqpifsgvpCVLMSPAyflERPLRWL-EAISEYG-GT 263
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 464 VELTPTVARLWCPA----------DIPTVKTLVMGGEPMLPNDISLWKDKL--------RLVCAYGPAECTVV------- 518
Cdd:PRK05691 264 ISGGPDFAYRLCSErvsesalerlDLSRWRVAYSGSEPIRQDSLERFAEKFaacgfdpdSFFASYGLAEATLFvsggrrg 343
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 519 -----------------------STVQSCvqelgniGRSPCGTCWIVSKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPC 575
Cdd:PRK05691 344 qgipaleldaealarnraepgtgSVLMSC-------GRSQPGHAVLIVDPQSLEVLGDNRVGEIWASGPSIAHGYWRNPE 416
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 576 LTANAFItnpewaslfHLNGSyRFYKTGDLvRYNADGTIAYIGRKDTQVKLNGQRVELGEIEHQAQ---PYFRDAVIAAE 652
Cdd:PRK05691 417 ASAKTFV---------EHDGR-TWLRTGDL-GFLRDGELFVTGRLKDMLIVRGHNLYPQDIEKTVErevEVVRKGRVAAF 485
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 653 VAAPAGRKPILILF-IARKYEYSVnmdctmllrPPSILFqekaqgtNTLLQEVLPRHMIPAAYIELL---AMPISRTGKV 728
Cdd:PRK05691 486 AVNHQGEEGIGIAAeISRSVQKIL---------PPQALI-------KSIRQAVAEACQEAPSVVLLLnpgALPKTSSGKL 549
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 729 NRKLLREAVEQASEKDFRAYYPITHNDMIQLPSTP--VLDQLRLLFSAALRIpeEKIKPNDSFFHLGGDSVSAIRLVGDA 806
Cdd:PRK05691 550 QRSACRLRLADGSLDSYALFPALQAVEAAQTAASGdeLQARIAAIWCEQLKV--EQVAADDHFFLLGGNSIAATQVVARL 627
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 807 RDQ-GLHITVESLFKRQTISKLAECTHQMSNGIGSPIPPfslLDPLGKGTYIAQATEQCSV-FPEQIEDiypctplQEAl 884
Cdd:PRK05691 628 RDElGIDLNLRQLFEAPTLAAFSAAVARQLAGGGAAQAA---IARLPRGQALPQSLAQNRLwLLWQLDP-------QSA- 696
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 885 mAYTSkrPGAfqaqfrFQLPHQLDMLRLKEAWRIVIAANPILRTRIVFCHTGALQVVLRPGE------------------ 946
Cdd:PRK05691 697 -AYNI--PGG------LHLRGELDEAALRASFQRLVERHESLRTRFYERDGVALQRIDAQGEfalqridlsdlpeaerea 767
|
810 820 830 840 850 860 870
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 992230864 947 ----------QLQWDLINGvhtspgslmsygvPL--VDMAITNDTAGKLsrtfCLTMHHAIFDGWSYGLIL 1005
Cdd:PRK05691 768 raaqireeeaRQPFDLEKG-------------PLlrVTLVRLDDEEHQL----LVTLHHIVADGWSLNILL 821
|
|
| FAA1 |
COG1022 |
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; |
237-649 |
2.70e-16 |
|
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism];
Pssm-ID: 440645 [Multi-domain] Cd Length: 603 Bit Score: 84.77 E-value: 2.70e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 237 LFRLQCILQPDAQAICAWDG----TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIfkkSK----WAIvAMLGVLKAGAA 308
Cdd:COG1022 16 LLRRRAARFPDRVALREKEDgiwqSLTWAEFAERVRALAAGLLALGVKPGDRVAIL---SDnrpeWVI-ADLAILAAGAV 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 309 FCMLDQSYPTKRLVNICKDVDAKVIVCSQE------LSIGVSGSTL--------SIGDHNTETATYSAIQAVNTASHDAA 374
Cdd:COG1022 92 TVPIYPTSSAEEVAYILNDSGAKVLFVEDQeqldklLEVRDELPSLrhivvldpRGLRDDPRLLSLDELLALGREVADPA 171
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 375 YV---------------VYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVL----------QFASYAFdvsvhe 429
Cdd:COG1022 172 ELearraavkpddlatiIYTSGTTGRPKGVMLTHRNLLSNARALLERLPLGPGDRTLsflplahvfeRTVSYYA------ 245
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 430 sltpLLLGGCVCIPseaqrvNSLKEAVSTLRvnwvELTPT----VARLW------------------------------- 474
Cdd:COG1022 246 ----LAAGATVAFA------ESPDTLAEDLR----EVKPTfmlaVPRVWekvyagiqakaeeagglkrklfrwalavgrr 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 475 -----------CPADIPT-------------------VKTLVMGGEPMLPnDISLWKD--KLRLVCAYGPAECTVVSTVQ 522
Cdd:COG1022 312 yararlagkspSLLLRLKhaladklvfsklrealggrLRFAVSGGAALGP-ELARFFRalGIPVLEGYGLTETSPVITVN 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 523 --SCVQeLGNIGRSPCGTCWIVSKDnhhrlmpvgciGELIIGGPIVGRGYLKQPCLTANAFITNpEWaslFHlngsyrfy 600
Cdd:COG1022 391 rpGDNR-IGTVGPPLPGVEVKIAED-----------GEILVRGPNVMKGYYKNPEATAEAFDAD-GW---LH-------- 446
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|..
gi 992230864 601 kTGDLVRYNADGTIAYIGR-KDTQVKLNGQRVELGEIEHQ--AQPYFRDAVI 649
Cdd:COG1022 447 -TGDIGELDEDGFLRITGRkKDLIVTSGGKNVAPQPIENAlkASPLIEQAVV 497
|
|
| A_NRPS_TubE_like |
cd05906 |
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) ... |
255-739 |
2.72e-16 |
|
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) synthesizing toxins and antitumor agents; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino)-acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family includes NRPSs that synthesize toxins and antitumor agents; for example, TubE for Tubulysine, CrpA for cryptophycin, TdiA for terrequinone A, KtzG for kutzneride, and Vlm1/Vlm2 for Valinomycin. Nonribosomal peptide synthetases are large multifunctional enzymes which synthesize many therapeutically useful peptides. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341232 [Multi-domain] Cd Length: 540 Bit Score: 84.64 E-value: 2.72e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 255 DGT---ITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCML-------DQSYPTKRLVNI 324
Cdd:cd05906 34 DGSeefQSYQDLLEDARRLAAGLRQLGLRPGDSVILQFDDNEDFIPAFWACVLAGFVPAPLtvpptydEPNARLRKLRHI 113
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 325 CKDVDAKVIVCSQELSIGVSG----------STLSIGDhntETATYSAIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHG 394
Cdd:cd05906 114 WQLLGSPVVLTDAELVAEFAGletlsglpgiRVLSIEE---LLDTAADHDLPQSRPDDLALLMLTSGSTGFPKAVPLTHR 190
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 395 SFCTNAIASSQAQNLDRSSRVLQFAsyAFD---VSVHESLTPLLLGgcvcipseAQRVNSLKEAVSTLRVNWVELTPT-- 469
Cdd:cd05906 191 NILARSAGKIQHNGLTPQDVFLNWV--PLDhvgGLVELHLRAVYLG--------CQQVHVPTEEILADPLRWLDLIDRyr 260
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 470 VARLWCP------------------ADIPTVKTLVMGGEPMLPNDIS-----LWKDKLR---LVCAYGPAE-CTVVSTVQ 522
Cdd:cd05906 261 VTITWAPnfafallndlleeiedgtWDLSSLRYLVNAGEAVVAKTIRrllrlLEPYGLPpdaIRPAFGMTEtCSGVIYSR 340
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 523 SCVQElgNIGRSP----CGTCW------IVSKDNhhRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFiTNPEWaslfh 592
Cdd:cd05906 341 SFPTY--DHSQALefvsLGRPIpgvsmrIVDDEG--QLLPEGEVGRLQVRGPVVTKGYYNNPEANAEAF-TEDGW----- 410
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 593 lngsyrfYKTGDLVrYNADGTIAYIGRKDTQVKLNGQRVELGEIEH---QAQpyfrdAVIAAEVAAPAGRKP-----ILI 664
Cdd:cd05906 411 -------FRTGDLG-FLDNGNLTITGRTKDTIIVNGVNYYSHEIEAaveEVP-----GVEPSFTAAFAVRDPgaeteELA 477
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 992230864 665 LFIARKYEYSVNMDCTMllrppsilfqEKAQGTNTLLQEVLPRHMIPaayIELLAMPISRTGKVNRKLLREAVEQ 739
Cdd:cd05906 478 IFFVPEYDLQDALSETL----------RAIRSVVSREVGVSPAYLIP---LPKEEIPKTSLGKIQRSKLKAAFEA 539
|
|
| LC_FACS_like |
cd17640 |
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA ... |
257-637 |
5.32e-16 |
|
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA synthetases, including an Arabidopsis gene At4g14070 that plays a role in activation and elongation of exogenous fatty acids. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341295 [Multi-domain] Cd Length: 468 Bit Score: 83.18 E-value: 5.32e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 257 TITYRQL-DRLSSTVQGLLqqyDLG--PGSVVPIIFKKSKWAIVAMLGVLKAGAafcmldqsyptkrlVNICKDVDAKVi 333
Cdd:cd17640 5 RITYKDLyQEILDFAAGLR---SLGvkAGEKVALFADNSPRWLIADQGIMALGA--------------VDVVRGSDSSV- 66
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 334 vcsQELSIgvsgstlsIGDHNTETATYsaiqaVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSS 413
Cdd:cd17640 67 ---EELLY--------ILNHSESVALV-----VENDSDDLATIIYTSGTTGNPKGVMLTHANLLHQIRSLSDIVPPQPGD 130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 414 RVLQFAS--YAFDVSVHeslTPLLLGGCVCIPSEaqrVNSLKEAVSTLRVNwveLTPTVARLW--------------CPA 477
Cdd:cd17640 131 RFLSILPiwHSYERSAE---YFIFACGCSQAYTS---IRTLKDDLKRVKPH---YIVSVPRLWeslysgiqkqvsksSPI 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 478 DIPTVKTLVMGGEPMLP----NDISLWKDK------LRLVCAYGPAECTVVSTVQ--SCVQeLGNIGRSPCGTCWIVSKD 545
Cdd:cd17640 202 KQFLFLFFLSGGIFKFGisggGALPPHVDTffeaigIEVLNGYGLTETSPVVSARrlKCNV-RGSVGRPLPGTEIKIVDP 280
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 546 NHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAfITNPEWaslfhlngsyrfYKTGDLVRYNADGTIAYIGR-KDTQV 624
Cdd:cd17640 281 EGNVVLPPGEKGIVWVRGPQVMKGYYKNPEATSKV-LDSDGW------------FNTGDLGWLTCGGELVLTGRaKDTIV 347
|
410
....*....|...
gi 992230864 625 KLNGQRVELGEIE 637
Cdd:cd17640 348 LSNGENVEPQPIE 360
|
|
| ACS-like |
cd17634 |
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the ... |
246-728 |
6.72e-16 |
|
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases. The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341289 [Multi-domain] Cd Length: 587 Bit Score: 83.40 E-value: 6.72e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICaWDG-------TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCML------ 312
Cdd:cd17634 67 GDRTAII-YEGddtsqsrTISYRELHREVCRFAGTLLDLGVKKGDRVAIYMPMIPEAAVAMLACARIGAVHSVIfggfap 145
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 313 ------------------DQSYPTKRLVNICKDVD--AKVIVCSQELSIGVSGSTLSIGD--------HNTETATYSAIQ 364
Cdd:cd17634 146 eavagriidsssrllitaDGGVRAGRSVPLKKNVDdaLNPNVTSVEHVIVLKRTGSDIDWqegrdlwwRDLIAKASPEHQ 225
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 365 AVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAiASSQAQNLD-RSSRVLQFASYAFDVSVHESLT--PLLLGGCVC 441
Cdd:cd17634 226 PEAMNAEDPLFILYTSGTTGKPKGVLHTTGGYLVYA-ATTMKYVFDyGPGDIYWCTADVGWVTGHSYLLygPLACGATTL 304
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 442 I-------PSEAQrvnsLKEAVSTLRVNWVELTPTVARLWCPA--------DIPTVKTLVMGGEPMLPNDISLWKDKLrl 506
Cdd:cd17634 305 LyegvpnwPTPAR----MWQVVDKHGVNILYTAPTAIRALMAAgddaiegtDRSSLRILGSVGEPINPEAYEWYWKKI-- 378
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 507 vcayGPAECTVVS------TVQSCVQEL-GNIG-RSPCGTCWIVSK-----DNHHRLMPVGCIGELIIGGPIVGRgylkq 573
Cdd:cd17634 379 ----GKEKCPVVDtwwqteTGGFMITPLpGAIElKAGSATRPVFGVqpavvDNEGHPQPGGTEGNLVITDPWPGQ----- 449
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 574 pcltANAFITNPEWASLFHLNGSYRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRDAVIAA 651
Cdd:cd17634 450 ----TRTLFGDHERFEQTYFSTFKGMYFSGDGARRDEDGYYWITGRSDDVINVAGHRLGTAEIESvlVAHPKVAEAAVVG 525
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 652 EVAAPAGRKPIlilfiarkyeysvnmdCTMLLR----PPSILFQEkaqgtntlLQEVLPRHMIPAAYIELL----AMPIS 723
Cdd:cd17634 526 IPHAIKGQAPY----------------AYVVLNhgvePSPELYAE--------LRNWVRKEIGPLATPDVVhwvdSLPKT 581
|
....*
gi 992230864 724 RTGKV 728
Cdd:cd17634 582 RSGKI 586
|
|
| SgcC5_NRPS-like |
cd19539 |
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- ... |
1591-1864 |
7.48e-16 |
|
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- bond forming activity and similar C-domains of modular NRPSs; SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. This subfamily also includes similar C-domains of modular NRPSs such as Penicillium chrysogenum N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase PCBAB. Condensation (C) domains of NRPSs normally catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380462 [Multi-domain] Cd Length: 427 Bit Score: 82.43 E-value: 7.48e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1591 AWFTLARRHPALRTHLI----DIP----LCDGMSSKIHVVHKDYMADaaiLSCEDEHVITEL-RKPFLPSDTGLYYPHAF 1661
Cdd:cd19539 44 ALRDVVARHEALRTLLVrddgGVPrqeiLPPGPAPLEVRDLSDPDSD---RERRLEELLREReSRGFDLDEEPPIRAVLG 120
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1662 RIcqtVSGRVFCKLEGGHAFLDATSVLIILRELAQAYD----GQLSSVPGP--SYSSAVAWlQSLPNGDNRM----DYWR 1731
Cdd:cd19539 121 RF---DPDDHVLVLVAHHTAFDAWSLDVFARDLAALYAarrkGPAAPLPELrqQYKEYAAW-QREALAAPRAaellDFWR 196
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1732 RQLKDASPC--IFPRLRDQDSPSDT----LVVTEQLasTATLTPVCTRHGLTVSNVLQVAWGLMLRRYTESDDVCFGALI 1805
Cdd:cd19539 197 RRLRGAEPTalPTDRPRPAGFPYPGadlrFELDAEL--VAALRELAKRARSSLFMVLLAAYCVLLRRYTGQTDIVVGTPV 274
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*....
gi 992230864 1806 SGRDSriPDVDKMVGPFFNVLVCQLRFGREDSLWDVLRRNQTEIGNRLLNQHCSLIEVL 1864
Cdd:cd19539 275 AGRNH--PRFESTVGFFVNLLPLRVDVSDCATFRDLIARVRKALVDAQRHQELPFQQLV 331
|
|
| FACL_fum10p_like |
cd05926 |
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL ... |
246-735 |
8.98e-16 |
|
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Fum10p is a fatty acid CoA ligase involved in the synthesis of fumonisin, a polyketide mycotoxin, in Gibberella moniliformis.
Pssm-ID: 341249 [Multi-domain] Cd Length: 493 Bit Score: 82.36 E-value: 8.98e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDGT--ITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVN 323
Cdd:cd05926 1 PDAPALVVPGSTpaLTYADLAELVDDLARQLAALGIKKGDRVAIALPNGLEFVVAFLAAARAGAVVAPLNPAYKKAEFEF 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 324 ICKDVDAKVIV-------------------------CSQELSIGVSGSTLSIGDhntETATYSAIQAVNTAShDAAYVVY 378
Cdd:cd05926 81 YLADLGSKLVLtpkgelgpasraasklglailelalDVGVLIRAPSAESLSNLL---ADKKNAKSEGVPLPD-DLALILH 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 379 TSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQ----FASYAFDVSVhesLTPLLLGGCVCIP--SEAQRVNSL 452
Cdd:cd05926 157 TSGTTGRPKGVPLTHRNLAASATNITNTYKLTPDDRTLVvmplFHVHGLVASL---LSTLAAGGSVVLPprFSASTFWPD 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 453 KEAVstlRVNWVELTPTVARLWC---PADIPTVKTLVM----GGEPMLPNDISLWKDKLR--LVCAYGPAECTVVST--- 520
Cdd:cd05926 234 VRDY---NATWYTAVPTIHQILLnrpEPNPESPPPKLRfirsCSASLPPAVLEALEATFGapVLEAYGMTEAAHQMTsnp 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 521 VQSCVQELGNIGRsPCGTcWIVSKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPewaslfhlngsyrFY 600
Cdd:cd05926 311 LPPGPRKPGSVGK-PVGV-EVRILDEDGEILPPGVVGEICLRGPNVTRGYLNNPEANAEAAFKDG-------------WF 375
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 601 KTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEHQAqpYFRDAViaAEVAAPAGRKPililfiarKYEYSVNMdct 680
Cdd:cd05926 376 RTGDLGYLDADGYLFLTGRIKELINRGGEKISPLEVDGVL--LSHPAV--LEAVAFGVPDE--------KYGEEVAA--- 440
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*....
gi 992230864 681 mllrppSILFQEKAQGTNTLLQEVLPRHM----IPAAYIELLAMPISRTGKVNRKLLRE 735
Cdd:cd05926 441 ------AVVLREGASVTEEELRAFCRKHLaafkVPKKVYFVDELPKTATGKIQRRKVAE 493
|
|
| 4CL |
cd05904 |
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the ... |
257-670 |
1.30e-15 |
|
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the phenylpropanoid metabolic pathway for monolignol and flavonoid biosynthesis. It catalyzes the synthesis of hydroxycinnamate-CoA thioesters in a two-step reaction, involving the formation of hydroxycinnamate-AMP anhydride and the nucleophilic substitution of AMP by CoA. The phenylpropanoid pathway is one of the most important secondary metabolism pathways in plants and hydroxycinnamate-CoA thioesters are the precursors of lignin and other important phenylpropanoids.
Pssm-ID: 341230 [Multi-domain] Cd Length: 505 Bit Score: 82.28 E-value: 1.30e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 257 TITYRQLDRLSSTVQG-----LLQQYD----LGPGSV-VPIIFkkskwaivamLGVLKAGAAFCMLDQSYPTKRLVNICK 326
Cdd:cd05904 32 ALTYAELERRVRRLAAglakrGGRKGDvvllLSPNSIeFPVAF----------LAVLSLGAVVTTANPLSTPAEIAKQVK 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 327 DVDAKVIVCSQEL---------SIGVSGSTLSIGDHNTE---TATYSAIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHG 394
Cdd:cd05904 102 DSGAKLAFTTAELaeklaslalPVVLLDSAEFDSLSFSDllfEADEAEPPVVVIKQDDVAALLYSSGTTGRSKGVMLTHR 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 395 SFCTNA--IASSQAQNLDRSSRVL----QFASYAFDVSVhesLTPLLLGGCVCIPSEAQrVNSLKEAVSTLRVNWVELTP 468
Cdd:cd05904 182 NLIAMVaqFVAGEGSNSDSEDVFLcvlpMFHIYGLSSFA---LGLLRLGATVVVMPRFD-LEELLAAIERYKVTHLPVVP 257
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 469 TV------ARLWCPADIPTVKTLVMGGEPMLPNDISLWKDKL---RLVCAYGPAECTVVSTvqSCVQELGNIGRSpcGTC 539
Cdd:cd05904 258 PIvlalvkSPIVDKYDLSSLRQIMSGAAPLGKELIEAFRAKFpnvDLGQGYGMTESTGVVA--MCFAPEKDRAKY--GSV 333
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 540 -WIVSK------D-NHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFitNPEwaslfhlngsyRFYKTGDLVRYNAD 611
Cdd:cd05904 334 gRLVPNveakivDpETGESLPPNQTGELWIRGPSIMKGYLNNPEATAATI--DKE-----------GWLHTGDLCYIDED 400
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 992230864 612 GTIAYIGR-KDTqVKLNGQRVELGEIEH--QAQPYFRDaviAAEVAAP---AGRKPilILFIARK 670
Cdd:cd05904 401 GYLFIVDRlKEL-IKYKGFQVAPAELEAllLSHPEILD---AAVIPYPdeeAGEVP--MAFVVRK 459
|
|
| BCL_4HBCL |
cd05959 |
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate ... |
256-734 |
1.53e-15 |
|
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate CoA ligase and 4-hydroxybenzoate-coenzyme A ligase catalyze the first activating step for benzoate and 4-hydroxybenzoate catabolic pathways, respectively. Although these two enzymes share very high sequence homology, they have their own substrate preference. The reaction proceeds via a two-step process; the first ATP-dependent step forms the substrate-AMP intermediate, while the second step forms the acyl-CoA ester, releasing the AMP. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Some bacteria can use benzoic acid or benzenoid compounds as the sole source of carbon and energy through degradation. Benzoate CoA ligase and 4-hydroxybenzoate-Coenzyme A ligase are key enzymes of this process.
Pssm-ID: 341269 [Multi-domain] Cd Length: 508 Bit Score: 82.03 E-value: 1.53e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 256 GTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVC 335
Cdd:cd05959 28 GSLTYAELEAEARRVAGALRALGVKREERVLLIMLDTVDFPTAFLGAIRAGIVPVPVNTLLTPDDYAYYLEDSRARVVVV 107
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 336 SQEL---------SIGVSGSTL-SIGDHNTETATYS----------AIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGS 395
Cdd:cd05959 108 SGELapvlaaaltKSEHTLVVLiVSGGAGPEAGALLlaelvaaeaeQLKPAATHADDPAFWLYSSGSTGRPKGVVHLHAD 187
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 396 FctNAIASSQAQN---LDRSSRVLQFASYAFDVSVHESLT-PLLLGG-CVCIPSE---------AQRVN-SLKEAVSTLR 460
Cdd:cd05959 188 I--YWTAELYARNvlgIREDDVCFSAAKLFFAYGLGNSLTfPLSVGAtTVLMPERptpaavfkrIRRYRpTVFFGVPTLY 265
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 461 VNWveltpTVARLWCPADIPTVKTLVMGGEPmLPNDISL-WKDKlrlvcaYGpaeCTVVSTVQScvQELGNI------GR 533
Cdd:cd05959 266 AAM-----LAAPNLPSRDLSSLRLCVSAGEA-LPAEVGErWKAR------FG---LDILDGIGS--TEMLHIflsnrpGR 328
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 534 SPCGTCW---------IVSKDNHHrlMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITnpEWaslfhlngsyrfYKTGD 604
Cdd:cd05959 329 VRYGTTGkpvpgyeveLRDEDGGD--VADGEPGELYVRGPSSATMYWNNRDKTRDTFQG--EW------------TRTGD 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 605 LVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRD-AVIAAEvaAPAGR-KPILILFIARKYEysvnmdct 680
Cdd:cd05959 393 KYVRDDDGFYTYAGRADDMLKVSGIWVSPFEVESalVQHPAVLEaAVVGVE--DEDGLtKPKAFVVLRPGYE-------- 462
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....
gi 992230864 681 mllrPPSILFQEkaqgTNTLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLR 734
Cdd:cd05959 463 ----DSEALEEE----LKEFVKDRLAPYKYPRWIVFVDELPKTATGKIQRFKLR 508
|
|
| MACS_like_2 |
cd05973 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
258-734 |
6.31e-15 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341277 [Multi-domain] Cd Length: 437 Bit Score: 79.48 E-value: 6.31e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 258 ITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVCSq 337
Cdd:cd05973 1 LTFGELRALSARFANALQELGVGPGDVVAGLLPRTPELVVTILGIWRLGAVYQPLFTAFGPKAIEHRLRTSGARLVVTD- 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 338 elsigvsgstlsigdhntetatysaiqAVNTASHDAAYVV--YTSGSTGAPKGIVIEhgsfcTNAIASSQAQ-----NLD 410
Cdd:cd05973 80 ---------------------------AANRHKLDSDPFVmmFTSGTTGLPKGVPVP-----LRALAAFGAYlrdavDLR 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 411 RSSRVLQFASYAFDVSVHESLT-PLLLGGCVCIPSEAQRVNSLKEAVSTLRVNWVELTPTVARLW--CPADIPTVKTLVM 487
Cdd:cd05973 128 PEDSFWNAADPGWAYGLYYAITgPLALGHPTILLEGGFSVESTWRVIERLGVTNLAGSPTAYRLLmaAGAEVPARPKGRL 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 488 -----GGEPMLPNDISLWKDKLRLVCA--YGPAEC-TVVSTVQSCVQEL--GNIGRSPCGTCWIVSKDNHHRLMPvGCIG 557
Cdd:cd05973 208 rrvssAGEPLTPEVIRWFDAALGVPIHdhYGQTELgMVLANHHALEHPVhaGSAGRAMPGWRVAVLDDDGDELGP-GEPG 286
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 558 ELII---GGPIVG-RGYLKQPCLTANAfitnpewaslfhlngsyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQR--- 630
Cdd:cd05973 287 RLAIdiaNSPLMWfRGYQLPDTPAIDG-----------------GYYLTGDTVEFDPDGSFSFIGRADDVITMSGYRigp 349
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 631 --VELGEIEHQaqpyfrdAVI-AAEVAAPAG-RKPILILFIarkyeysvnmdctmLLRPPSILFQEKAQGTNTLLQEVLP 706
Cdd:cd05973 350 fdVESALIEHP-------AVAeAAVIGVPDPeRTEVVKAFV--------------VLRGGHEGTPALADELQLHVKKRLS 408
|
490 500
....*....|....*....|....*...
gi 992230864 707 RHMIPAAYIELLAMPISRTGKVNRKLLR 734
Cdd:cd05973 409 AHAYPRTIHFVDELPKTPSGKIQRFLLR 436
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
1356-1844 |
1.52e-14 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 80.21 E-value: 1.52e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1356 QLISSLGQSLPRSAVPSLCLPVSFIPVDPLGQPDRIYLCEAASSmtldflhsltdPVNKYIDYHILPEEARLRGIVAHVL 1435
Cdd:PRK12467 975 ELKAQLRQVLPDYMVPAHLLLLDSLPLTPNGKLDRKALPKPDAS-----------AVQATFVAPQTELEKRLAAIWADVL 1043
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1436 SIDPqnISPKDDFFTLGGDSISAMQVVSLCRKH---QLSLTALdiFNGRTIELIATRLMPLTPYTPPSTPASDRslDRRF 1512
Cdd:PRK12467 1044 KVER--VGLTDNFFELGGHSLLATQVISRVRQRlgiQVPLRTL--FEHQTLAGFAQAVAAQQQGAQPALPDVDR--DQPL 1117
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1513 SLLFLNsdrdmERLesllmatYDIGSMDSIEDAY--PCSESHQGLLQTQMLRpfyyqsytiwevttrsksspvspvrlcN 1590
Cdd:PRK12467 1118 PLSYAQ-----ERQ-------WFLWQLEPGSAAYhiPQALRLKGPLDIEALE---------------------------R 1158
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1591 AWFTLARRHPALRTHLIDIplcDGMSSK-IHVV------HKDYMADAAILSCEDEHVITELRKPFLPSDTGLYYPHAFRI 1663
Cdd:PRK12467 1159 SFDALVARHESLRTTFVQE---DGRTRQvIHPVgsltleEPLLLAADKDEAQLKVYVEAEARQPFDLEQGPLLRVGLLRL 1235
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1664 CQTVSGRVfckLEGGHAFLDATSVLIILRELAQAYDG-------QLSSVPgPSYSSAVAWL-QSLPNG--DNRMDYWRRQ 1733
Cdd:PRK12467 1236 AADEHVLV---LTLHHIVSDGWSMQVLVDELVALYAAysqgqslQLPALP-IQYADYAVWQrQWMDAGerARQLAYWKAQ 1311
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1734 LKDASPCI-----FPRLRDQDSPSDTLVVTEQLASTATLTPVCTRHGLTVSNVLQVAWGLMLRRYTESDDVCFGALISGR 1808
Cdd:PRK12467 1312 LGGEQPVLelptdRPRPAVQSHRGARLAFELPPALAEGLRALARREGVTLFMLLLASFQTLLHRYSGQDDIRVGVPIANR 1391
|
490 500 510
....*....|....*....|....*....|....*.
gi 992230864 1809 DSRipDVDKMVGPFFNVLVCQLRFGREDSLWDVLRR 1844
Cdd:PRK12467 1392 NRA--ETEGLIGFFVNTQVLRAEVDGQASFQQLLQQ 1425
|
|
| PRK05852 |
PRK05852 |
fatty acid--CoA ligase family protein; |
246-637 |
1.62e-14 |
|
fatty acid--CoA ligase family protein;
Pssm-ID: 235625 [Multi-domain] Cd Length: 534 Bit Score: 78.78 E-value: 1.62e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDG--TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVN 323
Cdd:PRK05852 30 PEAPALVVTADriAISYRDLARLVDDLAGQLTRSGLLPGDRVALRMGSNAEFVVALLAASRADLVVVPLDPALPIAEQRV 109
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 324 ICKDVDAKVI------VCSQEL--------------SIGVSGSTLSIgdHNTETATYSAIQAVNTA-SHDAAYVVYTSGS 382
Cdd:PRK05852 110 RSQAAGARVVlidadgPHDRAEpttrwwpltvnvggDSGPSGGTLSV--HLDAATEPTPATSTPEGlRPDDAMIMFTGGT 187
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 383 TGAPKGIVIEHGSFCTNAIASSQAQNL-DRSSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQ-RVNSLKEAVSTLR 460
Cdd:PRK05852 188 TGLPKMVPWTHANIASSVRAIITGYRLsPRDATVAVMPLYHGHGLIAALLATLASGGAVLLPARGRfSAHTFWDDIKAVG 267
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 461 VNWVELTPTVARL--------WCPADIPTVKTLVMGGEPMLPNDISLWKDKLR--LVCAYGPAECT--VVST-------V 521
Cdd:PRK05852 268 ATWYTAVPTIHQIlleraatePSGRKPAALRFIRSCSAPLTAETAQALQTEFAapVVCAFGMTEAThqVTTTqiegigqT 347
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 522 QSCVQELGNIGRSPCGTCWIVSKDNHHrlMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNpeWaslfhlngsyrfYK 601
Cdd:PRK05852 348 ENPVVSTGLVGRSTGAQIRIVGSDGLP--LPAGAVGEVWLRGTTVVRGYLGDPTITAANFTDG--W------------LR 411
|
410 420 430
....*....|....*....|....*....|....*.
gi 992230864 602 TGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIE 637
Cdd:PRK05852 412 TGDLGSLSAAGDLSIRGRIKELINRGGEKISPERVE 447
|
|
| CBAL |
cd05923 |
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) ... |
245-649 |
3.55e-14 |
|
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) to 4-chlorobenzoyl-coenzyme A (4-CB-CoA) by the two-step adenylation and thioester-forming reactions. 4-Chlorobenzoate (4-CBA) is an environmental pollutant derived from microbial breakdown of aromatic pollutants, such as polychlorinated biphenyls (PCBs), DDT, and certain herbicides. The 4-CBA degrading pathway converts 4-CBA to the metabolite 4-hydroxybezoate (4-HBA), allowing some soil-dwelling microbes to utilize 4-CBA as an alternate carbon source. This pathway consists of three chemical steps catalyzed by 4-CBA-CoA ligase, 4-CBA-CoA dehalogenase, and 4HBA-CoA thioesterase in sequential reactions.
Pssm-ID: 341247 [Multi-domain] Cd Length: 493 Bit Score: 77.55 E-value: 3.55e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 245 QPDAQAICAWDGT--ITYRQL-DRLSSTVQGLLQQyDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRL 321
Cdd:cd05923 14 APDACAIADPARGlrLTYSELrARIEAVAARLHAR-GLRPGQRVAVVLPNSVEAVIALLALHRLGAVPALINPRLKAAEL 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 322 VN-ICKDVDAKVIVCSQEL----SIGVSGSTLSIGDHNTETATYSA---IQAVNTASHDAAYVVYTSGSTGAPKGIVIEH 393
Cdd:cd05923 93 AElIERGEMTAAVIAVDAQvmdaIFQSGVRVLALSDLVGLGEPESAgplIEDPPREPEQPAFVFYTSGTTGLPKGAVIPQ 172
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 394 GSFCTNAIA-SSQAQNL-DRSSRVLQFASYAFDVSVHESLT-PLLLGGCVCIPSEAQRVNSLKeAVSTLRVNWVELTPT- 469
Cdd:cd05923 173 RAAESRVLFmSTQAGLRhGRHNVVLGLMPLYHVIGFFAVLVaALALDGTYVVVEEFDPADALK-LIEQERVTSLFATPTh 251
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 470 -----VARLWCPADIPTVKTLVMGGEPMlpNDISLwkDKL------RLVCAYGPAEcTVVSTVQSCVQElGNIGR----S 534
Cdd:cd05923 252 ldalaAAAEFAGLKLSSLRHVTFAGATM--PDAVL--ERVnqhlpgEKVNIYGTTE-AMNSLYMRDART-GTEMRpgffS 325
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 535 PCGTCWIVSKDNHhrLMPVGCIGELII--GGPIVGRGYLKQPCLTANafitnpewaslfhlNGSYRFYKTGDLVRYNADG 612
Cdd:cd05923 326 EVRIVRIGGSPDE--ALANGEEGELIVaaAADAAFTGYLNQPEATAK--------------KLQDGWYRTGDVGYVDPSG 389
|
410 420 430
....*....|....*....|....*....|....*....
gi 992230864 613 TIAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRDAVI 649
Cdd:cd05923 390 DVRILGRVDDMIISGGENIHPSEIERvlSRHPGVTEVVV 428
|
|
| LCL_NRPS-like |
cd19531 |
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar ... |
1683-1844 |
4.88e-14 |
|
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar domains including the C-domain of SgcC5, a free-standing NRPS with both ester- and amide- bond forming activity; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. Streptomyces globisporus SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380454 [Multi-domain] Cd Length: 427 Bit Score: 76.62 E-value: 4.88e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1683 DATSVLIILRELAQAYD----GQLSSVPGPS-----YssAV---AWLQSlPNGDNRMDYWRRQLKDASPCI-----FPRL 1745
Cdd:cd19531 139 DGWSMGVLLRELAALYAaflaGRPSPLPPLPiqyadY--AVwqrEWLQG-EVLERQLAYWREQLAGAPPVLelptdRPRP 215
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1746 RDQDSPSDTLVVT--EQLasTATLTPVCTRHGLTVSNVLQVAWGLMLRRYTESDDVCFGALISGRDSriPDVDKMVGPFF 1823
Cdd:cd19531 216 AVQSFRGARVRFTlpAEL--TAALRALARREGATLFMTLLAAFQVLLHRYSGQDDIVVGTPVAGRNR--AELEGLIGFFV 291
|
170 180
....*....|....*....|.
gi 992230864 1824 NVLVCQLRFGREDSLWDVLRR 1844
Cdd:cd19531 292 NTLVLRTDLSGDPTFRELLAR 312
|
|
| C_PKS-NRPS |
cd19532 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
1582-1844 |
5.42e-14 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHxxxD motif, a few such as Monascus pilosus lovastatin nonaketide synthase MokA have a non-canonical HRxxxD motif in the C-domain and are unable to catalyze amide-bond formation. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380455 [Multi-domain] Cd Length: 421 Bit Score: 76.34 E-value: 5.42e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1582 PVSPVRLCNAWFTLARRHPALRThlidiplC------DGM-------SSKIHVVHKDYMADAAIlscedEHVITELRKpf 1648
Cdd:cd19532 35 PLDVARLERAVRAVGQRHEALRT-------CfftdpeDGEpmqgvlaSSPLRLEHVQISDEAEV-----EEEFERLKN-- 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1649 lpsdtglyypHAFRIcqtVSGRVF----CKLEGGHAFL---------DATSVLIILRELAQAYDGQLSSVPGPSYSS-AV 1714
Cdd:cd19532 101 ----------HVYDL---ESGETMrivlLSLSPTEHYLifgyhhiamDGVSFQIFLRDLERAYNGQPLLPPPLQYLDfAA 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1715 AWLQSLPNG--DNRMDYWRRQLKDASPCI--FPRLRDQDSPSdtLVVTEQLASTATLTP--------VCTRHGLTVSN-- 1780
Cdd:cd19532 168 RQRQDYESGalDEDLAYWKSEFSTLPEPLplLPFAKVKSRPP--LTRYDTHTAERRLDAalaarikeASRKLRVTPFHfy 245
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 992230864 1781 --VLQVawglMLRRYTESDDVCFGALISGRDSriPDVDKMVGPFFNVLVCQLRFGREDSLWDVLRR 1844
Cdd:cd19532 246 laALQV----LLARLLDVDDICIGIADANRTD--EDFMETIGFFLNLLPLRFRRDPSQTFADVLKE 305
|
|
| entE |
PRK10946 |
(2,3-dihydroxybenzoyl)adenylate synthase; |
245-742 |
5.72e-14 |
|
(2,3-dihydroxybenzoyl)adenylate synthase;
Pssm-ID: 236803 [Multi-domain] Cd Length: 536 Bit Score: 76.95 E-value: 5.72e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 245 QPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVvpiifkkskwAIV----------AMLGVLKAGAAFCMLDQ 314
Cdd:PRK10946 36 ASDAIAVICGERQFSYRELNQASDNLACSLRRQGIKPGDT----------ALVqlgnvaefyiTFFALLKLGVAPVNALF 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 315 SYPTKRLVNICKDVDAKVIVCS------------QELSIGVSG-STLSIGDHNTETATYSAIQ-------AVNTASHDAA 374
Cdd:PRK10946 106 SHQRSELNAYASQIEPALLIADrqhalfsdddflNTLVAEHSSlRVVLLLNDDGEHSLDDAINhpaedftATPSPADEVA 185
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 375 YVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQF--ASYAFDVSVHESLTPLLLGGCVCIPSEAQRVNSL 452
Cdd:PRK10946 186 FFQLSGGSTGTPKLIPRTHNDYYYSVRRSVEICGFTPQTRYLCAlpAAHNYPMSSPGALGVFLAGGTVVLAPDPSATLCF 265
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 453 kEAVSTLRVNWVELTPTVARLWCPA--------DIPTVKTLVMGGEPM-------LPNDISLwkdKLRLVcaYGPAECTV 517
Cdd:PRK10946 266 -PLIEKHQVNVTALVPPAVSLWLQAiaeggsraQLASLKLLQVGGARLsetlarrIPAELGC---QLQQV--FGMAEGLV 339
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 518 VSTV--QSCVQELGNIGR--SPCGTCWIVskDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPewaslfhl 593
Cdd:PRK10946 340 NYTRldDSDERIFTTQGRpmSPDDEVWVA--DADGNPLPQGEVGRLMTRGPYTFRGYYKSPQHNASAFDANG-------- 409
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 594 ngsyrFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEHQ--AQPyfrdAVI-AAEVAAP---AGRKpililfi 667
Cdd:PRK10946 410 -----FYCSGDLVSIDPDGYITVVGREKDQINRGGEKIAAEEIENLllRHP----AVIhAALVSMEdelMGEK------- 473
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 668 arkyeysvnmDCTML-----LRPPSILFQEKAQGtntLLQEVLPRHmipaayIELL-AMPISRTGKVNRKLLREAVEQAS 741
Cdd:PRK10946 474 ----------SCAFLvvkepLKAVQLRRFLREQG---IAEFKLPDR------VECVdSLPLTAVGKVDKKQLRQWLASRA 534
|
.
gi 992230864 742 E 742
Cdd:PRK10946 535 S 535
|
|
| beta-lac_NRPS |
cd19547 |
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis ... |
1588-1907 |
6.02e-14 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis NocB which exhibits an unusual cyclization to form beta-lactam rings in pro-nocardicin G synthesis; Nocardia uniformis NRPS NocB acts centrally in the biosynthesis of the nocardicin monocyclic beta-lactam antibiotics. Along with another NRPS NocA, it mediates an unusual cyclization to form beta-lactam rings in the synthesis of the beta-lactam-containing pentapeptide pro-nocardicin G. This small subfamily is related to DCL-type Condensation (C) domains, which catalyze condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; domains belonging to this subfamily have an HHHxxxD motif at the active site.
Pssm-ID: 380469 [Multi-domain] Cd Length: 422 Bit Score: 76.20 E-value: 6.02e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1588 LCNAWFTLARRHPALRTHLIdiplCDGMSSKIHVVHKDYMADAAIL--SCEDEHVITELRKPFLPSD--TGLYYP----H 1659
Cdd:cd19547 41 LREAWRRVADRYEILRTGFT----WRDRAEPLQYVRDDLAPPWALLdwSGEDPDRRAELLERLLADDraAGLSLAdcplY 116
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1660 AFRICQTVSGRVFCKLEGGHAFLDA-------TSVLIILRELAQAYDGQLSsvPGPSYSSAVAWLQS-LPNGDNRMDYWR 1731
Cdd:cd19547 117 RLTLVRLGGGRHYLLWSHHHILLDGwclsliwGDVFRVYEELAHGREPQLS--PCRPYRDYVRWIRArTAQSEESERFWR 194
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1732 RQLKDASPCIFPRL-RDQDSPSDTLV--VTEQLasTATLTPVCTRHGLTVSNVLQVAWGLMLRRYTESDDVCFGALISGR 1808
Cdd:cd19547 195 EYLRDLTPSPFSTApADREGEFDTVVheFPEQL--TRLVNEAARGYGVTTNAISQAAWSMLLALQTGARDVVHGLTIAGR 272
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1809 DSRIPDVDKMVGPFFNVLVCQLRFGREDSLWDVLRRNQTEIGNRLLNQHCSLIEVLRFST---YFGQPLFNTCISVEQPL 1885
Cdd:cd19547 273 PPELEGSEHMVGIFINTIPLRIRLDPDQTVTGLLETIHRDLATTAAHGHVPLAQIKSWASgerLSGGRVFDNLVAFENYP 352
|
330 340
....*....|....*....|....
gi 992230864 1886 SMDTPDASLCFK--ELETLEPTEY 1907
Cdd:cd19547 353 EDNLPGDDLSIQiiDLHAQEKTEY 376
|
|
| AACS_like |
cd05968 |
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This ... |
210-736 |
1.81e-13 |
|
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This uncharacterized acyl-CoA synthetase family (EC 6.2.1.16, or acetoacetate#CoA ligase or acetoacetate:CoA ligase (AMP-forming)) is highly homologous to acetoacetyl-CoA synthetase. However, the proteins in this family exist in only bacteria and archaea. AACS is a cytosolic ligase that specifically activates acetoacetate to its coenzyme A ester by a two-step reaction. Acetoacetate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is the first step of the mevalonate pathway of isoprenoid biosynthesis via isopentenyl diphosphate. Isoprenoids are a large class of compounds found in all living organisms.
Pssm-ID: 341272 [Multi-domain] Cd Length: 610 Bit Score: 75.60 E-value: 1.81e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 210 LSKHHQdqIAEWNRNAPIHPFDSCIHTLFRlqcilQPDAQAICAWDG------TITYRQLDRLSSTVQGLLQQYDLGPGS 283
Cdd:cd05968 45 LSGGKP--WAAWFVGGRMNIVEQLLDKWLA-----DTRTRPALRWEGedgtsrTLTYGELLYEVKRLANGLRALGVGKGD 117
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 284 VVPIIFKKSKWAIVAMLGVLKAGAAFCML------------------------DQSYPTKRLVNICKDVDAKVIVCSQ-E 338
Cdd:cd05968 118 RVGIYLPMIPEIVPAFLAVARIGGIVVPIfsgfgkeaaatrlqdaeakalitaDGFTRRGREVNLKEEADKACAQCPTvE 197
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 339 LSIGVSGSTLSIGDHN------TETATYSAIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQ-NLDR 411
Cdd:cd05968 198 KVVVVRHLGNDFTPAKgrdlsyDEEKETAGDGAERTESEDPLMIIYTSGTTGKPKGTVHVHAGFPLKAAQDMYFQfDLKP 277
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 412 SSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEA---QRVNSLKEAVSTLRVNWVELTPTVARLWCPA--------DIP 480
Cdd:cd05968 278 GDLLTWFTDLGWMMGPWLIFGGLILGATMVLYDGApdhPKADRLWRMVEDHEITHLGLSPTLIRALKPRgdapvnahDLS 357
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 481 TVKTLVMGGEPMLPnDISLW------KDKLRLVCAYGPAE-------CTVVSTVQSCvqelGNIGRSPcGTCWIVSKDNH 547
Cdd:cd05968 358 SLRVLGSTGEPWNP-EPWNWlfetvgKGRNPIINYSGGTEisggilgNVLIKPIKPS----SFNGPVP-GMKADVLDESG 431
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 548 HRLMPVgcIGELIIGGPIVG--RGYLKQPCLTANAFitnpeWASLfhlngsYRFYKTGDLVRYNADGTIAYIGRKDTQVK 625
Cdd:cd05968 432 KPARPE--VGELVLLAPWPGmtRGFWRDEDRYLETY-----WSRF------DNVWVHGDFAYYDEEGYFYILGRSDDTIN 498
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 626 LNGQRVELGEIEH--QAQPYFRDaviAAEVAAP---AGRKPIlilfiarkyeysvnmdCTMLLRPPSILFQEKAQGTNTL 700
Cdd:cd05968 499 VAGKRVGPAEIESvlNAHPAVLE---SAAIGVPhpvKGEAIV----------------CFVVLKPGVTPTEALAEELMER 559
|
570 580 590
....*....|....*....|....*....|....*.
gi 992230864 701 LQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLREA 736
Cdd:cd05968 560 VADELGKPLSPERILFVKDLPKTRNAKVMRRVIRAA 595
|
|
| COG4908 |
COG4908 |
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General ... |
1580-1778 |
2.63e-13 |
|
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General function prediction only];
Pssm-ID: 443936 [Multi-domain] Cd Length: 243 Bit Score: 71.61 E-value: 2.63e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1580 SSPVSPVRLCNAWFTLARRHPALRTHLIDIP------LCDGMSSKIHVVHKDYMADAAILSCEDEHVITELRKPFLPSDT 1653
Cdd:COG4908 27 EGPLDVEALERALRELVRRHPALRTRFVEEDgepvqrIDPDADLPLEVVDLSALPEPEREAELEELVAEEASRPFDLARG 106
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1654 GLyyphaFRIcqtvsgRVFCKLEGGHAFL--------DATSVLIILRELAQAY----DGQLSSVPGP--SYSSAVAWLQS 1719
Cdd:COG4908 107 PL-----LRA------ALIRLGEDEHVLLltihhiisDGWSLGILLRELAALYaallEGEPPPLPELpiQYADYAAWQRA 175
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 992230864 1720 LPNGDNR---MDYWRRQLKDAS-----PCIFPRLRDQDSPSDTLVVT--EQLasTATLTPVCTRHGLTV 1778
Cdd:COG4908 176 WLQSEALekqLEYWRQQLAGAPpvlelPTDRPRPAVQTFRGATLSFTlpAEL--TEALKALAKAHGATV 242
|
|
| PRK06814 |
PRK06814 |
acyl-[ACP]--phospholipid O-acyltransferase; |
256-742 |
2.68e-13 |
|
acyl-[ACP]--phospholipid O-acyltransferase;
Pssm-ID: 235865 [Multi-domain] Cd Length: 1140 Bit Score: 75.77 E-value: 2.68e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 256 GTITYRQLdRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVC 335
Cdd:PRK06814 657 GPLTYRKL-LTGAFVLGRKLKKNTPPGENVGVMLPNANGAAVTFFALQSAGRVPAMINFSAGIANILSACKAAQVKTVLT 735
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 336 S---------QELSIGVSGS-----------TLSIGDHNTETATYSAIQAVNTASH--DAAYVVYTSGSTGAPKGIVIEH 393
Cdd:PRK06814 736 SrafiekarlGPLIEALEFGiriiyledvraQIGLADKIKGLLAGRFPLVYFCNRDpdDPAVILFTSGSEGTPKGVVLSH 815
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 394 GSFCTNAIASSQAQNLDRSSRVLQ----FASYAFDVSVhesLTPLLLGGCV----------CIPSEAQRVNS-LKEAVST 458
Cdd:PRK06814 816 RNLLANRAQVAARIDFSPEDKVFNalpvFHSFGLTGGL---VLPLLSGVKVflypsplhyrIIPELIYDTNAtILFGTDT 892
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 459 LRVNWveltptvARLWCPADIPTVKTLVMGGEPMLPNDISLWKDK--LRLVCAYGPAECTVVSTVQSCVQ-ELGNIGRSP 535
Cdd:PRK06814 893 FLNGY-------ARYAHPYDFRSLRYVFAGAEKVKEETRQTWMEKfgIRILEGYGVTETAPVIALNTPMHnKAGTVGRLL 965
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 536 CGTcwivskdnHHRLMPVGCI---GELIIGGPIVGRGYLKqpcLTANAFITNPE--WaslfhlngsyrfYKTGDLVRYNA 610
Cdd:PRK06814 966 PGI--------EYRLEPVPGIdegGRLFVRGPNVMLGYLR---AENPGVLEPPAdgW------------YDTGDIVTIDE 1022
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 611 DGTIAYIGRKDTQVKLNGQRVELGEIEHQAQPYFRDAVIAAeVAAPAGRK-PILILFIARKyeysvnmDCTMllrpPSIL 689
Cdd:PRK06814 1023 EGFITIKGRAKRFAKIAGEMISLAAVEELAAELWPDALHAA-VSIPDARKgERIILLTTAS-------DATR----AAFL 1090
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*..
gi 992230864 690 FQEKAQGtntllqevLPRHMIPAAYIELLAMPISRTGKVN----RKLLREAVEQASE 742
Cdd:PRK06814 1091 AHAKAAG--------ASELMVPAEIITIDEIPLLGTGKIDyvavTKLAEEAAAKPEA 1139
|
|
| FADD10 |
cd17635 |
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain ... |
372-730 |
3.67e-13 |
|
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain fatty acid CoA ligases, including FadD10 which is involved in the synthesis of a virulence-related lipopeptide. FadD10 is a fatty acyl-AMP ligase (FAAL) that transfers fatty acids to an acyl carrier protein. Structures of FadD10 in apo- and complexed form with dodecanoyl-AMP, show a novel open conformation, facilitated by its unique inter-domain and intermolecular interactions, which is critical for the enzyme to carry out the acyl transfer onto the acyl carrier protein (Rv0100) rather than coenzyme A.
Pssm-ID: 341290 [Multi-domain] Cd Length: 340 Bit Score: 73.06 E-value: 3.67e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 372 DAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASY-AFDVSVHESLTPLLLGGCVCIPSEAQRVN 450
Cdd:cd17635 2 DPLAVIFTSGTTGEPKAVLLANKTFFAVPDILQKEGLNWVVGDVTYLPLPaTHIGGLWWILTCLIHGGLCVTGGENTTYK 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 451 SLKEAVSTLRVNWVELTPTvarLWCP---------ADIPTVKTLVMGGEPMLPNDIS--LWKDKLRLVCAYGPAECTVVS 519
Cdd:cd17635 82 SLFKILTTNAVTTTCLVPT---LLSKlvselksanATVPSLRLIGYGGSRAIAADVRfiEATGLTNTAQVYGLSETGTAL 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 520 TVQ--SCVQELGNIGRSPCGTCWIVsKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITnpEWaslfhlngsy 597
Cdd:cd17635 159 CLPtdDDSIEINAVGRPYPGVDVYL-AATDGIAGPSASFGTIWIKSPANMLGYWNNPERTAEVLID--GW---------- 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 598 rfYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEHQAQ--PYFRDAVIAAEVAAPAGRKPILILFIArkyeysv 675
Cdd:cd17635 226 --VNTGDLGERREDGFLFITGRSSESINCGGVKIAPDEVERIAEgvSGVQECACYEISDEEFGELVGLAVVAS------- 296
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*
gi 992230864 676 nmdctmllrppSILFQEKAQGTNTLLQEVLPRHMIPAAYIELLAMPISRTGKVNR 730
Cdd:cd17635 297 -----------AELDENAIRALKHTIRRELEPYARPSTIVIVTDIPRTQSGKVKR 340
|
|
| MACS_AAE_MA_like |
cd05970 |
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation ... |
245-637 |
4.95e-13 |
|
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This family of MACS enzymes is found in archaea and bacteria. It is represented by the acyl-adenylating enzyme from Methanosarcina acetivorans (AAE_MA). AAE_MA is most active with propionate, butyrate, and the branched analogs: 2-methyl-propionate, butyrate, and pentanoate. The specific activity is weaker for smaller or larger acids.
Pssm-ID: 341274 [Multi-domain] Cd Length: 537 Bit Score: 74.07 E-value: 4.95e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 245 QPDAQAIcAW--DGT----ITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPT 318
Cdd:cd05970 30 YPDKLAL-VWcdDAGeeriFTFAELADYSDKTANFFKAMGIGKGDTVMLTLKRRYEFWYSLLALHKLGAIAIPATHQLTA 108
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 319 KRLVNICKDVDAKVIVCSQELSI-----------GVSGSTLSIGDHNTE------------TATYSAIQA-VNTASHDAA 374
Cdd:cd05970 109 KDIVYRIESADIKMIVAIAEDNIpeeiekaapecPSKPKLVWVGDPVPEgwidfrkliknaSPDFERPTAnSYPCGEDIL 188
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 375 YVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQRVN--SL 452
Cdd:cd05970 189 LVYFSSGTTGMPKMVEHDFTYPLGHIVTAKYWQNVREGGLHLTVADTGWGKAVWGKIYGQWIAGAAVFVYDYDKFDpkAL 268
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 453 KEAVSTLRVNWVELTPTVARLWCPADI-----PTVKTLVMGGEPMLPNDISLWKDK--LRLVCAYGPAECTVVSTVQSCV 525
Cdd:cd05970 269 LEKLSKYGVTTFCAPPTIYRFLIREDLsrydlSSLRYCTTAGEALNPEVFNTFKEKtgIKLMEGFGQTETTLTIATFPWM 348
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 526 Q-ELGNIGRsPCGTCWIVSKDNHHRLMPVGCIGELII----GGPI-VGRGYLKQPCLTANAFITNpewaslfhlngsyrF 599
Cdd:cd05970 349 EpKPGSMGK-PAPGYEIDLIDREGRSCEAGEEGEIVIrtskGKPVgLFGGYYKDAEKTAEVWHDG--------------Y 413
|
410 420 430
....*....|....*....|....*....|....*...
gi 992230864 600 YKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIE 637
Cdd:cd05970 414 YHTGDAAWMDEDGYLWFVGRTDDLIKSSGYRIGPFEVE 451
|
|
| PRK08751 |
PRK08751 |
long-chain fatty acid--CoA ligase; |
247-655 |
5.42e-13 |
|
long-chain fatty acid--CoA ligase;
Pssm-ID: 181546 [Multi-domain] Cd Length: 560 Bit Score: 74.14 E-value: 5.42e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 247 DAQAICAWDGTITYRQLDRLSSTVQG-LLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNIC 325
Cdd:PRK08751 40 DRPAYHSFGKTITYREADQLVEQFAAyLLGELQLKKGDRVALMMPNCLQYPIATFGVLRAGLTVVNVNPLYTPRELKHQL 119
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 326 KDVDAKVIVCSQELSIGVSGS----------TLSIGD---------------------------------HNTETATYSA 362
Cdd:PRK08751 120 IDSGASVLVVIDNFGTTVQQViadtpvkqviTTGLGDmlgfpkaalvnfvvkyvkklvpeyringairfrEALALGRKHS 199
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 363 IQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQ----AQNLDRSSRVLQFA--SYAFDVSVHESLTPLLL 436
Cdd:PRK08751 200 MPTLQIEPDDIAFLQYTGGTTGVAKGAMLTHRNLVANMQQAHQwlagTGKLEEGCEVVITAlpLYHIFALTANGLVFMKI 279
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 437 GGCVCIPSEAQR----VNSLKE-------AVSTLrVNWVELTPTVARLwcpaDIPTVKTLVMGGEPMLPNDISLWKD--K 503
Cdd:PRK08751 280 GGCNHLISNPRDmpgfVKELKKtrftaftGVNTL-FNGLLNTPGFDQI----DFSSLKMTLGGGMAVQRSVAERWKQvtG 354
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 504 LRLVCAYGPAEctvvSTVQSCVQEL------GNIGRsPCGTCWIVSKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLT 577
Cdd:PRK08751 355 LTLVEAYGLTE----TSPAACINPLtlkeynGSIGL-PIPSTDACIKDDAGTVLAIGEIGELCIKGPQVMKGYWKRPEET 429
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 578 ANAfITNPEWaslFHlngsyrfykTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEHqaqpyfrdaVIA-----AE 652
Cdd:PRK08751 430 AKV-MDADGW---LH---------TGDIARMDEQGFVYIVDRKKDMILVSGFNVYPNEIED---------VIAmmpgvLE 487
|
...
gi 992230864 653 VAA 655
Cdd:PRK08751 488 VAA 490
|
|
| PRK07514 |
PRK07514 |
malonyl-CoA synthase; Validated |
246-402 |
7.57e-13 |
|
malonyl-CoA synthase; Validated
Pssm-ID: 181011 [Multi-domain] Cd Length: 504 Bit Score: 73.37 E-value: 7.57e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDG-TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNI 324
Cdd:PRK07514 16 RDAPFIETPDGlRYTYGDLDAASARLANLLVALGVKPGDRVAVQVEKSPEALALYLATLRAGAVFLPLNTAYTLAELDYF 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 325 CKDVDAKVIVCSQELSIGVS--------GSTLSIGDHNTETATYSAIQA------VNTASHDAAYVVYTSGSTGAPKGIV 390
Cdd:PRK07514 96 IGDAEPALVVCDPANFAWLSkiaaaagaPHVETLDADGTGSLLEAAAAApddfetVPRGADDLAAILYTSGTTGRSKGAM 175
|
170
....*....|..
gi 992230864 391 IEHGSFCTNAIA 402
Cdd:PRK07514 176 LSHGNLLSNALT 187
|
|
| OSB_MenE-like |
cd17630 |
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) ... |
374-735 |
2.22e-12 |
|
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) synthetase (also known as O-succinylbenzoic acid CoA ligase) that belongs to the ANL superfamily and catalyzes the ligation of CoA to o-succinylbenzoate (OSB). It includes MenE in the bacterial menaquinone biosynthesis pathway which is a promising target for the development of novel antibacterial agents. MenE catalyzes CoA ligation via an acyl-adenylate intermediate; tight-binding inhibitors of MenE based on stable acyl-sulfonyladenosine analogs of this intermediate provide a pathway toward the development of optimized MenE inhibitors.
Pssm-ID: 341285 [Multi-domain] Cd Length: 325 Bit Score: 70.44 E-value: 2.22e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 374 AYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLqFASYAFDVS----VHESltpLLLGGCVCIPSEAQrv 449
Cdd:cd17630 3 ATVILTSGSTGTPKAVVHTAANLLASAAGLHSRLGFGGGDSWL-LSLPLYHVGglaiLVRS---LLAGAELVLLERNQ-- 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 450 nSLKEAVSTLRVNWVELTPT-----VARLWCPADIPTVKTLVMGGEPMLPND-ISLWKDKLRLVCAYGPAEctVVSTVqs 523
Cdd:cd17630 77 -ALAEDLAPPGVTHVSLVPTqlqrlLDSGQGPAALKSLRAVLLGGAPIPPELlERAADRGIPLYTTYGMTE--TASQV-- 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 524 CVQELGNIGRSPCGtcwivsKDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAfitNPEWaslFHlngsyrfykTG 603
Cdd:cd17630 152 ATKRPDGFGRGGVG------VLLPGRELRIVEDGEIWVGGASLAMGYLRGQLVPEFN---EDGW---FT---------TK 210
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 604 DLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRDAVIAAEVAAPAGRKPILIlfiarkyeYSVNMDctm 681
Cdd:cd17630 211 DLGELHADGRLTVLGRADNMIISGGENIQPEEIEAalAAHPAVRDAFVVGVPDEELGQRPVAV--------IVGRGP--- 279
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....
gi 992230864 682 llRPPSILfqekaqgtNTLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLRE 735
Cdd:cd17630 280 --ADPAEL--------RAWLKDKLARFKLPKRIYPVPELPRTGGGKVDRRALRA 323
|
|
| Cyc_NRPS |
cd19535 |
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
1583-1865 |
2.34e-12 |
|
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Cyc (heterocyclization) domains catalyze two separate reactions in the creation of heterocyclized peptide products in nonribosomal peptide synthesis: amide bond formation followed by intramolecular cyclodehydration between a Cys, Ser, or Thr side chain and a carbonyl carbon on the peptide backbone to form a thiazoline, oxazoline, or methyloxazoline ring. Cyc-domains are homologous to standard NRPS Condensation (C) domains. C-domains typically have a conserved HHxxxD motif at the active site; Cyc-domains have an alternative, conserved DxxxxD active site motif, mutation of the aspartate residues in this motif can abolish or diminish condensation activity. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and Cyc-domains. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380458 [Multi-domain] Cd Length: 423 Bit Score: 71.37 E-value: 2.34e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1583 VSPVRLCNAWFTLARRHPALRTHLIDiplcDGMSSKIHVVHKDYMA--DAAILSCED-EHVITELRKpflpsdtglYYPH 1659
Cdd:cd19535 37 LDPDRLERAWNKLIARHPMLRAVFLD----DGTQQILPEVPWYGITvhDLRGLSEEEaEAALEELRE---------RLSH 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1660 afRICQTVSGRVF----CKLEGGHAFL---------DATSVLIILRELAQAY---DGQLSSVPgPSYSSAVAWLQSLPNG 1723
Cdd:cd19535 104 --RVLDVERGPLFdirlSLLPEGRTRLhlsidllvaDALSLQILLRELAALYedpGEPLPPLE-LSFRDYLLAEQALRET 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1724 DNR--MDYWRRQLKDaspciFPrlrdqDSPSDTLVV-TEQLAST------ATLTP--------VCTRHGLTVSNVLQVAW 1786
Cdd:cd19535 181 AYEraRAYWQERLPT-----LP-----PAPQLPLAKdPEEIKEPrftrreHRLSAeqwqrlkeRARQHGVTPSMVLLTAY 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1787 GLMLRRYTESDDVCFGALISGRDSRIPDVDKMVGPFFNVLVCQLRFGREDSLWDVLRRNQTEIGNRLlnQHCSL--IEVL 1864
Cdd:cd19535 251 AEVLARWSGQPRFLLNLTLFNRLPLHPDVNDVVGDFTSLLLLEVDGSEGQSFLERARRLQQQLWEDL--DHSSYsgVVVV 328
|
.
gi 992230864 1865 R 1865
Cdd:cd19535 329 R 329
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1357-1822 |
3.03e-12 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 72.68 E-value: 3.03e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1357 LISSLGQSLPRSAVPSLCLPVSFIPVDPLGQPDRIYLCEAASSmtlDFLHSLTDPVNKYidyhilpeEARLRGIVAHVLS 1436
Cdd:PRK12316 964 LKAHLAASLPEYMVPAQWLALERLPLTPNGKLDRKALPAPEAS---VAQQGYVAPRNAL--------ERTLAAIWQDVLG 1032
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1437 IDPqnISPKDDFFTLGGDSISAMQVVSLCRKHQLSLTALDIFNGRTIE---LIATR-------------LMPLTPytpps 1500
Cdd:PRK12316 1033 VER--VGLDDNFFELGGDSIVSIQVVSRARQAGIQLSPRDLFQHQTIRslaLVAKAgqataadqgpasgEVALAP----- 1105
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1501 tpasdrsLDRRFsllflnsdrdmerlesllmatydigsmdsIEDAYPcseSHQGLLQTQMLRPfyyqsytiwevttrskS 1580
Cdd:PRK12316 1106 -------VQRWF-----------------------------FEQAIP---QRQHWNQSLLLQA----------------R 1130
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1581 SPVSPVRLCNAWFTLARRHPALRTHLIDIplcDGMSSKIH-------VVHKDYMADAAILS--CEDEHVITELRK-PFLP 1650
Cdd:PRK12316 1131 QPLDPDRLGRALERLVAHHDALRLRFREE---DGGWQQAYaapqageVLWQRQAASEEELLalCEEAQRSLDLEQgPLLR 1207
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1651 SdtglyyphafRICQTVSGRVFCKLEGGHAFLDATSVLIILRELAQAYDGQLSSVPGPSySSAVAWLQSL----PNGDNR 1726
Cdd:PRK12316 1208 A----------LLVDMADGSQRLLLVIHHLVVDGVSWRILLEDLQRAYADLDADLPART-SSYQAWARRLhehaGARAEE 1276
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1727 MDYWRRQLKDAS---PCIFPRLRDQDSPSDTLVVT---EQLASTATLTPVCTRhgLTVSNVLQVAWGLMLRRYTESDDVC 1800
Cdd:PRK12316 1277 LDYWQAQLEDAPhelPCENPDGALENRHERKLELRldaERTRQLLQEAPAAYR--TQVNDLLLTALARVTCRWSGQASVL 1354
|
490 500
....*....|....*....|....
gi 992230864 1801 FGALISGRDSRIPDVD--KMVGPF 1822
Cdd:PRK12316 1355 VQLEGHGREDLFEDIDlsRTVGWF 1378
|
|
| PRK07768 |
PRK07768 |
long-chain-fatty-acid--CoA ligase; Validated |
258-641 |
3.10e-12 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236091 [Multi-domain] Cd Length: 545 Bit Score: 71.57 E-value: 3.10e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 258 ITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQsyPTKRL---------VNICKDV 328
Cdd:PRK07768 30 HTWGEVHERARRIAGGLAAAGVGPGDAVAVLAGAPVEIAPTAQGLWMRGASLTMLHQ--PTPRTdlavwaedtLRVIGMI 107
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 329 DAKVIVCSQ------ELSIGVSGSTLSIGDHNTETAtysaIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIA 402
Cdd:PRK07768 108 GAKAVVVGEpflaaaPVLEEKGIRVLTVADLLAADP----IDPVETGEDDLALMQLTSGSTGSPKAVQITHGNLYANAEA 183
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 403 SSQAqnldrssrvlqfASYAFDVSVHESLTPLL----LGGCVCIP----SEAQRVNSLKEAVSTLRvnWVEL------TP 468
Cdd:PRK07768 184 MFVA------------AEFDVETDVMVSWLPLFhdmgMVGFLTVPmyfgAELVKVTPMDFLRDPLL--WAELiskyrgTM 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 469 TVA----------RLWCPA-----DIPTVKTLVMGGEPMLPNDISLWKD-----KLR---LVCAYGPAECT--------- 516
Cdd:PRK07768 250 TAApnfayallarRLRRQAkpgafDLSSLRFALNGAEPIDPADVEDLLDagarfGLRpeaILPAYGMAEATlavsfspcg 329
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 517 ---VVSTVqsCVQELGNIGRS-PcgtcwiVSKDNHHRLMPVG---------------------CIGELIIGGPIVGRGYl 571
Cdd:PRK07768 330 aglVVDEV--DADLLAALRRAvP------ATKGNTRRLATLGpplpglevrvvdedgqvlpprGVGVIELRGESVTPGY- 400
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 572 kqpcLTANAFITnpewaslfhLNGSYRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEHQAQ 641
Cdd:PRK07768 401 ----LTMDGFIP---------AQDADGWLDTGDLGYLTEEGEVVVCGRVKDVIIMAGRNIYPTDIERAAA 457
|
|
| LC_FACL_like |
cd05914 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are ... |
257-637 |
4.43e-12 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are bacterial long-chain fatty acid CoA synthetase, most of which are as yet uncharacterized. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341240 [Multi-domain] Cd Length: 463 Bit Score: 70.55 E-value: 4.43e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 257 TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVCS 336
Cdd:cd05914 7 PLTYKDLADNIAKFALLLKINGVGTGDRVALMGENRPEWGIAFFAIWTYGAIAVPILAEFTADEVHHILNHSEAKAIFVS 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 337 QElsigvsgstlsigdhntetatysaiqavntasHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVL 416
Cdd:cd05914 87 DE--------------------------------DDVALINYTSGTTGNSKGVMLTYRNIVSNVDGVKEVVLLGKGDKIL 134
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 417 QFASYA------FDVsvhesLTPLLLGGCVC----IPSEaqRVNSLKEAVSTLR----VNWV-------ELTPTVAR--- 472
Cdd:cd05914 135 SILPLHhiypltFTL-----LLPLLNGAHVVfldkIPSA--KIIALAFAQVTPTlgvpVPLViekifkmDIIPKLTLkkf 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 473 LWCPADIPTV-------------------KTLVMGGEPMLPN-DISLWKDKLRLVCAYGPAECT-VVSTVQSCVQELGNI 531
Cdd:cd05914 208 KFKLAKKINNrkirklafkkvheafggniKEFVIGGAKINPDvEEFLRTIGFPYTIGYGMTETApIISYSPPNRIRLGSA 287
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 532 GRSPCGTCWIVSKDNhhrlmPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNpEWaslFHlngsyrfykTGDLVRYNAD 611
Cdd:cd05914 288 GKVIDGVEVRIDSPD-----PATGEGEIIVRGPNVMKGYYKNPEATAEAFDKD-GW---FH---------TGDLGKIDAE 349
|
410 420
....*....|....*....|....*..
gi 992230864 612 GTIAYIGRKDTQVKL-NGQRVELGEIE 637
Cdd:cd05914 350 GYLYIRGRKKEMIVLsSGKNIYPEEIE 376
|
|
| COG4908 |
COG4908 |
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General ... |
878-1055 |
1.04e-11 |
|
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General function prediction only];
Pssm-ID: 443936 [Multi-domain] Cd Length: 243 Bit Score: 66.99 E-value: 1.04e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 878 TPLQEALMAYtSKRPGAFQAQFRFQLPHQLDMLRLKEAWRIVIAANPILRTRIVFCHTGALQVVLrPGEQLQWDLINGVH 957
Cdd:COG4908 2 SPAQKRFLFL-EPGSNAYNIPAVLRLEGPLDVEALERALRELVRRHPALRTRFVEEDGEPVQRID-PDADLPLEVVDLSA 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 958 TSPGSLMSYGVPLVDMAITND---TAGKLSR-----------TFCLTMHHAIFDGWSYGLILGAVEDAYkhTNAVQ---- 1019
Cdd:COG4908 80 LPEPEREAELEELVAEEASRPfdlARGPLLRaalirlgedehVLLLTIHHIISDGWSLGILLRELAALY--AALLEgepp 157
|
170 180 190 200
....*....|....*....|....*....|....*....|....*..
gi 992230864 1020 ------RPFAPFI----KYILHCNYESAKHFWCSEFKDM-QALPFPV 1055
Cdd:COG4908 158 plpelpIQYADYAawqrAWLQSEALEKQLEYWRQQLAGApPVLELPT 204
|
|
| FACL_like_1 |
cd05910 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
257-624 |
1.27e-11 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341236 [Multi-domain] Cd Length: 457 Bit Score: 69.03 E-value: 1.27e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 257 TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIvcs 336
Cdd:cd05910 2 RLSFRELDERSDRIAQGLTAYGIRRGMRAVLMVPPGPDFFALTFALFKAGAVPVLIDPGMGRKNLKQCLQEAEPDAF--- 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 337 qelsIGVsgstlsigdhntetatysaiqavnTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVL 416
Cdd:cd05910 79 ----IGI------------------------PKADEPAAILFTSGSTGTPKGVVYRHGTFAAQIDALRQLYGIRPGEVDL 130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 417 Q-FASYA-FDVsvhesltplLLGGCVCIP----SEAQRVN--SLKEAVSTLRVNWVELTP----TVARlWCPAD---IPT 481
Cdd:cd05910 131 AtFPLFAlFGP---------ALGLTSVIPdmdpTRPARADpqKLVGAIRQYGVSIVFGSPalleRVAR-YCAQHgitLPS 200
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 482 VKTLVMGGEPMLPNDIS----LWKDKLRLVCAYGPAECTVVSTVQScvQELGNIGRSPC----GTC-------------- 539
Cdd:cd05910 201 LRRVLSAGAPVPIALAArlrkMLSDEAEILTPYGATEALPVSSIGS--RELLATTTAATsggaGTCvgrpipgvrvriie 278
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 540 ----WIVSKDNHHRLmPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPewaslfhlngSYRF-YKTGDLVRYNADGTI 614
Cdd:cd05910 279 iddePIAEWDDTLEL-PRGEIGEITVTGPTVTPTYVNRPVATALAKIDDN----------SEGFwHRMGDLGYLDDEGRL 347
|
410
....*....|
gi 992230864 615 AYIGRKDTQV 624
Cdd:cd05910 348 WFCGRKAHRV 357
|
|
| OSB_CoA_lg |
cd05912 |
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA ... |
257-735 |
1.37e-11 |
|
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA synthetase, or MenE); O-succinylbenzoic acid-CoA synthase catalyzes the coenzyme A (CoA)- and ATP-dependent conversion of o-succinylbenzoic acid to o-succinylbenzoyl-CoA. The reaction is the fourth step of the biosynthesis pathway of menaquinone (vitamin K2). In certain bacteria, menaquinone is used during fumarate reduction in anaerobic respiration. In cyanobacteria, the product of the menaquinone pathway is phylloquinone (2-methyl-3-phytyl-1,4-naphthoquinone), a molecule used exclusively as an electron transfer cofactor in Photosystem 1. In green sulfur bacteria and heliobacteria, menaquinones are used as loosely bound secondary electron acceptors in the photosynthetic reaction center.
Pssm-ID: 341238 [Multi-domain] Cd Length: 411 Bit Score: 68.91 E-value: 1.37e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 257 TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVivcs 336
Cdd:cd05912 1 SYTFAELFEEVSRLAEHLAALGVRKGDRVALLSKNSIEMILLIHALWLLGAEAVLLNTRLTPNELAFQLKDSDVKL---- 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 337 qelsigvsgstlsigdhntetatysaiqavntasHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVL 416
Cdd:cd05912 77 ----------------------------------DDIATIMYTSGTTGKPKGVQQTFGNHWWSAIGSALNLGLTEDDNWL 122
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 417 qFASYAFDVSVHESLTPLLLGGCVCIPSEAQRVNSLKEAVSTLRVNWVELTPT-VARL------WCPadiPTVKTLVMGG 489
Cdd:cd05912 123 -CALPLFHISGLSILMRSVIYGMTVYLVDKFDAEQVLHLINSGKVTIISVVPTmLQRLleilgeGYP---NNLRCILLGG 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 490 EPMLPNDISLWKDK-LRLVCAYGPAE-CTVVSTV--QSCVQELGNIGRsPCGTCWIVSKDNhhrLMPVGCIGELIIGGPI 565
Cdd:cd05912 199 GPAPKPLLEQCKEKgIPVYQSYGMTEtCSQIVTLspEDALNKIGSAGK-PLFPVELKIEDD---GQPPYEVGEILLKGPN 274
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 566 VGRGYLKQPCLTANAFITNpeWaslfhlngsyrfYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH--QAQPY 643
Cdd:cd05912 275 VTKGYLNRPDATEESFENG--W------------FKTGDIGYLDEEGFLYVLDRRSDLIISGGENIYPAEIEEvlLSHPA 340
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 644 FRDAVIAAEVAAPAGRKPilILFIARKYEYSvnmdctmllrppsilfQEKAQgtnTLLQEVLPRHMIPAAYIELLAMPIS 723
Cdd:cd05912 341 IKEAGVVGIPDDKWGQVP--VAFVVSERPIS----------------EEELI---AYCSEKLAKYKVPKKIYFVDELPRT 399
|
490
....*....|..
gi 992230864 724 RTGKVNRKLLRE 735
Cdd:cd05912 400 ASGKLLRHELKQ 411
|
|
| PRK07788 |
PRK07788 |
acyl-CoA synthetase; Validated |
246-411 |
1.46e-11 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236097 [Multi-domain] Cd Length: 549 Bit Score: 69.19 E-value: 1.46e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNIC 325
Cdd:PRK07788 63 PDRAALIDERGTLTYAELDEQSNALARGLLALGVRAGDGVAVLARNHRGFVLALYAAGKVGARIILLNTGFSGPQLAEVA 142
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 326 KDVDAKVIVCSQE---------------LSIGVSGSTLSIGDHNTET-----ATYSAIQAVNTASHdAAYVVYTSGSTGA 385
Cdd:PRK07788 143 AREGVKALVYDDEftdllsalppdlgrlRAWGGNPDDDEPSGSTDETlddliAGSSTAPLPKPPKP-GGIVILTSGTTGT 221
|
170 180
....*....|....*....|....*.
gi 992230864 386 PKGIVIEHGSfctnaIASSQAQNLDR 411
Cdd:PRK07788 222 PKGAPRPEPS-----PLAPLAGLLSR 242
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
987-1272 |
3.22e-11 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 69.12 E-value: 3.22e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 987 FCLTMHHAIFDGWSYGLIL--GAVEDAYKHTNAVQRPFAPFIKYILHCNY----------ESAKHFWCSEFKDMQALPFP 1054
Cdd:COG1020 145 LLLALHHIISDGLSDGLLLaeLLRLYLAAYAGAPLPLPPLPIQYADYALWqrewlqgeelARQLAYWRQQLAGLPPLLEL 224
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1055 VPPLSRGHMANSSTTTHRQI---HVSEWLSSYC-----TPSTIIQLAFTLLIAWRTESMDVLFGLTVTGRNAPvaGIHRT 1126
Cdd:COG1020 225 PTDRPRPAVQSYRGARVSFRlpaELTAALRALArrhgvTLFMVLLAAFALLLARYSGQDDVVVGTPVAGRPRP--ELEGL 302
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1127 TGPTIATFPLRTILYGTMNITDALLCMQNHIATL-----IPFEHtgLRRIKSFGTETARACQFQSLLIIQ--PVTYRESS 1199
Cdd:COG1020 303 VGFFVNTLPLRVDLSGDPSFAELLARVRETLLAAyahqdLPFER--LVEELQPERDLSRNPLFQVMFVLQnaPADELELP 380
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 992230864 1200 EIFFELESNEHEQSKFstcPLTLVCELRTHSVSVKAISDNAVVISGDMERLLDQLEYLIDMITKSPTLEIQNI 1272
Cdd:COG1020 381 GLTLEPLELDSGTAKF---DLTLTVVETGDGLRLTLEYNTDLFDAATIERMAGHLVTLLEALAADPDQPLGDL 450
|
|
| PP-binding |
pfam00550 |
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached ... |
1425-1484 |
3.39e-11 |
|
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached through a serine. This prosthetic group acts as a a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups. This domain forms a four helix bundle. This family includes members not included in Prosite. The inclusion of these members is supported by sequence analysis and functional evidence. The related domain of Swiss:P19828 has the attachment serine replaced by an alanine.
Pssm-ID: 425746 [Multi-domain] Cd Length: 62 Bit Score: 60.27 E-value: 3.39e-11
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 992230864 1425 ARLRGIVAHVLSIDPQNISPKDDFFTLGGDSISAMQVVS-LCRKHQLSLTALDIFNGRTIE 1484
Cdd:pfam00550 1 ERLRELLAEVLGVPAEEIDPDTDLFDLGLDSLLAVELIArLEEEFGVEIPPSDLFEHPTLA 61
|
|
| AcpP |
COG0236 |
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the ... |
760-829 |
3.56e-11 |
|
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the Pathway/BioSystem: Fatty acid biosynthesis
Pssm-ID: 440006 [Multi-domain] Cd Length: 80 Bit Score: 60.64 E-value: 3.56e-11
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 992230864 760 PSTPVLDQLRLLFSAALRIPEEKIKPNDSFFH-LGGDSVSAIRLVGDARDQ-GLHITVESLFKRQTISKLAE 829
Cdd:COG0236 2 PREELEERLAEIIAEVLGVDPEEITPDDSFFEdLGLDSLDAVELIAALEEEfGIELPDTELFEYPTVADLAD 73
|
|
| AcpA |
COG3433 |
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites ... |
1424-1490 |
4.23e-11 |
|
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442659 [Multi-domain] Cd Length: 295 Bit Score: 65.93 E-value: 4.23e-11
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 992230864 1424 EARLRGIVAHVLSIDPQNISPKDDFFTLGGDSISAMQVVSLCRKHQLSLTALDIFNGRTIELIATRL 1490
Cdd:COG3433 221 EEELRADVAELLGVDPEEIDPDDNLFDLGLDSIRLMQLVERWRKAGLDVSFADLAEHPTLAAWWALL 287
|
|
| PRK07529 |
PRK07529 |
AMP-binding domain protein; Validated |
350-621 |
4.28e-11 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236043 [Multi-domain] Cd Length: 632 Bit Score: 68.06 E-value: 4.28e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 350 IGDHNTETATYSAIQAV---NTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDrSSRVLQFASYAFDV- 425
Cdd:PRK07529 189 ILDFDAELARQPGDRLFsgrPIGPDDVAAYFHTGGTTGMPKLAQHTHGNEVANAWLGALLLGLG-PGDTVFCGLPLFHVn 267
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 426 -SVHESLTPLLLGGCVCIPSEA-----QRVNSLKEAVSTLRVNWVELTPTV--ARLWCP---ADIPTVKTLVMGGEPMLP 494
Cdd:PRK07529 268 aLLVTGLAPLARGAHVVLATPQgyrgpGVIANFWKIVERYRINFLSGVPTVyaALLQVPvdgHDISSLRYALCGAAPLPV 347
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 495 NDISLWKDK--LRLVCAYGPAECTVVSTVQSCVQE--LGNIG-RSPCGTCWIVSKDNHHRLM---PVGCIGELIIGGPIV 566
Cdd:PRK07529 348 EVFRRFEAAtgVRIVEGYGLTEATCVSSVNPPDGErrIGSVGlRLPYQRVRVVILDDAGRYLrdcAVDEVGVLCIAGPNV 427
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*.
gi 992230864 567 GRGYLKQpclTANAFItnpeWASLFHLNgsyrfykTGDLVRYNADGTIAYIGR-KD 621
Cdd:PRK07529 428 FSGYLEA---AHNKGL----WLEDGWLN-------TGDLGRIDADGYFWLTGRaKD 469
|
|
| MACS_euk |
cd05928 |
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step ... |
366-735 |
4.98e-11 |
|
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes. MACS enzymes are localized to mitochondria. Two murine MACS family proteins are found in liver and kidney. In rodents, a MACS member is detected particularly in the olfactory epithelium and is called O-MACS. O-MACS demonstrates substrate preference for the fatty acid lengths of C6-C12.
Pssm-ID: 341251 [Multi-domain] Cd Length: 530 Bit Score: 67.49 E-value: 4.98e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 366 VNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQA-QNLDRSSRVLQFASYAFDVSVHESL-TPLLLGGCVCIP 443
Cdd:cd05928 169 VETGSQEPMAIYFTSGTTGSPKMAEHSHSSLGLGLKVNGRYwLDLTASDIMWNTSDTGWIKSAWSSLfEPWIQGACVFVH 248
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 444 SEAQ-RVNSLKEAVSTLRVNWVELTPTVARLWCPADI-----PTVKTLVMGGEPMLPNDISLWKDK--LRLVCAYGPAEC 515
Cdd:cd05928 249 HLPRfDPLVILKTLSSYPITTFCGAPTVYRMLVQQDLssykfPSLQHCVTGGEPLNPEVLEKWKAQtgLDIYEGYGQTET 328
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 516 TVVSTVQSCVQ-ELGNIGR-SPCGTCWIVskDNHHRLMPVGCIGELIIggpivgRGYLKQPCLTANAFITNPE-WASLFH 592
Cdd:cd05928 329 GLICANFKGMKiKPGSMGKaSPPYDVQII--DDNGNVLPPGTEGDIGI------RVKPIRPFGLFSGYVDNPEkTAATIR 400
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 593 LNgsyrFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQR-----VELGEIEHQAqpyfrdAVIAAEVAAPAG-RKPILILF 666
Cdd:cd05928 401 GD----FYLTGDRGIMDEDGYFWFMGRADDVINSSGYRigpfeVESALIEHPA------VVESAVVSSPDPiRGEVVKAF 470
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 992230864 667 IARKYEYsvnmdctmLLRPPSILFQEkaqgtntlLQEVLPRHMIPAAY---IELLA-MPISRTGKVNRKLLRE 735
Cdd:cd05928 471 VVLAPQF--------LSHDPEQLTKE--------LQQHVKSVTAPYKYprkVEFVQeLPKTVTGKIQRNELRD 527
|
|
| PRK12583 |
PRK12583 |
acyl-CoA synthetase; Provisional |
356-637 |
5.41e-11 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237145 [Multi-domain] Cd Length: 558 Bit Score: 67.49 E-value: 5.41e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 356 ETATYSAIQAVNTA--SHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSR-VLQFASYAFDVSVHESLT 432
Cdd:PRK12583 184 ETVSREALAERQASldRDDPINIQYTSGTTGFPKGATLSHHNILNNGYFVAESLGLTEHDRlCVPVPLYHCFGMVLANLG 263
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 433 PLLLGGCVCIPSEAQRVNSLKEAVSTLRVNWVELTPT--VARLWCPA----DIPTVKTLVMGGEPMLPNDISLWKDKLRL 506
Cdd:PRK12583 264 CMTVGACLVYPNEAFDPLATLQAVEEERCTALYGVPTmfIAELDHPQrgnfDLSSLRTGIMAGAPCPIEVMRRVMDEMHM 343
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 507 ---VCAYGPAECTVVSTvQSCVQE-----LGNIGRS-PCGTCWIVskDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLT 577
Cdd:PRK12583 344 aevQIAYGMTETSPVSL-QTTAADdlerrVETVGRTqPHLEVKVV--DPDGATVPRGEIGELCTRGYSVMKGYWNNPEAT 420
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 578 ANAfITNPEWaslFHlngsyrfykTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIE 637
Cdd:PRK12583 421 AES-IDEDGW---MH---------TGDLATMDEQGYVRIVGRSKDMIIRGGENIYPREIE 467
|
|
| FACL_like_4 |
cd05944 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
372-734 |
7.30e-11 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341266 [Multi-domain] Cd Length: 359 Bit Score: 65.96 E-value: 7.30e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 372 DAAYVVYTSGSTGAPKgiVIEHGSFCTNAIASSQAQNLDRSSR-VLQFASYAFDV--SVHESLTPLLLGGCVCIPSEA-- 446
Cdd:cd05944 3 DVAAYFHTGGTTGTPK--LAQHTHSNEVYNAWMLALNSLFDPDdVLLCGLPLFHVngSVVTLLTPLASGAHVVLAGPAgy 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 447 ---QRVNSLKEAVSTLRVNWVELTPTV--ARLWCP--ADIPTVKTLVMGGEPMLPNDISLWKDK--LRLVCAYGPAECTV 517
Cdd:cd05944 81 rnpGLFDNFWKLVERYRITSLSTVPTVyaALLQVPvnADISSLRFAMSGAAPLPVELRARFEDAtgLPVVEGYGLTEATC 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 518 VSTVQ--SCVQELGNIG-RSPCGTCWIVSKD---NHHRLMPVGCIGELIIGGPIVGRGYLKQPcLTANAFITNpewaslf 591
Cdd:cd05944 161 LVAVNppDGPKRPGSVGlRLPYARVRIKVLDgvgRLLRDCAPDEVGEICVAGPGVFGGYLYTE-GNKNAFVAD------- 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 592 hlngsyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH--QAQPyfrdAV-IAAEVAAP---AGRKPILIL 665
Cdd:cd05944 233 ------GWLNTGDLGRLDADGYLFITGRAKDLIIRGGHNIDPALIEEalLRHP----AVaFAGAVGQPdahAGELPVAYV 302
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 992230864 666 FIARKYEYSVnmdcTMLLRPPSILFQEKAqgtntllqeVLPRHMIPaayieLLAMPISRTGKVNRKLLR 734
Cdd:cd05944 303 QLKPGAVVEE----EELLAWARDHVPERA---------AVPKHIEV-----LEELPVTAVGKVFKPALR 353
|
|
| PRK12492 |
PRK12492 |
long-chain-fatty-acid--CoA ligase; Provisional |
221-735 |
7.42e-11 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 171539 [Multi-domain] Cd Length: 562 Bit Score: 67.15 E-value: 7.42e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 221 WNRNAP--------IHPFDSCIHtLFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQY-DLGPGSVVPIIFKK 291
Cdd:PRK12492 6 WNDKRPagvpstidLAAYKSVVE-VFERSCKKFADRPAFSNLGVTLSYAELERHSAAFAAYLQQHtDLVPGDRIAVQMPN 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 292 SKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIV-------CSQELSIGVSGSTL---SIGD--------- 352
Cdd:PRK12492 85 VLQYPIAVFGALRAGLIVVNTNPLYTAREMRHQFKDSGARALVylnmfgkLVQEVLPDTGIEYLieaKMGDllpaakgwl 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 353 ---------------HNTETATY---------SAIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIA------ 402
Cdd:PRK12492 165 vntvvdkvkkmvpayHLPQAVPFkqalrqgrgLSLKPVPVGLDDIAVLQYTGGTTGLAKGAMLTHGNLVANMLQvracls 244
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 403 --SSQAQNLDRSSRVLQFAS------YAFDVSV--------HESL--TPLLLGGCVcipSEAQRVN-SLKEAVSTLRVNW 463
Cdd:PRK12492 245 qlGPDGQPLMKEGQEVMIAPlplyhiYAFTANCmcmmvsgnHNVLitNPRDIPGFI---KELGKWRfSALLGLNTLFVAL 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 464 VElTPTVARLwcpaDIPTVKTLVMGGEPMLPNDISLWKD--KLRLVCAYGPAECTVVSTVQSCVQ--ELGNIGRSPCGTC 539
Cdd:PRK12492 322 MD-HPGFKDL----DFSALKLTNSGGTALVKATAERWEQltGCTIVEGYGLTETSPVASTNPYGElaRLGTVGIPVPGTA 396
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 540 WIVSKDNHHRLmPVGCIGELIIGGPIVGRGYLKQPCLTANAfITNPEWaslfhlngsyrfYKTGDLVRYNADGTIAYIGR 619
Cdd:PRK12492 397 LKVIDDDGNEL-PLGERGELCIKGPQVMKGYWQQPEATAEA-LDAEGW------------FKTGDIAVIDPDGFVRIVDR 462
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 620 KDTQVKLNGQRVELGEIEHQAQPYFRDAVIAAeVAAPAGRK-PILILFIarkyeysvnmdctmLLRPPSILFQE-KAQGT 697
Cdd:PRK12492 463 KKDLIIVSGFNVYPNEIEDVVMAHPKVANCAA-IGVPDERSgEAVKLFV--------------VARDPGLSVEElKAYCK 527
|
570 580 590
....*....|....*....|....*....|....*...
gi 992230864 698 NTLLQEVLPRHMIPAAyiellAMPISRTGKVNRKLLRE 735
Cdd:PRK12492 528 ENFTGYKVPKHIVLRD-----SLPMTPVGKILRRELRD 560
|
|
| PRK07769 |
PRK07769 |
long-chain-fatty-acid--CoA ligase; Validated |
258-661 |
9.56e-11 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 181109 [Multi-domain] Cd Length: 631 Bit Score: 67.06 E-value: 9.56e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 258 ITYRQLDRLSSTVQGLLQQYDlGPGSVVPIIFKKSKWAIVAMLGVLKAGA-AFCMLDQSYP--TKRLVNICKDVDAKVIV 334
Cdd:PRK07769 56 LTWSQFGARNRAVGARLQQVT-KPGDRVAILAPQNLDYLIAFFGALYAGRiAVPLFDPAEPghVGRLHAVLDDCTPSAIL 134
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 335 CSQELSIGVSG--STLSIGDH----------NTETATYsaiQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIA 402
Cdd:PRK07769 135 TTTDSAEGVRKffRARPAKERprviavdavpDEVGATW---VPPEANEDTIAYLQYTSGSTRIPAGVQITHLNLPTNVLQ 211
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 403 SSQAQNLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQRVNS----LKE--AVSTLRVNWVELTPTVARLWC- 475
Cdd:PRK07769 212 VIDALEGQEGDRGVSWLPFFHDMGLITVLLPALLGHYITFMSPAAFVRRpgrwIRElaRKPGGTGGTFSAAPNFAFEHAa 291
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 476 ----------PADIPTVKTLVMGGEPMLPNDISLWKD--------KLRLVCAYGPAECTV-VSTVQSCVQ---------E 527
Cdd:PRK07769 292 arglpkdgepPLDLSNVKGLLNGSEPVSPASMRKFNEafapyglpPTAIKPSYGMAEATLfVSTTPMDEEptviyvdrdE 371
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 528 LGNiGR-------SP-------CGTC----W--IVSKDNHHRLmPVGCIGELIIGGPIVGRGYLKQPCLTANAF---ITN 584
Cdd:PRK07769 372 LNA-GRfvevpadAPnavaqvsAGKVgvseWavIVDPETASEL-PDGQIGEIWLHGNNIGTGYWGKPEETAATFqniLKS 449
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 585 PEWASlfHLNGS---YRFYKTGDLVRYnADGTIAYIGRKDTQVKLNGQRVELGEIEHQAQ---PYFRDAVIAAeVAAPAG 658
Cdd:PRK07769 450 RLSES--HAEGApddALWVRTGDYGVY-FDGELYITGRVKDLVIIDGRNHYPQDLEYTAQeatKALRTGYVAA-FSVPAN 525
|
...
gi 992230864 659 RKP 661
Cdd:PRK07769 526 QLP 528
|
|
| AcpA |
COG3433 |
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites ... |
552-829 |
1.05e-10 |
|
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442659 [Multi-domain] Cd Length: 295 Bit Score: 64.77 E-value: 1.05e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 552 PVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPEWaslfhlngSYRFYKTGDLVRYNADGTIAYIGRKDTQVKlnGQRV 631
Cdd:COG3433 42 GFGGEGGLLGAGLLLRIRLLAAAARAPFIPVPYPAQ--------PGRQADDLRLLLRRGLGPGGGLERLVQQVV--IRAE 111
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 632 ELGEIEHQAQPYFRDAVIAAEVAAPAGRKPILILFIArkyeYSVNMDCTMllrppsilfqekaqgTNTLLQEVLPRHMIP 711
Cdd:COG3433 112 RGEEEELLLVLRAAAVVRVAVLAALRGAGVGLLLIVG----AVAALDGLA---------------AAAALAALDKVPPDV 172
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 712 AAYIELLAMPISRTGKVNRKLLREAVEQAsEKDFRAYYPITHNDmiqlPSTPVLDQLRLLFSAALRIPEEKIKPNDSFFH 791
Cdd:COG3433 173 VAASAVVALDALLLLALKVVARAAPALAA-AEALLAAASPAPAL----ETALTEEELRADVAELLGVDPEEIDPDDNLFD 247
|
250 260 270
....*....|....*....|....*....|....*...
gi 992230864 792 LGGDSVSAIRLVGDARDQGLHITVESLFKRQTISKLAE 829
Cdd:COG3433 248 LGLDSIRLMQLVERWRKAGLDVSFADLAEHPTLAAWWA 285
|
|
| E-C_NRPS |
cd19544 |
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); ... |
874-1168 |
1.20e-10 |
|
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); Dual function Epimerization/Condensation (E/C) domains have both an epimerization and a DCL condensation activity. Dual E/C domains first epimerize the substrate amino acid to produce a D-configuration, then catalyze the condensation between the D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. They are D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. These Dual E/C domains contain an extended His-motif (HHx(N)GD) near the N-terminus of the domain in addition to the standard Condensation (C) domain active site motif (HHxxxD). C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains, these include the DCL-type, LCL-type, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C domains, and the X-domain.
Pssm-ID: 380466 [Multi-domain] Cd Length: 413 Bit Score: 65.92 E-value: 1.20e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 874 IYPCTPLQEA-----LMA-----YTSkrpgafQAQFRFQLPHQLDmlRLKEAWRIVIAANPILRTRIVfcHTG---ALQV 940
Cdd:cd19544 1 IYPLAPLQEGilfhhLLAeegdpYLL------RSLLAFDSRARLD--AFLAALQQVIDRHDILRTAIL--WEGlsePVQV 70
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 941 VLR----PGEQLQWDLINGV------HTSPGSL-MSYGV-PLVDMAITNDTAGklSRTF-CLTMHHAIFDGWSYGLILGA 1007
Cdd:cd19544 71 VWRqaelPVEELTLDPGDDAlaqlraRFDPRRYrLDLRQaPLLRAHVAEDPAN--GRWLlLLLFHHLISDHTSLELLLEE 148
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1008 VEdAYKHTNAVQ----RPFAPFIKYILHCNYES-AKHFwcseFKDMQA------LPF-----------------PVPP-L 1058
Cdd:cd19544 149 IQ-AILAGRAAAlpppVPYRNFVAQARLGASQAeHEAF----FREMLGdvdeptAPFglldvqgdgsditearlALDAeL 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1059 S---RGHManssttthRQIHVSewlssyctPSTIIQLAFTLLIAWRTESMDVLFGlTV-TGRNAPVAGIHRTTGPTIATF 1134
Cdd:cd19544 224 AqrlRAQA--------RRLGVS--------PASLFHLAWALVLARCSGRDDVVFG-TVlSGRMQGGAGADRALGMFINTL 286
|
330 340 350
....*....|....*....|....*....|....
gi 992230864 1135 PLRTILyGTMNITDALLCMQNHIATLIPFEHTGL 1168
Cdd:cd19544 287 PLRVRL-GGRSVREAVRQTHARLAELLRHEHASL 319
|
|
| AcpP |
COG0236 |
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the ... |
1424-1490 |
1.37e-10 |
|
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the Pathway/BioSystem: Fatty acid biosynthesis
Pssm-ID: 440006 [Multi-domain] Cd Length: 80 Bit Score: 59.10 E-value: 1.37e-10
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 992230864 1424 EARLRGIVAHVLSIDPQNISPKDDFFT-LGGDSISAMQVVSLCRKH-QLSLTALDIFNGRTIELIATRL 1490
Cdd:COG0236 7 EERLAEIIAEVLGVDPEEITPDDSFFEdLGLDSLDAVELIAALEEEfGIELPDTELFEYPTVADLADYL 75
|
|
| PRK08316 |
PRK08316 |
acyl-CoA synthetase; Validated |
245-654 |
1.51e-10 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181381 [Multi-domain] Cd Length: 523 Bit Score: 66.11 E-value: 1.51e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 245 QPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSkWAIVAM-LGVLKAGA--------------AF 309
Cdd:PRK08316 24 YPDKTALVFGDRSWTYAELDAAVNRVAAALLDLGLKKGDRVAALGHNS-DAYALLwLACARAGAvhvpvnfmltgeelAY 102
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 310 CmLDQSYPT-----KRLVNICKDVDAKVIVCSQELSIGVSGSTLSIGDHNTE---TATYSAIQAVNTASHDAAYVVYTSG 381
Cdd:PRK08316 103 I-LDHSGARaflvdPALAPTAEAALALLPVDTLILSLVLGGREAPGGWLDFAdwaEAGSVAEPDVELADDDLAQILYTSG 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 382 STGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQ----FASYAFDVsvheSLTPLLLGGCVCIPSEAQRVNSLKEAVS 457
Cdd:PRK08316 182 TESLPKGAMLTHRALIAEYVSCIVAGDMSADDIPLHalplYHCAQLDV----FLGPYLYVGATNVILDAPDPELILRTIE 257
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 458 TLRVNWVELTPTV--ARLWCP----ADIPTVKTLVMGGEPM-----------LPNdislwkdkLRLVCAYGPAECTVVST 520
Cdd:PRK08316 258 AERITSFFAPPTVwiSLLRHPdfdtRDLSSLRKGYYGASIMpvevlkelrerLPG--------LRFYNCYGQTEIAPLAT 329
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 521 VQSCVQELGNIGrsPCG------TCWIVskDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNpeWaslFHln 594
Cdd:PRK08316 330 VLGPEEHLRRPG--SAGrpvlnvETRVV--DDDGNDVAPGEVGEIVHRSPQLMLGYWDDPEKTAEAFRGG--W---FH-- 398
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 595 gsyrfykTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEHQAqpYFRDAViaAEVA 654
Cdd:PRK08316 399 -------SGDLGVMDEEGYITVVDRKKDMIKTGGENVASREVEEAL--YTHPAV--AEVA 447
|
|
| SgcC5_NRPS-like |
cd19539 |
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- ... |
876-1165 |
1.78e-10 |
|
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- bond forming activity and similar C-domains of modular NRPSs; SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. This subfamily also includes similar C-domains of modular NRPSs such as Penicillium chrysogenum N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase PCBAB. Condensation (C) domains of NRPSs normally catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380462 [Multi-domain] Cd Length: 427 Bit Score: 65.48 E-value: 1.78e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 876 PCTPLQEALMAYTSKRPG--AFQAQFRFQLPHQLDMLRLKEAWRIVIAANPILRTRIVFCHTG-ALQVVLRPG------- 945
Cdd:cd19539 3 PLSFAQERLWFIDQGEDGgpAYNIPGAWRLTGPLDVEALREALRDVVARHEALRTLLVRDDGGvPRQEILPPGpaplevr 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 946 ---------EQLQWDLINGVHTSPGSLmsYGVPLVDMAItndtaGKLSRT---FCLTMHHAIFDGWSYGLILGAVEDAYK 1013
Cdd:cd19539 83 dlsdpdsdrERRLEELLRERESRGFDL--DEEPPIRAVL-----GRFDPDdhvLVLVAHHTAFDAWSLDVFARDLAALYA 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1014 --HTNAVQRPFAPFIKYILHCNYES----------AKHFWCSEFKDMQALPFPvPPLSRGHMANSSTTTHRQIHVSEWLS 1081
Cdd:cd19539 156 arRKGPAAPLPELRQQYKEYAAWQRealaapraaeLLDFWRRRLRGAEPTALP-TDRPRPAGFPYPGADLRFELDAELVA 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1082 SY--------CTPSTIIQLAFTLLIAWRTESMDVLFGLTVTGRNAPvaGIHRTTGPTIATFPLRTILYGTMNITD----- 1148
Cdd:cd19539 235 ALrelakrarSSLFMVLLAAYCVLLRRYTGQTDIVVGTPVAGRNHP--RFESTVGFFVNLLPLRVDVSDCATFRDliarv 312
|
330
....*....|....*....
gi 992230864 1149 --ALLCMQNHIAtlIPFEH 1165
Cdd:cd19539 313 rkALVDAQRHQE--LPFQQ 329
|
|
| PLN02860 |
PLN02860 |
o-succinylbenzoate-CoA ligase |
241-637 |
2.33e-10 |
|
o-succinylbenzoate-CoA ligase
Pssm-ID: 215464 [Multi-domain] Cd Length: 563 Bit Score: 65.59 E-value: 2.33e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 241 QCI-----LQPDAQAICAWDGTITYRQ-LDRLSSTVQGLLQqYDLGPGSVVPIIFKKSKWAIVAMLGVLKAG-------- 306
Cdd:PLN02860 11 QCLtrlatLRGNAVVTISGNRRRTGHEfVDGVLSLAAGLLR-LGLRNGDVVAIAALNSDLYLEWLLAVACAGgivaplny 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 307 ------AAFCML---------DQS---YPTKRLVNICKDVDAKVIVCSQELSIGVSGSTLSIGDHNTETATYSAIQAVNT 368
Cdd:PLN02860 90 rwsfeeAKSAMLlvrpvmlvtDETcssWYEELQNDRLPSLMWQVFLESPSSSVFIFLNSFLTTEMLKQRALGTTELDYAW 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 369 ASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASsqaqnldrssrvLQFASYA-FDVSVHES-----------LTPLLL 436
Cdd:PLN02860 170 APDDAVLICFTSGTTGRPKGVTISHSALIVQSLAK------------IAIVGYGeDDVYLHTAplchigglssaLAMLMV 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 437 GGC-VCIPS----------EAQRVNSLKeAVSTLRVNWVELTPTvARLWcpADIPTVKTLVMGGEPM---LPNDISLWKD 502
Cdd:PLN02860 238 GAChVLLPKfdakaalqaiKQHNVTSMI-TVPAMMADLISLTRK-SMTW--KVFPSVRKILNGGGSLssrLLPDAKKLFP 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 503 KLRLVCAYGPAE-CTVVS-------TVQSCVQELGNIGRS-------PCGTCwiVSKDNHHRLMPVGC-----IGELIIG 562
Cdd:PLN02860 314 NAKLFSAYGMTEaCSSLTfmtlhdpTLESPKQTLQTVNQTksssvhqPQGVC--VGKPAPHVELKIGLdessrVGRILTR 391
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 992230864 563 GPIVGRGYLKQPCLTANAfITNPEWASlfhlngsyrfykTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIE 637
Cdd:PLN02860 392 GPHVMLGYWGQNSETASV-LSNDGWLD------------TGDIGWIDKAGNLWLIGRSNDRIKTGGENVYPEEVE 453
|
|
| PtmA |
cd17636 |
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, ... |
372-649 |
2.84e-10 |
|
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341291 [Multi-domain] Cd Length: 331 Bit Score: 63.86 E-value: 2.84e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 372 DAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQfASYAFDVSV-HESLTPLLLGG-CVCIP-SEAQR 448
Cdd:cd17636 1 DPVLAIYTAAFSGRPNGALLSHQALLAQALVLAVLQAIDEGTVFLN-SGPLFHIGTlMFTLATFHAGGtNVFVRrVDAEE 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 449 VNSLKEAVstlRVNWVELT-PTVA--------------RLWCPADIPtvktlvmGGEPMLPNDISLWKDKLRlvcAYGPA 513
Cdd:cd17636 80 VLELIEAE---RCTHAFLLpPTIDqivelnadglydlsSLRSSPAAP-------EWNDMATVDTSPWGRKPG---GYGQT 146
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 514 ECT-VVSTVQSCVQELGNIGR-SPCGTCWIVSKDNhhRLMPVGCIGELIIGGPIVGRGYLKQPCLtaNAFITNPEWaslf 591
Cdd:cd17636 147 EVMgLATFAALGGGAIGGAGRpSPLVQVRILDEDG--REVPDGEVGEIVARGPTVMAGYWNRPEV--NARRTRGGW---- 218
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 992230864 592 hlngsyrfYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRD-AVI 649
Cdd:cd17636 219 --------HHTNDLGRREPDGSLSFVGPKTRMIKSGAENIYPAEVERclRQHPAVADaAVI 271
|
|
| PRK13390 |
PRK13390 |
acyl-CoA synthetase; Provisional |
246-638 |
5.14e-10 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139538 [Multi-domain] Cd Length: 501 Bit Score: 64.26 E-value: 5.14e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQA-ICAWDG-TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVN 323
Cdd:PRK13390 11 PDRPAvIVAETGeQVSYRQLDDDSAALARVLYDAGLRTGDVVALLSDNSPEALVVLWAALRSGLYITAINHHLTAPEADY 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 324 ICKDVDAKVIVCSQELSiGVSGST-------LSIGDHNTETATYSAIQAVN----TASHDAAYVVYTSGSTGAPKGIVie 392
Cdd:PRK13390 91 IVGDSGARVLVASAALD-GLAAKVgadlplrLSFGGEIDGFGSFEAALAGAgprlTEQPCGAVMLYSSGTTGFPKGIQ-- 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 393 hgsfctnaiASSQAQNLDR-SSRVLQFASYAFDVS---VHESLTPLL-------------LGGCVCIPSEAQRVNSLKEa 455
Cdd:PRK13390 168 ---------PDLPGRDVDApGDPIVAIARAFYDISesdIYYSSAPIYhaaplrwcsmvhaLGGTVVLAKRFDAQATLGH- 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 456 VSTLRVNWVELTPTV--------ARLWCPADIPTVKTLVMGGEPmLPNDIslwkdKLRLVCAYGPA-----------ECT 516
Cdd:PRK13390 238 VERYRITVTQMVPTMfvrllkldADVRTRYDVSSLRAVIHAAAP-CPVDV-----KHAMIDWLGPIvyeyyssteahGMT 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 517 VVSTVQSCVQElGNIGRSPCGTCWIVSKDNHHrlMPVGCIGELIIGGPIVGRGYLKQPCLTANA-FITNPEWASLfhlng 595
Cdd:PRK13390 312 FIDSPDWLAHP-GSVGRSVLGDLHICDDDGNE--LPAGRIGTVYFERDRLPFRYLNDPEKTAAAqHPAHPFWTTV----- 383
|
410 420 430 440
....*....|....*....|....*....|....*....|...
gi 992230864 596 syrfyktGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH 638
Cdd:PRK13390 384 -------GDLGSVDEDGYLYLADRKSFMIISGGVNIYPQETEN 419
|
|
| PLN02574 |
PLN02574 |
4-coumarate--CoA ligase-like |
257-734 |
6.08e-10 |
|
4-coumarate--CoA ligase-like
Pssm-ID: 215312 [Multi-domain] Cd Length: 560 Bit Score: 64.09 E-value: 6.08e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 257 TITYRQLDRL-SSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGA-AFCMLDQSYPTkrlvnickDVDAKVIV 334
Cdd:PLN02574 66 SISYSELQPLvKSMAAGLYHVMGVRQGDVVLLLLPNSVYFPVIFLAVLSLGGiVTTMNPSSSLG--------EIKKRVVD 137
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 335 CSQELS-----------------IGVSGStlsiGDHNTETATYSAIQAVNTAS-----------HDAAYVVYTSGSTGAP 386
Cdd:PLN02574 138 CSVGLAftspenveklsplgvpvIGVPEN----YDFDSKRIEFPKFYELIKEDfdfvpkpvikqDDVAAIMYSSGTTGAS 213
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 387 KGIVIEHGSFCTNA-----IASSQAQNLDRSSRVL----QFASYAFDVSVheslTPLLLGGCVCIPSEAQRVNSLKEAVS 457
Cdd:PLN02574 214 KGVVLTHRNLIAMVelfvrFEASQYEYPGSDNVYLaalpMFHIYGLSLFV----VGLLSLGSTIVVMRRFDASDMVKVID 289
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 458 TLRVNWVELTPTV-------ARLWCPADIPTVKTLVMGGEPMLPNDISLWKDKL---RLVCAYGPAECTVVSTVQSCVQE 527
Cdd:PLN02574 290 RFKVTHFPVVPPIlmaltkkAKGVCGEVLKSLKQVSCGAAPLSGKFIQDFVQTLphvDFIQGYGMTESTAVGTRGFNTEK 369
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 528 LGN---IGR-SPCGTCWIVSKDNHHRLMPVGCiGELIIGGPIVGRGYLKQPCLTANAfITNPEWaslfhlngsyrfYKTG 603
Cdd:PLN02574 370 LSKyssVGLlAPNMQAKVVDWSTGCLLPPGNC-GELWIQGPGVMKGYLNNPKATQST-IDKDGW------------LRTG 435
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 604 DLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEHQ--AQPYFRDAVIAAEVAAPAGRKPilILFIARkyeysvnmdctm 681
Cdd:PLN02574 436 DIAYFDEDGYLYIVDRLKEIIKYKGFQIAPADLEAVliSHPEIIDAAVTAVPDKECGEIP--VAFVVR------------ 501
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|...
gi 992230864 682 llRPPSILFQEkaQGTNTLLQEVLPRHMIPAAyIELLAMPISRTGKVNRKLLR 734
Cdd:PLN02574 502 --RQGSTLSQE--AVINYVAKQVAPYKKVRKV-VFVQSIPKSPAGKILRRELK 549
|
|
| PRK07798 |
PRK07798 |
acyl-CoA synthetase; Validated |
246-661 |
6.80e-10 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236100 [Multi-domain] Cd Length: 533 Bit Score: 63.75 E-value: 6.80e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNIC 325
Cdd:PRK07798 17 PDRVALVCGDRRLTYAELEERANRLAHYLIAQGLGPGDHVGIYARNRIEYVEAMLGAFKARAVPVNVNYRYVEDELRYLL 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 326 KDVDAKVIVCSQELSIGV-------------------SGSTLSIGDHNTETA--TYSAIQAVNTASHDAAYVVYTSGSTG 384
Cdd:PRK07798 97 DDSDAVALVYEREFAPRVaevlprlpklrtlvvvedgSGNDLLPGAVDYEDAlaAGSPERDFGERSPDDLYLLYTGGTTG 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 385 APKGIVIEHGSF-----------CTNAIASSQAQnldrSSRVLQ-FASYAFDVS--VH-----ESLTPLLLGGCVCIPSE 445
Cdd:PRK07798 177 MPKGVMWRQEDIfrvllggrdfaTGEPIEDEEEL----AKRAAAgPGMRRFPAPplMHgagqwAAFAALFSGQTVVLLPD 252
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 446 AQ-RVNSLKEAVSTLRVNWVELT------PTVARLWC--PADIPTVKTLVMGGEPMLPNdislWKDKLR-------LVCA 509
Cdd:PRK07798 253 VRfDADEVWRTIEREKVNVITIVgdamarPLLDALEArgPYDLSSLFAIASGGALFSPS----VKEALLellpnvvLTDS 328
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 510 YGPAEC------TVVSTVQSCVQELGNIGRSPCgtcwiVSKDNHHRLMP-VGCIGELIIGGPIvGRGYLKQPCLTANAFI 582
Cdd:PRK07798 329 IGSSETgfggsgTVAKGAVHTGGPRFTIGPRTV-----VLDEDGNPVEPgSGEIGWIARRGHI-PLGYYKDPEKTAETFP 402
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 583 TnpewaslfhLNGSyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRDAV------------ 648
Cdd:PRK07798 403 T---------IDGV-RYAIPGDRARVEADGTITLLGRGSVCINTGGEKVFPEEVEEalKAHPDVADALvvgvpderwgqe 472
|
490
....*....|...
gi 992230864 649 IAAEVAAPAGRKP 661
Cdd:PRK07798 473 VVAVVQLREGARP 485
|
|
| PRK13295 |
PRK13295 |
cyclohexanecarboxylate-CoA ligase; Reviewed |
246-741 |
6.94e-10 |
|
cyclohexanecarboxylate-CoA ligase; Reviewed
Pssm-ID: 171961 [Multi-domain] Cd Length: 547 Bit Score: 63.92 E-value: 6.94e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAICAWDG------TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSkWAIVAM-LGVLKAGAAFCMLDQSYPT 318
Cdd:PRK13295 38 PDKTAVTAVRLgtgaprRFTYRELAALVDRVAVGLARLGVGRGDVVSCQLPNW-WEFTVLyLACSRIGAVLNPLMPIFRE 116
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 319 KRLVNICKDVDAKVIVCSQE-----------------------LSIGVSGSTlSIGDHNTETA--TYSAIQAVNTASH-- 371
Cdd:PRK13295 117 RELSFMLKHAESKVLVVPKTfrgfdhaamarrlrpelpalrhvVVVGGDGAD-SFEALLITPAweQEPDAPAILARLRpg 195
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 372 --DAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASYAFDVS-VHESLTPLLLGGCVCI-----P 443
Cdd:PRK13295 196 pdDVTQLIYTSGTTGEPKGVMHTANTLMANIVPYAERLGLGADDVILMASPMAHQTGfMYGLMMPVMLGATAVLqdiwdP 275
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 444 SEAQRVnslkeaVSTLRVNWV--------ELTPTVARLwcPADIPTVKTLVMGGEPMLPNDISLWKDKL--RLVCAYGPA 513
Cdd:PRK13295 276 ARAAEL------IRTEGVTFTmastpfltDLTRAVKES--GRPVSSLRTFLCAGAPIPGALVERARAALgaKIVSAWGMT 347
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 514 ECTVVSTVqscvqELGN-----IGRSPCGTCWIVSK--DNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFitnpe 586
Cdd:PRK13295 348 ENGAVTLT-----KLDDpderaSTTDGCPLPGVEVRvvDADGAPLPAGQIGRLQVRGCSNFGGYLKRPQLNGTDA----- 417
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 587 waslfhlNGsyrFYKTGDLVRYNADGTIAYIGR-KDTQVKlNGQRVELGEIEhqaQPYFRDAVIA--AEVAAPAgrkpil 663
Cdd:PRK13295 418 -------DG---WFDTGDLARIDADGYIRISGRsKDVIIR-GGENIPVVEIE---ALLYRHPAIAqvAIVAYPD------ 477
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 664 ilfiARKYEYSvnmdCTML-LRP-PSILFQE-----KAQGtntllqevLPRHMIPAAYIELLAMPISRTGKVNRKLLREA 736
Cdd:PRK13295 478 ----ERLGERA----CAFVvPRPgQSLDFEEmveflKAQK--------VAKQYIPERLVVRDALPRTPSGKIQKFRLREM 541
|
....*
gi 992230864 737 VEQAS 741
Cdd:PRK13295 542 LRGED 546
|
|
| PRK06164 |
PRK06164 |
acyl-CoA synthetase; Validated |
245-745 |
1.13e-09 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235722 [Multi-domain] Cd Length: 540 Bit Score: 63.22 E-value: 1.13e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 245 QPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPT------ 318
Cdd:PRK06164 23 RPDAVALIDEDRPLSRAELRALVDRLAAWLAAQGVRRGDRVAVWLPNCIEWVVLFLACARLGATVIAVNTRYRShevahi 102
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 319 ---------------------KRLVNICKDVDAKV----IVC--SQELSIGVSGSTLSIGD-HNTETATYSAIQAvntAS 370
Cdd:PRK06164 103 lgrgrarwlvvwpgfkgidfaAILAAVPPDALPPLraiaVVDdaADATPAPAPGARVQLFAlPDPAPPAAAGERA---AD 179
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 371 HDAAYVVYT-SGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASY--AFDVSvheSLTPLLLGGC--VCIP-- 443
Cdd:PRK06164 180 PDAGALLFTtSGTTSGPKLVLHRQATLLRHARAIARAYGYDPGAVLLAALPFcgVFGFS---TLLGALAGGAplVCEPvf 256
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 444 SEAQRVNSLKEAVSTLRVNWVELTPTVARLW-CPADIPTVKtlVMGGEPMLPNdislWKDKLRLVCA--------YGPAE 514
Cdd:PRK06164 257 DAARTARALRRHRVTHTFGNDEMLRRILDTAgERADFPSAR--LFGFASFAPA----LGELAALARArgvpltglYGSSE 330
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 515 ------CTVVSTVQSCVQELGNIGRSPCGTCWIVSKDNHhRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNPewa 588
Cdd:PRK06164 331 vqalvaLQPATDPVSVRIEGGGRPASPEARVRARDPQDG-ALLPDGESGEIEIRAPSLMRGYLDNPDATARALTDDG--- 406
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 589 slfhlngsyrFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRDAVIaaeVAAPAGRKPILILF 666
Cdd:PRK06164 407 ----------YFRTGDLGYTRGDGQFVYQTRMGDSLRLGGFLVNPAEIEHalEALPGVAAAQV---VGATRDGKTVPVAF 473
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 667 IArkYEYSVNMDCTMLLRPpsilfqekaqgtntlLQEVLPRHMIPAAYIELLAMPISRTG---KVNRKLLREAVEQ--AS 741
Cdd:PRK06164 474 VI--PTDGASPDEAGLMAA---------------CREALAGFKVPARVQVVEAFPVTESAngaKIQKHRLREMAQArlAA 536
|
....
gi 992230864 742 EKDF 745
Cdd:PRK06164 537 ERAA 540
|
|
| PP-binding |
pfam00550 |
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached ... |
766-825 |
1.27e-09 |
|
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached through a serine. This prosthetic group acts as a a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups. This domain forms a four helix bundle. This family includes members not included in Prosite. The inclusion of these members is supported by sequence analysis and functional evidence. The related domain of Swiss:P19828 has the attachment serine replaced by an alanine.
Pssm-ID: 425746 [Multi-domain] Cd Length: 62 Bit Score: 55.65 E-value: 1.27e-09
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 992230864 766 DQLRLLFSAALRIPEEKIKPNDSFFHLGGDSVSAIRLVGDARDQ-GLHITVESLFKRQTIS 825
Cdd:pfam00550 1 ERLRELLAEVLGVPAEEIDPDTDLFDLGLDSLLAVELIARLEEEfGVEIPPSDLFEHPTLA 61
|
|
| FACL_like_2 |
cd05917 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
371-637 |
1.34e-09 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341241 [Multi-domain] Cd Length: 349 Bit Score: 61.91 E-value: 1.34e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 371 HDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRV-LQFASYAFDVSVHESLTPLLLGGCVCIPSEAQRV 449
Cdd:cd05917 2 DDVINIQFTSGTTGSPKGATLTHHNIVNNGYFIGERLGLTEQDRLcIPVPLFHCFGSVLGVLACLTHGATMVFPSPSFDP 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 450 NSLKEAVSTLRVNWVELTPT--VARLWCPA----DIPTVKTLVMGGEPMLPNDISLWKDKLR---LVCAYGPAECTVVST 520
Cdd:cd05917 82 LAVLEAIEKEKCTALHGVPTmfIAELEHPDfdkfDLSSLRTGIMAGAPCPPELMKRVIEVMNmkdVTIAYGMTETSPVST 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 521 ----VQSCVQELGNIGR-SPCGTCWIVSKDNHhRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAfITNPEWaslfhlng 595
Cdd:cd05917 162 qtrtDDSIEKRVNTVGRiMPHTEAKIVDPEGG-IVPPVGVPGELCIRGYSVMKGYWNDPEKTAEA-IDGDGW-------- 231
|
250 260 270 280
....*....|....*....|....*....|....*....|...
gi 992230864 596 syrfYKTGDLVRYNADGTIAYIGR-KDTQVKlNGQRVELGEIE 637
Cdd:cd05917 232 ----LHTGDLAVMDEDGYCRIVGRiKDMIIR-GGENIYPREIE 269
|
|
| E-C_NRPS |
cd19544 |
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); ... |
1679-1877 |
1.35e-09 |
|
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); Dual function Epimerization/Condensation (E/C) domains have both an epimerization and a DCL condensation activity. Dual E/C domains first epimerize the substrate amino acid to produce a D-configuration, then catalyze the condensation between the D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. They are D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. These Dual E/C domains contain an extended His-motif (HHx(N)GD) near the N-terminus of the domain in addition to the standard Condensation (C) domain active site motif (HHxxxD). C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains, these include the DCL-type, LCL-type, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C domains, and the X-domain.
Pssm-ID: 380466 [Multi-domain] Cd Length: 413 Bit Score: 62.45 E-value: 1.35e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1679 HAFLDATSVLIILRELAQAYDGQLSSVPGP-SYSSAVAWLQSLPNGDNRMDYWRRQLKD-ASPCI-FpRLRD-QDSPSD- 1753
Cdd:cd19544 134 HLISDHTSLELLLEEIQAILAGRAAALPPPvPYRNFVAQARLGASQAEHEAFFREMLGDvDEPTApF-GLLDvQGDGSDi 212
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1754 ---TLVVTEQLAstATLTPVCTRHGLTVSNVLQVAWGLMLRRYTESDDVCFGALISGRDSRIPDVDKMVGPFFNVLVCQL 1830
Cdd:cd19544 213 teaRLALDAELA--QRLRAQARRLGVSPASLFHLAWALVLARCSGRDDVVFGTVLSGRMQGGAGADRALGMFINTLPLRV 290
|
170 180 190 200
....*....|....*....|....*....|....*....|....*...
gi 992230864 1831 RFGrEDSLWDVLRRNQTEIGNRLLNQHCSLIEVLRFS-TYFGQPLFNT 1877
Cdd:cd19544 291 RLG-GRSVREAVRQTHARLAELLRHEHASLALAQRCSgVPAPTPLFSA 337
|
|
| PRK05677 |
PRK05677 |
long-chain-fatty-acid--CoA ligase; Validated |
234-637 |
1.48e-09 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 168170 [Multi-domain] Cd Length: 562 Bit Score: 62.86 E-value: 1.48e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 234 IHTLFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQY-DLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCML 312
Cdd:PRK05677 26 IQAVLKQSCQRFADKPAFSNLGKTLTYGELYKLSGAFAAWLQQHtDLKPGDRIAVQLPNVLQYPVAVFGAMRAGLIVVNT 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 313 DQSYPTKRLVNICKDVDAKVIVCSQELSIGVSGSTLSIGDHN---TETA-----------------------TYSAIQAV 366
Cdd:PRK05677 106 NPLYTAREMEHQFNDSGAKALVCLANMAHLAEKVLPKTGVKHvivTEVAdmlpplkrllinavvkhvkkmvpAYHLPQAV 185
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 367 -----------------NTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQ--AQNLDRSSRVL-----QFASYA 422
Cdd:PRK05677 186 kfndalakgagqpvteaNPQADDVAVLQYTGGTTGVAKGAMLTHRNLVANMLQCRAlmGSNLNEGCEILiaplpLYHIYA 265
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 423 FdvSVHESLTPLLLGGCVCIPSEAQRVNSLKEAVSTLRVNWVELTPTVARLwCPA------DIPTVKTLVMGGEPMLPND 496
Cdd:PRK05677 266 F--TFHCMAMMLIGNHNILISNPRDLPAMVKELGKWKFSGFVGLNTLFVAL-CNNeafrklDFSALKLTLSGGMALQLAT 342
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 497 ISLWKDKLRL-VC-AYGPAECTVVSTVQ--SCVQeLGNIGRS-PCGTCWIVSKDNHHrlMPVGCIGELIIGGPIVGRGYL 571
Cdd:PRK05677 343 AERWKEVTGCaICeGYGMTETSPVVSVNpsQAIQ-VGTIGIPvPSTLCKVIDDDGNE--LPLGEVGELCVKGPQVMKGYW 419
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 992230864 572 KQPCLTANAFiTNPEWaslfhlngsyrfYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIE 637
Cdd:PRK05677 420 QRPEATDEIL-DSDGW------------LKTGDIALIQEDGYMRIVDRKKDMILVSGFNVYPNELE 472
|
|
| LC_FACS_euk1 |
cd17639 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The ... |
372-637 |
1.85e-09 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The members of this family are eukaryotic fatty acid CoA synthetases (EC 6.2.1.3) that activate fatty acids with chain lengths of 12 to 20 and includes fungal proteins. They act on a wide range of long-chain saturated and unsaturated fatty acids, but the enzymes from different tissues show some variation in specificity. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. In Schizosaccharomyces pombe, lcf1 gene encodes a new fatty acyl-CoA synthetase that preferentially recognizes myristic acid as a substrate.
Pssm-ID: 341294 [Multi-domain] Cd Length: 507 Bit Score: 62.62 E-value: 1.85e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 372 DAAYVVYTSGSTGAPKGIVIEHGSFC--TNAIASSQAQNLDRSSRVLQFASYA--FDVSVhESLTpLLLGGCVCIPSeaq 447
Cdd:cd17639 89 DLACIMYTSGSTGNPKGVMLTHGNLVagIAGLGDRVPELLGPDDRYLAYLPLAhiFELAA-ENVC-LYRGGTIGYGS--- 163
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 448 rVNSLKEAvSTLRVN--WVELTPT----VARLW------CPADIPTV----------------KTLVMGGEPMLPNDISL 499
Cdd:cd17639 164 -PRTLTDK-SKRGCKgdLTEFKPTlmvgVPAIWdtirkgVLAKLNPMgglkrtlfwtayqsklKALKEGPGTPLLDELVF 241
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 500 WK------DKLR------------------LVCA-----YGPAECTVVSTVQSCVQ-ELGNIGRsPCGTC------WIVS 543
Cdd:cd17639 242 KKvraalgGRLRymlsggaplsadtqeflnIVLCpviqgYGLTETCAGGTVQDPGDlETGRVGP-PLPCCeiklvdWEEG 320
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 544 KDNHHRLMPVGcigELIIGGPIVGRGYLKQPCLTANAFitNPEwaslfhlngsyRFYKTGDLVRYNADGTIAYIGRKDTQ 623
Cdd:cd17639 321 GYSTDKPPPRG---EILIRGPNVFKGYYKNPEKTKEAF--DGD-----------GWFHTGDIGEFHPDGTLKIIDRKKDL 384
|
330
....*....|....*
gi 992230864 624 VKL-NGQRVELGEIE 637
Cdd:cd17639 385 VKLqNGEYIALEKLE 399
|
|
| PRK12582 |
PRK12582 |
acyl-CoA synthetase; Provisional |
216-652 |
1.93e-09 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237144 [Multi-domain] Cd Length: 624 Bit Score: 62.76 E-value: 1.93e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 216 DQIAEWNRNAPIHPFdscihtlfrlqcILQPDAQAiCAWDGtITYRQLDRLSSTV-QGLLQQyDLGPGSVVPIIFKKSKW 294
Cdd:PRK12582 53 HLLAKWAAEAPDRPW------------LAQREPGH-GQWRK-VTYGEAKRAVDALaQALLDL-GLDPGRPVMILSGNSIE 117
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 295 AIVAMLGVLKAGA----------------------------AFCMLDQSYPTKRLVNICKDVDAKVIVCSQElsiGVSGS 346
Cdd:PRK12582 118 HALMTLAAMQAGVpaapvspayslmshdhaklkhlfdlvkpRVVFAQSGAPFARALAALDLLDVTVVHVTGP---GEGIA 194
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 347 TLSIGDHNTETATYSAIQAVNTASHDA-AYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRS---SRVLQFASYA 422
Cdd:PRK12582 195 SIAFADLAATPPTAAVAAAIAAITPDTvAKYLFTSGSTGMPKAVINTQRMMCANIAMQEQLRPREPDpppPVSLDWMPWN 274
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 423 FDVSVHESLTPLLLGGCVCIPSEAQRVNSLKEavSTLRvNWVELTPTVArlwcpADIPTVKTLVMggePMLPNDISLWKD 502
Cdd:PRK12582 275 HTMGGNANFNGLLWGGGTLYIDDGKPLPGMFE--ETIR-NLREISPTVY-----GNVPAGYAMLA---EAMEKDDALRRS 343
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 503 ---KLRLVcAYGPAecTVVSTVQSCVQELG--NIGR---------------SPCGTCWIVSKDN---------HHRLMPV 553
Cdd:PRK12582 344 ffkNLRLM-AYGGA--TLSDDLYERMQALAvrTTGHripfytgygatetapTTTGTHWDTERVGliglplpgvELKLAPV 420
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 554 GCIGELIIGGPIVGRGYLKQPCLTANAFitNPEwaslfhlnGsyrFYKTGDLVRY----NADGTIAYIGRKDTQVKL-NG 628
Cdd:PRK12582 421 GDKYEVRVKGPNVTPGYHKDPELTAAAF--DEE--------G---FYRLGDAARFvdpdDPEKGLIFDGRVAEDFKLsTG 487
|
490 500
....*....|....*....|....*...
gi 992230864 629 QRVELGEIEHQA----QPYFRDAVIAAE 652
Cdd:PRK12582 488 TWVSVGTLRPDAvaacSPVIHDAVVAGQ 515
|
|
| PRK04319 |
PRK04319 |
acetyl-CoA synthetase; Provisional |
257-394 |
2.71e-09 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 235279 [Multi-domain] Cd Length: 570 Bit Score: 62.22 E-value: 2.71e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 257 TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSY---PTKRLVNICkdvDAKVI 333
Cdd:PRK04319 73 KYTYKELKELSNKFANVLKELGVEKGDRVFIFMPRIPELYFALLGALKNGAIVGPLFEAFmeeAVRDRLEDS---EAKVL 149
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 992230864 334 VCSQELSIGVSGSTLS-------IGDHNTETA-TYSAIQAVNTASH----------DAAYVVYTSGSTGAPKGIVIEHG 394
Cdd:PRK04319 150 ITTPALLERKPADDLPslkhvllVGEDVEEGPgTLDFNALMEQASDefdiewtdreDGAILHYTSGSTGKPKGVLHVHN 228
|
|
| ACLS-CaiC |
cd17637 |
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ... |
372-620 |
3.40e-09 |
|
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized, but may be similar to Carnitine-CoA ligase (CaiC) which catalyzes the transfer of CoA to carnitine. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341292 [Multi-domain] Cd Length: 333 Bit Score: 60.75 E-value: 3.40e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 372 DAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNL---DRSSRVLQFasyaFDVS-VHESLTPLLLGGCVCI----- 442
Cdd:cd17637 1 DPFVIIHTAAVAGRPRGAVLSHGNLIAANLQLIHAMGLteaDVYLNMLPL----FHIAgLNLALATFHAGGANVVmekfd 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 443 PSEAQRVnSLKEAVSTlrvnWVELTPTVARLW-----CPADIPTVKtLVMGGEpmLPNDISLWKDKL--RLVCAYGPAEC 515
Cdd:cd17637 77 PAEALEL-IEEEKVTL----MGSFPPILSNLLdaaekSGVDLSSLR-HVLGLD--APETIQRFEETTgaTFWSLYGQTET 148
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 516 TVVSTVQSCVQELGNIGR-SPCGTCWIVskDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFitnpewaslfhLN 594
Cdd:cd17637 149 SGLVTLSPYRERPGSAGRpGPLVRVRIV--DDNDRPVPAGETGEIVVRGPLVFQGYWNLPELTAYTF-----------RN 215
|
250 260
....*....|....*....|....*.
gi 992230864 595 GsyrFYKTGDLVRYNADGTIAYIGRK 620
Cdd:cd17637 216 G---WHHTGDLGRFDEDGYLWYAGRK 238
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
1353-1831 |
3.58e-09 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 62.49 E-value: 3.58e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1353 QLQQLISSLGQSLPRSAVPSLCLPVSFIPVDPLGQPDRiylceaassmtldflHSLTDPVNKYIDyHILPEEARLRGIVA 1432
Cdd:PRK05691 1582 EAERLKAALAAELPEYMVPAQLIRLDQMPLGPSGKLDR---------------RALPEPVWQQRE-HVEPRTELQQQIAA 1645
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1433 ---HVLSIdPQnISPKDDFFTLGGDSISAMQVVSLCRKH---QLSLTALdiFNGRTIELIATRLmpltpytppstpASDR 1506
Cdd:PRK05691 1646 iwrEVLGL-PR-VGLRDDFFALGGHSLLATQIVSRTRQAcdvELPLRAL--FEASELGAFAEQV------------ARIQ 1709
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1507 SLDRRfsllflNSDRDMERLESllmatydigsmdsiEDAYPCSESHQG---LLQTQMLRPFYyqsytiwEVTTRSKSSPV 1583
Cdd:PRK05691 1710 AAGER------NSQGAIARVDR--------------SQPVPLSYSQQRmwfLWQMEPDSPAY-------NVGGMARLSGV 1762
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1584 SPV-RLCNAWFTLARRHPALRThliDIPLCDGMS-------SKIHVVHKDYMADAA--------ILSCEDEHVITEL-RK 1646
Cdd:PRK05691 1763 LDVdRFEAALQALILRHETLRT---TFPSVDGVPvqqvaedSGLRMDWQDFSALPAdarqqrlqQLADSEAHQPFDLeRG 1839
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1647 PFLpsdtglyyphafRICQTVSGRV--FCKLEGGHAFLDATSVLIILRELAQAYDGQLSSVPGPSYSSAVAWL------- 1717
Cdd:PRK05691 1840 PLL------------RACLVKAAERehYFVLTLHHIVTEGWAMDIFARELGALYEAFLDDRESPLEPLPVQYLdysvwqr 1907
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1718 QSLPNGD--NRMDYWRRQLKDASPCI-----FPRLRDQDSPSDTLVVTEQLASTATLTPVCTRHGLTVSNVLQVAWGLML 1790
Cdd:PRK05691 1908 QWLESGErqRQLDYWKAQLGNEHPLLelpadRPRPPVQSHRGELYRFDLSPELAARVRAFNAQRGLTLFMTMTATLAALL 1987
|
490 500 510 520
....*....|....*....|....*....|....*....|...
gi 992230864 1791 RRYTESDDVCFGALISGRDSriPDVDKMVGPFFN--VLVCQLR 1831
Cdd:PRK05691 1988 YRYSGQRDLRIGAPVANRIR--PESEGLIGAFLNtqVLRCQLD 2028
|
|
| C_NRPS-like |
cd19537 |
Condensation family domain with an atypical active site motif; Condensation (C) domains of ... |
1580-1822 |
4.94e-09 |
|
Condensation family domain with an atypical active site motif; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily typically have a non-canonical conserved SHXXXDX(14)Y motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380460 [Multi-domain] Cd Length: 395 Bit Score: 60.66 E-value: 4.94e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1580 SSPVSPVRLCNAWFTLARRHPALRTHLIDIPlcdgmsskiHVVHKDYmADAAILSCEDEH--VITELRKPFLPSDTglyy 1657
Cdd:cd19537 33 SGDVDRDRLASAWNTVLARHRILRSRYVPRD---------GGLRRSY-SSSPPRVQRVDTldVWKEINRPFDLERE---- 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1658 pHAFRICQT-------VSgrvfckleggHAFLDATSVLIILRELAQAYDGQLSSVPGPSYSSAVAWLQSLPNGDnrMDYW 1730
Cdd:cd19537 99 -DPIRVFISpdtllvvMS----------HIICDLTTLQLLLREVSAAYNGKLLPPVRREYLDSTAWSRPASPED--LDFW 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1731 RRQLKDASPCIFPRLRDQDSPSDTLVVTEQLASTAT-LTPVCTRHGLTVSNVLQVAWGLMLRRYTESDDVCFGALISGRD 1809
Cdd:cd19537 166 SEYLSGLPLLNLPRRTSSKSYRGTSRVFQLPGSLYRsLLQFSTSSGITLHQLALAAVALALQDLSDRTDIVLGAPYLNRT 245
|
250
....*....|...
gi 992230864 1810 SriPDVDKMVGPF 1822
Cdd:cd19537 246 S--EEDMETVGLF 256
|
|
| AFD_YhfT-like |
cd17633 |
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, ... |
375-730 |
5.28e-09 |
|
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, as well as long-chain fatty acid-CoA ligase VraA, all of which are as yet to be characterized. These proteins belong to the adenylate-forming enzymes which catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain
Pssm-ID: 341288 [Multi-domain] Cd Length: 320 Bit Score: 60.11 E-value: 5.28e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 375 YVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQrVNSLKE 454
Cdd:cd17633 4 YIGFTSGTTGLPKAYYRSERSWIESFVCNEDLFNISGEDAILAPGPLSHSLFLYGAISALYLGGTFIGQRKFN-PKSWIR 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 455 AVSTLRVNWVELTPTVARLWCPADIP--TVKTLVMGG---EPMLPNDISLWKDKLRLVCAYGPAECTVVSTvqSCVQEL- 528
Cdd:cd17633 83 KINQYNATVIYLVPTMLQALARTLEPesKIKSIFSSGqklFESTKKKLKNIFPKANLIEFYGTSELSFITY--NFNQESr 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 529 --GNIGRsPCGTCWIVSKDNHHrlmpvGCIGELIIGGPIVGRGYLKQPCLTANafitnpEWaslfhlngsyrfYKTGDLV 606
Cdd:cd17633 161 ppNSVGR-PFPNVEIEIRNADG-----GEIGKIFVKSEMVFSGYVRGGFSNPD------GW------------MSVGDIG 216
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 607 RYNADGTIAYIGRKDTQVKLNGQRVELGEIEHQ--AQPYFRDAVIAAEVAAPAGRKPILILFIArkyeysvNMDCTMLLR 684
Cdd:cd17633 217 YVDEEGYLYLVGRESDMIIIGGINIFPTEIESVlkAIPGIEEAIVVGIPDARFGEIAVALYSGD-------KLTYKQLKR 289
|
330 340 350 360
....*....|....*....|....*....|....*....|....*.
gi 992230864 685 ppsilfqekaqgtntLLQEVLPRHMIPAAYIELLAMPISRTGKVNR 730
Cdd:cd17633 290 ---------------FLKQKLSRYEIPKKIIFVDSLPYTSSGKIAR 320
|
|
| PRK05857 |
PRK05857 |
fatty acid--CoA ligase; |
245-641 |
5.64e-09 |
|
fatty acid--CoA ligase;
Pssm-ID: 180293 [Multi-domain] Cd Length: 540 Bit Score: 61.18 E-value: 5.64e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 245 QPDAQAICAWDGT--ITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLV 322
Cdd:PRK05857 27 QPEAIALRRCDGTsaLRYRELVAEVGGLAADLRAQSVSRGSRVLVISDNGPETYLSVLACAKLGAIAVMADGNLPIAAIE 106
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 323 NICKDVDAKVIVCSQELSIGVSG------STLSIGDHNTETATYSAIQA--------VNTASHDAAYVVYTSGSTGAPKG 388
Cdd:PRK05857 107 RFCQITDPAAALVAPGSKMASSAvpealhSIPVIAVDIAAVTRESEHSLdaaslagnADQGSEDPLAMIFTSGTTGEPKA 186
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 389 IVIEHGSFCtnAIASS-QAQNLDRSSRVLQFASYAFDVSVHES-----LTPLLLGGcVCIpSEAQRVNSLKEAVSTLRVN 462
Cdd:PRK05857 187 VLLANRTFF--AVPDIlQKEGLNWVTWVVGETTYSPLPATHIGglwwiLTCLMHGG-LCV-TGGENTTSLLEILTTNAVA 262
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 463 WVELTPT-VARL-----WCPADIPTVKTLVMGGEPMLPNDISLWKDK-LRLVCAYGPAE--CTV--VSTVQSCVQ--ELG 529
Cdd:PRK05857 263 TTCLVPTlLSKLvselkSANATVPSLRLVGYGGSRAIAADVRFIEATgVRTAQVYGLSEtgCTAlcLPTDDGSIVkiEAG 342
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 530 NIGRS-PCGTCWIVSKD----NHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNpeWASlfhlngsyrfykTGD 604
Cdd:PRK05857 343 AVGRPyPGVDVYLAATDgigpTAPGAGPSASFGTLWIKSPANMLGYWNNPERTAEVLIDG--WVN------------TGD 408
|
410 420 430
....*....|....*....|....*....|....*..
gi 992230864 605 LVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEHQAQ 641
Cdd:PRK05857 409 LLERREDGFFYIKGRSSEMIICGGVNIAPDEVDRIAE 445
|
|
| PRK13383 |
PRK13383 |
acyl-CoA synthetase; Provisional |
235-389 |
7.44e-09 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139531 [Multi-domain] Cd Length: 516 Bit Score: 60.40 E-value: 7.44e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 235 HTLFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQ 314
Cdd:PRK13383 38 YTLLAVTAARWPGRTAIIDDDGALSYRELQRATESLARRLTRDGVAPGRAVGVMCRNGRGFVTAVFAVGLLGADVVPIST 117
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 992230864 315 SYPTKRLVNICKDVDAKVIVCSQELSIGVSGSTLSIGDHNTETATYSAIQAVNTASHDAAYVVYTSGSTGAPKGI 389
Cdd:PRK13383 118 EFRSDALAAALRAHHISTVVADNEFAERIAGADDAVAVIDPATAGAEESGGRPAVAAPGRIVLLTSGTTGKPKGV 192
|
|
| PTZ00237 |
PTZ00237 |
acetyl-CoA synthetase; Provisional |
295-637 |
7.70e-09 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 240325 [Multi-domain] Cd Length: 647 Bit Score: 60.91 E-value: 7.70e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 295 AIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVCSQ-------------------ELS--------------- 340
Cdd:PTZ00237 130 PLIAMLSCARIGATHCVLFDGYSVKSLIDRIETITPKLIITTNygilndeiitftpnlkeaiELStfkpsnvitlfrndi 209
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 341 -----------IGVSGSTLSIGDH------NTETATYsaiQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGS--FCTNAI 401
Cdd:PTZ00237 210 tsesdlkkietIPTIPNTLSWYDEikkikeNNQSPFY---EYVPVESSHPLYILYTSGTTGNSKAVVRSNGPhlVGLKYY 286
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 402 ASSQAQNlDRSSRVLQFASYAFdVSVHESLTPLLLGGCVCIPSEA------------------QRVNSLKEAVSTLRvNW 463
Cdd:PTZ00237 287 WRSIIEK-DIPTVVFSHSSIGW-VSFHGFLYGSLSLGNTFVMFEGgiiknkhieddlwntiekHKVTHTLTLPKTIR-YL 363
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 464 VELTPTVARLWCPADIPTVKTLVMGGEPM---LPNDIslwKDKLRLVCA--YGPAECTVVSTVqsCVQELgNIGRSPCGT 538
Cdd:PTZ00237 364 IKTDPEATIIRSKYDLSNLKEIWCGGEVIeesIPEYI---ENKLKIKSSrgYGQTEIGITYLY--CYGHI-NIPYNATGV 437
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 539 CW------IVSKDNhhRLMPVGCIGELIIGGPIvgrgylkqPCLTANAFITNPE-WASLFHLNGSYrfYKTGDLVRYNAD 611
Cdd:PTZ00237 438 PSifikpsILSEDG--KELNVNEIGEVAFKLPM--------PPSFATTFYKNDEkFKQLFSKFPGY--YNSGDLGFKDEN 505
|
410 420
....*....|....*....|....*.
gi 992230864 612 GTIAYIGRKDTQVKLNGQRVELGEIE 637
Cdd:PTZ00237 506 GYYTIVSRSDDQIKISGNKVQLNTIE 531
|
|
| C_PKS-NRPS |
cd20483 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
1588-1843 |
9.07e-09 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHXXXD motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380471 [Multi-domain] Cd Length: 430 Bit Score: 59.97 E-value: 9.07e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1588 LCNAWFTLARRHPALRTHLID--------IPlcdgMSSKIHVVHKDYMADAAILSCEDEHViTELRKpflpsdtglyypH 1659
Cdd:cd20483 41 LQKALSELVRRHEVLRTAYFEgddfgeqqVL----DDPSFHLIVIDLSEAADPEAALDQLV-RNLRR------------Q 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1660 AFRICQTVSGRV-FCKL-EGGHAFL--------DATSVLIILRELAQAYD-----GQLSSVPGPSYSSA------VAWLQ 1718
Cdd:cd20483 104 ELDIEEGEVIRGwLVKLpDEEFALVlashhiawDRGSSKSIFEQFTALYDalragRDLATVPPPPVQYIdftlwhNALLQ 183
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1719 SlPNGDNRMDYWRRQLKDASPCI--FP-RLRDQDSPSDTLVVTEQLASTATLTP----VCTRHGLTVSNVLQVAWGLMLR 1791
Cdd:cd20483 184 S-PLVQPLLDFWKEKLEGIPDASklLPfAKAERPPVKDYERSTVEATLDKELLArmkrICAQHAVTPFMFLLAAFRAFLY 262
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|..
gi 992230864 1792 RYTESDDVCFGaLISGRDSRiPDVDKMVGPFFNVLVCQLRFGREDSLWDVLR 1843
Cdd:cd20483 263 RYTEDEDLTIG-MVDGDRPH-PDFDDLVGFFVNMLPIRCRMDCDMSFDDLLE 312
|
|
| FCS |
cd05921 |
Feruloyl-CoA synthetase (FCS); Feruloyl-CoA synthetase is an essential enzyme in the feruloyl ... |
257-652 |
1.05e-08 |
|
Feruloyl-CoA synthetase (FCS); Feruloyl-CoA synthetase is an essential enzyme in the feruloyl acid degradation pathway and enables some proteobacteria to grow on media containing feruloyl acid as the sole carbon source. It catalyzes the transfer of CoA to the carboxyl group of ferulic acid, which then forms feruloyl-CoA in the presence of ATP and Mg2. The resulting feruloyl-CoA is further degraded to vanillin and acetyl-CoA. Feruloyl-CoA synthetase (FCS) is a subfamily of the adenylate-forming enzymes superfamily.
Pssm-ID: 341245 [Multi-domain] Cd Length: 561 Bit Score: 60.14 E-value: 1.05e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 257 TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKS-KWAIVAmLGVLKAGAAFCMLDQSYPTK-----RLVNICKDV-- 328
Cdd:cd05921 25 RVTYAEALRQVRAIAQGLLDLGLSAERPLLILSGNSiEHALMA-LAAMYAGVPAAPVSPAYSLMsqdlaKLKHLFELLkp 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 329 ------------DAKVIVCSQELSIGVSGSTLSIGD--HNTETATYSAIQAVNtASHDA------AYVVYTSGSTGAPKG 388
Cdd:cd05921 104 glvfaqdaapfaRALAAIFPLGTPLVVSRNAVAGRGaiSFAELAATPPTAAVD-AAFAAvgpdtvAKFLFTSGSTGLPKA 182
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 389 IVIEHGSFCTNA--IASSQAQNLDRSSRVLQFASYAFDVSVHESLTPLLL-GGCVCI----PSE---AQRVNSLKEAVST 458
Cdd:cd05921 183 VINTQRMLCANQamLEQTYPFFGEEPPVLVDWLPWNHTFGGNHNFNLVLYnGGTLYIddgkPMPggfEETLRNLREISPT 262
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 459 LRVN----WVELTPTVAR--LWCPADIPTVKTLVMGGEPMLPNdisLWK-----------DKLRLVCAYGPAECTVVSTV 521
Cdd:cd05921 263 VYFNvpagWEMLVAALEKdeALRRRFFKRLKLMFYAGAGLSQD---VWDrlqalavatvgERIPMMAGLGATETAPTATF 339
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 522 QSCVQEL-GNIGRSPCGTcwivskdnHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFitNPEwaslfhlngsyRFY 600
Cdd:cd05921 340 THWPTERsGLIGLPAPGT--------ELKLVPSGGKYEVRVKGPNVTPGYWRQPELTAQAF--DEE-----------GFY 398
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 992230864 601 KTGDLVRYnADGT-----IAYIGRKDTQVKLN-GQRVELGEIEHQA----QPYFRDAVIAAE 652
Cdd:cd05921 399 CLGDAAKL-ADPDdpakgLVFDGRVAEDFKLAsGTWVSVGPLRARAvaacAPLVHDAVVAGE 459
|
|
| A_NRPS_SidN3_like |
cd05918 |
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); ... |
1294-1401 |
1.09e-08 |
|
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family of siderophore-synthesizing NRPS includes the third adenylation domain of SidN from the endophytic fungus Neotyphodium lolii, ferrichrome siderophore synthetase, HC-toxin synthetase, and enniatin synthase. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341242 [Multi-domain] Cd Length: 481 Bit Score: 59.86 E-value: 1.09e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1294 IEKKVYDYFGGDVFVLVDAIVPNGSSNRST-AMFVCETKRRREPTETSGLFTRPTDNIRWQLQQLISSLGQSLPRSAVPS 1372
Cdd:cd05918 373 IEHHLRQSLPGAKEVVVEVVKPKDGSSSPQlVAFVVLDGSSSGSGDGDSLFLEPSDEFRALVAELRSKLRQRLPSYMVPS 452
|
90 100
....*....|....*....|....*....
gi 992230864 1373 LCLPVSFIPVDPLGQPDRIYLCEAASSMT 1401
Cdd:cd05918 453 VFLPLSHLPLTASGKIDRRALRELAESLS 481
|
|
| PRK08279 |
PRK08279 |
long-chain-acyl-CoA synthetase; Validated |
245-394 |
1.29e-08 |
|
long-chain-acyl-CoA synthetase; Validated
Pssm-ID: 236217 [Multi-domain] Cd Length: 600 Bit Score: 59.89 E-value: 1.29e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 245 QPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNI 324
Cdd:PRK08279 50 HPDRPALLFEDQSISYAELNARANRYAHWAAARGVGKGDVVALLMENRPEYLAAWLGLAKLGAVVALLNTQQRGAVLAHS 129
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 325 CKDVDAKVIVCSQELSIGVSgstlSIGDHNTETATY-----------SAIQAVNTASH----------------DAAYVV 377
Cdd:PRK08279 130 LNLVDAKHLIVGEELVEAFE----EARADLARPPRLwvaggdtlddpEGYEDLAAAAAgapttnpasrsgvtakDTAFYI 205
|
170
....*....|....*..
gi 992230864 378 YTSGSTGAPKGIVIEHG 394
Cdd:PRK08279 206 YTSGTTGLPKAAVMSHM 222
|
|
| LC-FACS_euk |
cd05927 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are ... |
372-626 |
2.41e-08 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are eukaryotic fatty acid CoA synthetases that activate fatty acids with chain lengths of 12 to 20. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells.
Pssm-ID: 341250 [Multi-domain] Cd Length: 545 Bit Score: 58.77 E-value: 2.41e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 372 DAAYVVYTSGSTGAPKGIVIEHGSFCTNaIASsqaqnLDRSSRVLQFASyAFDVsvHESLTPL-------LLGGCVCIPS 444
Cdd:cd05927 115 DLATICYTSGTTGNPKGVMLTHGNIVSN-VAG-----VFKILEILNKIN-PTDV--YISYLPLahifervVEALFLYHGA 185
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 445 eaqRVNSLKEAVSTLRVNWVELTPT----VARLW---------CPADIPT------------------------------ 481
Cdd:cd05927 186 ---KIGFYSGDIRLLLDDIKALKPTvfpgVPRVLnriydkifnKVQAKGPlkrklfnfalnyklaelrsgvvraspfwdk 262
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 482 -------------VKTLVMGGEPMLPNDIslwkDKLRLVCA------YGPAECTVVSTVQ-SCVQELGNIGrSPCGTCWI 541
Cdd:cd05927 263 lvfnkikqalggnVRLMLTGSAPLSPEVL----EFLRVALGcpvlegYGQTECTAGATLTlPGDTSVGHVG-GPLPCAEV 337
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 542 VSKD----NHHRLMPVGcIGELIIGGPIVGRGYLKQPCLTANAFITnpewaslfhlNGsyrFYKTGDLVRYNADGTIAYI 617
Cdd:cd05927 338 KLVDvpemNYDAKDPNP-RGEVCIRGPNVFSGYYKDPEKTAEALDE----------DG---WLHTGDIGEWLPNGTLKII 403
|
....*....
gi 992230864 618 GRKDTQVKL 626
Cdd:cd05927 404 DRKKNIFKL 412
|
|
| PRK03640 |
PRK03640 |
o-succinylbenzoate--CoA ligase; |
244-740 |
5.65e-08 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 235146 [Multi-domain] Cd Length: 483 Bit Score: 57.66 E-value: 5.65e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 244 LQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVN 323
Cdd:PRK03640 14 LTPDRTAIEFEEKKVTFMELHEAVVSVAGKLAALGVKKGDRVALLMKNGMEMILVIHALQQLGAVAVLLNTRLSREELLW 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 324 ICKDVDAKVIVCSQEL-SIGVSGSTLSIGDhnTETATYSAIQAVNTASHD-AAYVVYTSGSTGAPKGIVIEHGSFCTNAI 401
Cdd:PRK03640 94 QLDDAEVKCLITDDDFeAKLIPGISVKFAE--LMNGPKEEAEIQEEFDLDeVATIMYTSGTTGKPKGVIQTYGNHWWSAV 171
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 402 ASsqAQNL-----DR----------SSRVLQFAS--YAFDVSVHESLtplllggcvcipsEAQRVNSLKE--AVSTLRVN 462
Cdd:PRK03640 172 GS--ALNLgltedDCwlaavpifhiSGLSILMRSviYGMRVVLVEKF-------------DAEKINKLLQtgGVTIISVV 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 463 WVELTPTVARL---WCPadiPTVKTLVMGGEPMLPNDISLWKDK-LRLVCAYGPAE-CTVVSTVQS--CVQELGNIGRS- 534
Cdd:PRK03640 237 STMLQRLLERLgegTYP---SSFRCMLLGGGPAPKPLLEQCKEKgIPVYQSYGMTEtASQIVTLSPedALTKLGSAGKPl 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 535 -PCGTCwiVSKDNhhRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFITNpeWaslfhlngsyrfYKTGDLVRYNADGT 613
Cdd:PRK03640 314 fPCELK--IEKDG--VVVPPFEEGEIVVKGPNVTKGYLNREDATRETFQDG--W------------FKTGDIGYLDEEGF 375
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 614 IAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRDAVIAAEVAAPAGRKPilILFIARKYEYSVNmdctmllrppsilfQ 691
Cdd:PRK03640 376 LYVLDRRSDLIISGGENIYPAEIEEvlLSHPGVAEAGVVGVPDDKWGQVP--VAFVVKSGEVTEE--------------E 439
|
490 500 510 520
....*....|....*....|....*....|....*....|....*....
gi 992230864 692 EKAQGtntllQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLREAVEQA 740
Cdd:PRK03640 440 LRHFC-----EEKLAKYKVPKRFYFVEELPRNASGKLLRHELKQLVEEM 483
|
|
| PRK07470 |
PRK07470 |
acyl-CoA synthetase; Validated |
372-744 |
6.58e-08 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 180988 [Multi-domain] Cd Length: 528 Bit Score: 57.36 E-value: 6.58e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 372 DAAYVVYTSGSTGAPKGIVIEHGSFC---TNAIA-----SSQAqnlDRSsrvLQFASYAFDVSVHEsLTPLLLGG-CVCI 442
Cdd:PRK07470 164 DPCWFFFTSGTTGRPKAAVLTHGQMAfviTNHLAdlmpgTTEQ---DAS---LVVAPLSHGAGIHQ-LCQVARGAaTVLL 236
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 443 PSEAQRVNSLKEAVSTLRVNWVELTPTVARLWC--PA----DIPTVKTLVMGGEPMLPNDISLWKDKL--RLVCAYGPAE 514
Cdd:PRK07470 237 PSERFDPAEVWALVERHRVTNLFTVPTILKMLVehPAvdryDHSSLRYVIYAGAPMYRADQKRALAKLgkVLVQYFGLGE 316
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 515 CTVVSTV-QSCVQELG-----NIGrsPCG---TCWIVS-KDNHHRLMPVGCIGELIIGGPIVGRGYLKQPCLTANAFItn 584
Cdd:PRK07470 317 VTGNITVlPPALHDAEdgpdaRIG--TCGferTGMEVQiQDDEGRELPPGETGEICVIGPAVFAGYYNNPEANAKAFR-- 392
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 585 pewaslfhlNGSYRfykTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEHQ--AQPyfrdAViaAEVAapagrkpi 662
Cdd:PRK07470 393 ---------DGWFR---TGDLGHLDARGFLYITGRASDMYISGGSNVYPREIEEKllTHP----AV--SEVA-------- 446
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 663 lILFIARKY--EYSVnMDCtmLLRPPSILfqeKAQGTNTLLQEVLPRHMIPAAYIELLAMPISRTGKVNRKLLREAVEQA 740
Cdd:PRK07470 447 -VLGVPDPVwgEVGV-AVC--VARDGAPV---DEAELLAWLDGKVARYKLPKRFFFWDALPKSGYGKITKKMVREELEER 519
|
....
gi 992230864 741 SEKD 744
Cdd:PRK07470 520 GLLD 523
|
|
| FATP_FACS |
cd05940 |
Fatty acid transport proteins (FATP) play dual roles as fatty acid transporters and its ... |
255-394 |
8.98e-08 |
|
Fatty acid transport proteins (FATP) play dual roles as fatty acid transporters and its activation enzymes; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. At least five copies of FATPs are identified in mammalian cells. This family also includes prokaryotic FATPs. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341263 [Multi-domain] Cd Length: 449 Bit Score: 56.98 E-value: 8.98e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 255 DGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIV 334
Cdd:cd05940 1 DEALTYAELDAMANRYARWLKSLGLKPGDVVALFMENRPEYVLLWLGLVKIGAVAALINYNLRGESLAHCLNVSSAKHLV 80
|
90 100 110 120 130 140
....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 335 CsqelsigvsgstlsigdhntetatysaiqavntashDAAYVVYTSGSTGAPKGIVIEHG 394
Cdd:cd05940 81 V------------------------------------DAALYIYTSGTTGLPKAAIISHR 104
|
|
| PRK07059 |
PRK07059 |
Long-chain-fatty-acid--CoA ligase; Validated |
237-637 |
1.02e-07 |
|
Long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235923 [Multi-domain] Cd Length: 557 Bit Score: 56.95 E-value: 1.02e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 237 LFRLQCILQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSY 316
Cdd:PRK07059 28 LLEESFRQYADRPAFICMGKAITYGELDELSRALAAWLQSRGLAKGARVAIMMPNVLQYPVAIAAVLRAGYVVVNVNPLY 107
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 317 PTKRLVNICKDVDAK-----------------------VIVCSQELSIGVSGSTL--------------SIGDHNTETAT 359
Cdd:PRK07059 108 TPRELEHQLKDSGAEaivvlenfattvqqvlaktavkhVVVASMGDLLGFKGHIVnfvvrrvkkmvpawSLPGHVRFNDA 187
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 360 YSA-----IQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQN--LDRSSRVLQFAS-------YAFDV 425
Cdd:PRK07059 188 LAEgarqtFKPVKLGPDDVAFLQYTGGTTGVSKGATLLHRNIVANVLQMEAWLQpaFEKKPRPDQLNFvcalplyHIFAL 267
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 426 SVHeSLTPLLLGGC-VCIPSEAQRVNSLKE----------AVSTLrVNWVELTPTVARLwcpaDIPTVKTLVMGG----E 490
Cdd:PRK07059 268 TVC-GLLGMRTGGRnILIPNPRDIPGFIKElkkyqvhifpAVNTL-YNALLNNPDFDKL----DFSKLIVANGGGmavqR 341
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 491 PMLPNdislWKDKLR--LVCAYGPAECTVVSTVQSC-VQEL-GNIGRsPCGTCWIVSKDNHHRLMPVGCIGELIIGGPIV 566
Cdd:PRK07059 342 PVAER----WLEMTGcpITEGYGLSETSPVATCNPVdATEFsGTIGL-PLPSTEVSIRDDDGNDLPLGEPGEICIRGPQV 416
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 992230864 567 GRGYLKQPCLTANAFITNPewaslfhlngsyrFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIE 637
Cdd:PRK07059 417 MAGYWNRPDETAKVMTADG-------------FFRTGDVGVMDERGYTKIVDRKKDMILVSGFNVYPNEIE 474
|
|
| PRK07787 |
PRK07787 |
acyl-CoA synthetase; Validated |
373-637 |
1.54e-07 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236096 [Multi-domain] Cd Length: 471 Bit Score: 56.15 E-value: 1.54e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 373 AAYVVYTSGSTGAPKGIVIEHgsfctNAIASsqaqNLDRSSRVLQFAsyAFDVSVHE------------SLTPLLLGGCV 440
Cdd:PRK07787 130 PALIVYTSGTTGPPKGVVLSR-----RAIAA----DLDALAEAWQWT--ADDVLVHGlplfhvhglvlgVLGPLRIGNRF 198
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 441 ---------CIPSEAQRVNSLKEAVSTLrvnWVELT--PTVARLWCPAdiptvKTLVMGGEPmLPNDISlwkDKL----- 504
Cdd:PRK07787 199 vhtgrptpeAYAQALSEGGTLYFGVPTV---WSRIAadPEAARALRGA-----RLLVSGSAA-LPVPVF---DRLaaltg 266
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 505 -RLVCAYGPAECTV-VSTVQSCVQELGNIGRSPCGTcwivskdnHHRLM-----PVGC----IGELIIGGPIVGRGYLKQ 573
Cdd:PRK07787 267 hRPVERYGMTETLItLSTRADGERRPGWVGLPLAGV--------ETRLVdedggPVPHdgetVGELQVRGPTLFDGYLNR 338
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 992230864 574 PCLTANAFiTNPEWaslfhlngsyrfYKTGDLVRYNADGTIAYIGRKDTQ-VKLNGQRVELGEIE 637
Cdd:PRK07787 339 PDATAAAF-TADGW------------FRTGDVAVVDPDGMHRIVGRESTDlIKSGGYRIGAGEIE 390
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
1354-1516 |
1.83e-07 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 56.71 E-value: 1.83e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1354 LQQLISSLGQSLPRSAVPSLCLPVSFIPVDPLGQPDRiylceaassmtldflHSLTDPVNKYIDYHILPE---EARLRGI 1430
Cdd:PRK12467 3549 RETLRDHLAASLPDYMVPAQLLVLAAMPLGPNGKVDR---------------KALPDPDAKGSREYVAPRsevEQQLAAI 3613
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1431 VAHVLSIdpQNISPKDDFFTLGGDSISAMQVVSLCRKH---QLSLTalDIFNGRTIELIATRL----MPLTPYTPPStpa 1503
Cdd:PRK12467 3614 WADVLGV--EQVGVTDNFFELGGDSLLALQVLSRIRQSlglKLSLR--DLMSAPTIAELAGYSplgdVPVNLLLDLN--- 3686
|
170
....*....|...
gi 992230864 1504 sdrSLDRRFSLLF 1516
Cdd:PRK12467 3687 ---RLETGFPALF 3696
|
|
| PRK08276 |
PRK08276 |
long-chain-fatty-acid--CoA ligase; Validated |
250-434 |
3.87e-07 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236215 [Multi-domain] Cd Length: 502 Bit Score: 54.91 E-value: 3.87e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 250 AICAWDG-TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDV 328
Cdd:PRK08276 3 VIMAPSGeVVTYGELEARSNRLAHGLRALGLREGDVVAILLENNPEFFEVYWAARRSGLYYTPINWHLTAAEIAYIVDDS 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 329 DAKVIVCS-----------QELSIGVSGSTLSIGDHNTeTATYSAIQAVNTASHDA-----AYVVYTSGSTGAPKGIVIE 392
Cdd:PRK08276 83 GAKVLIVSaaladtaaelaAELPAGVPLLLVVAGPVPG-FRSYEEALAAQPDTPIAdetagADMLYSSGTTGRPKGIKRP 161
|
170 180 190 200
....*....|....*....|....*....|....*....|..
gi 992230864 393 hgsfctnAIASSQAQNLDRSSRVLQFASYAFDVSVHESLTPL 434
Cdd:PRK08276 162 -------LPGLDPDEAPGMMLALLGFGMYGGPDSVYLSPAPL 196
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
1356-1488 |
4.07e-07 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 55.55 E-value: 4.07e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1356 QLISSLGQSLPRSAVPSLCLPVSFIPVDPLGQPDRIYLCEAASSMtldFLHSLTDPVNKYidyhilpeEARLRGIVAHVL 1435
Cdd:PRK12467 2042 ILKNHLKASLPEYMVPAHLVFLARMPLTPNGKLDRKALPAPDASE---LQQAYVAPQSEL--------EQRLAAIWQDVL 2110
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|...
gi 992230864 1436 SIdpQNISPKDDFFTLGGDSISAMQVVSLCRKHQLSLTALDIFNGRTIELIAT 1488
Cdd:PRK12467 2111 GL--EQVGLHDNFFELGGDSIISIQVVSRARQAGIRFTPKDLFQHQTVQSLAA 2161
|
|
| MACS_like_1 |
cd05974 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
258-637 |
4.09e-07 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341278 [Multi-domain] Cd Length: 432 Bit Score: 54.88 E-value: 4.09e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 258 ITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAfcmldqsyptkrlvnickdvdakVIVCSQ 337
Cdd:cd05974 1 VSFAEMSARSSRVANFLRSIGVGRGDRILLMLGNVVELWEAMLAAMKLGAV-----------------------VIPATT 57
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 338 ELSIGVSGSTLSIGDHNTetatysAIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQ 417
Cdd:cd05974 58 LLTPDDLRDRVDRGGAVY------AAVDENTHADDPMLLYFTSGTTSKPKLVEHTHRSYPVGHLSTMYWIGLKPGDVHWN 131
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 418 FASYAFDVSVHESL-TPLLLGGCVCIPSEAQ-RVNSLKEAVSTLRVNWVELTPTVARLWCPADIPTVKT----LVMGGEP 491
Cdd:cd05974 132 ISSPGWAKHAWSCFfAPWNAGATVFLFNYARfDAKRVLAALVRYGVTTLCAPPTVWRMLIQQDLASFDVklreVVGAGEP 211
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 492 MLPNDI----SLWKDKLRlvCAYGPAECTV-VSTVQSCVQELGNIGRsPCGTCWIVSKDNHHRLMPVGCIGELIIGGPIV 566
Cdd:cd05974 212 LNPEVIeqvrRAWGLTIR--DGYGQTETTAlVGNSPGQPVKAGSMGR-PLPGYRVALLDPDGAPATEGEVALDLGDTRPV 288
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 992230864 567 G--RGYLKQPCLTANAfitnpewaslfhLNGSYrfYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIE 637
Cdd:cd05974 289 GlmKGYAGDPDKTAHA------------MRGGY--YRTGDIAMRDEDGYLTYVGRADDVFKSSDYRISPFELE 347
|
|
| FACL_like_5 |
cd05924 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
369-655 |
5.06e-07 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341248 [Multi-domain] Cd Length: 364 Bit Score: 53.93 E-value: 5.06e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 369 ASHDAAYVVYTSGSTGAPKGIVIEHGSF--------------CTNAIASSQAQNLDRSSRVLQFASYAFDVSVHESLTPL 434
Cdd:cd05924 1 RSADDLYILYTGGTTGMPKGVMWRQEDIfrmlmggadfgtgeFTPSEDAHKAAAAAAGTVMFPAPPLMHGTGSWTAFGGL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 435 LLGGCVCIPSEAQRVNSLKEAVSTLRVNWVELT------PTVARL--WCPADIPTVKTLVMGGEPMLPNdislWKDKL-- 504
Cdd:cd05924 81 LGGQTVVLPDDRFDPEEVWRTIEKHKVTSMTIVgdamarPLIDALrdAGPYDLSSLFAISSGGALLSPE----VKQGLle 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 505 -----RLVCAYGPAEC--TVVSTVQSCVQELGNIGRSPCGTCWIvskDNHHRLMPVGcigeliigGPIVGR--------- 568
Cdd:cd05924 157 lvpniTLVDAFGSSETgfTGSGHSAGSGPETGPFTRANPDTVVL---DDDGRVVPPG--------SGGVGWiarrghipl 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 569 GYLKQPCLTANAFITnpewaslfhLNGSyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRD 646
Cdd:cd05924 226 GYYGDEAKTAETFPE---------VDGV-RYAVPGDRATVEADGTVTLLGRGSVCINTGGEKVFPEEVEEalKSHPAVYD 295
|
330
....*....|....*..
gi 992230864 647 AVIAA--------EVAA 655
Cdd:cd05924 296 VLVVGrpderwgqEVVA 312
|
|
| C_NRPS-like |
cd19537 |
Condensation family domain with an atypical active site motif; Condensation (C) domains of ... |
894-1119 |
5.07e-07 |
|
Condensation family domain with an atypical active site motif; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily typically have a non-canonical conserved SHXXXDX(14)Y motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380460 [Multi-domain] Cd Length: 395 Bit Score: 54.11 E-value: 5.07e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 894 AFQAQFRFQLPHQLDMLRLKEAWRIVIAANPILRTRIVFCHTGALQVVLRPGEQLQW----DLINGVHTsPGSLmsYGVP 969
Cdd:cd19537 23 SFNVSFACRLSGDVDRDRLASAWNTVLARHRILRSRYVPRDGGLRRSYSSSPPRVQRvdtlDVWKEINR-PFDL--ERED 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 970 LVDMAITNDtagklsrTFCLTMHHAIFDGWSYGLILGAVEDAYKHTNAVQrpfaPFIKYIlHCNY------ESAKHFWCS 1043
Cdd:cd19537 100 PIRVFISPD-------TLLVVMSHIICDLTTLQLLLREVSAAYNGKLLPP----VRREYL-DSTAwsrpasPEDLDFWSE 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1044 EFKDMQALPFPVPPLSRGHMANS-----STTTHRQihvsewLSSYCTPS--TIIQLAFT---LLIAWRTESMDVLFGLTV 1113
Cdd:cd19537 168 YLSGLPLLNLPRRTSSKSYRGTSrvfqlPGSLYRS------LLQFSTSSgiTLHQLALAavaLALQDLSDRTDIVLGAPY 241
|
....*.
gi 992230864 1114 TGRNAP 1119
Cdd:cd19537 242 LNRTSE 247
|
|
| hsFATP2a_ACSVL_like |
cd05938 |
Fatty acid transport proteins (FATP) including hsFATP2, hsFATP5, and hsFATP6, and similar ... |
255-393 |
1.31e-06 |
|
Fatty acid transport proteins (FATP) including hsFATP2, hsFATP5, and hsFATP6, and similar proteins; Fatty acid transport proteins (FATP) of this family transport long-chain or very-long-chain fatty acids across the plasma membrane. At least five copies of FATPs are identified in mammalian cells. This family includes hsFATP2, hsFATP5, and hsFATP6, and similar proteins. Each FATP has unique patterns of tissue distribution. These FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. The hsFATP proteins exist in two splice variants; the b variant, lacking exon 3, has no acyl-CoA synthetase activity. FATPs are key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341261 [Multi-domain] Cd Length: 537 Bit Score: 53.45 E-value: 1.31e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 255 DGTITYRQLDRLSSTV-QGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVI 333
Cdd:cd05938 3 GETYTYRDVDRRSNQAaRALLAHAGLRPGDTVALLLGNEPAFLWIWLGLAKLGCPVAFLNTNIRSKSLLHCFRCCGAKVL 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 334 VCSQELSIGVS---------GSTLSIGDHNTETATYSAIQA-VNTASHDA--------------AYVVYTSGSTGAPKGI 389
Cdd:cd05938 83 VVAPELQEAVEevlpalradGVSVWYLSHTSNTEGVISLLDkVDAASDEPvpaslrahvtikspALYIYTSGTTGLPKAA 162
|
....
gi 992230864 390 VIEH 393
Cdd:cd05938 163 RISH 166
|
|
| PRK09029 |
PRK09029 |
O-succinylbenzoic acid--CoA ligase; Provisional |
244-390 |
1.91e-06 |
|
O-succinylbenzoic acid--CoA ligase; Provisional
Pssm-ID: 236363 [Multi-domain] Cd Length: 458 Bit Score: 52.57 E-value: 1.91e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 244 LQPDAQAICAWDGTITYRQL-DRLSSTVQGLLQQydlG--PGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKR 320
Cdd:PRK09029 15 VRPQAIALRLNDEVLTWQQLcARIDQLAAGFAQQ---GvvEGSGVALRGKNSPETLLAYLALLQCGARVLPLNPQLPQPL 91
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 992230864 321 LVNICKDVDAKVIVCSQelsigvsgstlsigDHNTETATYSAIQAVNTASHDAAY-------VVYTSGSTGAPKGIV 390
Cdd:PRK09029 92 LEELLPSLTLDFALVLE--------------GENTFSALTSLHLQLVEGAHAVAWqpqrlatMTLTSGSTGLPKAAV 154
|
|
| PRK06334 |
PRK06334 |
long chain fatty acid--[acyl-carrier-protein] ligase; Validated |
250-666 |
2.46e-06 |
|
long chain fatty acid--[acyl-carrier-protein] ligase; Validated
Pssm-ID: 180533 [Multi-domain] Cd Length: 539 Bit Score: 52.51 E-value: 2.46e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 250 AICAWD---GTITYRQLDRLSSTVQGLLQQYdlgPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICK 326
Cdd:PRK06334 35 ATVCWDeqlGKLSYNQVRKAVIALATKVSKY---PDQHIGIMMPASAGAYIAYFATLLSGKIPVMINWSQGLREVTACAN 111
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 327 DVDAKVIVCSQEL--------SIGVS-----------GSTLSIGDhNTETATYSAI---------QAVNTASHDAAYVVY 378
Cdd:PRK06334 112 LVGVTHVLTSKQLmqhlaqthGEDAEypfsliymeevRKELSFWE-KCRIGIYMSIpfewlmrwfGVSDKDPEDVAVILF 190
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 379 TSGSTGAPKGIVIEHGSFCTNAIAS----SQAQNLDRSSRVLQFASYAFDVSvheSLTPLLLGGCVCIPSEAQRVNSLKE 454
Cdd:PRK06334 191 TSGTEKLPKGVPLTHANLLANQRAClkffSPKEDDVMMSFLPPFHAYGFNSC---TLFPLLSGVPVVFAYNPLYPKKIVE 267
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 455 AVSTLRVNWVELTP-------TVARLwCPADIPTVKTLVMGGEpmlpndisLWKDKLR-----------LVCAYGPAECT 516
Cdd:PRK06334 268 MIDEAKVTFLGSTPvffdyilKTAKK-QESCLPSLRFVVIGGD--------AFKDSLYqealktfphiqLRQGYGTTECS 338
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 517 VVSTV--------QSCVqelgniGRSPCGT-CWIVSKDNHhrlMPV--GCIGELIIGGPIVGRGYLKqpcltanafitNP 585
Cdd:PRK06334 339 PVITIntvnspkhESCV------GMPIRGMdVLIVSEETK---VPVssGETGLVLTRGTSLFSGYLG-----------ED 398
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 586 EWASLFHLNGSyRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGE-----IEHQAQPYFRDAvIAAEVAAPAGRK 660
Cdd:PRK06334 399 FGQGFVELGGE-TWYVTGDLGYVDRHGELFLKGRLSRFVKIGAEMVSLEAlesilMEGFGQNAADHA-GPLVVCGLPGEK 476
|
....*.
gi 992230864 661 PILILF 666
Cdd:PRK06334 477 VRLCLF 482
|
|
| LCL_NRPS-like |
cd19540 |
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; ... |
1728-1831 |
2.93e-06 |
|
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380463 [Multi-domain] Cd Length: 433 Bit Score: 52.04 E-value: 2.93e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1728 DYWRRQLKDAS-----PCIFPRLRDQDSPSDTLVVTEQLASTATLTPVCTRHGLTVSNVLQVAWGLMLRRYTESDDVCFG 1802
Cdd:cd19540 193 AYWRETLAGLPeelelPTDRPRPAVASYRGGTVEFTIDAELHARLAALAREHGATLFMVLHAALAVLLSRLGAGDDIPIG 272
|
90 100
....*....|....*....|....*....
gi 992230864 1803 ALISGRDSriPDVDKMVGPFFNVLVcqLR 1831
Cdd:cd19540 273 TPVAGRGD--EALDDLVGMFVNTLV--LR 297
|
|
| PrpE |
cd05967 |
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or ... |
257-637 |
2.96e-06 |
|
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or propionate#CoA ligase (PrpE) catalyzes the first step of the 2-methylcitric acid cycle for propionate catabolism. It activates propionate to propionyl-CoA in a two-step reaction, which proceeds through a propionyl-AMP intermediate and requires ATP and Mg2+. In Salmonella enterica, the PrpE protein is required for growth of Salmonella enterica on propionate and can substitute for the acetyl-CoA synthetase (Acs) enzyme during growth on acetate. PrpE can also activate acetate, 3HP, and butyrate to their corresponding CoA-thioesters, although with less efficiency.
Pssm-ID: 341271 [Multi-domain] Cd Length: 617 Bit Score: 52.32 E-value: 2.96e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 257 TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVCS 336
Cdd:cd05967 82 TYTYAELLDEVSRLAGVLRKLGVVKGDRVIIYMPMIPEAAIAMLACARIGAIHSVVFGGFAAKELASRIDDAKPKLIVTA 161
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 337 qelSIGVSG-----------STLSIGDH--------------------------NTETATYSAIQAVNTASHDAAYVVYT 379
Cdd:cd05967 162 ---SCGIEPgkvvpykplldKALELSGHkphhvlvlnrpqvpadltkpgrdldwSELLAKAEPVDCVPVAATDPLYILYT 238
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 380 SGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASyafDVS--VHESLT---PLLLGGC--------VCIPS-- 444
Cdd:cd05967 239 SGTTGKPKGVVRDNGGHAVALNWSMRNIYGIKPGDVWWAAS---DVGwvVGHSYIvygPLLHGATtvlyegkpVGTPDpg 315
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 445 ------EAQRVNSLKEAVSTLRVnwVELTPTVARLWCPADIPTVKTLVMGGEPMLPNDISLWKDKL-RLVCAY------G 511
Cdd:cd05967 316 afwrviEKYQVNALFTAPTAIRA--IRKEDPDGKYIKKYDLSSLRTLFLAGERLDPPTLEWAENTLgVPVIDHwwqtetG 393
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 512 PAECTVVSTVQSCVQELGNIGRSPCGTCWIVSKDNHHRLmPVGCIGELIIGGPIvgrgylkqPCLTANAFITNPEWASLF 591
Cdd:cd05967 394 WPITANPVGLEPLPIKAGSPGKPVPGYQVQVLDEDGEPV-GPNELGNIVIKLPL--------PPGCLLTLWKNDERFKKL 464
|
410 420 430 440
....*....|....*....|....*....|....*....|....*.
gi 992230864 592 HLNGSYRFYKTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIE 637
Cdd:cd05967 465 YLSKFPGYYDTGDAGYKDEDGYLFIMGRTDDVINVAGHRLSTGEME 510
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
1357-1488 |
1.08e-05 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 50.94 E-value: 1.08e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1357 LISSLGQSLPRSAVPSLCLPVSFIPVDPLGQPDRIYLceaassmtldflhSLTDPVNKYIDYhILPE---EARLRGIVAH 1433
Cdd:PRK05691 2655 LKAHLKQQLPDYMVPAHLILLDSLPLTANGKLDRRAL-------------PAPDPELNRQAY-QAPRselEQQLAQIWRE 2720
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*
gi 992230864 1434 VLSIdpQNISPKDDFFTLGGDSISAMQVVSLCRKHQLSLTALDIFNGRTIELIAT 1488
Cdd:PRK05691 2721 VLNV--ERVGLGDNFFELGGDSILSIQVVSRARQLGIHFSPRDLFQHQTVQTLAA 2773
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
1679-1844 |
1.87e-05 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 50.16 E-value: 1.87e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1679 HAFLDATSVLIILRELAQAYD----GQLSSVPG-P-SYSSAVAWLQS-LPNGDN--RMDYWRRQLKDASPCI-----FPR 1744
Cdd:PRK12467 183 HIISDGWSMRVLVEELVQLYSaysqGREPSLPAlPiQYADYAIWQRSwLEAGERerQLAYWQEQLGGEHTVLelptdRPR 262
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1745 LRDQDSPSDTLVVTEQLASTATLTPVCTRHGLTVSNVLQVAWGLMLRRYTESDDVCFGALISGRDsRIpDVDKMVGPFFN 1824
Cdd:PRK12467 263 PAVPSYRGARLRVDLPQALSAGLKALAQREGVTLFMVLLASFQTLLHRYSGQSDIRIGVPNANRN-RV-ETERLIGFFVN 340
|
170 180
....*....|....*....|
gi 992230864 1825 VLVCQLRFGREDSLWDVLRR 1844
Cdd:PRK12467 341 TQVLKAEVDPQASFLELLQQ 360
|
|
| PLN02387 |
PLN02387 |
long-chain-fatty-acid-CoA ligase family protein |
557-637 |
2.27e-05 |
|
long-chain-fatty-acid-CoA ligase family protein
Pssm-ID: 215217 [Multi-domain] Cd Length: 696 Bit Score: 49.34 E-value: 2.27e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 557 GELIIGGPIVGRGYLKQPCLTANAFITNPewaslfhlNGSYRFYkTGDLVRYNADGTIAYIGRKDTQVKL-NGQRVELGE 635
Cdd:PLN02387 503 GEIVIGGPSVTLGYFKNQEKTDEVYKVDE--------RGMRWFY-TGDIGQFHPDGCLEIIDRKKDIVKLqHGEYVSLGK 573
|
..
gi 992230864 636 IE 637
Cdd:PLN02387 574 VE 575
|
|
| PLN02736 |
PLN02736 |
long-chain acyl-CoA synthetase |
354-406 |
2.61e-05 |
|
long-chain acyl-CoA synthetase
Pssm-ID: 178337 [Multi-domain] Cd Length: 651 Bit Score: 49.33 E-value: 2.61e-05
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 992230864 354 NTETATYSAIQAVNTAS---------HDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQA 406
Cdd:PLN02736 195 GVEIVTYSKLLAQGRSSpqpfrppkpEDVATICYTSGTTGTPKGVVLTHGNLIANVAGSSLS 256
|
|
| hsFATP4_like |
cd05939 |
Fatty acid transport proteins (FATP), including FATP4 and FATP1, and similar proteins; Fatty ... |
255-396 |
2.73e-05 |
|
Fatty acid transport proteins (FATP), including FATP4 and FATP1, and similar proteins; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. At least five copies of FATPs are identified in mammalian cells. This family includes FATP4, FATP1, and homologous proteins. Each FATP has unique patterns of tissue distribution. FATP4 is mainly expressed in the brain, testis, colon and kidney. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341262 [Multi-domain] Cd Length: 474 Bit Score: 48.96 E-value: 2.73e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 255 DGTITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNickdvdakviv 334
Cdd:cd05939 1 DRHWTFRELNEYSNKVANFFQAQGYRSGDVVALFMENRLEFVALWLGLAKIGVETALINSNLRLESLLH----------- 69
|
90 100 110 120 130 140
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 992230864 335 csqelSIGVSGSTLSIGDHNT---ETATYSAIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHGSF 396
Cdd:cd05939 70 -----CITVSKAKALIFNLLDpllTQSSTEPPSQDDVNFRDKLFYIYTSGTTGLPKAAVIVHSRY 129
|
|
| FadD3 |
cd17638 |
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ... |
372-638 |
3.70e-05 |
|
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ligases, including FadD3 which is an acyl-CoA synthetase that initiates catabolism of cholesterol rings C and D in actinobacteria. The cholesterol catabolic pathway occurs in most mycolic acid-containing actinobacteria, such as Rhodococcus jostii RHA1, and is critical for Mycobacterium tuberculosis (Mtb) during infection. FadD3 catalyzes the ATP-dependent CoA thioesterification of 3a-alpha-H-4alpha(3'-propanoate)-7a-beta-methylhexahydro-1,5-indanedione (HIP) to yield HIP-CoA. Hydroxylated analogs of HIP, 5alpha-OH HIP and 1beta-OH HIP, can also be used.
Pssm-ID: 341293 [Multi-domain] Cd Length: 330 Bit Score: 47.88 E-value: 3.70e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 372 DAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCIPSEAQRVNS 451
Cdd:cd17638 1 DVSDIMFTSGTTGRSKGVMCAHRQTLRAAAAWADCADLTEDDRYLIINPFFHTFGYKAGIVACLLTGATVVPVAVFDVDA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 452 LKEAVSTLRVNWVELTPTV--ARLWCPA----DIPTVKTLVMGGEPMLPNDISLWKDKL---RLVCAYGPAECTVVS--- 519
Cdd:cd17638 81 ILEAIERERITVLPGPPTLfqSLLDHPGrkkfDLSSLRAAVTGAATVPVELVRRMRSELgfeTVLTAYGLTEAGVATmcr 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 520 TVQSCVQELGNIGRSPCGtcwivskdnhhrlMPVGCI--GELIIGGPIVGRGYLKQPCLTANAfITNPEWaslFHlngsy 597
Cdd:cd17638 161 PGDDAETVATTCGRACPG-------------FEVRIAddGEVLVRGYNVMQGYLDDPEATAEA-IDADGW---LH----- 218
|
250 260 270 280
....*....|....*....|....*....|....*....|.
gi 992230864 598 rfykTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH 638
Cdd:cd17638 219 ----TGDVGELDERGYLRITDRLKDMYIVGGFNVYPAEVEG 255
|
|
| alpha_am_amid |
TIGR03443 |
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are ... |
1361-1487 |
5.17e-05 |
|
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), product of the LYS2 gene. It is also called alpha-aminoadipate reductase. In fungi, lysine is synthesized via aminoadipate. Currently, all members of this family are fungal.
Pssm-ID: 274582 [Multi-domain] Cd Length: 1389 Bit Score: 48.52 E-value: 5.17e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1361 LGQSLPRSAVPSLCLPVSFIPVDPLGQPDRIYLCEAASSMtLDFLHSLTDPVNKYIDYHilPEEARLRGIVAHVLSIDPQ 1440
Cdd:TIGR03443 790 LKKKLPSYAIPTVIVPLKKLPLNPNGKVDKPALPFPDTAQ-LAAVAKNRSASAADEEFT--ETEREIRDLWLELLPNRPA 866
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|
gi 992230864 1441 NISPKDDFFTLGGDSISAMQVVSLCRKH---QLSLTAldIFNGRTIELIA 1487
Cdd:TIGR03443 867 TISPDDSFFDLGGHSILATRMIFELRKKlnvELPLGL--IFKSPTIKGFA 914
|
|
| starter-C_NRPS |
cd19533 |
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases ... |
989-1150 |
5.47e-05 |
|
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. While standard C-domains catalyze peptide bond formation between two amino acids, an initial, ('starter') C-domain may instead acylate an amino acid with a fatty acid. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380456 [Multi-domain] Cd Length: 419 Bit Score: 47.75 E-value: 5.47e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 989 LTMHHAIFDGWSYGLILGAVEDAY----KHTNAVQRPFAPFIKYIL-------HCNYESAKHFWCSEFKDmqaLPFPV-- 1055
Cdd:cd19533 129 QRVHHIVMDGFSFALFGQRVAEIYtallKGRPAPPAPFGSFLDLVEeeqayrqSERFERDRAFWTEQFED---LPEPVsl 205
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1056 ----PPLSRG---HMANSSTTTHRQIhvSEWLSSY-CTPSTIIQLAFTLLIAWRTESMDVLFGLTVTGRnAPVAGIHrTT 1127
Cdd:cd19533 206 arraPGRSLAflrRTAELPPELTRTL--LEAAEAHgASWPSFFIALVAAYLHRLTGANDVVLGVPVMGR-LGAAARQ-TP 281
|
170 180
....*....|....*....|...
gi 992230864 1128 GPTIATFPLRTILYGTMNITDAL 1150
Cdd:cd19533 282 GMVANTLPLRLTVDPQQTFAELV 304
|
|
| PKS_PP |
smart00823 |
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the ... |
764-829 |
5.81e-05 |
|
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the prosthetic group of acyl carrier proteins (ACP) in some multienzyme complexes where it serves as a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups.
Pssm-ID: 214834 [Multi-domain] Cd Length: 86 Bit Score: 43.39 E-value: 5.81e-05
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 992230864 764 VLDQLRLLFSAALRI-PEEKIKPNDSFFHLGGDSVSAIRLVGDARDQ-GLHITVESLFKRQTISKLAE 829
Cdd:smart00823 13 LLDLVREQVAAVLGHaAAEAIDPDRPFRDLGLDSLMAVELRNRLEAAtGLRLPATLVFDHPTPAALAE 80
|
|
| C_PKS-NRPS_PksJ-like |
cd20484 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
1679-1846 |
6.00e-05 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs), similar to Bacillus subtilis PksJ; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily have the typical C-domain HHxxxD motif. PksJ is involved in some intermediate steps for the synthesis of the antibiotic polyketide bacillaene which is important in secondary metabolism. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380472 [Multi-domain] Cd Length: 430 Bit Score: 47.70 E-value: 6.00e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1679 HAFLDATSVLIILRELAQAY----DGQ--LSSVPGPSYSSAVAWLQSL---PNGDNRMDYWRRQLKDASPCI-----FPR 1744
Cdd:cd20484 131 HIIFDGSSSLTLIHSLLDAYqallQGKqpTLASSPASYYDFVAWEQDMlagAEGEEHRAYWKQQLSGTLPILelpadRPR 210
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1745 LRDQDSPSDTLVVT------EQLASTATLtpvctrHGLTVSNVLQVAWGLMLRRYTESDDVCFGALISGR-DSRIpdvDK 1817
Cdd:cd20484 211 SSAPSFEGQTYTRRlpselsNQIKSFARS------QSINLSTVFLGIFKLLLHRYTGQEDIIVGMPTMGRpEERF---DS 281
|
170 180
....*....|....*....|....*....
gi 992230864 1818 MVGPFFNVLVCQLRFGREDSLWDVLRRNQ 1846
Cdd:cd20484 282 LIGYFINMLPIRSRILGEETFSDFIRKLQ 310
|
|
| ACSBG_like |
cd05933 |
Bubblegum-like very long-chain fatty acid CoA synthetase (VL-FACS); This family of very ... |
377-474 |
6.86e-05 |
|
Bubblegum-like very long-chain fatty acid CoA synthetase (VL-FACS); This family of very long-chain fatty acid CoA synthetase is named bubblegum because Drosophila melanogaster mutant bubblegum (BGM) has elevated levels of very-long-chain fatty acids (VLCFA) caused by a defective gene of this family. The human homolog (hsBG) has been characterized as a very long chain fatty acid CoA synthetase that functions specifically in the brain; hsBG may play a central role in brain VLCFA metabolism and myelinogenesis. VL-FACS is involved in the first reaction step of very long chain fatty acid degradation. It catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341256 [Multi-domain] Cd Length: 596 Bit Score: 47.74 E-value: 6.86e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 377 VYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLdRSSRVLQ--FASY---------AFDVsvhesLTPLLLGGCVCIPSE 445
Cdd:cd05933 156 IYTSGTTGMPKGVMLSHDNITWTAKAASQHMDL-RPATVGQesVVSYlplshiaaqILDI-----WLPIKVGGQVYFAQP 229
|
90 100 110
....*....|....*....|....*....|....
gi 992230864 446 aqrvNSLKEA-VSTLRvnwvELTPT----VARLW 474
Cdd:cd05933 230 ----DALKGTlVKTLR----EVRPTafmgVPRVW 255
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1355-1490 |
7.88e-05 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 48.03 E-value: 7.88e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1355 QQLISSLGQSLPRSAVPSLCLPVSFIPVDPLGQPDRIYLCEA-ASSMTLDFLHSLTDPvnkyidyhilpeEARLRGIVAH 1433
Cdd:PRK12316 5016 DELKAALRERLPEYMVPAHLVFLARMPLTPNGKLDRKALPQPdASLLQQAYVAPRSEL------------EQQVAAIWAE 5083
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*...
gi 992230864 1434 VLSIdpQNISPKDDFFTLGGDSISAMQVVSLCRKH-QLSLTALDIFNGRTIELIATRL 1490
Cdd:PRK12316 5084 VLQL--ERVGLDDNFFELGGHSLLAIQVTSRIQLElGLELPLRELFQTPTLAAFVELA 5139
|
|
| LCL_NRPS |
cd19538 |
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; ... |
1588-1831 |
1.13e-04 |
|
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380461 [Multi-domain] Cd Length: 432 Bit Score: 46.87 E-value: 1.13e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1588 LCNAWFTLARRHPALRTHlidIPLCDGMSSKIHVVHKDYMADAAILSCEDEHVITELrkpflpsDTGLYYPhaFRICQTV 1667
Cdd:cd19538 41 LQQALYDVVERHESLRTV---FPEEDGVPYQLILEEDEATPKLEIKEVDEEELESEI-------NEAVRYP--FDLSEEP 108
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1668 SGRV--FCKLEGGHAFL--------DATSVLIILRELAQAY-------DGQLSSVPgPSYSSAVAWLQSLPNGDN----- 1725
Cdd:cd19538 109 PFRAtlFELGENEHVLLlllhhiaaDGWSLAPLTRDLSKAYrarckgeAPELAPLP-VQYADYALWQQELLGDESdpdsl 187
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1726 ---RMDYWRRQLKDAS-----PCIFPRlrdQDSPSD-----TLVVTEQLAStaTLTPVCTRHGLTVSNVLQVAWGLMLRR 1792
Cdd:cd19538 188 iarQLAYWKKQLAGLPdeielPTDYPR---PAESSYeggtlTFEIDSELHQ--QLLQLAKDNNVTLFMVLQAGFAALLTR 262
|
250 260 270
....*....|....*....|....*....|....*....
gi 992230864 1793 YTESDDVCFGALISGRDSRipDVDKMVGPFFNVLVcqLR 1831
Cdd:cd19538 263 LGAGTDIPIGSPVAGRNDD--SLEDLVGFFVNTLV--LR 297
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1679-1843 |
1.23e-04 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 47.64 E-value: 1.23e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1679 HAFLDATSVLIILRELAQAYDG-------QLSSVPgPSYSSAVAWLQS-LPNGDN--RMDYWRRQLKDASPCI-FPRLRD 1747
Cdd:PRK12316 183 HIVSDGWSMNVLIEEFSRFYSAyatgaepGLPALP-IQYADYALWQRSwLEAGEQerQLEYWRAQLGEEHPVLeLPTDHP 261
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1748 Q---DSPSDTLV---VTEQLAstATLTPVCTRHGLTVSNVLQVAWGLMLRRYTESDDVCFGALISGRDSRipDVDKMVGP 1821
Cdd:PRK12316 262 RpavPSYRGSRYefsIDPALA--EALRGTARRQGLTLFMLLLGAFNVLLHRYSGQTDIRVGVPIANRNRA--EVEGLIGF 337
|
170 180
....*....|....*....|..
gi 992230864 1822 FFNVLVCQLRFGREDSLWDVLR 1843
Cdd:PRK12316 338 FVNTQVLRSVFDGRTRVATLLA 359
|
|
| PLN02387 |
PLN02387 |
long-chain-fatty-acid-CoA ligase family protein |
324-394 |
2.60e-04 |
|
long-chain-fatty-acid-CoA ligase family protein
Pssm-ID: 215217 [Multi-domain] Cd Length: 696 Bit Score: 45.88 E-value: 2.60e-04
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 992230864 324 ICKDVDAkviVCSQELSIGVSGSTLSIGDHNTETATYSAIQAVNTASHDAAYVVYTSGSTGAPKGIVIEHG 394
Cdd:PLN02387 206 IYMDDEG---VDSDSSLSGSSNWTVSSFSEVEKLGKENPVDPDLPSPNDIAVIMYTSGSTGLPKGVMMTHG 273
|
|
| PRK07638 |
PRK07638 |
acyl-CoA synthetase; Validated |
244-442 |
2.61e-04 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236071 [Multi-domain] Cd Length: 487 Bit Score: 45.93 E-value: 2.61e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 244 LQPDAQAICAWDGTITYRQLDRLSSTVQGLLQQYDLGPGSVVpIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVN 323
Cdd:PRK07638 13 LQPNKIAIKENDRVLTYKDWFESVCKVANWLNEKESKNKTIA-ILLENRIEFLQLFAGAAMAGWTCVPLDIKWKQDELKE 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 324 ICKDVDAKVIVCSQELS---IGVSGSTLSIGDHNTETATYSAIQA-VNTASHDAAYVVYTSGSTGAPKGIVIEHGSFCTN 399
Cdd:PRK07638 92 RLAISNADMIVTERYKLndlPDEEGRVIEIDEWKRMIEKYLPTYApIENVQNAPFYMGFTSGSTGKPKAFLRAQQSWLHS 171
|
170 180 190 200
....*....|....*....|....*....|....*....|...
gi 992230864 400 AIASSQAQNLDRSSRVLQFASYAFDVSVHESLTPLLLGGCVCI 442
Cdd:PRK07638 172 FDCNVHDFHMKREDSVLIAGTLVHSLFLYGAISTLYVGQTVHL 214
|
|
| X-Domain_NRPS |
cd19546 |
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to ... |
1683-1822 |
2.80e-04 |
|
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to the non-ribosomal peptide synthetase (NRPS); The X-domain is a catalytically inactive member of the Condensation (C) domain family of non-ribosomal peptide synthetase (NRPS). It has been shown to recruit oxygenases to the NRPS to perform side-chain crosslinking in the production of glycopeptide antibiotics. C-domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as this X-domain, the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, and dual E/C (epimerization and condensation) domains. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity; members of this X-domain subfamily lack the second H of this motif.
Pssm-ID: 380468 [Multi-domain] Cd Length: 440 Bit Score: 45.55 E-value: 2.80e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1683 DATSVLIILRELAQAYDGQLSS-----VPGP-SYSSAVAWLQSLPNGDNRMD--------YWRRQLKDASPCI---FPRL 1745
Cdd:cd19546 137 DDESLDVLVRDLAAAYGARREGraperAPLPlQFADYALWERELLAGEDDRDsligdqiaYWRDALAGAPDELelpTDRP 216
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 992230864 1746 RDQDSPSDTLVVTEQL--ASTATLTPVCTRHGLTVSNVLQVAWGLMLRRYTESDDVCFGALISGRDSRIpDVDKMVGPF 1822
Cdd:cd19546 217 RPVLPSRRAGAVPLRLdaEVHARLMEAAESAGATMFTVVQAALAMLLTRLGAGTDVTVGTVLPRDDEEG-DLEGMVGPF 294
|
|
| ttLC_FACS_AEE21_like |
cd12118 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This ... |
259-416 |
3.55e-04 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This family includes fatty acyl-CoA synthetases that can activate medium to long-chain fatty acids. These enzymes catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family has been shown to catalyze the long-chain fatty acid, myristoyl acid. Also included in this family are acyl activating enzymes from Arabidopsis, which contains a large number of proteins from this family with up to 63 different genes, many of which are uncharacterized.
Pssm-ID: 341283 [Multi-domain] Cd Length: 486 Bit Score: 45.37 E-value: 3.55e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 259 TYRQLDRLSSTVQGLLqqydLGPGSVVPIIFKKSKWAIVAMLGVLKAGAAFCMLDQSYPTKRLVNICKDVDAKVIVCSQE 338
Cdd:cd12118 35 TYDRCRRLASALAALG----ISRGDTVAVLAPNTPAMYELHFGVPMAGAVLNALNTRLDAEEIAFILRHSEAKVLFVDRE 110
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 992230864 339 LSigvSGSTLSIGDHNtetatYSAIQAVNtaSHDAAYVVYTSGSTGAPKGIVIEHGSFCTNAIASSQAQNLDRSSRVL 416
Cdd:cd12118 111 FE---YEDLLAEGDPD-----FEWIPPAD--EWDPIALNYTSGTTGRPKGVVYHHRGAYLNALANILEWEMKQHPVYL 178
|
|
| PLN02246 |
PLN02246 |
4-coumarate--CoA ligase |
252-669 |
7.46e-04 |
|
4-coumarate--CoA ligase
Pssm-ID: 215137 [Multi-domain] Cd Length: 537 Bit Score: 44.20 E-value: 7.46e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 252 CAWDG----TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGAA------FCM---------- 311
Cdd:PLN02246 41 CLIDGatgrVYTYADVELLSRRVAAGLHKLGIRQGDVVMLLLPNCPEFVLAFLGASRRGAVtttanpFYTpaeiakqaka 120
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 312 ------LDQSYPTKRLVNICKDVDAKVIVCSQELSIGVSGSTLSIGDHNtetatysAIQAVNTASHDAAYVVYTSGSTGA 385
Cdd:PLN02246 121 sgakliITQSCYVDKLKGLAEDDGVTVVTIDDPPEGCLHFSELTQADEN-------ELPEVEISPDDVVALPYSSGTTGL 193
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 386 PKGIVIEHGSFCTnaiasSQAQNLDRSSRVLQFASYafDVSV------H-ESLTPLLL-----GGCVCIPSEAQrVNSLK 453
Cdd:PLN02246 194 PKGVMLTHKGLVT-----SVAQQVDGENPNLYFHSD--DVILcvlpmfHiYSLNSVLLcglrvGAAILIMPKFE-IGALL 265
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 454 EAVSTLRVNWVELTP--TVARLWCPA----DIPTVKTLVMGGEPM-----------LPNDIslwkdklrLVCAYGPAEC- 515
Cdd:PLN02246 266 ELIQRHKVTIAPFVPpiVLAIAKSPVvekyDLSSIRMVLSGAAPLgkeledafrakLPNAV--------LGQGYGMTEAg 337
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 516 TVVSTVQSCVQELGNIGRSPCGTCW------IVSKDNHHRLmPVGCIGELIIGGPIVGRGYLKQPCLTANAfITNPEWas 589
Cdd:PLN02246 338 PVLAMCLAFAKEPFPVKSGSCGTVVrnaelkIVDPETGASL-PRNQPGEICIRGPQIMKGYLNDPEATANT-IDKDGW-- 413
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 590 lFHlngsyrfykTGDLVRYNADGTIAYIGRKDTQVKLNGQRVELGEIEH--QAQPYFRDAVIAAEVAAPAGRKPilILFI 667
Cdd:PLN02246 414 -LH---------TGDIGYIDDDDELFIVDRLKELIKYKGFQVAPAELEAllISHPSIADAAVVPMKDEVAGEVP--VAFV 481
|
..
gi 992230864 668 AR 669
Cdd:PLN02246 482 VR 483
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
1357-1490 |
8.73e-04 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 44.65 E-value: 8.73e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 1357 LISSLGQSLPRSAVPSLCLPVSFIPVDPLGQPDRiylcEAASSMTLDFLHSLTDPVNkyidyhilPEEARLRGIVAHVLS 1436
Cdd:PRK10252 925 LQAQLRERLPPHMVPVVLLQLDQLPLSANGKLDR----KALPLPELKAQVPGRAPKT--------GTETIIAAAFSSLLG 992
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*
gi 992230864 1437 IDPQNIspKDDFFTLGGDSISAMQV-VSLCRKHQLSLTALDIFNGRTIELIATRL 1490
Cdd:PRK10252 993 CDVVDA--DADFFALGGHSLLAMKLaAQLSRQFARQVTPGQVMVASTVAKLATLL 1045
|
|
| ACS |
cd05966 |
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); ... |
246-390 |
9.75e-04 |
|
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); Acetyl-CoA synthetase (ACS, EC 6.2.1.1, acetate#CoA ligase or acetate:CoA ligase (AMP-forming)) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is widely present in all living organisms. The activity of this enzyme is crucial for maintaining the required levels of acetyl-CoA, a key intermediate in many important biosynthetic and catabolic processes. Acetyl-CoA is used in the biosynthesis of glucose, fatty acids, and cholesterol. It can also be used in the production of energy in the citric acid cycle. Eukaryotes typically have two isoforms of acetyl-CoA synthetase, a cytosolic form involved in biosynthetic processes and a mitochondrial form primarily involved in energy generation.
Pssm-ID: 341270 [Multi-domain] Cd Length: 608 Bit Score: 44.09 E-value: 9.75e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 246 PDAQAIcAWDG-------TITYRQLDRLSSTVQGLLQQYDLGPGSVVPIIFKKSKWAIVAMLGVLKAGA----------- 307
Cdd:cd05966 67 GDKVAI-IWEGdepdqsrTITYRELLREVCRFANVLKSLGVKKGDRVAIYMPMIPELVIAMLACARIGAvhsvvfagfsa 145
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 992230864 308 ---------AFCML----DQSY------PTKRLVN----ICKDVDaKVIVCsQELSIGVS---GSTLsigDHNTETATYS 361
Cdd:cd05966 146 esladrindAQCKLvitaDGGYrggkviPLKEIVDealeKCPSVE-KVLVV-KRTGGEVPmteGRDL---WWHDLMAKQS 220
|
170 180 190
....*....|....*....|....*....|
gi 992230864 362 A-IQAVNTASHDAAYVVYTSGSTGAPKGIV 390
Cdd:cd05966 221 PeCEPEWMDSEDPLFILYTSGSTGKPKGVV 250
|
|
| PTZ00342 |
PTZ00342 |
acyl-CoA synthetase; Provisional |
557-632 |
1.08e-03 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 240370 [Multi-domain] Cd Length: 746 Bit Score: 43.94 E-value: 1.08e-03
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 992230864 557 GELIIGGPIVGRGYLKQPCLTANAFITNpewaslfhlngsyRFYKTGDLVRYNADGTIAYIGRKDTQVKLN-GQRVE 632
Cdd:PTZ00342 542 GELLIKSDSIFSGYFLEKEQTKNAFTED-------------GYFKTGDIVQINKNGSLTFLDRSKGLVKLSqGEYIE 605
|
|
| PTZ00216 |
PTZ00216 |
acyl-CoA synthetase; Provisional |
557-619 |
7.87e-03 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 240316 [Multi-domain] Cd Length: 700 Bit Score: 41.12 E-value: 7.87e-03
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 992230864 557 GELIIGGPIVGRGYLKQPCLTANAfITNPEWaslFHlngsyrfykTGDLVRYNADGTIAYIGR 619
Cdd:PTZ00216 508 GEILLRGPFLFKGYYKQEELTREV-LDEDGW---FH---------TGDVGSIAANGTLRIIGR 557
|
|
|